patentIDs: 863
web service: 337
to Remove: 135
patent from set:WO2014035351A1
patent from set:EP2575505A1
patent from set:WO2009089496A2
patent from set:EP2842950A4
patent from set:WO2012104576A2
patent from set:US20140148488A1
patent from set:US20140179657A1
patent from set:EP2111860A1
patent from set:WO2009052629A1
patent from set:EP2842950A1
patent from set:WO2004056972A2
patent from set:EP1470817A1
patent from set:US7345091B2
patent from set:US20050124033A1
patent from set:US20140308248A1
patent from set:US20110268759A1
patent from set:WO2014025938A1
patent from set:US20160331676A1
patent from set:US20100272790A1
patent from set:US7763649B2
patent from set:WO2001017374A1
patent from set:WO2006130174A2
patent from set:WO1998028403A1
patent from set:US20070099888A1
patent from set:US7723327B2
patent from set:EP2871973A1
patent from set:US6969595B2
patent from set:US9233081B2
patent from set:EP2619304A2
patent from set:WO2010081259A1
patent from set:US20150150770A1
patent from set:EP2741779A1
patent from set:US20110113508A1
patent from set:US20130209391A1
patent from set:US20100291008A1
patent from set:US20070224216A1
patent from set:US20140037678A1
patent from set:WO2011035179A1
patent from set:US20150133552A1
patent from set:EP2983498A1
patent from set:JP2009072132A
patent from set:EP1727530A2
patent from set:JP2004035528A
patent from set:WO2005087942A1
patent from set:US7695931B2
patent from set:US20050287625A1
patent from set:US8211461B2
patent from set:EP1919447A2
patent from set:JP2011168573A
patent from set:US20150157672A1
patent from set:US9220741B2
patent from set:WO2006126325A1
patent from set:US20160310555A1
patent from set:WO2011150229A2
patent from set:US20150140031A1
patent from set:WO2015004255A1
patent from set:US20120128777A1
patent from set:JP2010006783A
patent from set:EP1664794A2
patent from set:EP2664627B1
patent from set:US20160045560A1
patent from set:US20110118351A1
patent from set:EP2098222A1
patent from set:US6914075B2
patent from set:US8834855B2
patent from set:US20080161296A1
patent from set:EP2803276A1
patent from set:US7241463B2
patent from set:WO2016004363A2
patent from set:US20090004170A1
patent from set:EP2627764A1
patent from set:WO2016135400A1
patent from set:US20080038241A1
patent from set:US7026464B2
patent from set:EP2568961A2
patent from set:EP1693377B1
patent from set:EP1625204A2
patent from set:US6160617A
patent from set:US20120058248A1
patent from set:US20130337024A1
patent from set:US20140248410A1
patent from set:EP1693377A1
patent from set:WO2006078284A2
patent from set:WO2013068134A1
patent from set:WO2016175670A1
patent from set:WO2007060811A1
patent from set:WO2009066799A1
patent from set:US20080293673A1
patent from set:US20160000737A1
patent from set:EP2670392A2
patent from set:US20160375150A1
patent from set:US20160324933A1
patent from set:US20140243254A1
patent from set:EP2664627A1
patent from set:WO2008053517A1
patent from set:WO2013024048A1
patent from set:US20150203612A1
patent from set:WO2000068395A2
patent from set:US20150335574A1
patent from set:EP1463513A1
patent from set:EP2197410A2
patent from set:US20070065900A1
patent from set:WO2009130895A1
patent from set:JP2010275265A
patent from set:US20040259835A1
patent from set:WO2015073598A1
patent from set:EP2825638A1
patent from set:US20060121558A1
patent from set:US5591343A
patent from set:US6929928B2
patent from set:WO2015131152A1
patent from set:US20070148727A1
patent from set:US20040156802A1
patent from set:WO2014096992A1
patent from set:EP1982711A1
patent from set:EP1463513B1
patent from set:JP2010233517A
patent from set:US8623924B2
patent from set:US9480672B2
patent from set:WO2011018501A2
patent from set:EP2789245A1
patent from set:US20100076091A1
patent from set:EP2294193A2
patent from set:US7064196B2
patent from set:WO2016209732A1
patent from set:EP2218447A1
patent from set:WO2010104908A1
patent from set:WO2002000908A2
patent from set:WO2014161815A1
patent from set:US20120058542A1
patent from set:EP2553107A2
patent from set:WO1998028407A2
patent from set:JP2008280281A
patent from set:EP1776427A1
patent from set:US20110059192A1
patent from set:US9096875B2
patent from set:EP2441828B1
patent from set:US20050009930A1
patent from set:US20040146966A1
patent from set:WO2014065640A2
patent from set:EP2803276B1
patent from set:US7256014B2
patent from set:EP1374831A1
patent from set:US20050075337A1
patent from set:US20150315162A1
patent from set:US20050009758A1
patent from set:US20120220580A1
patent from set:WO2003051375A1
patent from set:US20110021843A1
patent from set:WO2007116980A1
patent from set:EP1866428A2
patent from set:US20150044737A1
patent from set:EP2812005A1
patent from set:US20110172185A1
patent from set:EP2273977A2
patent from set:US20090324800A1
patent from set:WO2016096986A1
patent from set:WO2005026269A1
patent from set:EP1138757A1
patent from set:US7070952B2
patent from set:US20140274966A1
patent from set:US20070065902A1
patent from set:WO2007062415A1
patent from set:WO2014089174A2
patent from set:WO2013144595A1
patent from set:US20130045504A1
patent from set:WO2004056974A2
patent from set:WO2016170784A1
patent from set:WO2016172787A1
patent from set:US20160074312A1
patent from set:US7217537B2
patent from set:US20050014219A1
patent from set:WO2014028585A1
patent from set:WO2014096990A1
patent from set:WO1995000130A1
patent from set:US20150065568A1
patent from set:US7635469B2
patent from set:WO2014074592A1
patent from set:EP2047842A1
patent from set:JP2009155331A
patent from set:WO2004104180A2
patent from set:WO2015041977A1
patent from set:EP2825629A1
patent from set:WO2011012715A1
patent from set:EP2988783A1
patent from set:EP2580966A1
patent from set:WO2016172282A1
patent from set:EP2890740A1
patent from set:US20140044653A1
patent from set:EP2832344A1
patent from set:EP2841109A1
patent from set:WO2010124391A1
patent from set:EP1581632A2
patent from set:WO2011123407A2
patent from set:WO2008042338A2
patent from set:WO2008063158A2
patent from set:EP2340805A2
patent from set:US20160082123A1
patent from set:WO2008095182A2
patent from set:US20090324637A1
patent from set:US20040161364A1
patent from set:US20130252236A1
patent from set:US20130310772A1
patent from set:WO2002018617A2
patent from set:US7375133B2
patent from set:US9161921B2
patent from set:WO2009051470A1
patent from set:US20140296257A1
patent from set:EP2710153A1
patent from set:EP2958890A1
patent from set:US9339845B2
patent from set:US20050065096A1
patent from set:US20080241119A1
patent from set:EP2129231A2
patent from set:WO2015174910A1
patent from set:EP1845927A1
patent from set:US20140023602A1
patent from set:US20140044677A1
patent from set:US20130017284A1
patent from set:US5350588A
patent from set:EP2371967B1
patent from set:WO2010124392A1
patent from set:US20130172407A1
patent from set:US20070026484A1
patent from set:EP2902101A1
patent from set:US20080015252A1
patent from set:US20140234928A1
patent from set:US8900602B2
patent from set:US8816040B2
patent from set:EP1377547A2
patent from set:EP1646713A2
patent from set:US20160060454A1
patent from set:EP2371967A1
patent from set:WO2012089615A1
patent from set:EP2997956A1
patent from set:EP2818154A1
patent from set:EP1554372A2
patent from set:US7521584B2
patent from set:EP2806756A2
patent from set:US20050226858A1
patent from set:US20160067203A1
patent from set:EP2676553A1
patent from set:EP2477620A1
patent from set:US20130189765A1
patent from set:US20080058400A1
patent from set:US20110039299A1
patent from set:US20040253663A1
patent from set:US7288387B2
patent from set:EP2606881A1
patent from set:US20150225539A1
patent from set:EP2658962A1
patent from set:WO2005044975A2
patent from set:EP2305373A1
patent from set:US20110052680A1
patent from set:EP1890691A2
patent from set:JP2010235574A
patent from set:EP2532251A1
patent from set:WO2011146833A1
patent from set:EP2172223A1
patent from set:US20120184612A1
patent from set:EP2928315A2
patent from set:JP2009033970A
patent from set:US8871217B2
patent from set:US20150157721A1
patent from set:EP2301659A1
patent from set:JPH10158156A
patent from set:US20080311175A1
patent from set:US9282759B2
patent from set:US9096508B2
patent from set:WO2009037947A2
patent from set:US20100150853A1
patent from set:US8574639B2
patent from set:EP1620454A2
patent from set:EP2074214A2
patent from set:EP0719866B1
patent from set:WO2012049306A1
patent from set:EP2935570A1
patent from set:WO2002068385A2
patent from set:WO2012138885A1
patent from set:US20100222422A1
patent from set:JP2010120939A
patent from set:WO1998028082A1
patent from set:WO2002068385A9
patent from set:WO2011143271A2
patent from set:EP2597156A1
patent from set:US20090306222A1
patent from set:US20130108706A1
patent from set:US20140274965A1
patent from set:US20120156259A1
patent from set:WO2007050769A2
patent from set:US20160067201A1
patent from set:US20070036742A1
patent from set:US9284294B2
patent from set:US20100137646A1
patent from set:US20130071525A1
patent from set:WO2013113027A2
patent from set:US20150030662A1
patent from set:EP2215168B1
patent from set:WO2009126738A2
patent from set:US7851199B2
patent from set:EP0732378A2
patent from set:WO2015187689A1
patent from set:WO2007120423A9
patent from set:JP2013540110A
patent from set:US20080119551A1
patent from set:US20160279130A1
patent from set:US20110091569A1
patent from set:US20150087688A1
patent from set:WO2007120423A2
patent from set:EP3077006A1
patent from set:US20120282358A1
patent from set:US20100215782A1
patent from set:US9234204B2
patent from set:EP2215168A1
patent from set:US20080261896A1
patent from set:US7393937B2
patent from set:EP1074254A2
patent from set:JP2001335480A
patent from set:US20160281041A1
patent from set:WO2009027850A2
patent from set:US20150174188A1
patent from set:US9198883B1
patent from set:EP0719866A1
patent from set:WO2008021574A2
patent from set:JPH06276956A
patent from set:EP1733720B1
patent from set:EP1573013A2
patent from set:US20060094077A1
patent from set:EP1573013A4
patent from set:US7192731B2
patent from set:US20130344180A1
patent from set:EP2214656A1
patent from set:US20020110604A1
patent from set:EP3068415A1
patent from set:US20130203883A1
patent from set:US8952217B2
patent from set:WO2009075383A1
patent from set:US20130102040A1
patent from set:JP2008291004A
patent from set:JPH083468A
patent from set:US20090253164A1
patent from set:US20160228400A1
patent from set:WO2012097018A1
patent from set:US20050113372A1
patent from set:JP2009120494A
patent from set:US9446055B2
patent from set:US5910254A
patent from set:US20090176673A1
patent from set:WO2003087234A1
patent from set:WO2014003740A1
patent from set:US9351967B2
patent from set:WO2012024291A1
patent from set:EP2418270B1
patent from set:EP2894191A1
patent from set:US20060165734A1
patent from set:US20120156261A1
patent from set:EP2496525A1
patent from set:US20150164843A1
patent from set:WO2014149280A1
patent from set:EP2418270A1
patent from set:US20160302462A1
patent from set:US20070154575A1
patent from set:JP2009201480A
patent from set:US20130189382A1
patent from set:WO2010058235A1
patent from set:WO2008023283A2
patent from set:WO2014138426A2
patent from set:US9072692B2
patent from set:US20030003528A1
patent from set:WO2013171100A1
patent from set:US20130264934A1
patent from set:WO2002094982A2
patent from set:US8445028B2
patent from set:WO2004037998A2
patent from set:US20060020127A1
patent from set:WO2010051918A2
patent from set:US20110059164A1
patent from set:US8367072B2
patent from set:US20150140619A1
patent from set:WO2016174599A1
patent from set:US20080206275A1
patent from set:US20140113301A1
patent from set:WO2012082731A2
patent from set:US20020120001A1
patent from set:EP2498602A1
patent from set:WO2016098874A1
patent from set:US20070122363A1
patent from set:US20130071451A1
patent from set:US20160023826A1
patent from set:JP2009173597A
patent from set:US20120045428A1
patent from set:US20160338983A1
patent from set:US20140335123A1
patent from set:WO2011152692A3
patent from set:JP2007297370A
patent from set:US20120177806A1
patent from set:US20120121743A1
patent from set:EP2263641A2
patent from set:EP2957166A1
patent from set:EP2465539A1
patent from set:EP1820538A1
patent from set:US20130224240A1
patent from set:US20050004235A1
patent from set:EP0882709B1
patent from set:US20100080785A1
patent from set:EP2007221A1
patent from set:WO2015101410A1
patent from set:EP2968206A1
patent from set:JP2009180565A
patent from set:EP1361281A1
patent from set:US20130115345A1
patent from set:US20080160116A1
patent from set:US5502041A
patent from set:EP2227216A1
patent from set:EP2977462A1
patent from set:US20070009932A1
patent from set:US20140162330A1
patent from set:US20080058406A1
patent from set:WO2012040698A2
patent from set:EP0882709A1
patent from set:US20050026874A1
patent from set:EP2990035A1
patent from set:US20150118329A1
patent from set:WO2011065412A1
patent from set:US8633009B2
patent from set:US7232665B2
patent from set:EP2741778A1
patent from set:WO2008010788A2
patent from set:US20110288125A1
patent from set:JP2008231198A
patent from set:US20050148517A1
patent from set:US20080102131A1
patent from set:EP2981557A1
patent from set:US20130209392A1
patent from set:WO2008010788A9
patent from set:US9056049B2
patent from set:US8197865B2
patent from set:US9476082B2
patent from set:WO2013119959A1
patent from set:US9066973B2
patent from set:US9297031B2
patent from set:EP2552413B1
patent from set:US20130337136A1
patent from set:US20140087448A1
patent from set:WO2015085173A1
patent from set:WO2009149374A2
patent from set:US20040126848A1
patent from set:EP2464248A2
patent from set:EP1806982A1
patent from set:US20120094339A1
patent from set:US7741070B2
patent from set:EP1806982A4
patent from set:WO2013024047A1
patent from set:US8007838B2
patent from set:US20110070258A1
patent from set:US20020177181A1
patent from set:EP2214625A1
patent from set:WO2005072086A2
patent from set:WO2015017625A1
patent from set:US20130072574A1
patent from set:EP0126991A1
patent from set:US20130225868A1
patent from set:US20160249668A1
patent from set:US8735137B2
patent from set:EP2210583A1
patent from set:US8747915B1
patent from set:US9056091B1
patent from set:EP2380552A1
patent from set:EP1497382A1
patent from set:US8288149B2
patent from set:WO2016073739A1
patent from set:US20150191444A1
patent from set:US20130273116A1
patent from set:WO2015144831A1
patent from set:EP1631660A2
patent from set:WO1998028404A1
patent from set:WO2009032987A1
patent from set:US5859700A
patent from set:EP2671596A1
patent from set:WO2014173759A1
patent from set:US5201930A
patent from set:US20150290264A1
patent from set:WO2015082688A1
patent from set:EP2465540B1
patent from set:JP2010270021A
patent from set:US20110052754A1
patent from set:WO2012091812A1
patent from set:US20120149886A1
patent from set:US20080031906A1
patent from set:US20040109920A1
patent from set:US20150322412A1
patent from set:US20080274195A1
patent from set:US20100269731A1
patent from set:US8697418B1
patent from set:WO2015021352A2
patent from set:WO2009023803A2
patent from set:US20160228391A1
patent from set:US20160130542A1
patent from set:EP2465540A1
patent from set:US20040219629A1
patent from set:EP2515107A1
patent from set:US8974839B2
patent from set:US7695932B2
patent from set:US20070065901A1
patent from set:US20120329978A1
patent from set:US20130156816A1
patent from set:US20070248668A1
patent from set:WO2014078459A1
patent from set:EP2731599A1
patent from set:US20150315550A1
patent from set:US20140155961A1
patent from set:EP2919772A1
patent from set:US20150284487A1
patent from set:EP2056835A2
patent from set:WO2014151326A1
patent from set:US8586107B2
patent from set:US20160000117A1
patent from set:US20070118916A1
patent from set:EP2644020A1
patent from set:US5229118A
patent from set:US20050002879A1
patent from set:EP1733720A1
patent from set:US20090110674A1
patent from set:WO2016182929A1
patent from set:EP2163252A1
patent from set:WO2007117556A2
patent from set:WO2009063333A2
patent from set:EP1181375A2
patent from set:US20100239621A1
patent from set:US9321872B2
patent from set:US20100210722A1
patent from set:US20110159152A1
patent from set:US5776349A
patent from set:US20100152286A1
patent from set:EP2552413A2
patent from set:US9011832B2
patent from set:US20050037995A1
patent from set:US9427010B2
patent from set:EP1336602A1
patent from set:US20050059635A1
patent from set:EP1384482A1
patent from set:US20160000701A1
patent from set:WO2014129974A1
patent from set:US20030185939A1
patent from set:WO2013119955A1
patent from set:US8110672B2
patent from set:US20130309218A1
patent from set:EP2939657A1
patent from set:WO2013137826A1
patent from set:US20110020519A1
patent from set:US20120165413A1
patent from set:WO2015137500A1
patent from set:US8709766B2
patent from set:US20110244512A1
patent from set:WO2002030412A1
patent from set:US20150342914A1
patent from set:US20070065903A1
patent from set:US20130131183A1
patent from set:WO2016012618A1
patent from set:US20040116514A1
patent from set:US20140037762A1
patent from set:WO2009038030A1
patent from set:WO2004087892A1
patent from set:US20140255524A1
patent from set:US8367395B2
patent from set:US20040166199A1
patent from set:US6540654B2
patent from set:US20050059659A1
patent from set:US20130309338A1
patent from set:US9452143B2
patent from set:US6000551A
patent from set:WO2013136025A1
patent from set:US20090181901A1
patent from set:US20130273123A1
patent from set:US20140370154A1
patent from set:US20110274746A1
patent from set:US20130102463A1
patent from set:US20030206972A1
patent from set:US20120214244A1
patent from set:JP2000004848A
patent from set:WO2006102342A2
patent from set:US9226911B2
patent from set:EP2078092A2
patent from set:EP1572990A2
patent from set:US8445035B2
patent from set:WO2012125953A2
patent from set:EP1572990A4
patent from set:US20100221306A1
patent from set:US9381223B2
patent from set:EP2345409A1
patent from set:US7776915B2
patent from set:US8927285B2
patent from set:EP2004801A2
patent from set:EP2226071A1
patent from set:WO2008075204A2
patent from set:US20160192689A1
patent from set:US20040175785A1
patent from set:EP2348868A1
patent from set:US20160000745A1
patent from set:US20040101942A1
patent from set:EP2745835B1
patent from set:US6579714B1
patent from set:EP2915838A1
patent from set:US8927043B2
patent from set:WO2007094430A1
patent from set:WO2013160340A1
patent from set:EP2226071B1
patent from set:US20080233209A1
patent from set:US20090324658A1
patent from set:EP2623335A2
patent from set:EP2745835A1
patent from set:WO2013071029A1
patent from set:EP2424512A1
patent from set:US20050065097A1
patent from set:US9447068B2
patent from set:US20100273727A1
patent from set:EP1932514A1
patent from set:EP1660596A1
patent from set:US7098005B2
patent from set:US20040224383A1
patent from set:EP2571991A1
patent from set:US20130017283A1
patent from set:WO2009135311A1
patent from set:US20080138851A1
patent from set:US20120171719A1
patent from set:WO2014011857A1
patent from set:WO2004056975A2
patent from set:US20130011455A1
patent from set:US20100197782A1
patent from set:WO2012103119A1
patent from set:EP1364943A1
patent from set:JP2008239609A
patent from set:WO2012115954A2
patent from set:US20050075316A1
patent from set:US20160263047A1
patent from set:US20150367366A1
patent from set:EP1328639A2
patent from set:US20130337116A1
patent from set:EP1364943B1
patent from set:US9199952B2
patent from set:EP2692331A1
patent from set:WO2016049236A1
patent from set:US8278358B2
patent from set:WO2015057751A1
patent from set:US20160296581A1
patent from set:US20100305341A1
patent from set:US8158683B2
patent from set:EP1377547B1
patent from set:US20110123680A1
patent from set:US8454970B2
patent from set:US20100272763A1
patent from set:EP3034612A1
patent from set:EP3030648A2
patent from set:JP2009191008A
patent from set:EP2812313A1
patent from set:EP2767274A1
patent from set:US8008061B2
patent from set:EP1553101B1
patent from set:US20140039052A1
patent from set:EP2752436B1
patent from set:US20150327446A1
patent from set:WO2006077433A1
patent from set:US20130309719A1
patent from set:WO2015136123A1
patent from set:US20110274716A1
patent from set:US20140356420A1
patent from set:EP2918278A1
patent from set:US20060188955A1
patent from set:WO2009048249A2
patent from set:EP1409454A4
patent from set:WO2009048249A3
patent from set:US7317008B2
patent from set:US20100255458A1
patent from set:EP1409454A2
patent from set:US20050009788A1
patent from set:US20080025929A1
patent from set:WO2011152689A3
patent from set:JP2014198706A
patent from set:WO2011152689A9
patent from set:EP2658610B1
patent from set:US8741337B2
patent from set:US20120052137A1
patent from set:EP2174658A1
patent from set:EP2902102A1
patent from set:WO2015073628A1
patent from set:EP1884238B1
patent from set:EP2453762A1
patent from set:US20150164782A1
patent from set:US20040268439A1
patent from set:WO2006034570A1
patent from set:JPH05331010A
patent from set:US8663690B2
patent from set:EP2658610A2
patent from set:WO2009089117A1
patent from set:EP1632556A1
patent from set:JPH07224278A
patent from set:US20160310460A1
patent from set:EP2459220A1
patent from set:US5951875A
patent from set:EP1884238A4
patent from set:US20110275592A1
patent from set:EP1553101A1
patent from set:EP1884238A1
patent from set:EP2752436A1
patent from set:US20100062040A1
patent from set:JP2008001623A
patent from set:JP2010168284A
patent from set:US20130052719A1
patent from set:WO2005026739A2
patent from set:JP2010209023A
patent from set:EP2554185A1
patent from set:US20140315279A1
patent from set:US20120189706A1
patent from set:US20100303913A1
patent from set:EP3028691A1
patent from set:US20060216251A1
patent from set:WO2005010156A2
patent from set:EP1871883A1
patent from set:US20050090469A1
patent from set:WO2011047530A1
patent from set:US20130137138A1
patent from set:US7320997B2
patent from set:EP2441828A1
patent from set:EP3057604A1
patent from set:US20080187526A1
patent from set:US20120141387A1
patent from set:WO2011047530A8
patent from set:US20110293525A1
patent from set:US20120128800A1
patent from set:EP2663198A1
patent from set:US20160068615A1
patent from set:US20100093847A1
patent from set:WO2002013835A1
patent from set:US8617886B2
patent from set:WO2016166755A1
patent from set:US8765198B2
patent from set:US8765719B2
patent from set:US20140194547A1
patent from set:US20160206588A1
patent from set:US20160256511A1
patent from set:US6620604B1
patent from set:EP1428884A1
patent from set:US7504236B2
patent from set:US20150044327A1
patent from set:EP2935571A1
patent from set:WO2009126890A2
patent from set:US20150111263A1
patent from set:WO1998028081A1
patent from set:EP2997955A1
patent from set:WO2015180993A1
patent from set:WO2004071996A2
patent from set:WO2016073843A2
patent from set:WO2009089115A1
patent from set:US7252942B2
patent from set:WO2010022364A1
patent from set:US6103940A
patent from set:WO2014131120A1
patent from set:WO2005001024A2
patent from set:US20160145668A1
patent from set:WO2008130372A2
patent from set:WO2011103464A1
patent from set:WO2014151329A1
patent from set:US20140170700A1
patent from set:US20160302452A1
patent from set:US20110217244A1
patent from set:US20130295623A1
patent from set:US20130172426A1
patent from set:US20080287393A1
patent from set:EP3079786A1
patent from set:EP2536293A1
patent from set:US20150342854A1
patent from set:WO2016007841A1
patent from set:WO2011073205A1
patent from set:WO2006092449A2
patent from set:US20040209365A1
patent from set:US9211238B2
patent from set:US20150133712A1
patent from set:US7838552B2
patent from set:WO2010048114A1
patent from set:EP2194140A2
patent from set:US8412469B1
patent from set:US20070015237A1
patent from set:EP2882494A1
patent from set:US20130337068A1
patent from set:US20060036088A1
patent from set:US20050143475A1
patent from set:WO2006002630A1
patent from set:WO2012155202A1
patent from set:WO2014112573A1
patent from set:EP2123263A1
patent from set:WO2013133903A1
patent from set:WO2005079143A2
patent from set:US20080153148A1
patent from set:US9388372B2
patent from set:JP2009108022A
patent from set:WO1998028083A1
patent from set:WO2007049786A1
patent from set:EP2676670A1
patent from set:US20050147579A1
patent from set:US7628984B2
patent from set:EP2296675A1
patent from set:US20130189722A1
patent from set:EP2982364A1
patent from set:US20080286254A1
patent from set:US20040115758A1
patent from set:US9410036B2
patent from set:EP3046555A1
patent from set:WO2016055196A1
patent from set:US9453232B2
patent from set:WO2013052433A2
patent from set:US20050049248A1
patent from set:EP2812372A1
patent from set:WO2011006261A1
patent from set:US20070298483A1
patent from set:WO2012089184A2
patent from set:WO2007112587A1
patent from set:WO2012040938A1
patent from set:US20070059790A1
patent from set:US20160051604A1
patent from set:EP2172196A1
patent from set:US9006493B2
patent from set:WO2012155094A1
patent from set:WO2010077922A1
patent from set:US20040059110A1
patent from set:EP2808015A1
patent from set:EP2573188A2
patent from set:US20160113915A1
patent from set:US20150216779A1
patent from set:WO2007138933A1
patent from set:WO2011060084A1
patent from set:WO2011116738A2
patent from set:EP3027058A1
patent from set:US20150157577A1
patent from set:US9149056B2
patent from set:US7232666B2
patent from set:US20160287528A1
patent from set:WO2014144765A1
patent from set:US20090004304A1
patent from set:US20080254188A1
patent from set:US20120315345A1
patent from set:US20160022556A1
patent from set:US20080274068A1
patent from set:US8017162B2
patent from set:WO2013012760A1
patent from set:WO1997046622A1
patent from set:US7892580B2
patent from set:EP2829263A1
patent from set:EP2574337A1
patent from set:US20160185899A1
patent from set:US20130162999A1
patent from set:US20040175407A1
patent from set:US20040077068A1
patent from set:US20150250203A1
patent from set:WO2009062518A1
patent from set:WO2002030419A1
patent from set:JP2007314451A
patent from set:US20080089851A1
patent from set:US8902423B2
patent from set:US4539230A
patent from set:US20160030455A1
patent from set:US20130196937A1
patent from set:EP2728012A1
patent from set:US20110111038A1
patent ID not in web: 0: WO2014035351A1
patent ID not in web: 1: EP2575505A1
patent ID not in web: 2: WO2009089496A2
patent ID not in web: 3: EP2842950A4
patent ID not in web: 4: WO2012104576A2
patent ID not in web: 5: EP2111860A1
patent ID not in web: 6: WO2009052629A1
patent ID not in web: 7: EP2842950A1
patent ID not in web: 8: WO2004056972A2
patent ID not in web: 9: EP1470817A1
patent ID not in web: 10: US20050124033A1
patent ID not in web: 11: US20140308248A1
patent ID not in web: 12: US20110268759A1
patent ID not in web: 13: WO2014025938A1
patent ID not in web: 14: US20160331676A1
patent ID not in web: 15: WO2001017374A1
patent ID not in web: 16: WO2006130174A2
patent ID not in web: 17: EP2871973A1
patent ID not in web: 18: US9233081B2
patent ID not in web: 19: EP2619304A2
patent ID not in web: 20: WO2010081259A1
patent ID not in web: 21: EP2741779A1
patent ID not in web: 22: WO2011035179A1
patent ID not in web: 23: EP2983498A1
patent ID not in web: 24: JP2009072132A
patent ID not in web: 25: EP1727530A2
patent ID not in web: 26: JP2004035528A
patent ID not in web: 27: WO2005087942A1
patent ID not in web: 28: EP1919447A2
patent ID not in web: 29: JP2011168573A
patent ID not in web: 30: US9220741B2
patent ID not in web: 31: WO2006126325A1
patent ID not in web: 32: US20160310555A1
patent ID not in web: 33: WO2011150229A2
patent ID not in web: 34: WO2015004255A1
patent ID not in web: 35: JP2010006783A
patent ID not in web: 36: EP1664794A2
patent ID not in web: 37: EP2664627B1
patent ID not in web: 38: EP2098222A1
patent ID not in web: 39: US8834855B2
patent ID not in web: 40: US20080161296A1
patent ID not in web: 41: EP2803276A1
patent ID not in web: 42: WO2016004363A2
patent ID not in web: 43: EP2627764A1
patent ID not in web: 44: WO2016135400A1
patent ID not in web: 45: EP2568961A2
patent ID not in web: 46: EP1693377B1
patent ID not in web: 47: EP1625204A2
patent ID not in web: 48: EP1693377A1
patent ID not in web: 49: WO2006078284A2
patent ID not in web: 50: WO2013068134A1
patent ID not in web: 51: WO2016175670A1
patent ID not in web: 52: WO2007060811A1
patent ID not in web: 53: WO2009066799A1
patent ID not in web: 54: EP2670392A2
patent ID not in web: 55: US20160375150A1
patent ID not in web: 56: US20160324933A1
patent ID not in web: 57: EP2664627A1
patent ID not in web: 58: WO2008053517A1
patent ID not in web: 59: WO2013024048A1
patent ID not in web: 60: EP1463513A1
patent ID not in web: 61: EP2197410A2
patent ID not in web: 62: WO2009130895A1
patent ID not in web: 63: JP2010275265A
patent ID not in web: 64: WO2015073598A1
patent ID not in web: 65: EP2825638A1
patent ID not in web: 66: US20060121558A1
patent ID not in web: 67: WO2015131152A1
patent ID not in web: 68: US20070148727A1
patent ID not in web: 69: WO2014096992A1
patent ID not in web: 70: EP1982711A1
patent ID not in web: 71: EP1463513B1
patent ID not in web: 72: JP2010233517A
patent ID not in web: 73: US9480672B2
patent ID not in web: 74: WO2011018501A2
patent ID not in web: 75: EP2789245A1
patent ID not in web: 76: EP2294193A2
patent ID not in web: 77: WO2016209732A1
patent ID not in web: 78: EP2218447A1
patent ID not in web: 79: WO2010104908A1
patent ID not in web: 80: WO2002000908A2
patent ID not in web: 81: WO2014161815A1
patent ID not in web: 82: EP2553107A2
patent ID not in web: 83: JP2008280281A
patent ID not in web: 84: EP1776427A1
patent ID not in web: 85: US20110059192A1
patent ID not in web: 86: US9096875B2
patent ID not in web: 87: EP2441828B1
patent ID not in web: 88: US20050009930A1
patent ID not in web: 89: US20040146966A1
patent ID not in web: 90: WO2014065640A2
patent ID not in web: 91: EP2803276B1
patent ID not in web: 92: EP1374831A1
patent ID not in web: 93: US20050009758A1
patent ID not in web: 94: WO2003051375A1
patent ID not in web: 95: US20110021843A1
patent ID not in web: 96: WO2007116980A1
patent ID not in web: 97: EP1866428A2
patent ID not in web: 98: EP2812005A1
patent ID not in web: 99: EP2273977A2
patent ID not in web: 100: US20090324800A1
patent ID not in web: 101: WO2016096986A1
patent ID not in web: 102: WO2005026269A1
patent ID not in web: 103: EP1138757A1
patent ID not in web: 104: WO2007062415A1
patent ID not in web: 105: WO2014089174A2
patent ID not in web: 106: WO2013144595A1
patent ID not in web: 107: WO2004056974A2
patent ID not in web: 108: WO2016170784A1
patent ID not in web: 109: WO2016172787A1
patent ID not in web: 110: US20050014219A1
patent ID not in web: 111: WO2014028585A1
patent ID not in web: 112: WO2014096990A1
patent ID not in web: 113: WO2014074592A1
patent ID not in web: 114: EP2047842A1
patent ID not in web: 115: JP2009155331A
patent ID not in web: 116: WO2004104180A2
patent ID not in web: 117: WO2015041977A1
patent ID not in web: 118: EP2825629A1
patent ID not in web: 119: WO2011012715A1
patent ID not in web: 120: EP2988783A1
patent ID not in web: 121: EP2580966A1
patent ID not in web: 122: WO2016172282A1
patent ID not in web: 123: EP2890740A1
patent ID not in web: 124: EP2832344A1
patent ID not in web: 125: EP2841109A1
patent ID not in web: 126: WO2010124391A1
patent ID not in web: 127: EP1581632A2
patent ID not in web: 128: WO2011123407A2
patent ID not in web: 129: WO2008042338A2
patent ID not in web: 130: WO2008063158A2
patent ID not in web: 131: EP2340805A2
patent ID not in web: 132: WO2008095182A2
patent ID not in web: 133: US20090324637A1
patent ID not in web: 134: WO2002018617A2
patent ID not in web: 135: US9161921B2
patent ID not in web: 136: WO2009051470A1
patent ID not in web: 137: EP2710153A1
patent ID not in web: 138: EP2958890A1
patent ID not in web: 139: US9339845B2
patent ID not in web: 140: US20050065096A1
patent ID not in web: 141: US20080241119A1
patent ID not in web: 142: EP2129231A2
patent ID not in web: 143: WO2015174910A1
patent ID not in web: 144: EP1845927A1
patent ID not in web: 145: US20130017284A1
patent ID not in web: 146: EP2371967B1
patent ID not in web: 147: WO2010124392A1
patent ID not in web: 148: US20070026484A1
patent ID not in web: 149: EP2902101A1
patent ID not in web: 150: EP1377547A2
patent ID not in web: 151: EP1646713A2
patent ID not in web: 152: EP2371967A1
patent ID not in web: 153: WO2012089615A1
patent ID not in web: 154: EP2997956A1
patent ID not in web: 155: EP2818154A1
patent ID not in web: 156: EP1554372A2
patent ID not in web: 157: EP2806756A2
patent ID not in web: 158: EP2676553A1
patent ID not in web: 159: EP2477620A1
patent ID not in web: 160: US20110039299A1
patent ID not in web: 161: US20040253663A1
patent ID not in web: 162: EP2606881A1
patent ID not in web: 163: EP2658962A1
patent ID not in web: 164: WO2005044975A2
patent ID not in web: 165: EP2305373A1
patent ID not in web: 166: US20110052680A1
patent ID not in web: 167: EP1890691A2
patent ID not in web: 168: JP2010235574A
patent ID not in web: 169: EP2532251A1
patent ID not in web: 170: WO2011146833A1
patent ID not in web: 171: EP2172223A1
patent ID not in web: 172: EP2928315A2
patent ID not in web: 173: JP2009033970A
patent ID not in web: 174: US8871217B2
patent ID not in web: 175: EP2301659A1
patent ID not in web: 176: JPH10158156A
patent ID not in web: 177: US20080311175A1
patent ID not in web: 178: US9282759B2
patent ID not in web: 179: US9096508B2
patent ID not in web: 180: WO2009037947A2
patent ID not in web: 181: EP1620454A2
patent ID not in web: 182: EP2074214A2
patent ID not in web: 183: WO2012049306A1
patent ID not in web: 184: EP2935570A1
patent ID not in web: 185: WO2002068385A2
patent ID not in web: 186: WO2012138885A1
patent ID not in web: 187: US20100222422A1
patent ID not in web: 188: JP2010120939A
patent ID not in web: 189: WO2002068385A9
patent ID not in web: 190: WO2011143271A2
patent ID not in web: 191: EP2597156A1
patent ID not in web: 192: WO2007050769A2
patent ID not in web: 193: US9284294B2
patent ID not in web: 194: US20100137646A1
patent ID not in web: 195: WO2013113027A2
patent ID not in web: 196: EP2215168B1
patent ID not in web: 197: WO2009126738A2
patent ID not in web: 198: WO2015187689A1
patent ID not in web: 199: WO2007120423A9
patent ID not in web: 200: JP2013540110A
patent ID not in web: 201: WO2007120423A2
patent ID not in web: 202: EP3077006A1
patent ID not in web: 203: US9234204B2
patent ID not in web: 204: EP2215168A1
patent ID not in web: 205: EP1074254A2
patent ID not in web: 206: JP2001335480A
patent ID not in web: 207: WO2009027850A2
patent ID not in web: 208: WO2008021574A2
patent ID not in web: 209: JPH06276956A
patent ID not in web: 210: EP1733720B1
patent ID not in web: 211: EP1573013A2
patent ID not in web: 212: EP1573013A4
patent ID not in web: 213: EP2214656A1
patent ID not in web: 214: EP3068415A1
patent ID not in web: 215: US8952217B2
patent ID not in web: 216: WO2009075383A1
patent ID not in web: 217: US20130102040A1
patent ID not in web: 218: JP2008291004A
patent ID not in web: 219: JPH083468A
patent ID not in web: 220: WO2012097018A1
patent ID not in web: 221: US20050113372A1
patent ID not in web: 222: JP2009120494A
patent ID not in web: 223: US9446055B2
patent ID not in web: 224: WO2003087234A1
patent ID not in web: 225: WO2014003740A1
patent ID not in web: 226: WO2012024291A1
patent ID not in web: 227: EP2418270B1
patent ID not in web: 228: EP2894191A1
patent ID not in web: 229: EP2496525A1
patent ID not in web: 230: WO2014149280A1
patent ID not in web: 231: EP2418270A1
patent ID not in web: 232: US20160302462A1
patent ID not in web: 233: US20070154575A1
patent ID not in web: 234: JP2009201480A
patent ID not in web: 235: WO2010058235A1
patent ID not in web: 236: WO2008023283A2
patent ID not in web: 237: WO2014138426A2
patent ID not in web: 238: US9072692B2
patent ID not in web: 239: US20030003528A1
patent ID not in web: 240: WO2013171100A1
patent ID not in web: 241: WO2002094982A2
patent ID not in web: 242: US8445028B2
patent ID not in web: 243: WO2004037998A2
patent ID not in web: 244: US20060020127A1
patent ID not in web: 245: WO2010051918A2
patent ID not in web: 246: WO2016174599A1
patent ID not in web: 247: US20080206275A1
patent ID not in web: 248: WO2012082731A2
patent ID not in web: 249: EP2498602A1
patent ID not in web: 250: WO2016098874A1
patent ID not in web: 251: JP2009173597A
patent ID not in web: 252: US20120045428A1
patent ID not in web: 253: US20160338983A1
patent ID not in web: 254: WO2011152692A3
patent ID not in web: 255: JP2007297370A
patent ID not in web: 256: US20120121743A1
patent ID not in web: 257: EP2263641A2
patent ID not in web: 258: EP2957166A1
patent ID not in web: 259: EP2465539A1
patent ID not in web: 260: EP1820538A1
patent ID not in web: 261: EP2007221A1
patent ID not in web: 262: WO2015101410A1
patent ID not in web: 263: EP2968206A1
patent ID not in web: 264: JP2009180565A
patent ID not in web: 265: EP1361281A1
patent ID not in web: 266: EP2227216A1
patent ID not in web: 267: EP2977462A1
patent ID not in web: 268: US20070009932A1
patent ID not in web: 269: WO2012040698A2
patent ID not in web: 270: EP2990035A1
patent ID not in web: 271: WO2011065412A1
patent ID not in web: 272: EP2741778A1
patent ID not in web: 273: WO2008010788A2
patent ID not in web: 274: JP2008231198A
patent ID not in web: 275: EP2981557A1
patent ID not in web: 276: WO2008010788A9
patent ID not in web: 277: US9056049B2
patent ID not in web: 278: US9476082B2
patent ID not in web: 279: WO2013119959A1
patent ID not in web: 280: US9066973B2
patent ID not in web: 281: US9297031B2
patent ID not in web: 282: EP2552413B1
patent ID not in web: 283: WO2015085173A1
patent ID not in web: 284: WO2009149374A2
patent ID not in web: 285: US20040126848A1
patent ID not in web: 286: EP2464248A2
patent ID not in web: 287: EP1806982A1
patent ID not in web: 288: US20120094339A1
patent ID not in web: 289: EP1806982A4
patent ID not in web: 290: WO2013024047A1
patent ID not in web: 291: EP2214625A1
patent ID not in web: 292: WO2005072086A2
patent ID not in web: 293: WO2015017625A1
patent ID not in web: 294: EP2210583A1
patent ID not in web: 295: EP2380552A1
patent ID not in web: 296: EP1497382A1
patent ID not in web: 297: WO2016073739A1
patent ID not in web: 298: WO2015144831A1
patent ID not in web: 299: EP1631660A2
patent ID not in web: 300: WO2009032987A1
patent ID not in web: 301: EP2671596A1
patent ID not in web: 302: WO2014173759A1
patent ID not in web: 303: WO2015082688A1
patent ID not in web: 304: EP2465540B1
patent ID not in web: 305: JP2010270021A
patent ID not in web: 306: WO2012091812A1
patent ID not in web: 307: WO2015021352A2
patent ID not in web: 308: WO2009023803A2
patent ID not in web: 309: US20160130542A1
patent ID not in web: 310: EP2465540A1
patent ID not in web: 311: EP2515107A1
patent ID not in web: 312: US20120329978A1
patent ID not in web: 313: WO2014078459A1
patent ID not in web: 314: EP2731599A1
patent ID not in web: 315: EP2919772A1
patent ID not in web: 316: EP2056835A2
patent ID not in web: 317: WO2014151326A1
patent ID not in web: 318: EP2644020A1
patent ID not in web: 319: EP1733720A1
patent ID not in web: 320: WO2016182929A1
patent ID not in web: 321: EP2163252A1
patent ID not in web: 322: WO2007117556A2
patent ID not in web: 323: WO2009063333A2
patent ID not in web: 324: EP1181375A2
patent ID not in web: 325: US9321872B2
patent ID not in web: 326: EP2552413A2
patent ID not in web: 327: US9011832B2
patent ID not in web: 328: US20050037995A1
patent ID not in web: 329: US9427010B2
patent ID not in web: 330: EP1336602A1
patent ID not in web: 331: EP1384482A1
patent ID not in web: 332: WO2014129974A1
patent ID not in web: 333: US20030185939A1
patent ID not in web: 334: WO2013119955A1
patent ID not in web: 335: EP2939657A1
patent ID not in web: 336: WO2013137826A1
patent ID not in web: 337: US20120165413A1
patent ID not in web: 338: WO2015137500A1
patent ID not in web: 339: WO2002030412A1
patent ID not in web: 340: WO2016012618A1
patent ID not in web: 341: WO2009038030A1
patent ID not in web: 342: WO2004087892A1
patent ID not in web: 343: US20040166199A1
patent ID not in web: 344: US9452143B2
patent ID not in web: 345: WO2013136025A1
patent ID not in web: 346: US20120214244A1
patent ID not in web: 347: JP2000004848A
patent ID not in web: 348: WO2006102342A2
patent ID not in web: 349: US9226911B2
patent ID not in web: 350: EP2078092A2
patent ID not in web: 351: EP1572990A2
patent ID not in web: 352: WO2012125953A2
patent ID not in web: 353: EP1572990A4
patent ID not in web: 354: US9381223B2
patent ID not in web: 355: EP2345409A1
patent ID not in web: 356: EP2004801A2
patent ID not in web: 357: EP2226071A1
patent ID not in web: 358: WO2008075204A2
patent ID not in web: 359: EP2348868A1
patent ID not in web: 360: EP2745835B1
patent ID not in web: 361: EP2915838A1
patent ID not in web: 362: US8927043B2
patent ID not in web: 363: WO2007094430A1
patent ID not in web: 364: WO2013160340A1
patent ID not in web: 365: EP2226071B1
patent ID not in web: 366: EP2623335A2
patent ID not in web: 367: EP2745835A1
patent ID not in web: 368: WO2013071029A1
patent ID not in web: 369: EP2424512A1
patent ID not in web: 370: US9447068B2
patent ID not in web: 371: EP1932514A1
patent ID not in web: 372: EP1660596A1
patent ID not in web: 373: US20040224383A1
patent ID not in web: 374: EP2571991A1
patent ID not in web: 375: US20130017283A1
patent ID not in web: 376: WO2009135311A1
patent ID not in web: 377: US20080138851A1
patent ID not in web: 378: US20120171719A1
patent ID not in web: 379: WO2014011857A1
patent ID not in web: 380: WO2004056975A2
patent ID not in web: 381: WO2012103119A1
patent ID not in web: 382: EP1364943A1
patent ID not in web: 383: JP2008239609A
patent ID not in web: 384: WO2012115954A2
patent ID not in web: 385: US20050075316A1
patent ID not in web: 386: EP1328639A2
patent ID not in web: 387: EP1364943B1
patent ID not in web: 388: US9199952B2
patent ID not in web: 389: EP2692331A1
patent ID not in web: 390: WO2016049236A1
patent ID not in web: 391: US8278358B2
patent ID not in web: 392: WO2015057751A1
patent ID not in web: 393: US20160296581A1
patent ID not in web: 394: US20100305341A1
patent ID not in web: 395: EP1377547B1
patent ID not in web: 396: EP3034612A1
patent ID not in web: 397: EP3030648A2
patent ID not in web: 398: JP2009191008A
patent ID not in web: 399: EP2812313A1
patent ID not in web: 400: EP2767274A1
patent ID not in web: 401: EP1553101B1
patent ID not in web: 402: EP2752436B1
patent ID not in web: 403: WO2006077433A1
patent ID not in web: 404: WO2015136123A1
patent ID not in web: 405: US20110274716A1
patent ID not in web: 406: EP2918278A1
patent ID not in web: 407: US20060188955A1
patent ID not in web: 408: WO2009048249A2
patent ID not in web: 409: EP1409454A4
patent ID not in web: 410: WO2009048249A3
patent ID not in web: 411: EP1409454A2
patent ID not in web: 412: WO2011152689A3
patent ID not in web: 413: JP2014198706A
patent ID not in web: 414: WO2011152689A9
patent ID not in web: 415: EP2658610B1
patent ID not in web: 416: EP2174658A1
patent ID not in web: 417: EP2902102A1
patent ID not in web: 418: WO2015073628A1
patent ID not in web: 419: EP1884238B1
patent ID not in web: 420: EP2453762A1
patent ID not in web: 421: US20040268439A1
patent ID not in web: 422: WO2006034570A1
patent ID not in web: 423: JPH05331010A
patent ID not in web: 424: EP2658610A2
patent ID not in web: 425: WO2009089117A1
patent ID not in web: 426: EP1632556A1
patent ID not in web: 427: JPH07224278A
patent ID not in web: 428: US20160310460A1
patent ID not in web: 429: EP2459220A1
patent ID not in web: 430: EP1884238A4
patent ID not in web: 431: EP1553101A1
patent ID not in web: 432: EP1884238A1
patent ID not in web: 433: EP2752436A1
patent ID not in web: 434: JP2008001623A
patent ID not in web: 435: JP2010168284A
patent ID not in web: 436: WO2005026739A2
patent ID not in web: 437: JP2010209023A
patent ID not in web: 438: EP2554185A1
patent ID not in web: 439: US20100303913A1
patent ID not in web: 440: EP3028691A1
patent ID not in web: 441: US20060216251A1
patent ID not in web: 442: WO2005010156A2
patent ID not in web: 443: EP1871883A1
patent ID not in web: 444: US20050090469A1
patent ID not in web: 445: WO2011047530A1
patent ID not in web: 446: EP2441828A1
patent ID not in web: 447: EP3057604A1
patent ID not in web: 448: US20080187526A1
patent ID not in web: 449: WO2011047530A8
patent ID not in web: 450: US20120128800A1
patent ID not in web: 451: EP2663198A1
patent ID not in web: 452: WO2002013835A1
patent ID not in web: 453: WO2016166755A1
patent ID not in web: 454: US8765719B2
patent ID not in web: 455: EP1428884A1
patent ID not in web: 456: EP2935571A1
patent ID not in web: 457: WO2009126890A2
patent ID not in web: 458: EP2997955A1
patent ID not in web: 459: WO2015180993A1
patent ID not in web: 460: WO2004071996A2
patent ID not in web: 461: WO2016073843A2
patent ID not in web: 462: WO2009089115A1
patent ID not in web: 463: WO2010022364A1
patent ID not in web: 464: WO2014131120A1
patent ID not in web: 465: WO2005001024A2
patent ID not in web: 466: WO2008130372A2
patent ID not in web: 467: WO2011103464A1
patent ID not in web: 468: WO2014151329A1
patent ID not in web: 469: US20160302452A1
patent ID not in web: 470: EP3079786A1
patent ID not in web: 471: EP2536293A1
patent ID not in web: 472: WO2016007841A1
patent ID not in web: 473: WO2011073205A1
patent ID not in web: 474: WO2006092449A2
patent ID not in web: 475: US20040209365A1
patent ID not in web: 476: US9211238B2
patent ID not in web: 477: WO2010048114A1
patent ID not in web: 478: EP2194140A2
patent ID not in web: 479: US20070015237A1
patent ID not in web: 480: EP2882494A1
patent ID not in web: 481: US20060036088A1
patent ID not in web: 482: WO2006002630A1
patent ID not in web: 483: WO2012155202A1
patent ID not in web: 484: WO2014112573A1
patent ID not in web: 485: EP2123263A1
patent ID not in web: 486: WO2013133903A1
patent ID not in web: 487: WO2005079143A2
patent ID not in web: 488: JP2009108022A
patent ID not in web: 489: WO2007049786A1
patent ID not in web: 490: EP2676670A1
patent ID not in web: 491: EP2296675A1
patent ID not in web: 492: EP2982364A1
patent ID not in web: 493: EP3046555A1
patent ID not in web: 494: WO2016055196A1
patent ID not in web: 495: US9453232B2
patent ID not in web: 496: WO2013052433A2
patent ID not in web: 497: EP2812372A1
patent ID not in web: 498: WO2011006261A1
patent ID not in web: 499: US20070298483A1
patent ID not in web: 500: WO2012089184A2
patent ID not in web: 501: WO2007112587A1
patent ID not in web: 502: WO2012040938A1
patent ID not in web: 503: US20070059790A1
patent ID not in web: 504: EP2172196A1
patent ID not in web: 505: US9006493B2
patent ID not in web: 506: WO2012155094A1
patent ID not in web: 507: WO2010077922A1
patent ID not in web: 508: US20040059110A1
patent ID not in web: 509: EP2808015A1
patent ID not in web: 510: EP2573188A2
patent ID not in web: 511: US20160113915A1
patent ID not in web: 512: WO2007138933A1
patent ID not in web: 513: WO2011060084A1
patent ID not in web: 514: WO2011116738A2
patent ID not in web: 515: EP3027058A1
patent ID not in web: 516: US9149056B2
patent ID not in web: 517: US20160287528A1
patent ID not in web: 518: WO2014144765A1
patent ID not in web: 519: WO2013012760A1
patent ID not in web: 520: WO1997046622A1
patent ID not in web: 521: EP2829263A1
patent ID not in web: 522: EP2574337A1
patent ID not in web: 523: US20160185899A1
patent ID not in web: 524: US20130162999A1
patent ID not in web: 525: WO2009062518A1
patent ID not in web: 526: WO2002030419A1
patent ID not in web: 527: JP2007314451A
patent ID not in web: 528: EP2728012A1
patent ID not in web: 529: US20110111038A1
patent web not in set: 0: 
patent web not in set: 1: US8628969
patent web not in set: 2: US8691555
patent web not in set: 3: US2008260662
patent web not in set: 4: US2013253070
patent web not in set: 5: US8034983

0: (1613194605158599744) patent: US20160331676A1 patent: US2016331676 patent: EP3091960 patent: CN105899186 patent: WO2015104484 patent: JP2017502087 patent: FR3016289 Title : PLANT EXTRACT COMPRISING SUCROSE ESTERS AS AN ACTIVE AGENT FOR USE IN COSMETIC, DERMATOLOGICAL OR NUTRICOSMETIC COMPOSITION) Abstract : Finally, it also relates to the preparation method of the said plant extract.) 

1: (6389425033673873189) patent: WO2001017374A1 patent: US6953583 patent: WO0117374 patent: AU6720500 patent: DE60027016D patent: JP2003508479 patent: AT321525T patent: AU6720300 patent: BR0013897 patent: WO0117498 patent: CN1157181C patent: ITMI991894 patent: KR100703142B patent: DE60027016T patent: ITMI991894D patent: JP2011063609 patent: ES2261228T patent: CA2384028 patent: AU6720000 patent: EP1214048 patent: CN1378441 patent: KR20030005156 patent: WO0118161 Title : COMPOSITIONS COMPRISING CONJUGATED LINOLEIC ACID (CLA)) Abstract : The present invention relates to new oral compositions comprising CLA in combination with food grade antioxidants and the use of said combination for the manufacture of a dietetic composition or a medicament useful in the treatment of atherosclerosis, overweight and in enhancing the immune response.) 

2: (1140325745604943069) patent: WO1998028403A1 patent: WO9828403 patent: AU5695598 Title : METHOD FOR CROSS FLOW MICROFILTRATION OF MICROALGAE IN THE ABSENCE OF FLOCCULATING AGENTS) Abstract : A process for dewatering the alga Dunaliella salina in brine is disclosed for the recovery of mixed carotenoids. The algal cells are ruptured. The brine is pumped in the absence of any added flocculating agents across a microporous filtration membrane having an absolute rating of about 10 microns or less. A retentate is generated that has an increased concentration of the algae and mixed carotenoids relative to the brine. A permeate is generated of brine that is substantially free of mixed carotenoids. Diafiltration steps may be performed to adjust the salt and carotenoid concentration in the retentate.) 

3: (1484148560636515340) patent: US20140037678A1 patent: US1437678 Title : Comminuted-fuel carburetor) 

4: (2295637208877934464) patent: JP2009072132A patent: JP2009072132 Title : METHOD FOR PRODUCING BROWN ALGAE RICH IN HEALTH-FUNCTIONAL INGREDIENT) Abstract : PROBLEM TO BE SOLVED: To provide a technology for easily and efficiently acquiring health-functional ingredients including fucoxanthin, fucosterol and protein for the purpose of industrially utilizing these ingredients in health foods, cosmetics, pharmaceuticals, etc. ;SOLUTION: A method for producing brown algae rich in health-functional ingredients is provided, which includes the culture of brown algae bodies in a medium spiked with at least nitrogen and phosphorus under the condition of being 450 [mu]mol*m<SP>-2</SP>*s<SP>-1</SP>or less in photosynthesis-effective photon flux density. ;COPYRIGHT: (C)2009,JPO&INPIT) 

5: (1408513220261527499) patent: JP2004035528A patent: JP4297654B patent: JP2004035528 Title : METHOD FOR ACQUIRING FUCOXANTHIN AND/OR FUCOSTEROL) Abstract : PROBLEM TO BE SOLVED: To provide a technique for economically acquiring fucoxanthin and/or fucosterol for the use of these compounds as pharmaceuticals, cosmetics and health food products. ;SOLUTION: The discoidal phase or conchocelis phase of brown algae is extracted with an organic solvent and the fucoxanthin and/or fucosterol are separated from the extract. ;COPYRIGHT: (C)2004,JPO) 

6: (3222613414863562070) patent: JP2011168573A patent: JP2011168573 Title : FUCOXANTHIN-DERIVED IMMUNOACTIVATOR, ACTIVATED OXYGEN INHIBITOR OR ANGIOGENESIS INHIBITOR) Abstract : PROBLEM TO BE SOLVED: To provide an immunoactivator, activated oxygen inhibitor or angiogenesis inhibitor, each with fucoxanthin as an active ingredient. ;SOLUTION: Fucoxanthin that is obtained by lyophilizing Cladosiphon okamuranus followed by making pulverization, treating the resultant material with isopropanol and then separating and fractionating it by adsorptive synthetic resin column chromatography, has immunoactivating effect, activated oxygen-inhibitory effect or angiogenesis-inhibitory effect, and also extremely low toxicity. ;COPYRIGHT: (C)2011,JPO&INPIT) 

7: (7358290906857667722) patent: US20150157672A1 patent: CA2873826 patent: US2015157672 Title : KITS AND METHODS FOR SUSTAINED WEIGHT LOSS) Abstract : Disclosed herein are compositions, methods and kits of effecting and prolonging weight loss by administering weight loss agents for treatment phases of predetermined durations.) 

8: (5745112741052395077) patent: US20150140031A1 patent: US2015140031 Title : WEIGHT MANAGEMENT SYSTEMS AND RELATED METHODS) Abstract : Systems and methods of weight management and compositions or formulations useful therein are disclosed and described.) 

9: (751623741787686230) patent: WO2015004255A1 patent: WO2015004255 Title : ISOLATION OF GLYCOPROTEINS FROM BROWN ALGAE) Abstract : The present invention relates to a novel process for the isolation of unique anti-oxidative glycoproteins from the pH precipitated fractions of enzymatic extracts of brown algae. Two brown seaweeds viz, Fucus serratus and Fucus vesiculosus were hydrolysed by using 3 enzymes viz, Alcalase, Viscozyme and Termamyl and the glycoproteins were isolated from these enzyme extracts.) 

10: (3423806467692178595) patent: EP2803276A1 patent: ES2549671T patent: ITPD20130133 patent: EP2803276 Title : Product for the diet of dogs afected by inflammatory intestinal diseases) Abstract : Product for the diet of dogs affected by inflammatory intestinal diseases, which comprises at least one source of fiber and at least one source of proteins. The source of fiber comprises ascophyllum nodosum, which is comprised in the product for the diet of dogs in a weight percentage comprised between 15% and 25%, and the protein carrier component is a protein hydrolysate, comprised in the product for the diet of dogs in a weight percentage comprised between 18% and 25%.) 

11: (7927383428245220926) patent: EP2627764A1 Title : ALGAL BIO-FLOCCULATION BY INACTIVATION OF PHOTORECEPTORS) 

12: (5548581242198561447) patent: WO2016135400A1 patent: FR3032879 patent: WO2016135400 Title : OBTAINING AN EXTRACT FROM BROWN ALGAE GAMETOPHYTES, AND USE OF SAID EXTRACT AS A COSMETIC ANTI-AGING ACTIVE PRINCIPLE) Abstract : The invention relates to a lipophilic extract of brown algae gametophytes obtained by the method including the following consecutive steps: - a Step A) for preparing a hydro-alcoholic suspension of gametophyte cells by mixing an aqueous suspension of brown algae gametophyte cells with at least one aliphatic alcohol comprising 1 to 4 carbon atoms; - a Step B) for mixing said hydro-alcoholic suspension of algae gametophyte cells, obtained in Step A), with at least one triglyceride from fatty acids that comprise 8 to 22 carbon atoms; - a Step C) for adding water to the multiphase mixture obtained in Step B); and - a Step D) for isolating said lipophilic extract of brown algae gametophytes from the mixture obtained in Step C). The invention also relates to the cosmetic and pharmaceutical use of said extract.) 

13: (3306035741921239030) patent: US20080038241A1 Title : Self-Polishing Anti-Fouling coating Compositions Comprising An Enzyme) Abstract : The present invention relates to self-polishing, anti-fouling coating compositions comprising an enzyme, methods for producing such coating compositions and uses thereof. The coating composition can comprise e. g. a pigment in which case the coating composition can be used as a painting composition. In a first aspect, the invention relates to a self-polishing anti-fouling coating composition comprising a first enzyme having anti-fouling activity, and at least one hydrolysable polymer composition capable of being non-enzymatically hydrolysed in an aqueous environment. In a further aspect there is provided a self-polishing anti-fouling coating composition comprising a first enzyme having anti-fouling activity, a second enzyme having polymer-hydrolysing activity, and at least one hydrolysable polymer composition capable of being hydrolysed by said second enzyme. In the latter case, the first enzyme does preferably not contribute to the self-polishing effect. The second enzyme typically does not have a direct anti-fouling species.) 

14: (2302302657233266036) patent: EP2568961A2 Title : THERAPEUTIC LIPOSOMES AND METHODS FOR PRODUCING AND USING THE SAME) 

15: (4995382295842058482) patent: EP1693377B1 Title : NOVEL CAROTENOID HYDROXYLASE GENE, PROCESS FOR PRODUCING HYDROXYLATED CAROTENOID, AND NOVEL GERANYLGERANYL PYROPHOSPHATE SYNTHASE GENE) Abstract : The present invention provides a Brevundimonas sp. strain SD212-derived peptide having -ionone ring-2-hydroxylase activity and a gene encoding the same, to thereby make it possible to produce rare carotenoids in which a hydroxyl group is introduced at the position 2 (2') carbon in their -ionone ring in large quantities. The present invention also provides a novel gene encoding an enzyme which introduces a hydroxyl group at the position 3 (3') carbon in the -ionone ring of carotenoids, and a novel gene encoding a geranylgeranyl pyrophosphate synthase.) 

16: (2706339368769418916) patent: EP1625204A2 Title : GENES ENCODING CAROTENOID COMPOUNDS) 

17: (164930240426780297) patent: US6160617A Title : High resolution imaging microscope (HIRIM) and uses thereof) Abstract : The invention pertains to a high resolution imaging microscope, and more specifically, to a digital imaging spectrophotometer (DIS) configured to enable the direct determination of the ground state absorption spectra of microscopic samples from violet to near infrared. The instrument is capable of simultaneously recording hundreds of spectra, and can, using image processing techniques identify features (such as a single microbial cell) on a microscope slide or thin section. The invention additionally relates to the use of such an instrument.) 

18: (458280487391490494) patent: US20120058248A1 Title : BOILER) 

19: (3661719313225910592) patent: WO2006078284A2 Title : METHODS AND COMPOSITIONS RELATED TO ANTIVIRAL THERAPY USING ALGAE AND CYANOBACTERIA) Abstract : Disclosed are methods and compositions related to treating and preventing viral infection.) 

20: (1534761852360894332) patent: WO2013068134A1 Title : DISHWASHING DETERGENTS COMPRISING EMULSIFIERS) Abstract : According to the invention, it has been found that hydrophilically modified terpenes and terpenoids effectively prevent or at least reduce the discoloration of plastic dishes during machine dishwashing.) 

21: (2804464230629962732) patent: WO2016175670A1 Title : A PROCESS OF ISOLATION AND PURIFICATION OF DIATOXANTHIN AND DIADINOXANTHIN) Abstract : The present invention discloses a process of isolation and purification of diatoxanthin and diadinoxanthin, which consists of five steps including: diatoms cultivation, pigment extraction, pigment partitioning, silica gel alkalization, open column chromatography, which performed in accordance with the invention allows to obtain diatoxanthin and diadinoxanthin of a purity of more than 99%.) 

22: (1739849167976605140) patent: US20160000737A1 Title : TREATMENT OF PETS WITH SIRTUIN ACTIVATORS) Abstract : The present invention provides for systems, compositions, methods and kits for regulating energy metabolism in pets. The systems, compositions, and kits can comprise, and methods can make use of, pet foods, pet treats, pet supplements, and pet drinks. In one aspect, the invention provides for pet food, treat, supplement, and drink compositions that comprise a combination of (a) leucine, and (b) a sirtuin activator, or any precursors or metabolites of (a) or (b). These combinations may be effective for reducing weight or adipose volume in the pet. In another aspect, the invention provides for methods of regulating energy metabolism by the administration of one or more compositions comprising leucine, a leucine metabolite, and/or a sirtuin activator. The invention also provides for kits comprising compositions of leucine, a leucine metabolite, and/or a sirtuin activator packaged in an oral dose form with usage instructions.) 

23: (8848565402366727294) patent: US20160375150A1 Title : POLYMER-CYCLODEXTRIN-LIPID CONJUGATES) Abstract : The invention comprises compounds, methods of making, and methods of using. A group of polymer-cyclodextrin-lipid conjugates having a center backbone and three or four appended functional groups are disclosed, wherein one of the hydrophilic components is cyclodextrin. The compounds may have a backbone with three or four appended functional groups: one or two lipophilic compounds including sterols or fat soluble vitamins or fatty acids, one or two hydrophilic polymer and one cyclodextrin. Specific functional groups may be selected for specific applications in formulating pharmaceuticals, cosmetics, nutriceuticals, and the like. Typical coupling reaction of the conjugates may involve one or more or combinations or in series of alkylation including N-alkylation or O-alkylation, etherification, esterification and amidation chemical processes. A variety of linkers between the center backbone and functional groups may also be selected to modify the carriers or center backbones for the coupling reactions and optimize performance of the conjugates.) 

24: (1639995765426984470) patent: US20160324933A1 Title : ALBUMIN-BASED NON-COVALENT COMPLEXES AND METHODS OF USE THEREOF) Abstract : A non-covalent complex of an albumin molecule and a hydrophobic ligand, compositions containing the same, and methods of use thereof are provided. The present complex may find use in delivering the hydrophobic ligand to microorganisms that have albumin-binding outer surfaces, such as a cell wall.) 

25: (142101295910514520) patent: US20140243254A1 Title : Polymeric Hyperbranched Carrier-Linked Prodrugs) Abstract : The present invention relates to water-soluble carrier-linked prodrugs of formula (I), wherein POL is a polymeric moiety, each Hyp is independently a hyperbranched moiety, each moiety SP is independently a spacer moiety, each L is independently a reversible prodrug linker moiety, m is 0 or 1, each n is independently an integer from 2 to 200 and each x is independently 0 or 1. It further relates to pharmaceutical compositions comprising said water-soluble carrier-linked prodrugs and methods of treatment.) 

26: (7979846397901031272) patent: WO2008053517A1 Title : AGENT FOR PROMOTING IN VIVO DHA SYNTHESIS AND SEAWEED OIL) Abstract : It is intended to provide an agent for promoting in vivo DHA synthesis and a seaweed oil which enable the supplementation of DHA to a living body instead of taking oxidizable DHA as a fish oil. According to the agent for promoting in vivo DHA synthesis and the seaweed oil which contain fucoxanthin, even if oxidizable DHA is not taken as a fish oil, an activity of in vivo DHA synthesis can be increased by taking fucoxanthin or the seaweed oil containing fucoxanthin, whereby the supplementation of DHA to a living body can be substituted. Further, by adding this fucoxanthin or seaweed oil containing fucoxanthin to a food material, medicinal product or feed, the food material, medicinal product or feed which has a function to promote in vivo DHA synthesis can be provided.) 

27: (90222125776088843) patent: US20150203612A1 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention aims to provide methods for surface-modifying a rubber vulcanizate or a thermoplastic elastomer, which can cost-effectively impart a variety of functions, such as sliding properties or biocompatibility, according to the application. The present invention relates to a method for surface-modifying an object of a rubber vulcanizate or a thermoplastic elastomer, the method including: step 1 of forming polymerization initiation points A on the surface of the object; and step 2 of radically polymerizing a non-functional monomer, starting from the polymerization initiation points A, to grow non-functional polymer chains, and further radically polymerizing a fluorine-containing functional monomer to grow fluorine-containing functional polymer chains.) 

28: (6969064572561807502) patent: EP1463513A1 Title : STABILIZED BRIVUDINE TOPICAL FORMULATIONS) 

29: (4991252332628291222) patent: EP2197410A2 Title : Adhesive gel sheet for use in cosmetics) 

30: (1075739865565543664) patent: US20070065900A1 Title : Process for chromosomal expression of foreign genes in the cytochrome-C peroxidase (cytCP) region of a methylotrophic microbial host cell) Abstract : Provided is a method for expressing an introduced gene or genes in a methylotrophic microorganism host wherein the gene(s) are integrated into the cytCP region of the chromosome. This method provides stable, high-level expression of the integrated genes in which growth rate of the host strain is not highly affected and a selection marker is not required. The use of this method for expressing carotenoid biosynthetic genes and resulting production of astaxanthin is also described.) 

31: (4449748073141139466) patent: WO2009130895A1 patent: CN102007216 patent: WO2009130895 Title : PROCESS FOR PRODUCTION OF FUCOXANTHIN, AND MICROALGA FOR USE IN THE PROCESS) Abstract : Disclosed are: a process for producing fucoxanthin alone or fucoxanthin together with a highly unsaturated fatty acid efficiently, which enables the mass production of fucoxanthin; and a microalga for use in the process. Specifically disclosed are: a process for producing fucoxanthin alone or fucoxanthin together with a highly unsaturated fatty acid, which is characterized by culturing a microalga, more specifically a microalga belonging to the class Pinguiophyceae, Chrysophyceae, Bacillariophyceae or Haptophyceae, and extracting/isolating fucoxanthin alone or fucoxanthin together with the highly unsaturated fatty acid from the cultured microalga; and a microalga for use in the production of each of the above-mentioned fucoxanthin components.) 

32: (5240629474005918885) patent: JP2010275265A Title : CHROMOGENIC GENE EXPRESSION INHIBITOR) Abstract : PROBLEM TO BE SOLVED: To provide a chromogenic gene expression inhibitor wherein the novel constituent is an active constituent. ;SOLUTION: The invention provides the chromogenic gene expression inhibitor wherein fucoxanthin is an active constituent. The chromogenic gene expression inhibitor may contain at least one extract selected from algae containing fucoxanthin as an active constituent. ;COPYRIGHT: (C)2011,JPO&INPIT) 

33: (6164041834177608274) patent: US20040259835A1 Title : Stabilized brivudine topical formulations) Abstract : Topical formulations containing the virustatic agent brivudine and stabilizers useful to present its photodegradation are disclosed.) 

34: (8645043953407036987) patent: US20060121558A1 Title : Gene targets for enhanced carotenoid production) Abstract : The present invention provides engineered cells and methods for utilizing same. Methods of enhanced carotenoid synthesis utilizing cells genetically disrupted for a yjiD, hnr or yjfP gene, or further disrupted for a gdhA, gpmB, aceE, ppc, talB or fdhF gene, or any combination thereof, or cells inhibited for their expression, activity or function are disclosed. Additionally, methods of enhanced carotenoid synthesis utilizing cells genetically disrupted for gdhA, aceE, fdhF, yjiD, hnr or yjfP gene expression or any combination thereof and ackA, appY, aspC, clp, clpP, clpXP, crcB, csdA, cyaA, evgS, fdhA, fdhD, feoB, funA, glnE, glxR, gntK, hycI, lipB, lysU, modA, moeA, nadA, nuoC, nuoK, pflB, pitA, pst, pstC, pta, p-yjiD, sohA, sipA, yagR, yaiD, ybaS, ycfZ, ydeN, yebB, yedN, yfcC, ygjP, yibD, yjfP, yjhH, or yliE gene expression, or a combination thereof or cells inhibited for their expression, activity or function are disclosed. Methods of enhanced carotenoid synthesis utilizing cells genetically engineered to overexpress dxs, idi, ispFD, yjiD, rpoS, torC, appY, ydgK, yeiA, yedR, tort, arcB, yggT, purDH, yfjN or a combination thereof, or further disrupted for the above-referenced genes are disclosed. Methods for identifying genes involved in optimized production of a carotenoid, and cells disrupted for, or inhibited for the expression, activity or function of genes thus identified are described.) 

35: (6343032169288937430) patent: US5591343A Title : Process for extraction of carotenoids from bacterial cells) Abstract : A process for extraction of a carotenoid compound from bacterial cells containing the carotenoid compound comprising the step of bringing the bacterial cells into contact with supercritical fluid so as to extract the carotenoid compound from the cells. The process provides carotenoid compounds which can be safely used as feed additives and food additives.) 

36: (1884128802149931745) patent: US6929928B2 Title : Genes encoding carotenoid compounds) Abstract : A unique carotenogenic biosynthetic gene cluster has been isolated from Panteoa agglomerans strain DC404, wherein the genetic organization of the cluster is crtE-idi-crtY-crtI-crtB-crtZ. The genes contained within this cluster encode geranylgeranyl pyrophosphate (GGPP) synthetase (CrtE), isopentenyl pyrophosphate isomerase (Idi), lycopene cyclase (CrtY), phytoene desaturase (CrtI), phytoene synthase (CrtB), and beta-carotene hydroxylase (CrtZ). The gene cluster, genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

37: (519267173369524158) patent: WO2015131152A1 Title : COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS) Abstract : Methods useful for reducing or preventing hepatic steatosis are provided herein. Such methods may comprise administering to a subject in need thereof a sirtuin pathway activator and/or PDE5 inhibitor alone or in combination with an amount of a branched amino acid in free amino acid form, or a metabolite thereof. Also provided herein are compositions and kits for practicing any of the methods described herein.) 

38: (5244421786976058433) patent: US20070148727A1 Title : Novel carotenoid hydroxylase gene, method for preparing hydroxylated carotenoid, and novel geranylgeranyl pyrophosphate synthase) Abstract : The present invention provides a Brevundimonas sp. strain SD212-derived peptide having beta-ionone ring-2-hydroxylase activity and a gene encoding the same, to thereby make it possible to produce rare carotenoids in which a hydroxyl group is introduced at the position 2 (2') carbon in their beta-ionone ring in large quantities. The present invention also provides a novel gene encoding an enzyme which introduces a hydroxyl group at the position 3 (3') carbon in the beta-ionone ring of carotenoids, and a novel gene encoding a geranylgeranyl pyrophosphate synthase.) 

39: (8953569771912465732) patent: US20040156802A1 Title : Cosmetics or external preparations for skin) Abstract : According to the present invention, there is provided cosmetics or external preparations for skin which comprises, as the effective ingredient, a chemical peeling agent, a bactericide, an anionic surfactant or a cationic surfactant component in combination with a compound capable of mitigating the irritation, inflammation, etc. of the skin caused by these components. The present invention is skin cosmetics, external preparations for skin or hair cosmetics which are characterized by containing the following components (A) and (B) or it is skin cosmetics or external preparations for skin which are characterized by containing the following components (C) and (D) Components (A) and (C): one or more members selected from a cystine derivative and salt thereof. Component (B): one or more of members selected from a chemical peeling agent, a bactericide and an anionic surfactant Component (C): a cationic surfactant) 

40: (9175863856127315842) patent: WO2014096992A1 Title : ACETYL TRANSFERASES AND THEIR USE FOR PRODUCING CAROTENOIDS) Abstract : The present invention relates to acetyl transferases, nucleic acid sequences coding therefore, expression constructs and vectors comprising these sequences, microorganisms transformed therewith and use thereof.) 

41: (5010237583233497461) patent: EP1982711A1 Title : Compositions comprsing nebivolol) Abstract : Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other cardiovascular agent, wherein the at least one other cardiovascular agent is an angiotesin II receptor antagonist.) 

42: (6296524062697191660) patent: JP2010233517A Title : CULTURED MICROALGAE CONTAINING FUCOXANTHIN AND METHOD FOR PRODUCING THE SAME) Abstract : PROBLEM TO BE SOLVED: To provide a method for efficiently producing fucoxanthin. ;SOLUTION: The method for producing fucoxanthin includes a step of culturing a unicellular diatom of genus Phaeodactylum, a unicellular diatom of genus Thalassiosira, or unicellular haptophyte of genus Isochrysis, and a step of collecting the fucoxanthin from cultured product. ;COPYRIGHT: (C)2011,JPO&INPIT) 

43: (1429213505296957428) patent: US8623924B2 Title : Compositions and methods for modulating metabolic pathways) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

44: (4400906599497550495) patent: US9480672B2 Title : Internal composition) Abstract : An object of the present invention is to provide an internal composition capable of exerting various physiological functions such as a brain-function improving function. That is, the present invention provides an internal composition including docosahexaenoic acid and capsanthin, or docosahexaenoic acid, capsanthin, lutein, and zeaxanthin as active ingredients.) 

45: (6685439773543707913) patent: EP2789245A1 Title : EMULSION COMPOSITION, AND COMPOSITION CONTAINING SAME) Abstract : The present invention provides an emulsion composition that ensures excellent emulsion stability and excellent solubility in water, as well as excellent transparency and storage stability of a solution prepared by adding the emulsion composition to water. The present invention also provides an aqueous composition, in particular, a solution aqueous composition (aqueous liquid composition), preferably food or a beverage, containing the emulsion composition. The emulsion composition is an emulsion composition prepared by emulsifying an oil phase component and an aqueous phase component using gum ghatti, wherein the emulsion composition comprises gum ghatti in a proportion of more than 25 parts by weight based on 100 parts by weight, i. e., the total amount, of the oil phase component; and the gum ghatti has a viscosity of 50 to 3000 mPa s, which is measured by preparing a 15 wt% aqueous solution of the gum ghatti and measuring its viscosity for 1 minute at 20C and 30 rpm using a Brookfield viscometer.) 

46: (8566627940632869972) patent: US20100076091A1 Title : COMPOSITION AND METHOD FOR SUPPRESSING LIPOOXIDATION OF ERYTHROCYTE) Abstract : The present invention relates to a composition for suppressing lipoperoxidation of erythrocytes, which comprises xanthophyll or an ester thereof as an active ingredient, a composition for preventing or treating dementia, and a method for diagnosing dementia, which comprises measuring the concentration of xanthophyll or an ester thereof in mammalian erythrocytes.) 

47: (3061210214150698848) patent: EP2294193A2 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) 

48: (8136578093026623911) patent: US7064196B2 Title : Genes encoding carotenoid compounds) Abstract : Genes have been isolated from strain DC260, a member of the Enterobacteriaceae family, encoding geranylgeranyl pyrophosphate (GGPP) synthetase (CrtE), phytoene synthase (CrtB), phytoene desaturase (CrtI), lycopene cyclase (CrtY), beta-carotene hydroxylase (CrtZ), and zeaxanthin glucosyl transferase (CrtX) activity. The genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

49: (7077914082281883746) patent: WO2016209732A1 Title : POLYMER-CYCLODEXTRIN-LIPID CONJUGATES) Abstract : The invention comprises compounds, methods of making, and methods of using. A group of polymer-cyclodextrin-lipid conjugates having a center backbone and three or four appended functional groups are disclosed, wherein one of the hydrophilic components is cyclodextrin. The compounds may have a backbone with three or four appended functional groups: one or two lipophilic compounds including sterols or "fat soluble" vitamins or fatty acids, one or two hydrophilic polymer and one cyclodextrin. Specific functional groups may be selected for specific applications in formulating pharmaceuticals, cosmetics, nutriceuticals, and the like. Typical coupling reaction of the conjugates may involve one or more or combinations or in series of alkylation including N-alkylation or O-alkylation, etherification, esterification and amidation chemical processes. A variety of linkers between the center backbone and functional groups may also be selected to modify the carriers or center backbones for the coupling reactions and optimize performance of the conjugates.) 

50: (4651279230626156823) patent: WO2010104908A1 Title : SYSTEMS AND METHODS FOR REGULATING ALGAL BIOMASS) Abstract : The invention relates to systems and methods for regulating algal biomass in offshore waters near an oil and gas production platform. The systems of the invention encompasses a plurality of modules for managing nutrients, algae, and aquaculture, including enclosures for containing aquatic organisms, and various operating subsystems that are operably associated with surface and underwater structures of the platform. In one embodiment of the invention, aquatic organisms are cultured in eutrophic water to feed on algae, thereby reducing the algal biomass. In other embodiments, the diversity of algae in an algal bloom is modified and the productivity of oligotrophic water is increased.) 

51: (1112927719371267588) patent: WO2002000908A2 Title : METHODS FOR PROCESSING CRUSTACEAN MATERIAL) Abstract : The inventor has found that enzymatic treatment of crustaceans with lipolytic enzymes promotes the extraction of coloured pigment. Accordingly, the invention relates to a method for recovering coloured pigment, e. g. astaxanthin, and/or chitin or chitosan and/or lysolecithins from crustaceans. Lipolytic enzyme(s) may e. g. be lipase or phospholipase. The lipolytic enzyme treated crustacean material may be subjected to additional process steps, including treatment with non-lipolytic enzymes such as e. g. protease. The process of the invention provides several suitable products and several uses of such products. Furthermore, the invention also relates to the cosmetic and consumable products (feed and food (including beverages) products and additives produced therefrom.) 

52: (5561654523711110523) patent: WO2014161815A1 Title : GLYCOGEN-BASED WATER SOLUBILITY ENHANCERS) Abstract : The present invention relates to glycogen-based polymers and the use thereof for enhancing the solubility in water of lipophilic compounds, to complexes of the said glycogen-based polymers with lipophilic compounds and the use thereof for administering lipophilic compounds, and to pharmaceutical, nutraceutical, and cosmetic compositions comprising the said complexes.) 

53: (588813805237476822) patent: US20120058542A1 Title : SYSTEMS AND METHODS FOR REGULATING ALGAL BIOMASS) Abstract : The invention relates to systems and methods for regulating algal biomass in offshore waters near an oil and gas production platform. The systems of the invention encompasses a plurality of modules for managing nutrients, algae, and aquaculture, including enclosures for containing aquatic organisms, and various operating subsystems that are operably associated with surface and underwater structures of the platform. In one embodiment of the invention, aquatic organisms are cultured in eutrophic water to feed on algae, thereby reducing the algal biomass. In other embodiments, the diversity of algae in an algal bloom is modified and the productivity of oligotrophic water is increased.) 

54: (3429442368890431495) patent: JP2008280281A Title : ANTIOBESITIC ACTIVE AGENT) Abstract : PROBLEM TO BE SOLVED: To provide an antiobesitic active agent that is inexpensive and mass-producible. ;SOLUTION: Neoxanthin having an allene structure and bearing a polar group, namely, a hydroxy group (OH group) and/or an epoxide group exhibits remarkable antiobesitic activity. The antiobesitic active agent comprising, as an effective ingredient, carotenoid having the allene structure (excluding fucoxanthin and fucoxanthinol) is inexpensive and mass-producible and exhibits immeasurable antiobesitic active effects. ;COPYRIGHT: (C)2009,JPO&INPIT) 

55: (5075851915479622819) patent: EP1776427A1 Title : SELF-POLISHING ANTI-FOULING COATING COMPOSITIONS COMPRISING AN ENZYME) 

56: (253578483275795289) patent: US9096875B2 Title : BICARBONATE TRIGGER FOR INDUCING LIPID ACCUMULATION IN ALGAL SYSTEMS) Abstract : The present invention provides bicarbonate containing and/or bicarbonate-producing compositions and methods to induce lipid accumulation in an algae growth system, wherein the algae growth system is under light-dark cycling condition. By adding said compositions at a specific growth stage, said methods lead to much higher lipid accumulation and/or significantly reduced total time required for accumulating lipid in the algae growth system.) 

57: (4718506586691330091) patent: EP2441828B1 Title : Algal bio-flocculation by inactivation of photoreceptors) Abstract : The present invention relates to a method to induce alga and/or diatom cell bio-flocculation comprising inactivation of the expression of at least one photoreceptor in said alga and/or diatom, constructs able to inhibit the expression of at least one photoreceptor and uses thereof.) 

58: (5202042354792342156) patent: US20040146966A1 Title : Mutations affecting carotenoid production) Abstract : Mutations in genes having no direct relationship to the carotenoid biosynthetic pathway have been found to increase carbon flux through that pathway. Complete disruption in the deaD, mreC, and yfhE genes were effective. Additionally where genes of the lower carotenoid pathway reside on a plasmid having either a p15A or pMB1 replicon, mutations in the thrS, rspA, rpoC, yjeR, and rhoL were found effective.) 

59: (1171657788759726131) patent: WO2014065640A2 patent: KR101487065B patent: KR20140045161 patent: WO2014065640 Title : COMPOSITION FOR TREATING OR PREVENTING INFLAMMATORY DISEASES CONTAINING MYAGROPSIS MYAGROIDES EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT) Abstract : The present invention relates to a composition for treating or preventing inflammatory diseases and, more particularly, to a pharmaceutical composition for preventing and treating inflammatory diseases, containing Myagropsis myagroides extract or a fraction of the extract as an active ingredient. Even though the Myagropsis myagroides extract or the fraction of the extract of the present invention does not contain the conventionally known fucoxanthin, the Myagropsis myagroides extract or the fraction of the extract exhibits the effects of effectively inhibiting the expression of iNOS and COX-2 and the generation of nitrogen monoxide (NO), prostaglandin E2 (PGE2) and inflammatory cytokines, and thus can be useful for preventing and treating inflammatory diseases.) 

60: (3204604837507129467) patent: EP2803276B1 patent: ES2549671T patent: ITPD20130133 patent: EP2803276 Title : Product for the diet of dogs afected by inflammatory intestinal diseases) Abstract : Product for the diet of dogs affected by inflammatory intestinal diseases, which comprises at least one source of fiber and at least one source of proteins. The source of fiber comprises ascophyllum nodosum, which is comprised in the product for the diet of dogs in a weight percentage comprised between 15% and 25%, and the protein carrier component is a protein hydrolysate, comprised in the product for the diet of dogs in a weight percentage comprised between 18% and 25%.) 

61: (2712534644999095523) patent: US20050075337A1 Title : Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease) Abstract : A method for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals in a subject whereby a subject is administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The analog or derivative is administered such that the subject's risk of experiencing diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals may be thereby reduced. The analog or analog combination may be administered to a subject for the inhibition and/or amelioration of any disease that involves production of reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals. In some embodiments, the invention may include a pharmaceutical composition including an analog or derivative of a carotenoid. The carotenoid analog or derivative may be synthetic. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include an acyclic alkene including at least one substituent and/or a cyclic ring including at least one substituent. In some embodiments, a carotenoid analog or derivative may include at least one substituent. The substituent may enhance the solubility of the carotenoid analog or derivative such that the carotenoid analog or derivative at least partially dissolves in water. In some embodiments, a pharmaceutical composition may include a biologically inactive carrier. The pharmaceutical composition may be adapted to be administered to a human subject.) 

62: (8542686229733197921) patent: US20150315162A1 patent: US2015315162 Title : Process for producing fucoxanthinol extract and methods of use) Abstract : A process for obtaining a purified fucoxanthinol extract from an Echinozoa tissue or organ is disclosed, as well as methods of using said extract. Compositions comprising the extract, and their uses, are also described. Uses of the purified extract include methods for making medicaments or treatments for conditions such as, but not limited to, obesity, cancer, oxidative stress, diabetes, neurodegenerative disorders, and high blood pressure.) 

63: (2025385098377915368) patent: US20120220580A1 Title : PREPARATION OF CAROTENOID DERIVATIVES AND THEIR APPLICATIONS) Abstract : Compounds having the structure of general formula I or pharmaceutically acceptable salts thereof which are derivatives of fucoxanthin and fucoxanthol are disclosed. A preparation method of the compound and its use in weight reducing are also disclosed.) 

64: (815951080099710709) patent: US20110021843A1 Title : FRONT-WHEEL HOLDER FOR BICYCLES AND MOTOR-CYCLES.) 

65: (8550431198140117642) patent: EP1866428A2 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) 

66: (9068458645191244269) patent: US20150044737A1 Title : Elimination of interference in carrier systems) 

67: (1672673423486946903) patent: EP2812005A1 Title : POLYHYDROXYLATED PENTACYCLIC TRITERPENE ACIDS AS HMG-COA REDUCTASE INHIBITORS) 

68: (6722524780950236176) patent: US20110172185A1 Title : THERAPEUTIC DRUG FOR ADULT T-CELL LEUKEMIA) Abstract : An object is to provide a novel therapeutic drug for adult T-cell leukemia having an ATL cell specific antitumor effect. The therapeutic drug for adult T-cell leukemia according to the invention is characterized by containing a compound represented by the formula I or a prodrug thereof, wherein R1 is H, OH, an alkoxy group, an acyl group, or a thioacyl group, R2 is an acyl group, a thioacyl group, CONR7R8, or CSNR7R8 (R7 and R8 being each independently H, an alkyl group containing 1 to 3 carbon atoms, or a phenyl group), or R1 and R2 together may form a ring, X1 and X2 may be the same or different and are each -CR3R4-, -SiR3R4- or oxygen, and R3 and R4 may be the same or different and are each an alkyl group containing 1 to 6 carbon atoms.) 

69: (7626393463511364508) patent: WO2005026269A1 Title : MICROORGANISM COATING COMPONENTS, COATINGS, AND COATED SURFACES) Abstract : Disclosed herein are novel paints and coatings comprising a cell-based particulate material. Specifically disclosed herein is cell-based particulate material prepared from microorganisms for use as a coating component. Also disclosed herein are methods of preparing a coating that comprises a cell-based particulate material.) 

70: (6209894579563337154) patent: US7070952B2 Title : Genes encoding carotenoid compounds) Abstract : Genes have been isolated from Pectobacterium cypripedii encoding geranylgeranyl pyrophosphate (GGPP) synthase (CrtE), phytoene synthase (CrtB), phytoene desaturase (Crtl), lycopene cyclase (CrtY), beta-carotene hydroxylase (CrtZ), and zeaxanthin glucosyl transferase (CrtX) activity. The genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

71: (3848616893740915657) patent: US20070065902A1 Title : Process for chromosomal expression of foreign genes in the fliC region of a methylotrophic microbial host cell) Abstract : Provided is a method for expressing an introduced gene or genes in a methylotrophic microorganism host wherein the gene(s) are integrated into the fliC region of the chromosome. This method provides stable, high-level expression of the integrated genes in which growth rate of the host strain is not adversely affected and a selection marker is not required. The use of this method for expressing carotenoid biosynthetic genes and resulting production of astaxanthin is also described.) 

72: (5692426969316901074) patent: WO2007062415A1 Title : CORPOREAL DELIVERY OF CAROTENOIDS) Abstract : A method for delivery of a phytochemical supplement to a corporeal body. The method of delivery comprises providing a phytochemical supplement in an orally acceptable composition and applying the orally acceptable composition including the phytochemical supplement in contact with a feature of the oral cavity of a corporeal body. An oral care composition comprising a phytochemical supplement for one or more of ingestion or trans-mucosal absorption and a method for making the same are also disclosed.) 

73: (3443091523741880818) patent: WO2014089174A2 Title : AEROSOL DISPENSER WITH EDIBLE CARTRIDGE) Abstract : An aerosolizing delivery device can include a carriage configured to be detachably connected to a mouthpiece and to receive and support an aerosolizable powder-filled cartridges in a desired position relative to the mouthpiece. The carriage can include: a housing defining a reservoir and a carriage outlet, the carriage outlet configured to permit fluid communication between the reservoir and an exterior of the carriage. A surface of the housing can be configured to define a bypass port between the housing and a surface of the mouthpiece when the carriage is assembled with the mouthpiece to form the delivery device.) 

74: (6967523969075851372) patent: WO2013144595A1 Title : PERIDININ-CHLOROPHYLL BINDING PROTEINS) Abstract : The invention relates to novel peridinin-chlorophyll binding proteins (PCPs) and describes for the first time the recombinant expression of soluble PCPs. The invention also relates to nucleic acid sequences encoding the PCPs and to the production of the PCPs. Novel gene sequences were isolated from the Symbiodinium species (zooxanthellae) in the soft coral Sinularia flexibilis. Expression in E. coli produces high yields of soluble, active PCPs. The recombinant PCPs are highly stable and become near infra-red emitting on binding to chlorophylls and carotenoids. The novel PCPs are useful, for example, in fluorescent labelling.) 

75: (6858432805567152288) patent: US20130045504A1 Title : Door-closer) 

76: (1000521622971220535) patent: WO2004056974A2 Title : MUTATIONS AFFECTING CAROTENOID PRODUCTION) Abstract : Mutations in genes having no direct relationship to the carotenoid biosynthetic pathway have been found to increase carbon flux through that pathway. Complete disruption in the deaD, mreC, and yfhE genes were effective. Additionally where genes of the lower carotenoid pathway reside on a plasmid having either a p15A or pMB1 replicon, mutations in the thrS, rspA, rpoC, yjeR, and rhoL were found effective.) 

77: (4518654503084978452) patent: WO2016170784A1 Title : FERTILIZER AND AGROCHEMICAL FORMULATION) Abstract : A transparent, homogeneous liquid or liquiform fertilizer and agrochemical formulation is provided. The formulation includes an agrochemical and a fertilizer together with glycol ether.) 

78: (6395221718745711395) patent: WO2016172787A1 Title : OXIDIZED CAROTENOIDS AND COMPONENTS THEREOF FOR PREVENTING NECROTIC ENTERITIS) Abstract : Necrotic enteritis (NE) has been largely found in commercial broiler chickens when they are produced without the use of antimicrobial growth promoters. The present invention provides a method and use of oxidized carotenoids, components thereof and compositions and products containing same, such as OxBC ('OxC-betaTM, Product from Avivagen Inc., Canada) for preventing necrotic enteritis in animals, such as poultry. Related compositions, kits are also herein included in the invention.) 

79: (937648357693189653) patent: US20160074312A1 Title : Loom) 

80: (1465541748016325450) patent: US7217537B2 Title : Method to increase carotenoid production in a microbial host cell by down-regulating glycogen synthase) Abstract : A method to increase carotenoid production in carotenogenic microbial host cells is provided by down-regulating or disrupting glycogen synthesis. Disruption of glycogen synthase activity in a carotenogenic microbial host cell significantly increased carotenoid production. Carotenogenic microorganisms are also provided that have been optimized for the production of carotenoid compounds through the down-regulation and/or disruption of glycogen synthase activity.) 

81: (7730361023578544637) patent: US20050014219A1 Title : Genes encoding carotenoid compounds) Abstract : A carotenogenic biosynthetic gene cluster has been isolated from Panteoa stewartii strain DC413, wherein the genetic organization of the cluster is crtE-idi-crt)(-crtY-crtI-crtB-crtZ. The genes contained within this cluster encode geranylgeranyl pyrophosphate (GGPP) synthetase (CrtE), isopentenyl pyrophosphate isomerase (Idi), zeaxanthin glucosyl transferase (CrtX), lycopene cyclase (CrtY), phytoene desaturase (Crtl), phytoene synthase (CrtB), and beta-carotene hydroxylase (CrtZ). The gene cluster, genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

82: (9157061360545226239) patent: WO2014028585A1 Title : COMPOSITIONS FOR TARGETED ANTI-AGING THERAPY) Abstract : This invention relates to compositions for delaying aging. The compositions comprise branched-chain amino acids and whey protein, and combinations thereof, containing the same, such as L-leucine, L-isoleucine, L-valine, lactoferrin, and - lactoglobulin. The compositions are heat stable when dissolved in water at near neutral pH. The compositions are palatable and suitable for delivering orally administrable anti-aging agents such as -3 fatty acids, coenzyme Q10, xanthophylls, L-arginine, and L-glutathione.) 

83: (5784114739128170745) patent: WO2014096990A1 Title : CAROTENE HYDROXYLASE AND ITS USE FOR PRODUCING CAROTENOIDS) Abstract : The present invention relates to a novel hydroxylase, nucleic acid sequence coding therefore, expression constructs and vectors comprising this sequence, microorganisms transformed therewith, processes for the microbiological hydroxylation of isoprenoids, for example processes for converting beta-carotene into beta-cryptoxanthin and zeaxanthin, canthaxanthin into astaxanthin.) 

84: (6129296720260064889) patent: WO1995000130A1 Title : USE OF HYDROPHILIC CAROTENOIDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES HAVING AN OXYGENATION MECHANISM) Abstract : Lutein and other hydrophilic carotenoids are disclosed for use in treatment by therapy or prophylaxis of diseases having an oxygenation mechanism. The carotenoids disclosed are especially useful in treatment of coronary heart disease and may be combined with e. g. aspirin.) 

85: (8763990498465873290) patent: US20150065568A1 Title : METHOD FOR PRODUCING COMPOSITION CONTAINING FUCOXANTHIN) Abstract : A method for producing a composition containing fucoxanthin includes a first step of adding a water-soluble solvent containing 0 to 80% by weight of water to seaweed to obtain a seaweed component extract, and then adding water and/or a water-soluble solvent to the seaweed component extract in such a manner that the concentration of the water-soluble solvent is 20 to 45% by weight and also adding a diluent thereto to obtain a diluent-containing extract, and a second step of stirring the diluent-containing extract, and then collecting a substance aggregating into the diluent-containing extract as a composition containing fucoxanthin by separation.) 

86: (147827907898347098) patent: US7635469B2 Title : Micronutrient formulations for hearing health) Abstract : A hearing health micronutrient formulation is provided and the formulation comprises dietary antioxidants and endogenous antioxidants, and the dietary antioxidants are selected from a group consisting essentially of Vitamin A (Palmitate), Vitamin E, Vitamin C (Calcium Ascorbate), Vitamin D3 (Cholecalciferol), B Vitamins, Biotin, Pantothenic Acid (as D-Calcium Pantothenate), Calcium Citrate, Magnesium Citrate, Zinc Glycinate, Selenium (Seleno-L-Methionine), Chromium (as Chromium Picolinate), Mixed Carotenoids and mixtures thereof, and the endogenous antioxidants are selected from a group consisting essentially of N-Acetyl Cysteine (NAC), Coenzyme Q10, R-alpha Lipoic Acid, L-Carnitine and mixtures thereof.) 

87: (3933050448053375462) patent: WO2014074592A1 Title : SEAWEED EXTRACTS, UNSATURATED FATTY ACIDS, AND METHODS OF TREATMENT) Abstract : The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)- mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.) 

88: (1008607760714933740) patent: EP2047842A1 Title : COSMETIC AND METHOD FOR PRODUCTION THEREOF) Abstract : A cosmetic exhibiting improved thermal stability and storage stability, which is prepared by using a three-phase emulsification-dispersing method in an aqueous phase. In the cosmetic containing an oily base material and/or a pigment as a component to be emulsification-dispersed, an emulsification-dispersing agent and water, the thermal stability and storage stability are improved, and the emulsification-dispersing agent composed of a polysaccharide having a particulate structure as a main component, and two or more kinds of components to be emulsification-dispersed are contained. The components to be emulsification-dispersed exhibit a dielectric constant ranging from 1 to 5 (F/m), and an inorganicity/organicity ratio ranging from 0 to 0.5.) 

89: (5304793583596378954) patent: JP2009155331A Title : ANTI-FATIGUE AGENT) Abstract : PROBLEM TO BE SOLVED: To provide an anti-fatigue agent using, as an active ingredient, fucoxanthin and/or fucoxanthin which are known to have functions such as a diabetes-improving action, a neovascularization-inhibiting action, and a DHA synthesis-promoting action, and is furthermore effective for reducing fatigues. ;SOLUTION: This anti-fatigue agent comprises the fucoxanthin and/or fucoxanthin as an active ingredient. The fatigue is a phenomenon that a living body exhibits a function and consequently deteriorates the function. The anti-fatigue effect includes an action for reducing the fatigue state, an action for recovering the fatigue state, or an action for preventing the fatigue state. ;COPYRIGHT: (C)2009,JPO&INPIT) 

90: (1849062037067729272) patent: WO2004104180A2 Title : GENES ENCODING CAROTENOID COMPOUNDS) Abstract : Genes have been isolated from strain DC260, a member of the Enterobacteriaceae family, encoding geranylgeranyl pyrophosphate (GGPP) synthetase (CrtE), phytoene synthase (CrtB), phytoene desaturase (Crtl), lycopene cyclase (CrtY), beta-carotene hydroxylase (CrtZ), and zeaxanthin glucosyl tranferase (CrtX) activity. The genes and their products are useful for the conversion of farnesyl phyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes b recombinant DNA technology in transformed host organisms are disclosed.) 

91: (4256691135404554183) patent: WO2015041977A1 Title : COMPOSITIONS CAPABLE OF ENHANCING THERMOGENESIS AND USES THEREOF) Abstract : The present invention refers to novel compositions and to methods of using the compositions to treat and/or prevent obesity, obesity-related diseases or disorders (e. g., hyperglycemia, hyperinsulinemia, elevated hemoglobin A1c (HbA1c), diabetes, or cardiovascular disease), and overweight. This invention also generally relates to compositions and to methods of using the compositions to increase basal metabolic rate.) 

92: (8544800028473117475) patent: EP2825629A1 Title : PRODUCTION OF DOCOSAHEXAENOIC ACID AND/OR EICOSAPENTAENOIC ACID AND/OR CAROTENOIDS IN MIXOTROPHIC MODE USING NITZSCHIA) 

93: (5749197715256438616) patent: WO2011012715A1 Title : BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS) Abstract : The present invention relates to biodegradable polyethylene glycol based water-insoluble hydrogels comprising backbone moieties which are interconnected by hydrolytically degradable bonds, the backbone moieties further comprising reactive functional groups, wherein the water-insoluble hydrogel is further characterized in that the ratio between the time period for the complete degradation of the hydrogel by hydrolysis of the degradable bonds into water-soluble degradation products comprising one or more backbone moieties and the time period for the release of the first 10 mol-% of water-soluble degradation products comprising one or more backbone moieties based on the total amount of backbone moieties in the hydrogel is greater than 1 and equal to or less than 2. The invention further relates to conjugates of such hydrogels with ligands or ligating groups, prodrugs and pharmaceutical compositions as well as their use in a medicament.) 

94: (6523936185752836987) patent: EP2988783A1 Title : HYDROGEL-LINKED PRODRUGS RELEASING MODIFIED DRUGS) 

95: (517337702854265560) patent: EP2580966A1 Title : METHOD FOR PREVENTING CAROTENOID DYE FROM ADHERING TO CONTAINER) Abstract : This invention relates to a method for preventing adhesion of a carotenoid pigment to manufacturing equipment or containers such as PET bottles during production of liquid foods such as beverages containing a carotenoid pigment. The method comprises adding gum ghatti to a system in which a carotenoid pigment is present.) 

96: (7256768027616147480) patent: WO2016172282A1 Title : MICROBIAL PRODUCTION OF TERPENOIDS) Abstract : The present invention provides genetically engineered host organisms capable of producing terpenoids. The present invention also relates terpenoids obtained from such genetically engineered organisms. Examples of the produced terpenoids include carotenoids, ionones, abienol, and other isoprenoid derived compounds. In addition, the invention relates to a methods of for the preparation of terpenoids using such a genetically engineered organism.) 

97: (3115855449310496518) patent: EP2890740A1 Title : A BIO-BASED POLYMER ADDITIVE, A PROCESS FOR PREPARING THE BIO-BASED POLYMER ADDITIVE AND A BIODEGRADABLE POLYMER COMPOSITION COMPRISING SAID BIO-BASED POLYMER ADDITIVE) 

98: (5635864985484838351) patent: US20140044653A1 Title : TOPICAL COMPOSITION COMPRISING TRANSFORMED BACTERIA EXPRESSING A COMPOUND OF INTEREST) Abstract : Compositions comprised of a population of transformed bacteria formulated for topical application to a subject are described. The population of transformed bacteria are created from a non-pathogenic bacteria and transformed to express a compound of interest for a therapeutic or a cosmetic purpose. In one embodiment, the composition is for protection of the skin from ultraviolet rays.) 

99: (1388064291636776448) patent: EP2832344A1 Title : COMPOSITION, AND EXTERNAL PREPARATION FOR THE SKIN OR FUNCTIONAL FOOD EACH CONTAINING SAID COMPOSITION) Abstract : The present invention provides a composition which has an effect of preventing or improving symptoms of skin such as fine wrinkles or sagging of skin, and an external preparation for skin or a functional food containing the composition. The present invention is a composition containing carotenoid and pterostilbene and an external preparation for skin or a functional food containing the composition.) 

100: (2649690979362900965) patent: EP2841109A1 Title : PRODRUGS OF HYDROXYL-COMPRISING DRUGS) 

101: (1424062052207397439) patent: WO2010124391A1 Title : METHODS AND COMPOSITIONS FOR IMPROVING THE HEALTH OF ANIMALS) Abstract : The invention features compositions and methodsfor the administration of an oxidatively transformed carotenoid, or a fractionated component thereof, for improving the health of animals, such as increasing joint mobility, increasing activity, and improving coat quality.) 

102: (6123196470003521803) patent: EP1581632A2 Title : MUTATIONS AFFECTING CAROTENOID PRODUCTION) 

103: (4043760086792204396) patent: WO2011123407A2 Title : PENTOSE PHOSPHATE PATHWAY UPREGULATION TO INCREASE PRODUCTION OF NON-NATIVE PRODUCTS OF INTEREST IN TRANSGENIC MICROORGANISMS) Abstract : Coordinately regulated over-expression of the genes encoding glucose 6-phosphate dehydrogenase ["G6PDH"] and 6-phospho-gluconolactonase ["6PGL"] in transgenic strains of the oleaginous yeast, Yarrowia lipolytica, comprising a functional polyunsaturated fatty acid ["PUFA"] biosynthetic pathway, resulted in increased production of PUFAs and increased total lipid content in the Yarrowia cells. This is achieved by increased cellular availability of the reduced form of nicotinamide adenine dinucleotide phosphate ["NADPH"], an important reducing equivalent for reductive biosynthetic reactions, within the transgenic microorganism.) 

104: (2549855962370086536) patent: WO2008042338A2 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

105: (3528740449283460914) patent: WO2008063158A2 Title : METHOD FOR NANOENCAPSULATION) Abstract : Methods of nanoencapsulation are described herein. Embodiments of the method utilize the coacervation of a cationic polyelectrolyte with an anionic polyelectrolyte to form a novel capsular matrix. In particular, the novel methods may be used to encapsulate a suspension of a hydrophobic material such as a carotenoid. The disclosed methods do not require lengthy pH adjustments nor do they require the use of any toxic crosslinking agents. In one embodiment, a method of encapsulation comprises dispersing a hydrophobic compound in an organic solvent to form a solution. The method also comprises admixing an anionic polyelectrolyte and a cationic polyelectrolyte with the suspension to form a mixture. In addition, the method comprises quiescently cooling the mixture so as to cause self-crosslinking of a capsular matrix encapsulating the hydrophobic particles.) 

106: (5158458670989129003) patent: EP2340805A2 Title : Holder system for enclosing lipophilic agents and oils in high concentrations) Abstract : Nanocapsule (I) comprises at least one liquid lipid core, and a shell continuously surrounding the core, where the shell is made of at least one hydrophobically modified polysaccharide and at least one membrane-forming emulsifier. An independent claim is included for a preparation comprising (I). ACTIVITY : Dermatological. MECHANISM OF ACTION : None given.) 

107: (8530031978642491874) patent: US20160082123A1 Title : Hydrogel-Linked Prodrugs Releasing Tagged Drugs) Abstract : The present invention relates to a process for the preparation of a hydrogel-linked prodrug releasing a tag moiety-biologically active moiety conjugate, to a hydrogel-linked prodrug releasing a tag moiety-bio logically active moiety conjugate obtainable by such process, to pharmaceutical compositions comprising said prodrug and their use as a medicament.) 

108: (6497057043935532840) patent: WO2008095182A2 Title : FORMULATIONS OF LIPOPHILIC BIOACTIVE MOLECULES) Abstract : This invention provides aqueous and non-aqueous clear formulations including at least one lipophilic bioactive molecules and an amphiphilic solubilizing agent. Exemplary aqueous formulations include a water-soluble reducing agent, which diminishes or prevents chemical degradation of the lipophilic bioactive molecule. The invention also provides methods of using the formulations of the invention. For example, the invention provides beverages including the formulations of the invention. The invention further provides methods of making the formulations and beverages.) 

109: (205337163538179304) patent: US20090324637A1 Title : PROCESS FOR PRODUCING A STABLE CONCENTRATED DIETARY SUPPLEMENT AND SUPPLEMENT PRODUCED THEREBY) Abstract : A process for producing a stable concentrated dietary supplement containing fucoxanthin as the main active component. The method entails grinding crude freeze-dried flakes of wakame seaweed (Undaria pinnatifida) with desirable characteristics into a powder, extracting the active fucoxanthin from the powder with use of an aliphatic or aromatic organic solvent, then filtering and distilling the extract to form a thick syrupy fucoxanthin-containing mass having a solids content of from about 10-99% by wt.; The mass is then purified by dissolving it in an organic non-polar solvent having a Polarity Index of <6, wherein the resultant solution is filtered to remove any solid material therefrom and the remaining liquid is then concentrated to a dried mass by removing substantially all of the solvent, which mass is thereafter ground and sifted to obtain a plurality of particles measuring approximately 60-100 mesh in size. The particles contain at least about 10% by weight of fucoxanthin. The particles by themselves, or in admixture with other components well known in the relevant art, thus comprise a supplement which may be constituted in a form selected from, for example, tablets, capsules, powders and granules.) 

110: (2587348263656034027) patent: US20040161364A1 Title : Carbon sequestration in aqueous environments) Abstract : The present invention relates to the use of a substance, such as an aquatic herbicide, to facilitate the sequestration carbon dioxide by removing a portion of a plant biomass from a body of water.) 

111: (5091780843093337060) patent: US20130252236A1 Title : TUMOR STEM CELLS) Abstract : Tumor stem cells can be obtained by culturing a tumor cell population, and exposing the cultured tumor cell population to free radicals. In certain embodiments, the free radical agent can be a nitric oxide (NO) donor. In one embodiment, the free radical agent can be Diethylenetriamine NONOate (DETA NONOate) or agents that constitutively increase cellular nitric oxide, such as phosphodiesterase inhibitors or L-arginine, or agents that increase NO synthase in the population. The methods can further include inducing stem cells present in the population to expand and/or inducing dedifferentiation of tumor cells into tumor stem cells. Additionally, the present invention provides methods of selecting stem cells from a tumor cell population. Another aspect provides methods of screening for anti-tumor stem cell teherapeutic compounds by providing high nitric oxide (HNO) tumor cells, exposing the HNO cells to at least one compound, assessing one or more indicators of HNO cell health and determining toxicity of the compound to HNO tumor cells.) 

112: (2721460724650426631) patent: US20130310772A1 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention aims to provide a surface modification method for a rubber vulcanizate or a thermoplastic elastomer, which can impart excellent sliding properties and durability against repeated sliding motion and can allow the surface to maintain the sealing properties, without using expensive self-lubricating plastics. The present invention relates to a surface modification method for modifying a rubber vulcanizate or a thermoplastic elastomer as an object to be modified, the method including: Step 1 of allowing a photopolymerization initiator to be adsorbed on a surface of the object to be modified; and Step 2 of radical polymerizing monomers, starting from the adsorbed photopolymerization initiator, by irradiation with UV light at a wavelength of 300 nm to 400 nm to grow polymer chains on the surface of the object to be modified.) 

113: (8143047175321040826) patent: WO2002018617A2 Title : CAROTENOID PRODUCTION FROM A SINGLE CARBON SUBSTRATE) Abstract : A method for the production of carotenoid compounds is disclosed. The method relies on the use of microorganisms which metabolize single carbon substrates for the production of carotenoid compounds in high yields.) 

114: (5865554262614560077) patent: US7375133B2 Title : Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease) Abstract : A method for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals in a subject whereby a subject is administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The analog or derivative is administered such that the subject's risk of experiencing diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals may be thereby reduced. The analog or analog combination may be administered to a subject for the inhibition and/or amelioration of any disease that involves production of reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals.; In some embodiments, the invention may include a pharmaceutical composition including a carotenoid analog or derivative. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ether functionality. In some embodiments, a pharmaceutical composition may include a biologically inactive carrier. The pharmaceutical composition may be adapted to be administered to a human subject.) 

115: (7434161083371212488) patent: US9161921B2 Title : Colloidal Carrier System with Penetration Properties for Encapsulating Lipophilic Active Agents and Oils for Topical Use) Abstract : The invention relates to a colloidal carrier system in the form of a nanocapsule, comprising at least the following components: a liquid lipid core, a continuous shell surrounding the core, containing at least one membrane-forming, natural anionic emulsifier and at least one single-chain, natural non-ionic co-emulsifier selected from the group of diglyceryl-monooleates, diglyceryl-monolinoleates, polyglyceryl-monooleates, polyglyceryl-monolinoleates.) 

116: (4089304041469680493) patent: WO2009051470A1 Title : FLAVOUR ENHANCERS/FOOD SEASONING FROM SEAWEEDS AND A METHOD FOR PRODUCING AND USES THEREOF) Abstract : A method for preparing a seaweeds based flavour enhancer/seasoning with cardiovascular health promoting, degenerative disease preventing and organ protective properties comprises the steps of pre-treating seaweeds; pulverization or extracting the pre-treated seaweeds using a solvent; with or without the addition of polyphenol rich plants/extracts and other food additives. Further, the present invention also relates to a method for preparing a non-toxic anti-cancer agent and healthcare, oral and topical nutraceutical ingredients for humans and animals. The steps of pre-treating alcoholic extracts derive from plants of the tropical seaweeds, Solanum and Piper spp.; extracting the pre-treated alcoholic extracts of by using a solvent; removing the pre-treated alcoholic extracts of from the used solvent; and concentrating the used solvent to acquire the nutraceutical ingredients. Also provided is a method for preparing a wound healing accelerator and general healthcare, oral and topical nutraceutical ingredients for diabetics and non-diabetics humans and animals. The steps of pre-treating vegetative parts derive from plants of the seaweeds and Arecaceae family; extracting the pre-treated vegetative parts by using a solvent; removing the pre-treated vegetative parts from the used solvent; and concentrating the used solvent to acquire the nutraceutical ingredients.) 

117: (2265887491182207924) patent: US20140296257A1 Title : High-Loading Water-Soluable Carrier-Linked Prodrugs) Abstract : The present invention relates to water-soluble carrier-linked prodrugs of formula (I), wherein B, A and Hyp form the carrier, B is a branching core, each A is independently a poly(ethylene glycol)-based polymeric chain, each Hyp is independently a branched moiety, each SP is independently a spacer moiety, each L is independently a reversible prodrug linker moiety, each D is independently a biologically active moiety, each x is independently 0 or 1, each m is independently an integer of from 2 to 64, n is an integer from 3 to 32; or the pharmaceutically acceptable salt thereof. It further relates to pharmaceutical compositions comprising said water-soluble carrier-linked prodrugs, their use as medicament or diagnostic, and methods of treatment.) 

118: (3465528857680000428) patent: EP2710153A1 Title : DETECTION OF SAXITOXIN-PRODUCING DINOFLAGELLATES) 

119: (7337511139910558535) patent: EP2958890A1 Title : PROCESS FOR THE ISOLATION OF CAROTENOIDS) 

120: (287024130090844596) patent: US9339845B2 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention aims to provide a surface modification method for a rubber vulcanizate or a thermoplastic elastomer, which can impart excellent sliding properties and durability against repeated sliding motion and can allow the surface to maintain the sealing properties, without using expensive self-lubricating plastics. The present invention relates to a surface modification method for modifying a rubber vulcanizate or a thermoplastic elastomer as an object to be modified, the method including: Step 1 of allowing a photopolymerization initiator to be adsorbed on a surface of the object to be modified; and Step 2 of radical polymerizing monomers, starting from the adsorbed photopolymerization initiator, by irradiation with UV light at a wavelength of 300 nm to 400 nm to grow polymer chains on the surface of the object to be modified.) 

121: (5783407373740249712) patent: US20050065096A1 Title : Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease) Abstract : A method for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals in a subject whereby a subject is administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The analog or derivative is administered such that the subject's risk of experiencing diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals may be thereby reduced. The analog or analog combination may be administered to a subject for the inhibition and/or amelioration of any disease that involves production of reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals.; In some embodiments, the invention may include a pharmaceutical composition including a carotenoid analog or derivative. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ether functionality. In some embodiments, a pharmaceutical composition may include a biologically inactive carrier. The pharmaceutical composition may be adapted to be administered to a human subject.) 

122: (9082211385587471446) patent: US20080241119A1 Title : Micronutrient formulations for pulmonary and heart health) Abstract : A heart and pulmonry health micronutrient formulation is provided and the formulation comprises dietary antioxidants and endogenous antioxidants, and the formulation comprising dietary micronutrients and endogenous antioxidants, the dietary antioxidants are selected from a group consisting essentially of Vitamin A (Palmitate), Vitamin E, Vitamin C, Vitamin D3 (Cholecalciferol), B Vitamins, Biotin, Pantothenic Acid (as D-Calcium Pantothenate), Calcium Citrate, Magnesium Citrate, Zinc Glycinate, Selenium (Seleno-L-Methionine), Chromium (as Chromium Picolinate), Mixed Carotenoids and mixtures thereof, and the endogenous antioxidants are selected from a group consisting essentially of N-Acetyl Cysteine (NAC), Coenzyme Q10, R-alpha Lipoic Acid, Omega-3 fatty Acid, and L-Carnitine and mixtures thereof.) 

123: (738784423770556826) patent: EP2129231A2 Title : FORMULATIONS OF LIPOPHILIC BIOACTIVE MOLECULES) 

124: (1609939236957023102) patent: WO2015174910A1 Title : COMPOSITION HAVING IMPROVED SPRAYING CHARACTERISTICS COMPRISING VEGETABLE OILS AND TRIGLYCERIDES AND/OR MINERAL OILS) Abstract : A composition with improved spray characteristics consists of i) a lipophilic component comprising 40-60 % by weight of a medium to high viscosity vegetable oil or oil mixtureand 40-60 % by weight of low viscous triglyceride(s) and/or mineral oil(s),and optionally ii) 0-5 %by weight of surfactant(s), iii) 0-5 % by weight of pharmaceutically active agent(s), and iv) 0-20 % by weight of propellant(s).) 

125: (3859437933018814641) patent: EP1845927A1 Title : SUNSCREEN COMPOSITIONS COMPRISING CAROTENOIDS) 

126: (6924771643305950864) patent: US20140023602A1 Title : EXTERNAL PREPARATION FOR SKIN CONTAINING A PHOSPHORYLATED SACCHARIDE) Abstract : Provided is an external preparation for skin, comprising a phosphorylated saccharide. The phosphorylated saccharide may be an inorganic salt of a phosphorylated saccharide. The phosphorylated saccharide may be a calcium, magnesium, potassium, zinc, iron or sodium salt. Also provided is an external preparation for skin, comprising a phosphorylated saccharide and a second component, wherein the second component is selected from the group consisting of moisturizing agents, whitening components, ultraviolet absorbents, anti-inflammatory agents, cell-activating agents and antioxidants. The moisturizing agent may be ascorbic acid or an ascorbic acid derivative.) 

127: (8149050431293953868) patent: US20140044677A1 Title : Heel) 

128: (4747963039017648867) patent: US20130017284A1 Title : COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

129: (333972346403034214) patent: US5350588A Title : Feed and water additive and method of making same) Abstract : An animal feed and water additive prepared from seaweed and a method of preparing an additive for animal consumption containing seaweed. Seaweed is dried, ground to a powder, frozen and extracted at warm temperature. A solution of elements, and an oxygen-aloe solution are added to the extract. The extract may be given to animals with their drinking water and/or food.) 

130: (5424720811224947619) patent: EP2371967B1 Title : Production of carotenoids in oleaginous yeast and fungi) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

131: (5560723906970016678) patent: WO2010124392A1 Title : METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS) Abstract : The invention features compositions, methods, and kits for the administration of an oxidatively transformed carotenoid, or a fractionated component thereof, for treating inflammatory conditions.) 

132: (3093354073225714437) patent: US20130172407A1 Title : Inhibition of Cancer Cell Proliferation Using Oleoylethanolamide) Abstract : A pharmaceutical composition including oleoylethanolamide (OEA) is administered to inhibit tumor/cancer cell proliferation. The pharmaceutically composition may additionally include vitamin A, carotenoids, omega-3 polyunsaturated fatty acid, omega-6 polyunsaturated fatty acid and/or conjugated linolenic acid. The tumor/cancer may be colorectal cancer, lung adenocarcinoma, breast cancer, hepatoma, oral cancer and/or stomach adenocarcinoma.) 

133: (7502772323683158136) patent: US20070026484A1 Title : Method to increase hydrophobic compound titer in a recombinant microorganism) Abstract : Expression of at least one plant oleosin gene in a microbial cell engineered to produce hydrophobic/lipophilic compounds significantly increases the overall titer of the compound. The hydrophobic nature of the oleosin core is believed to increase the microbial host cell's internal storage capacity for any hydrophobic/lipophilic compound. The method is exemplified using a bacterial host cell engineered to produce significant amount of various carotenoids.) 

134: (8612061220979850475) patent: EP2902101A1 Title : LYCOPENE-CONTAINING OIL-IN-WATER EMULSION COMPOSITION AND PRODUCTION METHOD THEREFOR) Abstract : A lycopene-containing oil-in-water emulsion composition and a method of producing the emulsion composition, the emulsion composition includes an oil phase containing lycopene in an amount of from 0.00001 % to 0.1 % by mass or less with respect to a total mass of the emulsion composition, and an aqueous phase containing at least one kind selected from the group consisting of ascorbic acid, derivatives thereof, salts thereof ascorbic acid and derivatives of ascorbic acid, wherein an average particle diameter of emulsion particles is 120 nm or less.) 

135: (5932090918452733456) patent: US20080015252A1 Title : THERAPEUTIC AGENT FOR VIRUS-ASSOCIATED MALIGNANCY) Abstract : A therapeutic agent comprising fucoxanthin or fucoxanthinol as an active component is disclosed. The therapeutic agent is effective and high clinical utility for medical treatment and prevention of virus-associated malignancy such as adult T-cell leukemia and Burkitt lymphoma.) 

136: (7895636484619340641) patent: US20140234928A1 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express retinolic compounds.) 

137: (6051464686789704934) patent: US8900602B2 Title : DISINTEGRATING PARTICLE COMPOSITION AND ORALLY RAPIDLY DISINTEGRATING TABLET) Abstract : Disclosed is an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity. The orally rapidly disintegrating tablet, which has a good texture and taste, an appropriate hardness, and good disintegrating properties, can be produced by using a composition, which is prepared by dispersing, by spray-drying, an inorganic excipient and starch(es) in complex particles composed of mannitol and xylitol, in an orally rapidly disintegrating tablet.) 

138: (1662948683546352701) patent: US8816040B2 Title : POLYMER DYE) Abstract : A polymer dye has repeating units of formula (I): Each of R1, R2, and R3 is independently a monocyclic carbocyclic group, a condensed polycyclic carbocyclic group, a monocyclic heterocyclic group, or a condensed polycyclic heterocyclic group. In any case, each of R1, R2, and R3 independently may have a substituent. R1 is a divalent group, and R2 and R3 are monovalent groups. D is an organic dye group and n is an integer of from 0 to 10. The polymer dye has a number-average molecular weight of from 500 to 500,000. The dye can be a component in a film. The dye can also be included in various industrial materials in automobiles; communication instruments, such as mobile phones, PDA, remote controllers, mobile information terminals, electronic dictionaries, and electronic organizers; home electric appliances; construction parts; and the like.) 

139: (959570300666906016) patent: EP1377547A2 Title : NOVEL CAROTENOID ESTERS) 

140: (1487994071795348841) patent: EP1646713A2 Title : GENES ENCODING CAROTENOID COMPOUNDS) 

141: (8881206826508269891) patent: US20160060454A1 Title : Automatic reversible foot-lever lift for mowers) 

142: (7555909958180979893) patent: EP2371967A1 Title : Production of carotenoids in oleaginous yeast and fungi) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

143: (549647098940872664) patent: WO2012089615A1 Title : NUTRACEUTICAL PREPARATION MADE FROM MACROALGAE EXTRACT, COMESTIBLE SUBSTANCE COMPRISING IT, AND EXTRACTION PROCESS) Abstract : A process of generating a nutraceutical preparation is described. The process comprises heating a body of liquid containing macroalgae matter therein during a first time period for increasing bioactivity, Collecting leached liquid from the macroalgae matter during the first time period. Applying a hot liquid extraction step to the macroalgae matter during a second time period resulting in a liquid extract. The second time period occurring after the first time period has elapsed. Preparing the nutraceutical preparation by combining the leached liquid with the liquid extract.) 

144: (5984902529600478805) patent: EP2997956A1 Title : WATER-IN-OIL COSMETIC) Abstract : A water-in-oil cosmetic including surface-treated powder including at least one oxide selected from a group consisting of titanium oxide and zinc oxide and having 4-tert-butyl-4-methoxy benzoyl methane on a surface, at least one carotenoid, at least one sorbitan fatty acid ester, at least one polyether-modified silicone, and at least one compound selected from a group consisting of a coating-forming silicone polymer and an alkyl (meth)acrylate polymer.) 

145: (4265051788070467382) patent: EP2818154A1 Title : TOPICAL SKIN PREPARATION AND HEALTHY SKIN CELL ACTIVATION AGENT) Abstract : A topical skin preparation and a normal skin cell activating agent that include lycopene and astaxanthin, a total content of the lycopene and the astaxanthin is in a range of from 0.00001% by mass to 0.2% by mass.) 

146: (3048118752044880290) patent: EP1554372A2 Title : NATURAL PROMOTERS FOR GENE EXPRESSION IN C1 METABOLIZING BACTERIA) 

147: (4036871790483785912) patent: US7521584B2 Title : Carotenoid analogs or derivatives for the inhibition and amelioration of disease) Abstract : A method for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals in a subject whereby a subject is administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The analog or derivative is administered such that the subject's risk of experiencing diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals may be thereby reduced. The analog or analog combination may be administered to a subject for the inhibition and/or amelioration of any disease that involves production of reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals.; In some embodiments, the invention may include a chemical compound including an analog or derivative of a carotenoid. The carotenoid analog or derivative may be synthetic. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include an acyclic alkene including at least one substituent and/or a cyclic ring including at least one substituent. In some embodiments, a carotenoid analog or derivative may include at least one substituent. The substituent may enhance the solubility of the carotenoid analog or derivative such that the carotenoid analog or derivative at least partially dissolves in water.) 

148: (7511264285929079707) patent: EP2806756A2 Title : ENCLOSING MATERIALS IN NATURAL TRANSPORT SYSTEMS) 

149: (6488838704399835490) patent: US20050226858A1 Title : Compositions containing reduced coenzyme Q10 and carotenoid) Abstract : A composition having an antioxidative activity, especially, having a sufficient activity for removing active oxygen and/or free radicals is provided. The composition includes both reduced coenzyme Q10 and a carotenoid, and the activity for removing active oxygen and/or free radicals is synergistically enhanced. A method for removing active oxygen and/or free radicals by using the composition containing both reduced coenzyme Q10 and a carotenoid is also provided.) 

150: (7968098114829278875) patent: US20160067203A1 Title : INTERNAL COMPOSITION) Abstract : An object of the present invention is to provide an internal composition capable of exerting various physiological functions such as a brain-function improving function. That is, the present invention provides an internal composition including docosahexaenoic acid and capsanthin, or docosahexaenoic acid, capsanthin, lutein, and zeaxanthin as active ingredients.) 

151: (6001914807623671091) patent: EP2676553A1 Title : CAROTENOID-CONTAINING COMPOSITION) Abstract : A carotenoid-containing composition, comprising: a carotenoid component comprising at least one crystalline carotenoid, at least 90% by mass of the crystalline carotenoid being non-crystalline; a (poly)glycerol fatty acid ester having from 1 to 6 glycerin units and from 1 to 6 fatty acid units and having at least one hydroxyl group from a glycerin unit; and at least one phenolic antioxidant selected from the group consisting of aromatic carboxylic acids, cinnamic acids, and ellagic acids.) 

152: (456825491947607305) patent: EP2477620A1 Title : METHOD OF SLOWING THE AGING PROCESS BY ACTIVATING SIRTUIN ENZYMES WITH A COMBINATION OF FUCOXANTHIN AND PUNICIC ACID) 

153: (2606518364045056275) patent: US20130189765A1 Title : ALGAL BIO-FLOCCULATION BY INACTIVATION OF PHOTORECEPTORS) Abstract : The present invention relates to a method to induce alga and/or diatom cell bio-flocculation comprising inactivation of the expression of at least one photoreceptor in said alga and/or diatom, constructs able to inhibit the expression of at least one photoreceptor and uses thereof.) 

154: (5176501706846484269) patent: US20080058400A1 Title : Skin external preparation) Abstract : A skin external preparation includes at least arginine, aspartic acid, isoleucine, leucine, lysine, threonine, glycine, histidine, serine, valine, tyrosine, cysteine, phenylalanine, hydroxyproline and acylglutamine among amino acids, or salts thereof, and a skin external preparation includes: at least arginine, aspartic acid, isoleucine, leucine, lysine and threonine among amino acids, or salts thereof, and a hydrolyzed silk.) 

155: (6413544942029128169) patent: US20110039299A1 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

156: (8283073968310449276) patent: US20040253663A1 Title : Genes encoding carotenoid compounds) Abstract : A unique carotenogenic biosynthetic gene cluster has been isolated from Panteoa agglomerans strain DC404, wherein the genetic organization of the cluster is crtE-idi-crtY-crtI-crtB-crtZ. The genes contained within this cluster encode geranylgeranyl pyrophosphate (GGPP) synthetase (CrtE), isopentenyl pyrophosphate isomerase (Idi), lycopene cyclase (CrtY), phytoene desaturase (CrtI), phytoene synthase (CrtB), and beta-carotene hydroxylase (CrtZ). The gene cluster, genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

157: (6753806189176246971) patent: US7288387B2 Title : Genes of strain DC413 encoding enzymes involved in biosynthesis of carotenoid compounds) Abstract : A carotenogenic biosynthetic gene cluster has been isolated from Panteoa stewartii strain DC413, wherein the genetic organization of the cluster is crtE-idi-crtX-crtY-crtI-crtB-crtZ. The genes contained within this cluster encode geranylgeranyl pyrophosphate (GGPP) synthetase (CrtE), isopentenyl pyrophosphate isomerase (Idi), zeaxanthin glucosyl transferase (CrtX), lycopene cyclase (CrtY), phytoene desaturase (CrtI), phytoene synthase (CrtB), and beta-carotene hydroxylase (CrtZ). The gene cluster, genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

158: (799896005045566363) patent: EP2606881A1 Title : FAT-REDUCING AGENT) Abstract : A fat-reducing agent includes a carotenoid-containing composition as an active ingredient, the carotenoid-containing composition including: a carotenoid component including at least one crystalline carotenoid, wherein at least 90% by mass of the crystalline carotenoid is in the non-crystalline state; and a (poly)glycerin fatty acid ester containing from 1 to 6 glycerin units and from 1 to 6 fatty acid units, and having at least one hydroxyl group in the glycerin units.) 

159: (761510633670885964) patent: US20150225539A1 Title : BIO-BASED POLYMER ADDITIVE, A PROCESS FOR PREPARING THE BIO-BASED POLYMER ADDITIVE AND A BIODEGRADABLE POLYMER COMPOSITION COMPRISING SAID BIO-BASED POLYMER ADDITIVE) Abstract : The present invention disclosed a bio-based polymer additive, its preparation process and a biodegradable polymer composition comprising the said bio-based polymer additive for use in manufacturing of biodegradable plastic. The said additive is prepared from the biomass of broken microorganism cell such as microalgae, yeast or other microorganisms. In particular, the bio-based polymer additive is for enhancing rheological properties and/or biodegradability of a polymer. In particular, the additive is for use as a pigment.) 

160: (2379676355335867517) patent: EP2658962A1 Title : USE OF SACCHAROMYCES CEREVISIAE SUC2 GENE IN YARROWIA LIPOLYTICA FOR SUCROSE UTILIZATION) 

161: (304389394013013021) patent: WO2005044975A2 Title : GENES ENCODING CAROTENOID COMPOUNDS) Abstract : A unique carotenogenic biosynthetic gene cluster has been isolated from Panteoa agglomerans strain DC404, wherein the genetic organization of the cluster is crtE-idi-crtY-crtI-crtB-crtZ. The genes contained within this cluster encode geranylgeranyl pyrophosphate (GGPP) synthetase (CrtE), isopentenyl pyrophosphate isomerase (Idi), lycopene cyclase (CrtY), phytoene desaturase (CrtI), phytoene synthase (CrtB), and beta-carotene hydroxylase (CrtZ). The gene cluster, genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

162: (88696330455699483) patent: EP2305373A1 Title : MICROCAPSULE, PROCESS FOR PRODUCTION THEREOF, AND FOOD OR BEVERAGE CONTAINING MICROCAPSULE) Abstract : The method of producing microcapsules 100 comprises a primary dispersion step in which a water-soluble substance and a fat-soluble substance are mixed to obtain a primary dispersion liquid having primary dispersion particles 10 composed of the water-soluble substance dispersed in the fat-soluble substance, a secondary dispersion step in which the primary dispersion liquid and a sodium alginate aqueous solution are mixed to obtain a secondary dispersion liquid having secondary dispersion particles 20 composed of the primary dispersion liquid dispersed in the sodium alginate aqueous solution, and a spraying step in which the secondary dispersion liquid is sprayed for contact with a calcium ion-containing solution 9 to form a calcium alginate gel 30 and to obtain microcapsules 100 having the secondary dispersion particles 20 dispersed in the calcium alginate gel 30.) 

163: (9131278765009892270) patent: US20110052680A1 Title : ELECTRICALLY-INSULATED BEARING.) 

164: (6274025668694974001) patent: EP1890691A2 Title : COMPOSITIONS COMRISING NEBIVOLOL) 

165: (4844051276904914645) patent: JP2010235574A Title : FUCOXANTHIN CLATHRATE) Abstract : PROBLEM TO BE SOLVED: To provide a photostable fucoxanthin cyclodextrin (CD) clathrate and a composition of the same by establishment of a simple process for the production the same. ;SOLUTION: The fucoxanthin CD clathrate excellent in stability and hard to discolor can be obtained by dissolving CD in water under heating at 40C and adding a fucoxanthin-ethanol solution thereto followed by vacuum drying of the resultant mixture at 40C or lower. ;COPYRIGHT: (C)2011,JPO&INPIT) 

166: (6168966649383444511) patent: EP2532251A1 Title : Functional food and pharmaceutical compositions for anti-obesity comprising capsanthin and its fatty acylester derivatives having anti-adipogenic activity) Abstract : One or more embodiments of the present invention describe a novel use of capsanthin and/or fatty-acyl ester of capsanthin to inhibit both the differentiation of pre-adipocytes to adipocytes and the accumulation of fat in the adipocytes. One or more embodiments of the present invention are based on findings that capsanthin contained in some natural products such as red pepper, paprika, bell pepper, etc. have anti-adipogenic activity by inhibiting both the differentiation of pre-adipocyte into adipocyte and the accumulation of fat in adipocytes, Therefore, this findings provide a functional food and a pharmaceutical composition wherein capsanthins and the extract of any natural products containing the same components are included in the functional food and the pharmaceutical composition, to offer obesity prevention and/or treatment effects.) 

167: (1089088779653746516) patent: WO2011146833A1 Title : METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST) Abstract : Yeast strains capable of increased prenyl phosphate production are provided, enabling increased terpenoid molecule production. Heterologous yeast strains with high prenyl phosphate availability are prepared using one or both of two different strategies for increasing the availability of prenyl phosphates for terpenoid production. First, by co- expressing multiple mevalonate pathway gene analogs, a novel heterologous combination of genes results, some of which increases the inherent availability of prenyl phosphates in yeast. Second, by expressing the non-endogenous enzyme ATP citrate lysase (ACL), a buildup of high cytosolic concentration of acetyl-CoA is produced in the cytosol of S. cerevisiae.) 

168: (1956951410941351793) patent: EP2172223A1 Title : COMPOSITION CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCE) Abstract : The present invention provides a powder superior in water-dispersibility/solubility, workability and tabletability, which contains an oil component containing a bioactive substance, a water-soluble polymer, a saccharide other than polysaccharides and a surfactant, at a particular ratio. The powder can be utilized for food, food with nutrient function claims, food for specified health uses, nutritional supplement, nutritional product, animal drug, drinks, feed, pharmaceutical product, quasi-drug, cosmetic and the like.) 

169: (3543462199295187786) patent: US20120184612A1 Title : Compositions and Methods Relating to Carotenoids) Abstract : A pet food composition having at least two carotenoids. The carotenoids can include a keto-carotenoid and at least one non-keto-carotenoid. The keto-carotenoid can include astaxanthin. The keto-carotenoid can include astaxanthin ester. The non-keto-carotenoid can include beta-carotene and/or lutein.) 

170: (7238625285340161379) patent: EP2928315A2 Title : AEROSOL DISPENSER WITH EDIBLE CARTRIDGE) 

171: (5370726635504916787) patent: JP2009033970A Title : PROCESS FOR PRODUCING FUCOXANTHINOL) Abstract : PROBLEM TO BE SOLVED: To provide a process for producing fucoxanthinol by which the fucoxanthinol is produced at a low cost and in high yield in a short time. ;SOLUTION: Fucoxanthin and a first surfactant are dissolved in a first organic solvent which is then evaporated to dry the fucoxanthin and the surfactant. The resultant dry substance is subsequently dissolved in a pH buffer solution and a lipase is added to the pH buffer solution in which the dry substance is dissolved to carry out incubation at a prescribed temperature for only a prescribed time to produce unpurified fucoxanthinol. The resultant unpurified fucoxanthinol is then dissolved in a second organic solvent and developed by chromatography to thereby afford the purified fucoxanthinol. ;COPYRIGHT: (C)2009,JPO&INPIT) 

172: (7898214848405026058) patent: US8871217B2 Title : Method for Producing Fucoxanthin) Abstract : The present invention provides a method for producing fucoxanthin extract, said method comprising: performing absorption of the fucoxanthin extract by using absorbent and then performing elution to remove heavy metals and arsenic salt contained in the fucoxanthin extract, wherein the absorbent is selected from a group having macroporous resin, polyamide, activated carbon, alumina and a combination thereof. The method for producing fucoxanthin extract according to the present invention, the content of heave metal in the fucoxanthin extract can be reduced, while the content of fucoxanthin in the fucoxanthin extract can increase. In addition, the present invention also provides a fucoxanthin extract obtained by the above method, as well as fucoxanthin products containing the fucoxanthin extract.) 

173: (4268300348780923260) patent: US20150157721A1 Title : POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY) Abstract : The invention comprises compounds, methods of making, and methods of using. The compounds may have a linear or cylic backbone and three or four appended functional groups: one or two lipohilic compounds including sterols or fat soluble vitamins, one or two hydrophilic polymer, and one or two carbohydrate. A group of polymer-carbohydrate conjugates having a central backbone and three appended functional groups are disclosed wherein one lipophilic compound is void of both steroid acids. The conjugate may have fatty acids as the primary lipophilic carrier, one hydrophilic polymer, and one carbohydrate. Specific functional groups may be selected for specific applications in formulating pharmaceuticals, cosmetics, nutriceuticals, and the like. Typical coupling reaction of the conjugates may involve one or more or combinations or in series of alkylation including N-alkylation or O-alkylation, etherification, esterification and amidation chemical processes. A variety of linkers between the backbone and functional groups may also be selected to modify the carriers or center backbones for the coupling reactions and optimize performance of the conjugates.) 

174: (5974069407677273260) patent: EP2301659A1 Title : MICROCAPSULES, METHOD OF PRODUCING THE MICROCAPSULES AND FOOD AND DRINK CONTAINING THE MICROCAPSULES) Abstract : A method of producing microcapsules that comprises an emulsification step in which a fat-soluble substance and a sodium alginate aqueous solution are mixed to obtain an emulsified liquid in which there are dispersed emulsified particles composed of the fat-soluble substance and having a mean particle size of not greater than 800 nm, and a spraying step in which the emulsified liquid is sprayed into a calcium ion-containing solution to obtain microcapsules in which the emulsified particles are encapsulated.) 

175: (274935983950394990) patent: JPH10158156A Title : WIRING-PIPING DEVICE FOR MACHINE TOOL) Abstract : PROBLEM TO BE SOLVED: To provide a machine tool in which a main spindle side shaft-fed by a high speed and high acceleration is moved in three axes direction of X, Y, Z axes and the man hour of the wiring and piping from a fixed part to a move part can be reduced. SOLUTION: In the lateral machining center of a table 9 fixed type by three axes movement including that a column 3 provided with a rotary main spindle 1 is moved in a Z-axis direction on a saddle 5 and an entire saddle is moved in an X-axis direction, the wiring and piping relay box 15 from the fixed part 19 to a moving member stays on an exclusive guide rail 23 and the box is followed to the movement of the saddle 5 by a communication bracket 25 and the intermediate part, of the longitudinal direction of some wirings and pipings is fixed to the relay box 15 through a connector and the wiring man hour is reduced.) 

176: (1320777300351365785) patent: US20080311175A1 Title : Compositions and Methods for Promoting Weight Gain and Feed Conversion) Abstract : The invention features compositions for administration of an oxidatively transformed carotenoid or a component thereof and methods of promoting weight gain and feed conversion efficiency therewith.) 

177: (4914326050545136494) patent: US9282759B2 Title : Composition including an unsaponifiable fraction) Abstract : The present invention relates to a composition, notably cosmetic, nutraceutical, dermatological, pharmaceutical or dietary, including at least one unsaponifiable extract, a drug including one such composition, the use of one such composition, a treatment method consisting in administering one such composition and a method comprising the administration of one such composition.) 

178: (7181021598135474319) patent: US9096508B2 Title : METHOD FOR PRODUCING CAROTENOID COMPOSITION) Abstract : The present invention provides an efficient method for industrially producing a naturally-derived carotenoid composition with a large amount of a carotenoid such as astaxanthin from a culture of a yeast of the genus Xanthophyllomyces without requiring any special extraction equipment and any complicated refinement process and without any need for organic solvents harmful to humans. Provided is a method for producing a carotenoid composition, including the steps of washing a carotenoid-containing yeast of the genus Xanthophyllomyces with an organic solvent (A) at 30 DEGC. or lower, and extracting a carotenoid from the washed yeast with an organic solvent (B) at 10 DEGC. to 70 DEGC.) 

179: (4282594808169488256) patent: WO2009037947A2 Title : ADHESIVE GEL SHEET FOR LIVING ORGANISMS AND SHEET FORM COSMETICS COMPRISING THE SAME) Abstract : To provide an adhesive gel sheet for living organisms which may allow efficient permeation of the skin by carotenoid, and also provide a sheet-form cosmetic using the same, It is provided an adhesive gel sheet for living organisms which includes a hydrogel having a carotenoid-containing O/W emulsion, gelatin or a derivative thereof and a hydrophilic polymer, and further comprises a polyvalent inorganic salt, wherein the content of the polyvalent inorganic salt is 0.1% or less by mass of the entire mass of the hydrogel. It is preferable that the hydrophilic polymer be a polysaccharide that forms a thermoreversible gel.) 

180: (7677116137343136283) patent: US20100150853A1 Title : Artificially coloring the skin with a carotene compound, a xanthophyll compound and a lipophilic green dye composition) Abstract : A method for artificially coloring the skin entails topical application thereon of a composition containing, formulated into a physiologically acceptable medium: a) at least one compound of the carotene type, b) at least one compound of the xanthophyll type, c) at least one lipophilic green dye; the composition advantageously includes a mixture of dyes including: a) at least one compound of the carotene type, b) at least astaxanthin, c) at least one lipophilic green dye.) 

181: (2855581025301286975) patent: US8574639B2 Title : Fermented ginseng concentrate having IH-901) Abstract : The present invention relates to a method for preparing a fermented ginseng concentrate. The method first involves subjecting ginseng to an extraction with a solvent to obtain a ginseng extract. Next, pectinase and beta-galactosidase are added to the ginseng extract under conditions effective to ferment the ginseng extract. The fermented extract is then concentrated to produce a fermented ginseng concentrate. The method may further involve drying the fermented ginseng concentrate to obtain fermented ginseng powder. Combinations of the invention ginseng materials with other active and/or inactive materials are also disclosed.) 

182: (1249338317688569722) patent: EP1620454A2 Title : GENES ENCODING CAROTENOID COMPOUNDS) 

183: (402831740473048992) patent: EP2074214A2 Title : PRODUCTION OF STEROLS IN OLEAGINOUS YEAST AND FUNGI) 

184: (3067633375471283650) patent: EP0719866B1 Title : Process for extraction of carotenoids from bacterial cells) Abstract : A process for extraction of a carotenoid compound from bacterial cells containing the carotenoid compound comprising the step of bringing the bacterial cells into contact with supercritical fluid so as to extract the carotenoid compound from the cells. The process provides carotenoid compounds which can be safely used as feed additives and food additives.) 

185: (1347872187540067871) patent: WO2012049306A1 Title : ALGAL BIO-FLOCCULATION BY INACTIVATION OF PHOTORECEPTORS) Abstract : The present invention relates to a method to induce alga and/or diatom cell bio-flocculation comprising inactivation of the expression of at least one photoreceptor in said alga and/or diatom, constructs able to inhibit the expression of at least one photoreceptor and uses thereof.) 

186: (8575348337333807024) patent: EP2935570A1 Title : CAROTENE HYDROXYLASE AND ITS USE FOR PRODUCING CAROTENOIDS) 

187: (6566288204558363924) patent: WO2002068385A2 Title : NOVEL CAROTENOID ESTERS) Abstract : Monoesters, diesters and polyesters are provided wherein both the acid-derived moiety and the alcohol-derived moiety of the esters are carotenoid compounds. The synthetic ester linkage between two or more carotenoids provides new compounds in which the similar and complementary properties of the individual carotenoids are combined. The new all-carotenoid esters may be useful as antioxidants, therapeutic agents, pigmenting ingredients in poultry feed or as coloring agents for fats. The polyesters have the potential to act as molecular wires with unique electrical conductance characteristics. The all-carotenoid esters may be prepared from the esterification of at least one hydroxy carotenoid with at least one carboxylic carotenoid, or via the reaction of the acid chloride of a carboxylic carotenoid with a hydroxy carotenoid. Preferred hydroxy carotenoids include lutein, zeaxanthin, cryptoxanthin, violaxanthin, carotene diol, hydroxy carotene, hydroxylcopene, alloxanthin and dehydrocryptoxanthin. Preferred caroxylic carotenoids include bixin, norbixin, beta -apo-8-carotenoic acid, crocetin, diapocarotenoic acid, carboxylcarotene and azafrin.) 

188: (5649731553332403121) patent: WO2012138885A1 Title : MACROCYSTIS PYRIFERA DERIVED HEALTH AND WELLNESS PRODUCTS AND METHODS OF USING THE SAME) Abstract : The exudate of macroalage is collected and selectively dried to produce a health supplement capable of oral, topical, or transdermal delivery to benefit the health of user. The macroalage is preferably brown macroalage of the species Macrocystis pyrifera and the exudate preferably collected within 12 to 24 hours of harvest. High purity Fucoidan derived from Macrocystis pyrifera is administered in an effective amount to benefit the health of a user. Collected exudate, dried exudate or High Purity Fucoidan may be combined with other materials such as krill oil to create a synergistic boost to Antioxidant power and health benefits.) 

189: (4266380366260292698) patent: US20100222422A1 Title : DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF ARONIA AND METHODS OF USING SAME TO PROMOTE WEIGHT LOSS) Abstract : A dietary supplement composition comprising aronia extract containing at least 20% anthocyanins by dry weight. The aronia extract is derived from the aronia melanocarpa plant. The aronia extract comprises approximately 10%-30% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is provided in the composition. The dietary supplement composition is administered orally to promote weight loss.) 

190: (4023639763395440630) patent: JP2010120939A Title : METHOD FOR PRODUCING FUCOXANTHIN-CONTAINING EXTRACT) Abstract : PROBLEM TO BE SOLVED: To provide a method for producing a fucoxanthin-containing extract which can reduce the heavy metal content to increase a fucoxanthin content, a fucoxanthin-containing extract obtained by the production method, and a fucoxanthin product containing the fucoxanthin-containing extract. ;SOLUTION: The method for producing a fucoxanthin-containing extract whose heavy metal content and arsenic content are reduced includes a step of extracting seaweeds with an extracting solvent to obtain an extracted fluid and an adsorbent treatment step of treating the obtained extracted fluid with an adsorbent. ;COPYRIGHT: (C)2010,JPO&INPIT) 

191: (2041529359394653702) patent: WO1998028082A1 Title : FLOTATION SEPARATION METHODS AND SYSTEMS FOR DEWATERING SUSPENSIONS OF MICROALGAE AND EXTRACTING COMPONENTS THEREFROM) Abstract : A process and system are disclosed for recovering mixed carotenoids from the alga Dunaliella salina. The harvested cells are ruptured, typically by circulating the algal suspension at high pressure through a pump loop. The cells can then be dewatered by absorptive bubble separation techniques, including a froth flotation circuit that has a roughing zone and a concentrating zone. If further concentration is desired, the algal concentrate can be mechanically filtered in a cross flow microfiltration unit in the absence of flocculating agents with substantially no loss of carotenoids in the permeate. Various methods for extracting mixed carotenoids and other components from the algae are disclosed, including dense gas extraction, and extractions with natural and synthetic flavorants, and edible oils.) 

192: (8177240171931141494) patent: WO2002068385A9 Title : NOVEL CAROTENOID ESTERS) Abstract : Monoesters, diesters and polyesters are provided wherein both the acid-derived moiety and the alcohol-derived moiety of the esters are carotenoid compounds. The synthetic ester linkage between two or more carotenoids provides new compounds in which the similar and complementary properties of the individual carotenoids are combined. The new all-carotenoid esters may be useful as antioxidants, therapeutic agents, pigmenting ingredients in poultry feed or as coloring agents for fats. The polyesters have the potential to act as molecular wires with unique electrical conductance characteristics. The all-carotenoid esters may be prepared from the esterification of at least one hydroxy carotenoid with at least one carboxylic carotenoid, or via the reaction of the acid chloride of a carboxylic carotenoid with a hydroxy carotenoid. Preferred hydroxy carotenoids include lutein, zeaxanthin, cryptoxanthin, violaxanthin, carotene diol, hydroxy carotene, hydroxylcopene, alloxanthin and dehydrocryptoxanthin. Preferred caroxylic carotenoids include bixin, norbixin, beta -apo-8-carotenoic acid, crocetin, diapocarotenoic acid, carboxylcarotene and azafrin.) 

193: (8558870036019793226) patent: WO2011143271A2 Title : THERAPEUTIC LIPOSOMES AND METHODS FOR PRODUCING AND USING THE SAME) Abstract : The present invention provides therapeutic liposomes and methods for producing and using the same. In particular, therapeutic liposomes of the invention comprise phospholipids comprising C16-C22 fatty acid ester moieties. In some embodiments, these therapeutic liposomes are used in assisting delivery of an active compound, e. g., a drug and/or a nutraceutical, to a subject. In some embodiments, compositions of the invention have synergistic therapeutic effect.) 

194: (2687315157427089081) patent: EP2597156A1 Title : METHOD FOR MANUFACTURING A FAT-SOLUBLE BIOACTIVE SUBSTANCE) Abstract : Provided is a production method of a lipophilic bioactive substance, which includes mixing an aqueous suspension of a microbial cell containing the lipophilic bioactive substance or a microbial cell homogenate thereof and an organic solvent in the presence of a particular surfactant, and extracting the lipophilic bioactive substance into the organic solvent phase. This production method enables extraction without using special dehydrating, drying facility, and without causing a decrease in the yield due to degraded separability between solvent and fungus body component, as well as efficient industrial production.) 

195: (7874105358782996212) patent: US20090306222A1 Title : FOOD SUPPLEMENTS AND USES THEREOF) Abstract : The invention features compositions for administration of an oxidatively transformed carotenoid, fractionated oxidatively transformed carotenoid and components of oxidatively transformed carotenoid. The compositions are useful for supplementing the diet of an animal.) 

196: (9147624327254410498) patent: US20130108706A1 Title : DIETARY FORMULATIONS) Abstract : The present invention relates to the field of nutritional support for individuals and reducing the effects of muscle conditions caused by high levels of physical activity. In particular, the invention provides dietary formulations, compositions comprising these formulations and uses of these compositions to support the body's muscle regeneration process.) 

197: (6172018406405631636) patent: US20140274965A1 Title : Drink Product and Use Thereof) Abstract : A drink product having as an active ingredient an inositol hexaphosphate and optionally additional inositol moieties. Hexaphosphates for use in the invention include myoinositol hexaphosphate and/or any of the other 8 optical isomers thereof. The optional additional inositols include myoinositol and/or any of the other 8 optical isomers thereof. Uses for prevention, treatment, and reduction in risk of developing or progression of a number of conditions are disclosed.) 

198: (4935226200023224017) patent: US20120156259A1 Title : Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels) Abstract : The present invention relates to biodegradable polyethylene glycol based water-insoluble hydrogels comprising backbone moieties which are interconnected by hydrolytically degradable bonds, the backbone moieties further comprising reactive functional groups, wherein the water-insoluble hydrogel is further characterized in that the ratio between the time period for the complete degradation of the hydrogel by hydrolysis of the degradable bonds into water-soluble degradation products comprising one or more backbone moieties and the time period for the release of the first 10 mol-% of water-soluble degradation products comprising one or more backbone moieties based on the total amount of backbone moieties in the hydrogel is greater than 1 and equal to or less than 2. The invention further relates to conjugates of such hydrogels with ligands or ligating groups, prodrugs and pharmaceutical compositions as well as their use in a medicament.) 

199: (6223947835224807773) patent: WO2007050769A2 Title : GENE TARGETS FOR ENHANCED CAROTENOID PRODUCTION) Abstract : The present invention provides engineered cells and methods for utilizing same. Methods for producing carotenoids or for enhanced carotenoid synthesis utilizing cells with enhanced dxs, idi, or ispFD gene expression, diminished or abrogated gdhA, aceE, fdhF, yjiD, hnr or yjfP gene expression or any combination thereof and diminished or abrogated ackA, appY, aspC, clp, clpP, clpXP, crcB, csdA, cyaA, evgS, fdhA, fdhD, feoB, fumA, glnE, glxR, gntK, hycI, lipB, lysU, modA, moeA, nadA, nuoC, nuoK, pflB, pitA, pst, pstC, pta, yjiD, sohA, stpA, yagR, yaiD, ybaS, ycfZ, ydeN, yebB, yedN, yfcC, ygjP, yibD, yjfP, yjhH, or yliE gene expression, or a combination thereof are disclosed. Genes with diminished or abrogated expression may have inhibited expression, activity or function.) 

200: (3563172354987139160) patent: US20160067201A1 Title : COMPOSITIONS AND METHODS FOR THE REDUCTION OR PREVENTION OF HEPATIC STEATOSIS) Abstract : Methods useful for reducing or preventing non-alcoholic steatohepatitis or hepatic steatosis are provided herein. Such methods may comprise administering to a subject in need thereof a sirtuin pathway activator and/or PDE5 inhibitor alone or in combination with an amount of a branched amino acid in free amino acid form, or a metabolite thereof. Also provided herein are compositions and kits for practicing any of the methods described herein.) 

201: (7811077360569570342) patent: US20070036742A1 Title : Methods and compositions for modulating hair growth or regrowth) Abstract : The present invention relates to compositions and methods for modulating hair growth or regrowth. The compositions of the present invention comprise extracts of one or more of the following: Boswellia serrata, Undaria pinnatifida, green tea (e. g., Camellia sinensis), shiso, Pureraria mirifica, luteolin (e. g. Perilla ocymoides leaf extract), astilbin, vitamin E, amentoflavone, tetrahydropiperine, licochalcone, astaxanthin, red clover, Brassica juncea, unfermented green rooibos, enzyme CoQ10, salvia, ximenynic acid, hops oleoresin, apple, soy, saw palmetto, or ellagic extract, or any derivative thereof. In particular, the compositions and methods of the present invention can be used to stimulate or increase hair growth and/or prevent or slow the loss of hair by having one or more of the following functions: (a) inhibiting synthesis of DHT; (b) inhibiting proteasomal activity; (c) inhibiting IL-1 activity; (d) increasing vascularization; (e) increasing expression of vascular endothelial growth factor; (f) increasing expression of keratinocyte growth factor; (g) inhibiting inflammation; or (h) acting as an antibacterial.) 

202: (8850920886384381269) patent: US9284294B2 Title : Functionalized polymer compositions) Abstract : The invention relates to functionalized polymers including homopolymers and copolymers and their uses in industrial applications and in agricultural applications. In particular, the homopolymers and copolymers may be, for example, used in polymer blends, used as nutritives and in feed compositions, and used in combination with a pharmaceutical or nutritive.) 

203: (5257069268120162863) patent: US20100137646A1 Title : PROCESS FOR THE PREPARATION OF XANTHOPHYLL CRYSTALS) Abstract : The invention describes the preparation and isolation of xanthophylls from plant sources. whereby a transesterification process is utilized without the necessity of an aqueous format.) 

204: (8966810875103006550) patent: US20130071525A1 Title : COATING FAT COMPOSITION AND PARTICULATE COMPOSITION USING THE SAME) Abstract : A particulate composition, wherein a hydrophilic substance is polydispersed in a matrix of a fat composition having a solid fat content at 25 C of 58% or more and a solid fat content at 37 C of 90% or less; and a coating fat composition containing 45% by weight or more of a triglyceride comprising at least both a saturated fatty acid having 6 to 12 carbon atoms and a saturated fatty acid having 14 or more carbon atoms as constituent fatty acids, wherein the proportion of the saturated fatty acid having 14 or more carbon atoms in the constituent fatty acids of the whole fat exceeds 50% by weight.) 

205: (4028521139288358449) patent: WO2013113027A2 Title : ENCLOSING MATERIALS IN NATURAL TRANSPORT SYSTEMS) Abstract : An edible composition, particularly an edible transport system, comprising an edible substance and a cross-linked matrix encapsulating the edible substance, the cross-linked matrix comprising (1) at least one edible polymer and edible particles or (2) a plurality of edible polymers.) 

206: (3282008269092173311) patent: US20150030662A1 Title : Wall construction and method of forming the same) 

207: (1302757633575309486) patent: EP2215168B1 Title : ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL) 

208: (5677491070695670806) patent: WO2009126738A2 Title : DRIED FORMULATIONS) Abstract : The present invention provides novel formulations with improved bioavailability for substances such as ubiquinone, ubiquinol and omega-3 fatty acid. The present invention provides methods and compositions for drying formulations of such substances, wherein those dried formulations can readily be dissolved in water. The compositions and methods of the invention are of particular use in adding nutrients, such as vitamins and minerals, to food products such as beverages.) 

209: (1452293494885233056) patent: US7851199B2 Title : Production of carotenoids in oleaginous yeast and fungi) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

210: (4983060665059639556) patent: EP0732378A2 Title : Method for purifying xanthophyll compound) Abstract : A method for purifying a xanthophyll compound involves the steps of: (a) adding a nonpolar solvent and water to an aqueous organic solvent solution containing the xanthophyll compound; (b) subjecting to liquid-liquid extraction to thereby obtain a nonpolar solvent phase; and (c) subjecting the nonpolar solvent phase to at least one step selected from the following steps (c-1) to (c-3): step (c-1) of concentrating the nonpolar solvent phase; step (c-2) of adding water to the nonpolar solvent phase followed by further subjecting at least once to liquid-liquid extraction; and step (c-3) of further adding a nonpolar solvent to the nonpolar solvent phase whereby the xanthophyll compound is precipitated.) 

211: (8418765915574910406) patent: WO2015187689A1 Title : METHODS AND COMPOSITIONS TO STABILIZE DIFFERENT STEM CELL STATES) Abstract : Provided herein are methods and compositions for maintaining human stem cells in either a nave state or a primed state, inducing, promoting, inhibiting, or controlling the transition from one state to another, and detecting the state of a stem cell. Also disclosed are compositions comprising substantially homogenous populations of primed state or nave state stem cells.) 

212: (4391616829194418533) patent: WO2007120423A9 Title : PRODUCTION OF QUINONE DERIVED COMPOUNDS IN OLEAGINOUS YEAST FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express quinone derived compounds.) 

213: (6306128503743841239) patent: JP2013540110A 

214: (869660687938856360) patent: US20080119551A1 Title : SKIN COSMETICS COMPRISING A CYSTINE DERIVATIVE AND A CHEMICAL PEELING AGENT, A BACTERICIDE, AN ANIONIC SUFACTANT, OR A CATIONIC SURFACTANT) Abstract : The present invention provides cosmetics or external preparations for skin are provided that contain, as the effective ingredient, a chemical peeling agent, a bactericide, an anionic surfactant or a cationic surfactant component in combination with a cystine derivative of formula (1):) 

215: (5814266054946313393) patent: US20160279130A1 Title : COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions comprise a combination of a PDE 5 inhibitor, such as sildenafil or icariin, and resveratrol, and a branched amino acid such as leucine, or its metabolite.) 

216: (3251992045881076493) patent: US20110091569A1 Title : ECHINODERM-DERIVED EXTRACTS, METHODS OF PREPARATION AND USES THEREOF) Abstract : An Echinozoa tissue or organ extract comprising antioxidant compounds is disclosed. Also disclosed is a process for obtaining an Echinozoa tissue or organ extract, as well an extract obtained by this process. Compositions comprising such an extract are also described. Uses of such extracts/compositions, as well as corresponding methods of treatment, for example as an antioxidant or to decrease or inhibit oxidative stress in a cell, tissue or subject are also described.) 

217: (7454956899645372812) patent: US20150087688A1 Title : PRODRUGS OF HYDROXYL-COMPRISING DRUGS) Abstract : The present invention relates to a prodrug or a pharmaceutically acceptable salt thereof comprising a biologically active moiety-linker conjugate D-L, wherein D is a hydroxyl-comprising biologically active moiety; and L is a promoiety comprising a moiety L1 represented by formula (I) and wherein L1 is substituted with one to four groups L2-Z and optionally further substituted, provided that the hydrogen marked with the asterisk in formula (I) is not replaced by a substituent; wherein L2 is a single chemical bond or a spacer and Z is a carrier group. The invention also relates to pharmaceutical compositions comprising said prodrugs and their use as medicaments.) 

218: (8477074618053638959) patent: WO2007120423A2 Title : PRODUCTION OF QUINONE DERIVED COMPOUNDS IN OLEAGINOUS YEAST FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express quinone derived compounds.) 

219: (6571395887024920385) patent: EP3077006A1 Title : POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY) 

220: (8615952287862458653) patent: US20120282358A1 Title : ORAL ADMINISTRATION COMPOSITION) Abstract : A composition which has high safety and is excellent in the effect of reducing body fat, such as visceral fat, subcutaneous fat and the like, and neutral fat, and a food, a pharmaceutical and a feed comprising the same, are provided. An oral administration composition having a body fat reducing action and/or a neutral fat reducing action, which is a composition comprising a carotenoid and a sphingolipid or a carotenoid and a flavonoid and/or a derivative thereof, preferably a composition comprising a cryptoxanthin and a sphingolipid or a cryptoxanthin and a flavonoid and/or a derivative thereof, wherein the cryptoxanthin and/or the sphingolipid and/or the flavonoid are derived from a citrus fruit and the citrus fruit is preferably Citrus unshiu.) 

221: (2206112562257533731) patent: US20100215782A1 Title : NOVEL MITOCHONDRIAL UNCOUPLING METHODS AND COMPOSITIONS FOR ENHANCING ADIPOCYTE THERMOGENESIS) Abstract : Disclosed are methods, compounds, and compositions comprising botanically based drugs, medical foods, and dietary supplements for the prevention and treatment of metabolic disorders, in particular obesity, weight gain, insulin resistance syndromes, diabetes, fasting hyperlipidemia and osteoarthritis. More specifically, the invention relates to pharmaceutical therapeutic methods and compositions utilizing phytochemicals, natural plant extracts and combinations to modify adipocyte physiology to enhance thermogenesis and modify cytokine secretion.) 

222: (4281836885284601384) patent: US9234204B2 Title : Topical composition comprising transformed bacteria expressing a compound of interest) Abstract : Compositions comprised of a population of transformed bacteria formulated for topical application to a subject are described. The population of transformed bacteria are created from a non-pathogenic bacteria and transformed to express a compound of interest for a therapeutic or a cosmetic purpose. In one embodiment, the composition is for protection of the skin from ultraviolet rays.) 

223: (8593547521870570562) patent: EP2215168A1 Title : ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL) 

224: (2298619352101492984) patent: US20080261896A1 Title : Testosterone generating and metabolizing enhancer) Abstract : A testosterone generating and metabolizing enhancer is proposed in the invention, which increases concentrations of testosterone in both seminal vesicle and bloodstream, and may further promote the gene expression of metabolizing testosterone into 5alpha-reductase of dihydrotestosterone. The testosterone generating and metabolizing enhancer of the invention is characterized in that an effective component thereof may be phenylethanoid glycosides; said phenylethanoid glycosides may comprise at least one of echinacoside and acteoside, or may comprise both echinacoside and acteoside, more preferably. The testosterone generating and metabolizing enhancer of the invention may be applied in medicines, substances for external uses on skin, and foods and beverages for mammals (including humans); as well as an animal feed for mammals.) 

225: (8599158610840243728) patent: US7393937B2 Title : N-acetylglucosamine derivatives and use thereof) Abstract : The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: wherein R<1 >is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R<2>, R<3>, and R<4 >are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be alpha or beta; provided that R<1>, R<2>, R<3>, and R<4 >must not be all hydrogen atoms. It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.) 

226: (5094824475511759938) patent: EP1074254A2 Title : Use of plant polyphenols with vitamines for treating iron overload) Abstract : The present invention relates to the use of anthocyanins or proantocyanidins in combination with lipophilic antioxidant vitamins for the treatment of the iron overloading conditions. Also claimed are compositions comprising anthocyanins or proantocyanidins and lipophilic antioxidant vitamins, preferably combined with selected pro-antioxidant vitamins and minerals, to be orally administered for the amelioration of the clinical parameters caused by the excess of body iron.) 

227: (7030648781442353898) patent: JP2001335480A Title : PROTECTIVE AGENT FOR NEUROCYTE) Abstract : PROBLEM TO BE SOLVED: To obtain a pharmacologically effective substance capable of suppressing disorders due to ischemia and reperfusion and having protective actions on neurocytes with high safety. SOLUTION: A fucoxanthin contained in brown algae such as Undaria pinnatifida Suringar is ingested.) 

228: (8851742633302401183) patent: US20160281041A1 Title : BIOREACTOR USING MACROALGAE) Abstract : The invention features a bioreactor for the growth of macroalgae and methods for using the bioreactor to maintain optimal nutrient levels for the organisms in an aquarium or aquaculture system. The devices and methods of the invention provide for the bioremediation of excess nutrients in order to maintain nutrient balance in an aquarium or aquaculture system that facilitates growth and/or health of one or more of the organisms that reside therein.) 

229: (7914999270019815325) patent: WO2009027850A2 Title : PROCESS FOR THE PREPARATION OF XANTHOPHYLL CRYSTALS) Abstract : The invention describes the preparation and isolation of xanthophylls from plant sources, whereby a transesterification process is utilized without the necessity of an aqueous format.) 

230: (7032178651266972143) patent: US20150174188A1 Title : METHODS FOR INHIBITING ADVANCED GLYCATION END PRODUCT PRODUCTION, INHIBITING FIBROBLAST APOPTOSIS, AND/OR PROMOTING HUMAN FIBROBLAST-COLLAGEN GRATING FORMULATION USING CHERRY BLOSSOM AND CHERRY LEAF EXTRACT) Abstract : Disclosed is an AGE production inhibitor or the like, which effectively inhibits the production of an advanced glycation end product (AGE), while having improved biological safety. Specifically disclosed is an AGE production inhibitor or the like, which contains en extract of cherry tree (preferably blossoms or leaves thereof) and/or a processed product of the extract as an active substance. The AGE production inhibitor or the like contains, as an active substance, at least one compound that is selected from among 1-O-(E)-Caffeoyl--D-glucopyranoside, 1-O-(E)-Coumaroyl--D-glucopyranoside, 1-O-(E)-Cinnamoyl--D-glucopyranoside, Kaempferol 3-O--D-glucopyranoside, Quercetin 3-O--D-glucopyranoside, Kaempferol 3-O-(6-malony)--D-glucopyranoside, and Quercetin 3-O-(6-malony)--D-glucopyranoside.) 

231: (4890513723294663137) patent: US9198883B1 Title : Compositions and methods for modulating metabolic pathways) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

232: (1559341614897086537) patent: EP0719866A1 Title : Process for extraction of carotenoids from bacterial cells) Abstract : A process for extraction of a carotenoid compound from bacterial cells containing the carotenoid compound comprising the step of bringing the bacterial cells into contact with supercritical fluid so as to extract the carotenoid compound from the cells. The process provides carotenoid compounds which can be safely used as feed additives and food additives.) 

233: (6738097301297240263) patent: WO2008021574A2 Title : MODULATING PLANT CAROTENOID LEVELS) Abstract : Methods and materials for modulating (e. g., increasing or decreasing) carotenoid levels in plants are disclosed. For example, nucleic acids encoding carotenoid -modulating polypeptides are disclosed as well as methods for using such nucleic acids to transform plant cells. Also disclosed are plants having increased carotenoid levels and plant products produced from plants having increased carotenoid levels.) 

234: (3651385615181571081) patent: JPH06276956A Title : NUTRIENT COMPOSITION) Abstract : PURPOSE:To obtain a nutrient composition effective for remarkably increasing the accumulation concentration of carotenoid in the biotissue of sea bream, etc., and contributing to the improvement of the production efficiency and the quality of product by compounding L-ascorbic acid glucoside together with carotenoids. CONSTITUTION:The composition for feeding to young yellowtail, sea bream, salmon, trout, sweetfish, shrimp, crab, carp, goldfish and chicken is produced by compounding (A) carotenoids selected from astaxanthin, beta-carotene, zeaxanthin, lutein, salmoxanthin, tunaxanthin, doradexanthin, retinal, halocynthiaxanthin, fucoxanthin, capsanthin, canthaxantin, beta-apo-8'-carotenoic acid ethyl ester and their steric isomers with (B) L-ascorbic acid 2-glucoside. The composition is preferably formed in the form of porous pellets with an extruder, etc., at 100-200 deg. C.) 

235: (8718726228079016367) patent: EP1733720B1 Title : COMPOSITION COMPRISING REDUCED-FORM COENZYME Q10 AND CAROTENOID COMPOUND) Abstract : A composition having an antioxidative activity, especially, having a sufficient activity for removing active oxygen and/or free radicals is provided. The composition includes both reduced coenzyme Q 10 and a carotenoid, and the activity for removing active oxygen and/or free radicals is synergistically enhanced. A method for removing active oxygen and/or free radicals by using the composition containing both reduced coenzyme Q 10 and a carotenoid is also provided.) 

236: (3423805564525492025) patent: EP1573013A2 Title : PARALLEL CHROMOSOMAL STACKING OF TRAITS IN BACTERIA) 

237: (8713784456803550934) patent: US20060094077A1 Title : Increasing bioavailability of carotenoids) Abstract : A method of increasing a fraction of free carotenoids in a source of carotenoids in which at least some of the carotenoids are fatty acid esterified carotenoids is disclosed. The method is effected by contacting the source of carotenoids with an effective amount of an esterase under conditions effective in deesterifying the fatty acid esterified carotenoids, thereby increasing the fraction of free carotenoids in the source of carotenoids.) 

238: (1813649389523871708) patent: EP1573013A4 Title : PARALLEL CHROMOSOMAL STACKING OF TRAITS IN BACTERIA) 

239: (3679184634547010771) patent: US7192731B2 Title : Methods for efficient extraction of carotenoids using an esterase) Abstract : A method of increasing a fraction of free carotenoids in a source of carotenoids in which at least some of the carotenoids are fatty acid esterified carotenoids is disclosed. The method is effected by contacting the source of carotenoids with an effective amount of an esterase under conditions effective in deesterifying the fatty acid esterified carotenoids, thereby increasing the fraction of free carotenoids in the source of carotenoids.) 

240: (4360896487252574335) patent: US20130344180A1 Title : WEIGHT LOSS AND SATIATION COMPOSITION) Abstract : Weight loss compositions and systems are disclosed that may include various combinations of essential oils and other components, which may be effective in promoting weight loss. Some implementations may include a fat blocker, a filler component, an insulin sensitizer, and a fat growth suppressant. In some instances, the fat blocker may include a carotenoid. In other instances, the fat blocker may be selected from the group consisting of fucoxanthin and punicic acid. A weight loss composition may include a first component and a second component, wherein the combination of the first and second components may be effective in promoting weight loss. The first element may include a fat blocker, a filler component, and a first insulin sensitizer. The second element may comprise a fat growth suppressant and a second insulin sensitizer.) 

241: (967399381163172084) patent: EP2214656A1 Title : COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE) 

242: (2798891052868091165) patent: US20020110604A1 Title : Composition exhibiting synergistic antioxidant activity) Abstract : A novel formulation is provided that serves to synergistically inhibit the generation of free radicals and oxidative stress in animals. The formulation comprises as a first component a carotenoid species, and, as a second component, at least one member selected from the group consisting of lipoic acid, dihydrolipoic acid (DHLA), a stilbene species, ergothioneine, a flavone species, a triterpene species, ascorbic acid and derivatives thereof.) 

243: (8859638221102447175) patent: EP3068415A1 Title : TREATMENT OR PROPHYLAXIS OF CIRCADIAN PROTEIN RELATED CONDITIONS) 

244: (790563874027864053) patent: US20130203883A1 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention aims to provide a surface modification method for a rubber vulcanizate or a thermoplastic elastomer, which can impart various functions such as sliding properties and biocompatibility according to its use. The present invention relates to a surface modification method for modifying a rubber vulcanizate or a thermoplastic elastomer as an object to be modified, the method including: Step 1 of forming polymerization initiation points on a surface of the object to be modified; Step 2 of radical polymerizing monomers starting from the polymerization initiation points to grow polymer chains on the surface of the object to be modified; and Step 3 of functionalizing the polymer chains.) 

245: (3504497120424414808) patent: US8952217B2 Title : Process for decreasing verbascose in a plant by expression of a chloroplast-targeted fimD protein) Abstract : The present invention relates to a process for decreasing verbascose in a plant by expression of a chloroplast-targeted polypeptide which is a member of the fimD superfamily in a plant cell, plant, or a part thereof. The invention furthermore relates to a process for producing a plant cell, plant, or part thereof with a decrease in the amount of verbascose. Also provided are nucleic acid constructs and vectors useful for practicing the methods as well as plants, plant tissues, propagation materials and harvested materials thus obtained. Agricultural compositions comprising the plant materials thus obtained is also provided.) 

246: (3598274354074644853) patent: WO2009075383A1 Title : SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING THE SAME) Abstract : ABSTRACT A skin external preparation includes an oil-in-water emulsion composition. The emulsion composition contains first oil droplet particles having a minimum particle diameter of 200 nm or more and second oil droplet particles having an average particle diameter of 70 nm or less. The first oil droplet particles contain a first functional oil component, and the second oil droplet particles contain a second functional oil component. A method of producing the skin external preparation includes mixing a first emulsion containing the first oil droplet particles having a minimum particle diameter of 200 nm or more and a second emulsion containing the second oil droplet particles having an average particle diameter of 70 nm or less) 

247: (135929359234174624) patent: US20130102040A1 Title : USE OF ENDOGENOUS PROMOTERS IN GENETIC ENGINEERING OF NANNOCHLOROPSIS GADITANA) Abstract : The present disclosure is directed to novel polynucleotide sequences for use in Nannochloropsis gaditana. The novel polynucleotide sequences include control sequences and coding sequences. Also disclosed are novel gene expression constructs wherein N. gaditana promoters/control regions are operatively linked to N. gaditana or non-N. gaditana coding sequences. These novel polynucleotide sequences and expression constructs can be introduced into N. gaditana and can recombine into the N. gaditana genome. Expression from these polynucleotide sequences and expression constructs can enhance N. gaditana biomass and/or lipid biosynthesis. Also disclosed are methods for modifying N. gaditana, for example by stably transforming N. gaditana with nucleic acid sequences, growing the modified N. gaditana, and obtaining biomass and biofuels from the modified N. gaditana.) 

248: (1298563065920181962) patent: JP2008291004A Title : COMPOSITION FOR BEAUTIFUL SKIN) Abstract : PROBLEM TO BE SOLVED: To provide a composition for a beautiful skin containing a novel ingredient having activity for inhibiting elastase, hyaluronidase and the like. ;SOLUTION: The composition for a beautiful skin contains fucoxanthin as an active ingredient. The composition for lustrous skin contains an extract of marine algae and/or brown algae as an active ingredient. The composition for a beautiful skin can be added in beverages, animal feeds, medicinal agents for mammals (including human) and skin preparations for external use for mammals (including human). ;COPYRIGHT: (C)2009,JPO&INPIT) 

249: (4737431921554716101) patent: JPH083468A Title : PRODUCTION OF COLORANT, PRODUCTION OF COLORED SEAWEED EXTRACT, AND PRODUCTION OF SEAWEED FOOD MATERIAL) Abstract : PURPOSE:To obtain a method for producing a colorant which has color and smell similar to those of a natural seaweed by bringing a seaweed contg. chlorophyll and fucoxanthin into contact with an aq. ethanol soln. of a specified concn. at a specified temp. CONSTITUTION:After a seaweed contg. chlorophyll and fucoxanthin is brought into contact with an aq. ethanol soln. of a concn. of 55-70% at 0 deg. C or higher but lower than 50 deg. C, the soln. and the seaweed are separated from each other. The soln. is then concentrated to give a colorant which has a yellowish color and smell and flavor with a strong smell of the sea characteristic of a seaweed.; The seaweed separated from the soln. is used as a seaweed food material or is further brought into contact with an aq. ethanol soln. of a concn. of 60% or higher at 50-78.3 deg. C to give a colorant which has a greenish color and the smell and flavor with smell of the sea. The precipitation of chlorophyll in the above treatments is prevented by adding a sugar alcohol to the soln. and heating it to concentrate. The colorant is added to a seaweed extract to give a colored seaweed extract.) 

250: (3899687304096466677) patent: US20090253164A1 Title : E. COLI FOR EFFICIENT PRODUCTION OF CARATENOIDS) Abstract : An improved E. coli for carotenoid production comprising exogenous nucleic acids for expressing a carotenoid that the E. coli requires as necessary condition for the E. coli to reproduce. Some E. coli embodiments have diminished or abrogated expression of a gene in the group consisting of ldhA, frdA, poxB, pta, adhE, pykF, zwf, and maeB.) 

251: (7408668693724199419) patent: US20160228400A1 Title : COMPOSITIONS CAPABLE OF ENHANCING THERMOGENESIS AND USES THEREOF) Abstract : The present invention refers to novel compositions and to methods of using the compositions to treat and/or prevent obesity, obesity-related diseases or disorders (e. g., hyperglycemia, hyperinsulinemia, elevated hemoglobin A1c (HbA1c), diabetes, or cardiovascular disease), and overweight. This invention also generally relates to compositions and to methods of using the compositions to increase basal metabolic rate.) 

252: (8330921150545601842) patent: WO2012097018A1 Title : COMPOSITIONS AND METHODS RELATING TO CAROTENOIDS) Abstract : A pet food composition having at least two carotenoids. The carotenoids can include a keto-carotenoid and at least one non-keto-carotenoid. The keto-carotenoid can include astaxanthin. The keto-carotenoid can include astaxanthin ester. The non-keto-carotenoid can include beta-carotene and/or lutein.) 

253: (1034739038477306703) patent: US20050113372A1 Title : Carotenoid analogs or derivatives for the inhibition and amelioration of disease) Abstract : A method for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals in a subject whereby a subject is administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The analog or derivative is administered such that the subject's risk of experiencing diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals may be thereby reduced. The analog or analog combination may be administered to a subject for the inhibition and/or amelioration of any disease that involves production of reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals.; In some embodiments, the invention may include a chemical compound including an analog or derivative of a carotenoid. The carotenoid analog or derivative may be synthetic. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include an acyclic alkene including at least one substituent and/or a cyclic ring including at least one substituent. In some embodiments, a carotenoid analog or derivative may include at least one substituent. The substituent may enhance the solubility of the carotenoid analog or derivative such that the carotenoid analog or derivative at least partially dissolves in water.) 

254: (714972809700518724) patent: JP2009120494A Title : METHOD FOR PRODUCING BROWN ALGAE EXTRACT HIGHLY CONTAINING FUCOXANTHIN) Abstract : PROBLEM TO BE SOLVED: To provide a technology efficiently separating and purifying fucoxanthin which is a health functional component contained in brown algae, and utilizing it as a food (health food), cosmetic, medicine and reagent used for research. ;SOLUTION: This method for producing the brown algae extract highly containing the fucoxanthin is characterized by obtaining the brown algae extract by extracting the brown algae with a solvent containing an organic solvent, and then adsorbing the fucoxanthin in the extract with a synthetic adsorbing resin and eluting. ;COPYRIGHT: (C)2009,JPO&INPIT) 

255: (5421711991725105261) patent: US9446055B2 Title : Disintegrating particle composition and orally rapidly disintegrating tablet) Abstract : There has been a need for an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity and can sustain a sufficient hardness even under humid conditions after opening. Disclosed are a disintegrating particle composition which is prepared by dispersing, in the presence of water, mannitol, xylitol, an inorganic excipient, a disintegrating agent and carmellose and drying, and an orally rapidly disintegrating tablet which comprises said disintegrating particle composition, an active substance and a disintegrating agent. The disintegrating tablet has a good texture and taste, an appropriate hardness and good disintegrating properties and can sustain a sufficient hardness under humid conditions.) 

256: (438533865339322285) patent: US5910254A Title : Method for dewatering microalgae with a bubble column) Abstract : A process for dewatering an aqueous suspension of microalgae is disclosed in which the aqueous suspension of the algae is introduced into a bubble column or a modified bubble column for generating a froth of bubbles and adsorbed algal cells that can be separated from the aqueous suspension. In one advantageous embodiment, the bubble column is a multi-stage loop-flow flotation column that has three loop-flow zones, each of which is defined by a draft tube concentrically mounted in the column to divide each loop-flow zone into a riser and the downcomer. Fine bubbles of gas and brine are in cocurrent upward flow in the riser and in cocurrent downward flow the downcomer. A higher gas holdup is promoted in the riser than in the downcomer, thereby circulating the brine in loop-flow upwardly through the riser and downwardly through the downcomer. Liquid communication between adjacent loop-flow zones is substantially eliminated. A froth enriched in algae is generated that can be separated from the aqueous suspension. The process has application in the recovery of mixed carotenoids from Dunaliella salina.) 

257: (5493337554256807619) patent: US20090176673A1 Title : COLOR-CHANGING CLEANSING COMPOSITIONS AND METHODS) Abstract : The present invention provides methods, kits and compositions that are nontoxic color changing cleansers The cleansers include a mixture having a first component mixture and a second component mixture, wherein the first component mixture comprises a nontoxic color changing dye and the first component mixture in combination with the second component mixture such that the color of the nontoxic color changing dye is of a different color than the nontoxic color changing dye in the first component mixture.) 

258: (5859453544129752523) patent: WO2003087234A1 Title : ANTIFOULING COMPOSITION COMPRISING AN ENZYME IN THE ABSENCE OF ITS SUBSTRATE) Abstract : The present invention in one aspect relates to a coating composition comprising at least one enzyme capable of acting on a compound, wherein said action results in the formation of an antifouling species comprising an antifouling activity, and wherein said compound does not form part of said coating composition. The coating composition preferably comprises at least one oxidase capable of acting on a compound, such as a substrate for said oxidase, wherein said action results in the formation of an antifouling species including an antimicrobial species comprising an antimicrobial activity. More preferred, the oxidase comprises an activity which results in the formation of a peroxide. The oxidase can be present in said coating composition in combination with one or more additional enzymes including, but not limited to, an esterase, including a lipase, an amidase, including a protease, and a polysaccharide degrading enzyme, wherein said one or more additional enzyme(s), alone or in any combination, can be included in the presence or absence of one or more substrates for one or more of said enzymes.) 

259: (8273298654211469687) patent: WO2014003740A1 Title : WEIGHT LOSS AND SATIATION COMPOSITION) Abstract : Weight loss compositions and systems are disclosed that may include various combinations of essential oils and other components, which may be effective in promoting weight loss. Some implementations may include a fat blocker, a filler component, an insulin sensitizer, and a fat growth suppressant. In some instances, the fat blocker may include a carotenoid. In other instances, the fat blocker may be selected from the group consisting of fucoxanthin and punicic acid. A weight loss composition may include a first component and a second component, wherein the combination of the first and second components may be effective in promoting weight loss. The first element may include a fat blocker, a filler component, and a first insulin sensitizer. The second element may comprise a fat growth suppressant and a second insulin sensitizer.) 

260: (347622188194537601) patent: US9351967B2 Title : Compositions and methods for modulating metabolic pathways) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

261: (7451458563522300544) patent: WO2012024291A1 Title : METHODS FOR PREPARING A FERMENTED GINSENG CONCENTRATE OR POWDER) Abstract : The present invention relates to a method for preparing a fermented ginseng concentrate. The method first involves subjecting ginseng to an extraction with a solvent to obtain a ginseng extract. Next, pectinase and beta-galactosidase are added to the ginseng extract under conditions effective to ferment the ginseng extract. The fermented extract is then concentrated to produce a fermented ginseng concentrate. The method may further involve drying the fermented ginseng concentrate to obtain fermented ginseng powder. Combinations of the invention ginseng materials with other active and/or inactive materials are also disclosed.) 

262: (3774108093791006832) patent: EP2418270B1 Title : MICRO-ALGA BELONGING TO GENUS NAVICULA, PROCESS FOR PRODUCTION OF OIL BY CULTURE OF THE MICRO-ALGA, AND OIL COLLECTED FROM THE MICRO-ALGA) Abstract : Disclosed are: a microalga highly capable of producing aliphatic hydrocarbons of 16 to 26 carbon atoms; a process for producing oil, which comprises a step of culturing the microalga; oil collected from the microalga; a fuel produced from the microalga; and a method for fixing carbon dioxide, which comprises a step of culturing the microalga. Specifically disclosed is a microalga belonging to the genus Navicula, which is capable of producing aliphatic hydrocarbons of 16 to 26 carbon atoms. More specifically disclosed is a microalga, Navicula oiliticus strain JPCC DA0580 (FERM BP-11201).) 

263: (289918277407723587) patent: EP2894191A1 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention aims to provide methods for surface-modifying a rubber vulcanizate or a thermoplastic elastomer, which can cost-effectively impart a variety of functions, such as sliding properties or biocompatibility, according to the application. The present invention relates to a method for surface-modifying an object of a rubber vulcanizate or a thermoplastic elastomer, the method including: step 1 of forming polymerization initiation points A on the surface of the object; and step 2 of radically polymerizing a non-functional monomer, starting from the polymerization initiation points A, to grow non-functional polymer chains, and further radically polymerizing a fluorine-containing functional monomer to grow fluorine-containing functional polymer chains.) 

264: (8164247518017544653) patent: US20060165734A1 Title : Novel method of deodorization for fat odor and composition obtained by the same) Abstract : The present invention provides a novel deodorizing composition and a novel deodorizing method. A composition is provided in which oily odors have been deodorized by containing a xanthophyll or other carotenoid in an oil such as a highly unsaturated fatty acid or compound containing a highly unsaturated fatty acid as a constituent fatty acid, and a deodorizing method, for oily odors, comprising containing a carotenoid in an oil is provided.) 

265: (5352685096053693608) patent: US20120156261A1 Title : DISINTEGRATING PARTICLE COMPOSITION AND ORALLY RAPIDLY DISINTEGRATING TABLET) Abstract : There has been a need for an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity and can sustain a sufficient hardness even under humid conditions after opening. Disclosed are a disintegrating particle composition which is prepared by dispersing, in the presence of water, mannitol, xylitol, an inorganic excipient, a disintegrating agent and carmellose and drying, and an orally rapidly disintegrating tablet which comprises said disintegrating particle composition, an active substance and a disintegrating agent. The disintegrating tablet has a good texture and taste, an appropriate hardness and good disintegrating properties and can sustain a sufficient hardness under humid conditions.) 

266: (4902914106824211605) patent: EP2496525A1 Title : METHOD AND APPARATUS FOR CONTROLLING THE PROPAGATION OF CYANOBACTERIA IN A BODY OF WATER) 

267: (7110187827938136071) patent: US20150164843A1 Title : STABILIZED FORMULATIONS OF FATTY ACIDS) Abstract : Disclosed herein are stabilized powder and aqueous formulations comprising a substantially water insoluble lipophilic bioactive compound and a micelle-forming surfactant. In one embodiment, the formulation further comprises a water soluble reducing agent, and/or a water insoluble reducing agent, and/or a metal chelator, and/or a metal bisulfite reducing agent, or combinations thereof, wherein the formulation remains substantially clear and stable when stored at or below room temperature for a period of at least 6 months or at least 12 months; and methods for preparing these formulations.) 

268: (6316400010397033506) patent: WO2014149280A1 Title : TREATMENT OF PETS WITH SIRTUIN ACTIVATORS) Abstract : The present invention provides for systems, compositions, methods and kits for regulating energy metabolism in pets. The systems, compositions, and kits can comprise, and methods can make use of, pet foods, pet treats, pet supplements, and pet drinks. In one aspect, the invention provides for pet food, treat, supplement, and drink compositions that comprise a combination of (a) leucine, and (b) a sirtuin activator, or any precursors or metabolites of (a) or (b). These combinations may be effective for reducing weight or adipose volume in the pet. In another aspect, the invention provides for methods of regulating energy metabolism by the administration of one or more compositions comprising leucine, a leucine metabolite, and/or a sirtuin activator. The invention also provides for kits comprising compositions of leucine, a leucine metabolite, and/or a sirtuin activator packaged in an oral dose form with usage instructions.) 

269: (1104087043933344618) patent: EP2418270A1 Title : MICRO-ALGA BELONGING TO GENUS NAVICULA, PROCESS FOR PRODUCTION OF OIL BY CULTURE OF THE MICRO-ALGA, AND OIL COLLECTED FROM THE MICRO-ALGA) Abstract : Disclosed are: a microalga highly capable of producing aliphatic hydrocarbons of 16 to 26 carbon atoms; a process for producing oil, which comprises a step of culturing the microalga; oil collected from the microalga; a fuel produced from the microalga; and a method for fixing carbon dioxide, which comprises a step of culturing the microalga. Specifically disclosed is a microalga belonging to the genus Navicula, which is capable of producing aliphatic hydrocarbons of 16 to 26 carbon atoms. More specifically disclosed is a microalga, Navicula oiliticus strain JPCC DA0580 (FERM BP-11201).) 

270: (1678621958397933055) patent: US20160302462A1 Title : BIOMASS FORMULATION) Abstract : The present invention relates to a solid formulation comprising a carotenoid producing source bioorganism, which is storage stable, as well as the process of production of this formulation.) 

271: (2594398497548758092) patent: US20070154575A1 Title : Anti-inflammatory agent) Abstract : This invention provides an anti-inflammatory agent or the like which is safer and less adverse and has the great effectiveness to prevent and treat arthritis, or the like. An anti-inflammatory agent or the like in this invention is characterized by comprising anthocyanidin and gingerol as an active substance. Also, the abovementioned anthocyanidin and gingerol are preferably extracted from red ginger.) 

272: (8634732490783699961) patent: JP2009201480A Title : CULTIVATION METHOD FOR INCREASING FUCOXANTHIN CONTENT OF BROWN ALGA) Abstract : PROBLEM TO BE SOLVED: To provide a cultivation method for further increasing a fucoxanthin content so as to increase an additional value, in view of the fact that it is recently found that brown algae belonging to Fucales such as Sargassum horneri richly contain fucoxanthin, but almost the brown algae are unused or low used, and there is no information related to a cultivation method for increasing a fucoxanthin content of the brown algae. ;SOLUTION: This cultivation method can easily increase a fucoxanthin content through cultivating brown algae belonging to Fucales. In more details, the cultivation method includes controlling water temperature, quantity of light, sunshine hours, and nutrient salt so as to sufficiently increase a fucoxanthin content. ;COPYRIGHT: (C)2009,JPO&INPIT) 

273: (6616634977237421906) patent: US20130189382A1 Title : Use of fucoxanthin in the preparation of product for improving memory and having neuroprotective effect associated with neurodegenerative disorder) Abstract : Use of fucoxanthin in the preparation of a product having neuroprotective effect associated with neurodegenerative disorder and improving memory is disclosed in the disclosure. A product having neuroprotective effect associated with neurodegenerative disorder is also disclosed in the disclosure. Fucoxanthin can inhibit oxidative stress of cells and has the effect of preventing or treating Alzheimer's disease and improving memory.) 

274: (8267439271368525667) patent: WO2010058235A1 Title : METHOD FOR THE PREPARATION OF OXYCAROTENOIDS) Abstract : A high-yield process for preparing astaxanthin (3,3'-dihydroxy-, - carotene-4, 4'- dione) from silylated derivatives of zeaxanthin (3,3'-dihydroxy-, - carotene-3, 3'-diol), whether it be of synthetic or natural origin, is described.) 

275: (1889428500675048653) patent: WO2008023283A2 Title : STABILIZED ESTERS OF LUTEIN) Abstract : The invention describes lipoic acid or dihydrolipoic acid esters of xanthophylls, such as lutein, that have improved stability and bioavailablity versus simple mixtures of lipoic or dihydrolipoic acid and the xanthophyll.) 

276: (8618539522095369071) patent: WO2014138426A2 Title : METHODS AND COMPOSITIONS FOR REDUCING BODY FAT AND ADIPOCYTES) Abstract : Provided are methods and compositions for reducing body fat, and/or adipocytes in a subject, comprising administering a compound and/or natural product extract that is an activator of adenosine monophosphate-activated kinase (AMPK).) 

277: (2309221835848926664) patent: US9072692B2 Title : MAGNETO-MACHINE FOR USE IN CONNECTION WITH THE IGNITION SYSTEMS OF INTERNAL-COMBUSTION ENGINES.) 

278: (1381138212392239600) patent: US20030003528A1 Title : Carotenoid production from a single carbon substrate) Abstract : A method for the production of carotenoid compounds is disclosed. The method relies on the use of microorganisms which metabolize single carbon substrates for the production of carotenoid compounds in high yields.) 

279: (38061272063435002) patent: WO2013171100A1 Title : POLYHYDROXYLATED PENTACYCLIC TRITERPENE ACIDS AS HMG-COA REDUCTASE INHIBITORS) Abstract : The present invention relates to certain polyhydroxylated pentacyclic triterpene acids of formula (I) for use as HMG-Co A reductase inhibitors in the prophylactic and/or therapeutic treatment of a disease, disorder or condition that responds to a reduction of the HMG-Co A reductase activity in a mammal, preferably a human being. The present invention further relates to certain mixtures and plant extracts comprising euscaphic acid and tormentic acid, wherein the amount of euscaphic acid to tormentic acid exceeds a certain ratio. Further, the present invention also relates to a formulation, preferably pharmaceutical or nutraceutical formulation, comprising one or more of said compounds of formula (I), a composition according to the present invention or a plant extract according to the present invention. Also, the present invention relates to a process for obtaining certain polyhydroxylated pentacyclic triterpene acids of formula (I), a composition according to the present invention or a plant extract according to the present invention.) 

280: (9106707277146739238) patent: US20130264934A1 Title : LIGHT EMITTING DEVICE, LED LIGHT SOURCE FOR PLANT CULTIVATION, AND PLANT FACTORY) Abstract : A substrate-type LED light source (10) includes: at least one blue LED chip (2) which has an emission peak in a range from 400 nm to 480 nm so as to correspond to a blue light region absorption peak of chlorophyll; a red phosphor (7b) which emit, upon receiving excitation light from the at least one blue LED chip (2), light having a peak wavelength in a range from 620 nm to 700 nm so as to correspond to a red light region absorption peak of chlorophyll; and a resin layer (7) in which the red phosphor 7b is dispersed and which covers the at least one blue LED chip (2).) 

281: (7125251606009385836) patent: WO2002094982A2 Title : INCREASING BIOAVAILABILITY OF CAROTENOIDS) Abstract : A method of increasing a fraction of free carotenoids in a source of carotenoids in which at least some of the carotenoids are fatty acid esterified carotenoids is disclosed. The method is effected by contacting the source of carotenoids with an effective amount of an esterase under conditions effective in deesterifying the fatty acid esterified carotenoids, thereby increasing the fraction of free carotenoids in the source of carotenoids.) 

282: (3848877645769938009) patent: US8445028B2 Title : ECHINODERM-DERIVED EXTRACTS, METHODS OF PREPARATION AND USES THEREOF) Abstract : An Echinozoa tissue or organ extract comprising antioxidant compounds is disclosed. Also disclosed is a process for obtaining an Echinozoa tissue or organ extract, as well an extract obtained by this process. Compositions comprising such an extract are also described. Uses of such extracts/compositions, as well as corresponding methods of treatment, for example as an antioxidant or to decrease or inhibit oxidative stress in a cell, tissue or subject are also described.) 

283: (359094536777330162) patent: WO2004037998A2 Title : NATURAL PROMOTERS FOR GENE EXPRESSION IN C1 METABOLIZING BACTERIA) Abstract : Genes have been identified in the Methylomonas genome that are responsive to various metabolic and growth conditions. The identified responsiveness of these genes allows for the use of their promoters in regulated gene expression in C1 metabolizing bacteria. In particular, the hps promoter, which in its native state drives the expression of 3-hexulose-6-phosphate synthase (HPS), was found to be useful for directing expression of heterolgous coding regions (e. g., crtZ) in the obligate methanotroph Methylomonas sp. 16a.) 

284: (6770531267777480455) patent: US20060020127A1 Title : N-acetylglucosamine derivatives and use thereof) Abstract : The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: wherein R<1 >is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R<2>, R<3>, and R<4 >are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be alpha or beta; provided that R<1>, R<2>, R<3>, and R<4 >must not be all hydrogen atoms. It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.) 

285: (4504110565739419961) patent: WO2010051918A2 Title : COMPOSITIONS CONTAINING LIPID MICRO- OR NANOPARTICLES FOR THE ENHANCEMENT OF THE DERMAL ACTION OF SOLID PARTICLES) Abstract : The invention is related to compositions which can be used as dermal formulations for supporting the skin to restore normal conditions in case of e. g. irritated skin, or to support medical therapy of skin with atopic dermatitis symptoms, atopic dermatitis, psoriasis or related diseases (e. g. accompanied by distorted barrier function of the skin and microbial load). The compositions of the invention can be used for dermo-cosmetic products but also for pharmaceutical/ - medical products, depending on the composition and the additional actives incorporated (cosmetic actives or drugs). The invention is based on the synergistic effect of metallic particles, in particular silver particles (such as microsilver, nanosilver) and lipid particles (lipid nanoparticles or lipid microparticles). As alternatives to silver particles, other metallic particles (e. g. zinc, copper) or nanocrystalline actives can be incorporated (e. g. replacing the anti -oxidative silver by anti -oxidative nanocrystals of plant molecules such as hesperitin). This leads to combinations of lipid particles with nanocrystals for dermal use.) 

286: (312775061260136833) patent: US20110059164A1 Title : ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS) Abstract : An encapsulated material containing an oxidation-sensitive core is covered by at least a dried synthetic organelle layer and optional additional ingredients in the organelle layer or additional layers. By using microencapsulation to mimic or otherwise adapt the storage concepts used by seeds to protect triacylglycerol cores, oxidatively unstable materials may be provided with a synthetic, seed-like oxygen-resistant protective barrier and rendered less susceptible to oxidative degradation.) 

287: (7894657575673404006) patent: US8367072B2 Title : Composition for treating obesity and method of using the same) Abstract : A composition for a medicinal or health effect of a treatment of liver fat and body fat, a reduction of blood pressure, an increase of the energy expenditure rate, a reduction of inflammatory C-reactive proteins and a reduction of plasma aminotransferase enzymes, comprising an effective amount of fucoxanthin alone or in combination with pomegranate seed oil, a pharmaceutically acceptable salt, a prodrug thereof, or a salt of the prodrug; and a method of using the same. The fucoxanthin may be used in pure form, or as a component of a brown marine vegetable extract.) 

288: (1236866874004968156) patent: US20150140619A1 Title : USE OF MARINE ALGAE FOR CO-PRODUCING ALKENONES, ALKENONE DERIVATIVES, AND CO-PRODUCTS) Abstract : A method comprising a series of selective extraction techniques for the parallel production of biodiesel and isolation of several valuable co-products including an alkenone hydrocarbon mixture of the kerosene/jet fuel range (primarily C10-, C12-, and C17-hydrocarbons) and fucoxanthin, a high-valued carotenoid, from the marine alkenone-producing microalgae Isochrysis.) 

289: (7592769217296782580) patent: WO2016174599A1 Title : CAPSICUM COMPOSITIONS AND USES THEREOF) Abstract : Capsicum compositions are described that include biologically active constituents non- capsaicinoids and capsaicinoids in a specific ratio are useful for the treatment and management of cardiometabolic syndrome and associated risk factors, in a subject in need thereof. The capsicum compositions include a capsicum extract which is prepared by extracting capsicum pods by using suitable polar and non-polar solvents. Capsicum compositions include non- capsaicinoid components like saponins and polyphenols such as flavonoids, which along with capsaicinoids effectively reduce risk factors of cardiometabolic syndrome and also reduce oxidative stress on vital body organs by reducing inflammatory and/or oxidative markers. The capsicum compositions inhibit pancreatic lipase enzyme and enhance lipolysis, when administered in an effective amount to a subject in need thereof. Capsicum compositions as described herein are prepared by human intervention and are safe for consumption.) 

290: (9105095618205008890) patent: US20080206275A1 Title : Composition for treating obesity and method of using the same) Abstract : The present invention provides a composition for a medicinal or health effect of a treatment of liver fat and body fat, a reduction of blood pressure, an increase of the energy expenditure rate, a reduction of inflammatory C-reactive proteins and a reduction of plasma aminotransferase enzymes, comprising an effective amount of fucoxanthin alone or in combination with pomegranate seed oil, a pharmaceutically acceptable salt, a prodrug thereof, or a salt of the prodrug; and a method of using the same. The fucoxanthin may be used in pure form, or as a component of a brown marine vegetable extract.) 

291: (3287587866433531784) patent: US20140113301A1 Title : DETECTION OF SAXITOXIN-PRODUCING DINOFLAGELLATES) Abstract : The current disclosure generally relates to the field of saxitoxins and the identification of microorganisms capable of producing them. In particular, the saxitoxin A (sxtA) gene comprising catalytic domain sequences saxitoxin A1 (sxtA1) and saxitoxin A4 (sxtA4) is identified in a number of dinoflagellate species. The disclosure relates to methods of detection of saxitoxin-producing dinoflagellates by amplification and detection of the sxtA gene (in particular by PCR) and kits and primers for use in the method are also disclosed. Saxitoxin-producing dinoflagellate genera detected by the method include Alexandrium, Pyrodinium or Gymnodinium.) 

292: (4246353346156000950) patent: WO2012082731A2 Title : ENGINEERED MICROALGAE WITH ENHANCED LIPID PRODUCTION) Abstract : Described herein are engineered microalgae that exhibit enhanced lipid production during exponential growth. Such engineered microalgae are useful, for example, for the production of biofuels.) 

293: (805075016182577968) patent: US20020120001A1 Title : Compositions containing tryptamines, cartenoids and tocotrienols and having synergistic antioxidant effect) Abstract : A novel formulation is provided that serves to synergistically inhibit the generation of free radicals and oxidative stress in warm blooded animals. The formulation comprises an effective amount of a first component of a tryptamine species or derivatives thereof, and, as a second component, at least one member selected from the group consisting of a carotenoid species, a tocotrienol species and derivatives thereof, and provides for synergistic anti-oxidant activity.) 

294: (942097686561414790) patent: EP2498602A1 Title : STABILIZED FORMULATIONS OF FATTY ACIDS) 

295: (8680392643528122244) patent: WO2016098874A1 Title : ) Abstract : The present invention addresses the problem of discovering a composition for internal use, with which it is possible to produce a satisfactory fat-reducing effect. Specifically, the present invention provides a composition for internal use containing a component (a): lactoferrin, and a component (b): fucoxanthin and/or a metabolyte thereof. The proportion of component (b)/component (a) is preferably 0.0001 to less than 0.3. The present invention also provides a body fat reduction promotor having component (a) and component (b) as effective components; a body fat reducing agent having component (a) and component (b) as effective components; an agent for lowering neutral lipids in the blood, having component (a) and component (b) as effective components; and an agent for lowering free fatty acids in the blood, having component (a) and component (b) as effective components.) 

296: (2514023639163115690) patent: US20070122363A1 Title : CORPOREAL DELIVERY OF CAROTENOIDS) Abstract : A method for delivery of a phytochemical supplement to a corporeal body. The method of delivery comprises providing a phytochemical supplement in an orally acceptable composition and applying the orally acceptable composition including the phytochemical supplement in contact with a feature of the oral cavity of a corporeal body. An oral care composition comprising a phytochemical supplement for one or more of ingestion or trans-mucosal absorption and a method for making the same are also disclosed.) 

297: (4840248374990627503) patent: US20130071451A1 Title : Fascine mat) 

298: (848807019373291840) patent: US20160023826A1 Title : Poppet valve) 

299: (2117451497400271999) patent: JP2009173597A Title : PREVENTIVE OR AMELIORATING AGENT OF HYPERLIPIDEMIA) Abstract : PROBLEM TO BE SOLVED: To provide a preventive or ameliorating agent of hyperlipidemia that is highly safe and exhibits high VLDL secretion-inhibiting activity at the same time. ;SOLUTION: The preventive or ameliorating agent of hyperlipidemia comprises fucoxanthin or zeaxanthin as an effective ingredient. The VLDL secretion-inhibiting agent comprises fucoxanthin and/or zeaxanthin as an effective ingredient. The preventive or ameliorating agent of hyperlipidemia and the VLDL secretion-inhibiting agent exhibit clear VLDL secretion-inhibiting activity and are safe even when they are taken over a long period of time. ;COPYRIGHT: (C)2009,JPO&INPIT) 

300: (2355364384033690355) patent: US20120045428A1 Title : METHODS FOR PREPARING A FERMENTED GINSENG CONCENTRATE OR POWDER) Abstract : The present invention relates to a method for preparing a fermented ginseng concentrate. The method first involves subjecting ginseng to an extraction with a solvent to obtain a ginseng extract. Next, pectinase and beta-galactosidase are added to the ginseng extract under conditions effective to ferment the ginseng extract. The fermented extract is then concentrated to produce a fermented ginseng concentrate. The method may further involve drying the fermented ginseng concentrate to obtain fermented ginseng powder. Combinations of the invention ginseng materials with other active and/or inactive materials are also disclosed.) 

301: (4382457151035303792) patent: US20160338983A1 Title : COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

302: (1068065801177447343) patent: US20140335123A1 Title : Food Composition and Uses for Diabetes) Abstract : The present invention provides a composition to promote healthy weight and reduce diabetic complications. The composition provides biologically active ingredients that are combined in a food and provide dietary fiber, trace minerals and phytonutrients, wherein the composition may be used alone or in combination with other foods in a method for improving health.) 

303: (7365458431753638023) patent: WO2011152692A3 Title : ANTI-OBESITY CREAM COMPOSITION CONTAINING FUCOXANTHIN) Abstract : The present invention relates to an anti-obesity cream composition containing more stabilized fucoxanthin as an active ingredient by the extraction step using vitamin C. The anti-obesity cream composition of the present invention remarkably increases the expression of UCP 1 in white body fat compared with known cases to cause the apoptosis of fat cells, thereby reducing fat cells including cellulite to a satisfactory degree.) 

304: (7023743059991356776) patent: JP2007297370A Title : SUPPRESSOR OF INCREASE IN BLOOD GLUCOSE LEVEL) Abstract : PROBLEM TO BE SOLVED: To specify a substance having a higher effect among many reported chemical substances derived from natural materials which can suppress the increase in blood glucose level, and to provide a suppressor for the increase in blood glucose level which is free from the concern of deterioration in odor or flavor and is also free from the concern of adverse side-effects. ;SOLUTION: The suppressor comprises fucoxanthin as an active ingredient. Fucoxanthin may be added to a food, a beverage, a nutritional supplement, a pet food, a sanitary product, a cosmetic or a pharmaceutical product. Fucoxanthin may be selected from one extracted/purified from a natural material, one produced by organic synthesis and one synthesized in a microorganism and may be used alone or in combination. ;COPYRIGHT: (C)2008,JPO&INPIT) 

305: (5331619537315215199) patent: US20120177806A1 Title : NATURAL AND SUSTAINABLE SEAWEED FORMULA THAT REPLACES SYNTHETIC ADDITIVES IN FISH FEED) Abstract : A seaweed-based commercial salmon feed additive which replaces the synthetic chemical additives that are currently used in salmon fish feed is provided. Synthetic additives are replaced with a combination of seaweed species thereby providing a natural product that improves the nutritional value of the farmed fish, qualifies the fish for marketing as organic, reduces the environmental impact of fish farming practices and may replace the chemical use of lice treatment.) 

306: (6041168582115471955) patent: US20120121743A1 Title : SCHISANDRA SPHENANTHERA FRUIT EXTRACT AND COSMETIC, DERMATOLOGICAL AND NUTRACEUTICAL COMPOSITIONS COMPRISING SAME) Abstract : The present invention relates to a cosmetic, dermatological or nutraceutical composition comprising a Schisandra sphenanthera fruit extract. Said Schisandra sphenanthera fruit extract is selected from a peptide and sugar extract, a crude oil, a refined oil, a refined oil concentrate or the unsaponifiable fraction of said concentrate. The invention also relates to a method for preparing a peptide and sugar extract, a refined oil, and a concentrate and an unsaponifiable fraction of oil of Schisandra sphenanthera fruit. Finally, the invention relates to the dermatological, cosmetic and nutraceutical uses of said extracts.) 

307: (4754896210852299879) patent: EP2263641A2 Title : Anti-wrinkle cosmetics with antioxidants) Abstract : Cosmetic composition comprises a tetrapeptide (Lys-Asp-Ile-Cit-NH 2) and at least one antioxidant comprising: carotenoids, preferably astaxanthin and lycopene; dihydroquercetin; 3,4-dihydro-7-methoxy-2,2-dimethyl-2H-1-benzopyran-6-ol; Vitis viniferapolyphenols; ubiquinones and/or ubiquinols; superoxide dismutase; and/or ellagic acid and/or ellagate. ACTIVITY : Dermatological. No biological data given. MECHANISM OF ACTION : None given.) 

308: (2646787226033475908) patent: EP2957166A1 Title : LED LIGHT SOURCE FOR PLANT CULTIVATION) Abstract : A plant cultivation LED light source (1A) of the present invention includes: a substrate (2A); at least one blue LED chip (11), provided on the substrate (2A), for emitting blue light; a red phosphor mixed resin (12) which is provided so as to cover the blue LED chip (11) and contains red phosphors (12a) being dispersed or settled down therein, each of the red phosphors (12a) emitting red light in response to excitation light emitted from the blue LED chip (11); and a silicone resin (13) which is transparent and is provided so as to cover the red phosphor mixed resin (12).) 

309: (5252801279999079562) patent: EP2465539A1 Title : DISINTEGRATING PARTICLE COMPOSITION AND ORALLY RAPIDLY DISINTEGRATING TABLET) Abstract : There has been a need for an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity and can sustain a sufficient hardness even under humid conditions after opening. Disclosed are a disintegrating particle composition which is prepared by dispersing, in the presence of water, mannitol, xylitol, an inorganic excipient, a disintegrating agent and carmellose and drying, and an orally rapidly disintegrating tablet which comprises said disintegrating particle composition, an active substance and a disintegrating agent. The disintegrating tablet has a good texture and taste, an appropriate hardness and good disintegrating properties and can sustain a sufficient hardness under humid conditions.) 

310: (3200692837968750396) patent: EP1820538A1 Title : COSMETICS AND PROCESS FOR PRODUCTION THEREOF) Abstract : An emulsion and dispersion system exhibiting excellent stability against heat and excellent stability over a long period time in interfaces between functional oily bases and water, or between functional granules as solid particles and water, etc., a cosmetic composition containing an emulsifying dispersant which is capable of performing emulsification and dispersion independently of required HLB values of the functional oily bases or the surface states of the functional granules, and a producing method of such a cosmetic composition. A cosmetic composition characterized in that an emulsifying dispersant including polysaccharides with particulate structure as a main component, and components to be emulsified are contained, and a producing method thereof. And a cosmetic composition characterized in that the emulsifying dispersant exists as a three-phase emulsifying dispersant which adheres to a periphery of the components to be emulsified like a layer to form an intermediate layer, and a producing method thereof.) 

311: (3966847355248856307) patent: US20130224240A1 Title : METHOD OF REDUCING WEIGHT USING COMPOSITION CONTAINING FUCOXANTHIN EXTRACT) Abstract : A method of reducing a weight of a subject includes administering to the subject in need thereof a composition comprised of fucoxanthin extract and at least one selected from the group consisting of tocotrienol, fucoidan and a combination thereof, wherein the subject is a mammal.) 

312: (3887461085547551382) patent: US20050004235A1 Title : Carotenoid analogs or derivatives for the inhibition and amelioration of liver disease) Abstract : A method of treating liver disease in a subject. The method may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include an acyclic alkene including at least one substituent and/or a cyclic ring including at least one substituent. In some embodiments, a carotenoid analog or derivative may include at least one substituent.) 

313: (2579846002862995362) patent: EP0882709B1 Title : Process for the preparation of zeaxanthin, intermediates for this process and process for their preparation) Abstract : Preparation of (3R,3'R)-zeaxanthin (I) comprises: (i) reacting (4R)-4-hydroxy-2,2,6-trimethyl-cyclohexanone (II) with dichloromethyl lithium in an inert solvent at -120 to -40 degrees C and warming the reaction mixture to 20-60 degrees C; (ii) reacting the obtained (4R,6R)-1-formyl-2,2,6-trimethyl-7-oxa-bicyclo (2.2.1) heptane of formula (IV) (in isolated form or directly in the reaction mixture) with acetone or a dialkyl (2-oxo-propyl)-phosphonate; (iii) converting the obtained (4R,6R)-1-(3-oxo-but-1-en-1-yl)-2,2,6-trimethyl-7-oxa-bicyclo (2.2.1) heptane of formula (V) into (4R,6R)-1-(3-hydroxy-3-methylpenta-1,4-dienyl)-2,2,6-trimethyl-7-oxa-b icyclo (2.2.1) heptane (VI) by conventional vinylation (or ethynylation followed by partial hydrogenation); (iv) reacting (VI) with a triaryl phosphine (preferably PPh3) and a strong acid to give a mixture of a C15 triaryl phosphonium salt of formula (III) and the isomer of formula (III'); and (v) subjecting 2 moles of the mixture to a double Wittig olefin synthesis reaction with 2,7-dimethyl-octa-2,4,6-triene-1,8-dial (VIII) to give (I). Ar = aryl (preferably optionally substituted phenyl); and X = 1 equivalent of an anion of a strong acid (preferably Cl, Br or HSO4). The preparation of (I) by step (v) is claimed per se. Also claimed are (IV) and (V) and (III') in mixtures with (III).) 

314: (2736765979966406117) patent: US20100080785A1 Title : DRIED FORMULATIONS) Abstract : The present invention provides novel formulations with improved bioavailability for substances such as ubiquinone, ubiquinol and omega-3 fatty acid. The present invention provides methods and compositions for drying formulations of such substances, wherein those dried formulations can readily be dissolved in water. The compositions and methods of the invention are of particular use in adding nutrients, such as vitamins and minerals, to food products such as beverages.) 

315: (6844940281500204433) patent: EP2007221A1 Title : CAROTENOID-CONTAINING DIETARY SUPPLEMENT) 

316: (5583831995109294544) patent: WO2015101410A1 Title : METHOD FOR THE EXTRACTION OF FUCOXANTHIN) Abstract : The present invention relates to a method for the extraction of fucoxanthin, comprising at least one extraction step, in which a liquid-solid extraction of fucoxanthin is carried out by at least one alkane, and the fucoxanthin is isolated from the extract, for example, by crystallization.) 

317: (5222330336822593279) patent: EP2968206A1 Title : TREATMENT OF PETS WITH SIRTUIN ACTIVATORS) 

318: (6169908229636155912) patent: JP2009180565A Title : SIMPLE QUANTIFICATION METHOD OF FUCOXANTHIN) Abstract : PROBLEM TO BE SOLVED: To provide a method which enables the simple and precise quantification of fucoxanthin from a specimen in which impurities coexist. ;SOLUTION: The concentration of fucoxanthin in a solution is quantified by utilizing the equation (I): Y=(10/MW)*(X<SB>1</SB>/[epsilon]) [wherein Y is a concentration (M), MW is a molecular weight, X<SB>1</SB>is a value calculated by subtracting absorbance at a non-absorbing wavelength from absorbance at an absorbing maximum wavelength, and [epsilon] is a molecular absorption coefficient]. ;COPYRIGHT: (C)2009,JPO&INPIT) 

319: (5905275817906428264) patent: EP1361281A1 Title : A PROCESS FOR PURIFYING CRUDE XANTHOPHYLLS) Abstract : There is disclosed herein a process for purifying a crude xanthophyll which is characterized by acting a lipase on the crude xanthophyll, which is obtained by extracting algae with a solvent, in the present of water under an acidic condition without adjusting the pH whereupon the contaminating neutral lipids (mono-, di- and triglycerides) are selectively hydrolyzed, subjecting the lipase-treated liquor to oil/water separation and removing free fatty acids from the oil layer fractioned thereby elevating the content of xanthophyll. <IMAGE>) 

320: (207887156125274021) patent: US20130115345A1 Title : METHOD FOR PREVENTING CAROTENOID PIGMENT FROM ADHERING TO CONTAINER) Abstract : This invention relates to a method for preventing adhesion of a carotenoid pigment to manufacturing equipment or containers such as PET bottles during production of liquid foods such as beverages containing a carotenoid pigment. The method comprises adding gum ghatti to a system in which a carotenoid pigment is present.) 

321: (3342718418519708276) patent: US20080160116A1 Title : Compositions and Methods Comprising Zingiber Species) Abstract : An aspect of the present invention relates to compositions comprising a gingerol, for example, compositions comprising gingerol in an amount greater than about 2% by weight. In some aspects of the invention, the composition comprises 6-gingerol, 8-gingerol, 10-gingerol, 6-shagaol, or combinations thereof. Another aspect of the invention relates to a method for extracting a ginger species comprising, sequentially extracting a ginger species plant material to yield an essential oil fraction, a gingerol fraction, a phenolic fraction, and a polysaccharide fraction, wherein the essential oil and gingerol fractions are derived by extracting plant feedstock material by supercritical carbon dioxide extraction, the phenolic fraction is extracted from the plant feedstock material or from the remainder of the essential oil and gingerol extractions by hydroalcoholic extraction, and the polysaccharide fraction is derived by water extraction of the remainder of the phenolic extraction.) 

322: (4248347062286991917) patent: US5502041A Title : Potent inhibitor of HIV reverse transcriptase) Abstract : An isolated, substantially pure, novel compound possessing HIV reverse transcriptase inhibitory activity, and method of preparing same are described.) 

323: (6872124561816568880) patent: EP2227216A1 Title : SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING THE SAME) 

324: (689611494003987176) patent: EP2977462A1 Title : In vivo production of a recombinant carotenoid-protein complex) Abstract : The present invention relates to a method for producing a carotenoid-protein complex in vivo comprising the steps of transforming of prokaryote cell with a plasmid containing genes involved in carotenoid synthesis and with a plasmid containing an apo-carotenoprotein gens; culturing said porokaryote cells such as to induce sequential genes expression, isolating and purifying the carotenoid-protein complex.) 

325: (8242533513019083853) patent: US20070009932A1 Title : Promoter engineering and genetic control) Abstract : The present invention relates to expression cassettes libraries of expression vectors comprising the same, wherein each vector comprises at least one gene of interest and a promoter operatively linked thereto wherein each promoter comprises a nucleic acid, whose sequence is randomly mutated with respect to that of another in the library and cells comprising the same. Methods utilizing either the libraries or cells of this invention, in optimizing gene expression, protein expression, or optimized gene or protein delivery are described.) 

326: (7623846301895148883) patent: US20140162330A1 Title : ENGINEERED MICROALGAE WITH ENHANCED LIPID PRODUCTION) Abstract : Described herein are engineered microalgae that exhibit enhanced lipid production during exponential growth. Such engineered microalgae are useful, for example, for the production of biofuels.) 

327: (7744929291317248854) patent: US20080058406A1 Title : LIPOIC ACID DERIVATIVES) Abstract : The invention describes alpha lipoic acid complexes, that can be oligomeric, polymeric, monomeric and mixtures thereof. The complexes can be salts, chelates, etc. of the oligomers, polymers, or monomeric alpha lipoic acid.) 

328: (4428472896972915156) patent: WO2012040698A2 Title : BICARBONATE TRIGGER FOR INDUCING LIPID ACCUMULATION IN ALGAL SYSTEMS) Abstract : The present invention provides bicarbonate containing and/or bicarbonate-producing compositions and methods to induce lipid accumulation in an algae growth system, wherein the algae growth system is under light-dark cycling condition. By adding said compositions at a specific growth stage, said methods lead to much higher lipid accumulation and/or significantly reduced total time required for accumulating lipid in the algae growth system.) 

329: (8135889928453054811) patent: EP0882709A1 Title : Process for the preparation of zeaxanthin, intermediates for this process and process for their preparation) Abstract : Preparation of (3R,3'R)-zeaxanthin (I) comprises: (i) reacting (4R)-4-hydroxy-2,2,6-trimethyl-cyclohexanone (II) with dichloromethyl lithium in an inert solvent at -120 to -40 degrees C and warming the reaction mixture to 20-60 degrees C; (ii) reacting the obtained (4R,6R)-1-formyl-2,2,6-trimethyl-7-oxa-bicyclo (2.2.1) heptane of formula (IV) (in isolated form or directly in the reaction mixture) with acetone or a dialkyl (2-oxo-propyl)-phosphonate; (iii) converting the obtained (4R,6R)-1-(3-oxo-but-1-en-1-yl)-2,2,6-trimethyl-7-oxa-bicyclo (2.2.1) heptane of formula (V) into (4R,6R)-1-(3-hydroxy-3-methylpenta-1,4-dienyl)-2,2,6-trimethyl-7-oxa-b icyclo (2.2.1) heptane (VI) by conventional vinylation (or ethynylation followed by partial hydrogenation); (iv) reacting (VI) with a triaryl phosphine (preferably PPh3) and a strong acid to give a mixture of a C15 triaryl phosphonium salt of formula (III) and the isomer of formula (III'); and (v) subjecting 2 moles of the mixture to a double Wittig olefin synthesis reaction with 2,7-dimethyl-octa-2,4,6-triene-1,8-dial (VIII) to give (I). Ar = aryl (preferably optionally substituted phenyl); and X = 1 equivalent of an anion of a strong acid (preferably Cl, Br or HSO4). The preparation of (I) by step (v) is claimed per se. Also claimed are (IV) and (V) and (III') in mixtures with (III).) 

330: (501029751297001270) patent: US20050026874A1 Title : Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver disease) Abstract : A method of treating liver disease in a subject. The method may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ether functionality.) 

331: (3920487195182028149) patent: EP2990035A1 Title : 1,5-ANHYDRO-D-GLUCITOL-CONTAINING COLLAGEN PRODUCTION ACCELERATOR) Abstract : A collagen production promoter in cells, containing at least one member selected from the group consisting of 1,5-anhydro-D-glucitol and derivatives thereof; and a composition containing the collagen production promoter. Since the collagen production promoter containing 1,5-AG or derivatives thereof of the present invention is suitably used as cosmetics, medicinal formulations, foods, and the like, for promoting collagen production in cells, for example, preventing and/or improving wrinkles of skin.) 

332: (760903415278832966) patent: US20150118329A1 Title : METHOD FOR PROMOTING ADIPONECTIN PRODUCTION, PREVENTION AND TREATMENT OF HYPOADIPONECTINEMIA) Abstract : Provided is an adiponectin production-promoting agent comprising Botanbouhu as an active component. Such an adiponectin production-promoting agent is able to be used for prevention or treatment of hypoadiponectinemia.) 

333: (5606029370571736945) patent: WO2011065412A1 Title : FUCOXANTHIN-ENRICHED ALGAE PRODUCT AND METHOD FOR PRODUCING THE SAME, AND ALGAE LIPID AND METHOD FOR PRODUCING THE SAME) Abstract : Provided is an algae product that has a low inorganic arsenic content, but is lipid-rich and has a particularly high fucoxanthin content, and further provided is a method for producing the algae product. It is possible to obtain the algae product by means of a method for producing a fucoxanthin-enriched algae product including each of the following steps at least twice: a step for treating a specific type of algae with an organic acid or alkali; and a step for separating the algae that has been treated with the organic acid or alkali.) 

334: (2277620770852729527) patent: US8633009B2 Title : PRODUCTION OF QUINONE DERIVED COMPOUNDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express quinone derived compounds.) 

335: (8765599046961830977) patent: US7232665B2 Title : Mutations affecting carotenoid production) Abstract : Mutations in genes having no direct relationship to the carotenoid biosynthetic pathway have been found to increase carbon flux through that pathway. Complete disruption in the deaD, mreC, and yfhE genes were effective. Additionally where genes of the lower carotenoid pathway reside on a plasmid having either a p15A or pMB1 replicon, mutations in the thrS, rspA, rpoC, yjeR, and rhoL were found effective.) 

336: (6182608048489146811) patent: EP2741778A1 Title : POLYMERIC HYPERBRANCHED CARRIER-LINKED PRODRUGS) 

337: (8103362535385450904) patent: WO2008010788A2 Title : COMPOSITIONS AND METHODS FOR MAKING AND USING NANOEMULSIONS) Abstract : The present invention discloses an improved nanoemulsion comprising a uniform and discrete range of very small particle nano-sized diameters. This uniformity results in improved bioavailability of incorporated compounds (i. e., pharmaceuticals or nutraceuticals) as reflected in various pharmacokinetic parameters including, but not limited to, decreased Tmax, increased Cmax, and increased AUC. The improved method of making these uniform nanoemulsions utilizes microfluidization which differs in both process and mechanics when compared to conventional milling and grinding techniques used to generate nanoparticulate compositions. Further, the improvement results, in part, from a novel step of mixing a substantially soluble compound into a heated dispersion medium. This is unlike current nanoparticulate composition methods that mix an insoluble compound with an unheated dispersion medium.; Further, these nanoemulsions are observed to be bacterial-resistant and stable to extremes in both temperature and pH changes. Consequently, these nanoemulsions are expected to have a significantly prolonged shelf-life than currently available nanoemulsions.) 

338: (3060993116631686360) patent: US20110288125A1 Title : NOVEL USE OF PIPERINE) Abstract : The present invention is related to novel use of piperine, and more specifically, it is related to a pharmaceutical or food composition for preventing and treating obesity comprising piperine or a salt thereof as an active ingredient. The present invention is related to novel use of piperine, and it provides a pharmaceutical or food composition for preventing and treating obesity comprising piperine or a salt thereof as an active ingredient. The composition comprising piperine of the present disclosure is effective on suppression of abdominal fat accumulation and body weight loss. Therefore, the composition can be effectively used to prevent and treat obesity.) 

339: (3693058891582574834) patent: JP2008231198A Title : FUCOXANTHIN-CONTAINING FAT-SOLUBLE OIL, METHOD FOR PRODUCING THE SAME, AND METHOD FOR PRODUCING FUCOXANTHIN) Abstract : PROBLEM TO BE SOLVED: To provide a fucoxanthin-containing fat-soluble oil extracted economically in a high yieLd, to provide a method for producing the same, and to provide a method for producing fucoxanthin. ;SOLUTION: A fucoxanthin-containing fat-soluble oil is substantially perfectly extracted by performing a first step of heat-treating seaweeds of Sargassaceae and a second step of extracting the fat-soluble oil from the seaweeds of Sargassaceae heat-treated in the first step with an organic solvent. Fucoxanthin can be easily purified by passing a fat-soluble oil obtained from seaweeds of Sargassaceae subjected to the above heat treatment, in particular, to immersion in hot water through a chromatographic column packed with silica gel. ;COPYRIGHT: (C)2009,JPO&INPIT) 

340: (3814514594531430081) patent: US20050148517A1 Title : Carotenoid ether analogs or derivatives for controlling connexin 43 expression) Abstract : A method of controlling (e. g., influencing or affecting) connexin 43 expression in a subject may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. In some embodiments, controlling connexin 43 expression in a subject may effectively treat cardiac arrhythmia and/or cancerous and pre-cancerous cells in a subject. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ether functionality.) 

341: (2786605285291800518) patent: US20080102131A1 

342: (2585814301265516896) patent: EP2981557A1 Title : GLYCOGEN-BASED WATER SOLUBILITY ENHANCERS) 

343: (1148553817404452304) patent: US20130209392A1 Title : HETEROATOM CONTAINING CYCLIC DIMERS) Abstract : The present invention provides cyclic dimers of alpha acids and polymers derived therefrom. Also provided are processes for preparing and methods of using the cyclic dimers and the polymers derived from the cyclic dimers.) 

344: (1484854179186819841) patent: WO2008010788A9 Title : COMPOSITIONS AND METHODS FOR MAKING AND USING NANOEMULSIONS) Abstract : The present invention discloses an improved nanoemulsion comprising a uniform and discrete range of very small particle nano-sized diameters. This uniformity results in improved bioavailability of incorporated compounds (i. e., pharmaceuticals or nutraceuticals) as reflected in various pharmacokinetic parameters including, but not limited to, decreased Tmax, increased Cmax, and increased AUC. The improved method of making these uniform nanoemulsions utilizes microfluidization which differs in both process and mechanics when compared to conventional milling and grinding techniques used to generate nanoparticulate compositions. Further, the improvement results, in part, from a novel step of mixing a substantially soluble compound into a heated dispersion medium. This is unlike current nanoparticulate composition methods that mix an insoluble compound with an unheated dispersion medium.; Further, these nanoemulsions are observed to be bacterial-resistant and stable to extremes in both temperature and pH changes. Consequently, these nanoemulsions are expected to have a significantly prolonged shelf-life than currently available nanoemulsions.) 

345: (8380798340470747830) patent: US9056049B2 Title : Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels) Abstract : The present invention relates to a micro-particle for extending satiety and controlling blood glucose and lipid levels, comprising a core having the protein extract from sweet potato, an active ingredient layer coated on the core, and a protection layer coated over the active ingredient layer as an external layer, wherein the protein extract from sweet potato contains trypsin inhibitor and glycoprotein. The micro-particle comprising a protein extract from sweet potato can effectively extend satiety, control blood glucose and lipid levels and increase metabolism effectively.) 

346: (4748558341568422672) patent: US8197865B2 Title : Methods and Compositions for Modulating Hair Growth or Regrowth) Abstract : The present invention relates to compositions and methods for modulating hair growth or regrowth. The compositions of the present invention include extracts of one or more of the following: Boswellia serrata, Undaria pinnatifida, green tea (e. g., Camellia sinensis), shiso, Pureraria mirifica, luteolin (e. g. Perilla ocymoides leaf extract), astilbin, vitamin E, amentoflavone, tetrahydropiperine, lichochalcone, astaxanthin, red clover, Brassica juncea, unfermented green rooibos, enzyme CoQ10, salvia, ximenynic acid, hops oleoresin, apple, soy, saw palmetto, or ellagic extract, or any derivative thereof.) 

347: (7853308694203509436) patent: US9476082B2 Title : Method of producing isoprenoid compounds in yeast) Abstract : Yeast strains capable of increased prenyl phosphate production are provided, enabling increased terpenoid molecule production. Heterologous yeast strains with high prenyl phosphate availability are prepared using one or both of two different strategies for increasing the availability of prenyl phosphates for terpenoid production. First, by co-expressing multiple mevalonate pathway gene analogs, a novel heterologous combination of genes results, some of which increases the inherent availability of prenyl phosphates in yeast. Second, by expressing the non-endogenous enzyme ATP citrate lysase (ACL), a buildup of high cytosolic concentration of acetyl-CoA is produced in the cytosol of S. cerevisiae.) 

348: (8972456666707595647) patent: WO2013119959A1 Title : HETEROATOM CONTAINING CYCLIC DIMERS) Abstract : The present invention provides cyclic dimers of alpha acids and polymers derived therefrom. Also provided are processes for preparing and methods of using the cyclic dimers and the polymers derived from the cyclic dimers.) 

349: (3438900332371375762) patent: US9066973B2 Title : SPRING LOCKING-WASHER.) 

350: (923344338302598236) patent: US9297031B2 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express retinolic compounds.) 

351: (3844591722970535150) patent: EP2552413B1 Title : NOVEL SUPPORT SYSTEM FOR THE TRANSPORT OF ACTIVE SUBSTANCES INTO THE SKIN) 

352: (2588059188751186443) patent: US20130337136A1 Title : CAROTENOID-CONTAINING COMPOSITION) Abstract : A carotenoid-containing composition, comprising: a carotenoid component comprising at least one crystalline carotenoid, at least 90% by mass of the crystalline carotenoid being non-crystalline; a (poly)glycerol fatty acid ester having from 1 to 6 glycerin units and from 1 to 6 fatty acid units and having at least one hydroxyl group from a glycerin unit; and at least one phenolic antioxidant selected from the group consisting of aromatic carboxylic acids, cinnamic acids, and ellagic acids.) 

353: (257091101759571656) patent: US20140087448A1 Title : PROCESS FOR OBTAINING A BROWN ALGAE LYOPHILISATE, AND COSMETIC PREPARATIONS THEREOF) Abstract : A process for obtaining a freeze-dried product of gametophytes cells of brown algae, and a cosmetic preparation for tropical use including the freeze-dried product of gametophytes cells of brown algae obtained.) 

354: (5850337752424364601) patent: WO2015085173A1 Title : POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY) Abstract : The invention comprises compounds, methods of making, and methods of using. The compounds may have a linear or cylic backbone and three or four appended functional groups: one or two lipohilic compounds including sterols or "fat soluble" vitamins, one or two hydrophilic polymer, and one or two carbohydrate. A group of polymer-carbohydrate conjugates having a central backbone and three appended functional groups are disclosed whereinone lipophilic compound is void of both steroid acids. The conjugate may have fatty acids as the primary lipophilic carrier, one hydrophilic polymer, and one carbohydrate. Specific functional groups may be selected for specific applications in formulating pharmaceuticals, cosmetics, nutriceuticals, and the like. Typical coupling reaction of the conjugates may involve one or more or combinations or in series of alkylation including N-alkylation or O-alkylation, etherification, esterification and amidation chemical processes. A variety of linkers between the backbone and functional groups may also be selected to modify the carriers or center backbones for the coupling reactions and optimize performance of the conjugates.) 

355: (2387060116217836188) patent: WO2009149374A2 Title : MULTI-PART CHEMISTRY SYSTEM) Abstract : The present invention provides methods, kits and compositions that are nontoxic color changing compositions. The compositions include a mixture having a first component and a second component, wherein the first component comprises a color changing dye and the first component in combination with the second component such that the color of the nontoxic color changing dye is of a different color than the color changing dye in the first component.) 

356: (5560515635739809098) patent: US20040126848A1 Title : Natural promoters for gene expression in C1 metabolizing bacteria) Abstract : Genes have been identified in the Methylomonas genome that are responsive to various metabolic and growth conditions. The identified responsiveness of these genes allows for the use of their promoters in regulated gene expression in C1 metabolizing bacteria. In particular, the hps promoter, which in its native state drives the expression of 3-hexulose-6-phosphate synthase (HPS), was found to be useful for directing expression of heterolgous coding regions (e. g., crtZ) in the obligate methanotroph Methylomonas sp. 16a.) 

357: (6521992495087839935) patent: EP2464248A2 Title : COMPOSITION INCLUDING AN UNSAPONIFIABLE FRACTION) 

358: (8780180128378407541) patent: EP1806982A1 Title : COMPOSITIONS AND METHODS FOR PROMOTING WEIGHT GAIN AND FEED CONVERSION) 

359: (6413544837360188479) patent: US20120094339A1 Title : GATE.) 

360: (5407410703976247865) patent: US7741070B2 Title : Gene targets for enhanced carotenoid production) Abstract : The present invention provides engineered cells and methods for utilizing same. Methods of enhanced carotenoid synthesis utilizing cells genetically disrupted for a yjiD, hnr or yjfP gene, or further disrupted for a gdhA, gpmB, aceE, ppc, talB or fdhF gene, or any combination thereof, or cells inhibited for their expression, activity or function are disclosed. Additionally, methods of enhanced carotenoid synthesis utilizing cells genetically disrupted for gdhA, aceE, fdhF, yjiD, hnr or yjfP gene expression or any combination thereof and ackA, appY, aspC, clp, clpP, clpXP, crcB, csdA, cyaA, evgS, fdhA, fdhD, feoB, funA, glnE, glxR, gntK, hycI, lipB, lysU, modA, moeA, nadA, nuoC, nuoK, pflB, pitA, pst, pstC, pta, p-yjiD, sohA, stpA, yagR, yaiD, ybaS, ycfZ, ydeN, yebB, yedN, yfcC, ygjP, yibD, yjfP, yjhH, or yliE gene expression, or a combination thereof or cells inhibited for their expression, activity or function are disclosed. Methods of enhanced carotenoid synthesis utilizing cells genetically engineered to overexpress dxs, idi, ispFD, yjiD, rpoS, torC, appY, ydgK, yeiA, yedR, tort, arcB, yggT, purDH, yfjN or a combination thereof, or further disrupted for the above-referenced genes are disclosed. Methods for identifying genes involved in optimized production of a carotenoid, and cells disrupted for, or inhibited for the expression, activity or function of genes thus identified are described.) 

361: (805082049451979093) patent: EP1806982A4 Title : COMPOSITIONS AND METHODS FOR PROMOTING WEIGHT GAIN AND FEED CONVERSION) 

362: (3158596624250021995) patent: WO2013024047A1 Title : HIGH-LOADING WATER-SOLUBLE CARRIER-LINKED PRODRUGS) Abstract : The present invention relates to water-soluble carrier-linked prodrugs of formula (I), wherein B, A and Hyp form the carrier, B is a branching core, each A is independently a poly(ethylene glycol)-based polymeric chain, each Hyp is independently a branched moiety, each SP is independently a spacer moiety, each L is independently a reversible prodrug linker moiety, each D is independendly a biologically active moiety, each x is independently 0 or 1, each m is independently an integer of from 2 to 64, n is an integer from 3 to 32; or the pharmaceutically acceptable salt thereof. It further relates to pharmaceutical compositions comprising said water-soluble carrier-linked prodrugs, their use asmedicament or diagnostic, and methods of treatment.) 

363: (4131780958912714627) patent: US8007838B2 Title : LAMP-BURNER.) 

364: (4821157806821903159) patent: US20110070258A1 Title : METHOD OF SLOWING THE AGING PROCESS BY ACTIVATING SIRTUIN ENZYMES) Abstract : The fucoxanthin/pomegranate seed oil composition describes a method of slowing the aging process in a mammalian subject by activating at least one member of the sirtuin family of proteins, wherein the activating step includes administering to the subject a synergistic combination of fucoxanthin and punicic acid. Sirtuin enzymes exert their function by removing acetyl groups from proteins. The deacetylation results in inactivation of the proteins' role in cell metabolism and prevents genes from over-expression, thereby putting a cell into a state of hibernation and increasing its lifespan.) 

365: (3923009923900335036) patent: US20020177181A1 Title : Increasing bioavailability of carotenoids) Abstract : A method of increasing a fraction of free carotenoids in a source of carotenoids in which at least some of the carotenoids are fatty acid esterified carotenoids is disclosed. The method is effected by contacting the source of carotenoids with an effective amount of an esterase under conditions effective in deesterifying the fatty acid esterified carotenoids, thereby increasing the fraction of free carotenoids in the source of carotenoids.) 

366: (3948887513265729121) patent: EP2214625A1 Title : EMULSION COMPOSITION) 

367: (2308047884827892283) patent: WO2005072086A2 Title : OPTIMIZED BACTERIAL HOST STRAINS OF METHYLOMONAS SP.16A) Abstract : Methanotrophic bacterial strains are provided that have been optimized for the production of carotenoid compounds through the down-regulation of one or more of the crtN1, ald, crtN2 and crtN3 genes of the carotenoid biosynthetic pathway. The resulting strains lack pigmented C30 carotenoid compounds, and show an increase in the production of C40 carotenoids. The use of the optimized host strains for the production of the C40 carotenoids canthaxanthin and astaxanthin is also described.) 

368: (352612231871902011) patent: WO2015017625A1 Title : ENCAPSULATED FUNCTIONAL FOOD COMPOSITIONS) Abstract : A functional food composition comprising an edible or potable substance, a cross-linked edible matrix encapsulating the edible or potable substance, a probiotic, and a prebiotic, with the proviso that the edible or potable substance and the matrix do not both contain the probiotic or both contain the prebiotic. The encapsulated composition provides certain advantages in its transport, handling and consumption. The edible membrane matrix can be constructed to include edible particles that impart advantages to the performance of the membrane matrix, provide functional nutrition, health and well-being benefits, therapeutic treatment to the consumer, and/or enhance consumer gustatory experience. In particular aspects, the functional food composition provides nutritive and health benefits for disease treatment and prevention, and health maintenance through the incorporation of certain biologically active compounds in the edible substance and/or as particles in the membrane matrix.) 

369: (5199321836831160266) patent: US20130072574A1 Title : Mechanical time-fuse) 

370: (3872277514702920854) patent: EP0126991A1 Title : A method for preventing deposition of polymer scale and a coating agent therefor.) 

371: (78976684512379649) patent: US20130225868A1 Title : METHOD FOR MANUFACTURING A FAT-SOLUBLE BIOACTIVE SUBSTANCE) Abstract : Provided is a production method of a lipophilic bioactive substance, which includes mixing an aqueous suspension of a microbial cell containing the lipophilic bioactive substance or a microbial cell homogenate thereof and an organic solvent in the presence of a particular surfactant, and extracting the lipophilic bioactive substance into the organic solvent phase. This production method enables extraction without using special dehydrating, drying facility, and without causing a decrease in the yield due to degraded separability between solvent and fungus body component, as well as efficient industrial production.) 

372: (5164297205781204932) patent: US20160249668A1 Title : HYDROGEN-CONTAINING DRINK THAT CONTAINS FUNCTIONAL INGREDIENT) Abstract : A hydrogen-containing drink containing a functional ingredient such as tea and hydrogen water, which maintains a high dissolved hydrogen concentration. A hydrogen-containing drink wherein at least one functional ingredient selected from the group consisting of teas; fruits, vegetables, and plants; sugars and sweeteners; polyphenols; vitamins and coenzymes; amino acids and proteins; oxidoreductases; citric acids; and yeast extracts and polydextroses is blended in hydrogen water, the hydrogen-containing drink being prepared by: degassing water as a raw material, dissolving hydrogen gas in the degassed water through a gas-permeable hollow fiber membrane so as to produce hydrogen water, and dissolving or mixing the functional ingredient in the produced hydrogen water, or dissolving or mixing the functional ingredient in water as a raw material, degassing the obtained solution or mixture, and dissolving hydrogen gas in the degassed solution or mixture through a gas-permeable hollow fiber membrane.) 

373: (6271015981039668455) patent: US8735137B2 Title : Use of Saccharomyces cerevisiae SUC2 gene in Yarrowia lipolytica for sucrose utilization) Abstract : Disclosed herein are transformed Yarrowia lipolytica comprising an exogenous polynucleotide encoding a polypeptide having sucrose invertase activity. Also disclosed are methods of using the transformed Y. lipolytica.) 

374: (8220806648288255380) patent: EP2210583A1 Title : GEL SHEET AND COSMETIC PREPARATION IN SHEET FORM USING THE SAME) Abstract : A gel sheet including a hydrogel, the hydrogel including at least 50 parts by mass of water-soluble divalent metal salt with respect to 100 parts by mass of anionic polymer compound is provided.) 

375: (3518329514887181450) patent: US8747915B1 Title : Dietary supplement system for multifunctional anti-aging management and method of use) Abstract : A dietary supplement system includes a dietary supplement composition for oral administration by an individual in the morning, the composition, including (a) a telomere maintenance complex including: Purslane extract (aerial parts); Turmeric rhizome extract (95% curcuminoids); Quercetin dehydrate, Cayenne pepper fruit; Vanadium (as vanadyl sulfate); Fenugreek seed; Astragalus root extract, Omega fatty acid complex including linoleic acid; alpha-linolenic acid; oleic acid borage seed oil gamma-linolenic acid), evening primrose oil fish body oil (eicosapentaenoic acid; docosahexaenoic acid); (b) a calorie restriction mimetics and gene expression complex including Trans-resveratrol (from Polygonum cuspidatum root extract); Pterostilbene Fisetin 50% (Buxus microphlla Sieb (stem and leaf; Alpha lipoic acid, Coenzyme Q-10, Betaine HCl, Sulfur (from methylsulfonylmethane); L-Carnitine tartrate; L-Carnitine HCl, and (c) a free radical scavenger complex, including Green tea leaf extract catechin and polyphenols); Anthocyanins (from bilberry fruit and grape skin extracts).) 

376: (2880815631586878879) patent: US9056091B1 Title : Composition for regulation of liver X receptor) Abstract : The present invention provides a composition for the regulation of Liver X Receptor (LXR) in a cell, and the composition comprises fucoxanthin and its metabolite, fucoxanthinol. The composition of the present invention regulates the transactivation activity of LXR in cell, and antagonizes the transactivation activity of LXR[alpha] and/or LXR[beta] induced by LXR agonists. In other aspects, the present invention also provides a method of regulating a liver X receptor. The composition for the regulation of liver X receptor and the application thereof according to the present invention can regulate the transactivation activity of LXR in cell, and can further be used as alternatives for LXR agonist or antagonist, or supplements, for enhancing LXR-related symptoms.) 

377: (1782486868211678440) patent: EP2380552A1 Title : EMULSION COMPOSITION, AND FOOD AND COSMETIC EACH CONTAINING THE EMULSION COMPOSITION) Abstract : The invention provides an emulsion composition obtained by mixing an oil phase containing a carotenoid having a melting point of 100C or more as detected when it is contained in an oil; and an aqueous phase containing a polyglycerol fatty acid ester and a nonionic emulsifier different from the polyglycerol fatty acid ester, wherein a weight ratio (A)/(B) of an amount (A) of the polyglycerol fatty acid ester to an amount (B) of the nonionic emulsifier different from the polyglycerol fatty acid ester is in the range of 2.5 to 10, and a particle diameter of dispersed particles that contain the carotenoid is 200 nm or less.) 

378: (715072001490246754) patent: EP1497382A1 Title : ANTIFOULING COMPOSITION COMPRISING AN ENZYME IN THE ABSENCE OF ITS SUBSTRATE) 

379: (1412676099263225102) patent: US8288149B2 Title : Production of carotenoids in oleaginous yeast and fungi) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

380: (1224102634162991160) patent: WO2016073739A1 Title : METHODS AND MATERIALS FOR PRODUCING RECOMBINANT VIRUSES IN EUKARYOTIC MICROALGAE) Abstract : The present invention is directed to methods and materials for producing recombinant viruses. In particular, methods and materials are provided for producing recombinant viruses in eukaryotic microalgae such as Chlamydomonas reinhardtii. Recombinant adeno- associated viruses are examples of recombinant viruses produced according to the invention.) 

381: (7671650958616749498) patent: US20150191444A1 Title : HETEROATOM CONTAINING CYCLIC DIMERS) Abstract : The present invention provides cyclic dimers of alpha acids and polymers derived therefrom. Also provided are processes for preparing and methods of using the cyclic dimers and the polymers derived from the cyclic dimers.) 

382: (7865954462547844914) patent: US20130273116A1 Title : ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL) Abstract : The present invention also relates to an anti-fouling composition comprising one or more aerogels. In one embodiment the aerogel encapsulate one or more bioactive agents. The one or more encapsulated bioactive agents can in one preferred embodiment be released from the aerogel over time. In one embodiment the encapsulated bioactive agents comprise one or more enzymes. In one preferred embodiment the anti-fouling composition comprising one or more aerogels is a coating composition.) 

383: (6995042140331388167) patent: WO2015144831A1 Title : PROCESS FOR ISOLATING A CAROTENOID FROM A CAROTENOID-PRODUCING BIOORGANISM) Abstract : The present invention relates to an improved process for isolating a carotenoid from a carotenoid-producing bioorganism, as well as to a formulation comprising such a carotenoid, and the use of such a solid formulation in feed products (or premixes).) 

384: (8297087834158238733) patent: EP1631660A2 Title : GENES ENCODING CAROTENOID COMPOUNDS) 

385: (7333771127563289750) patent: WO1998028404A1 Title : METHOD FOR DEEP BED FILTRATION OF MICROALGAE) Abstract : A method for deep bed filtration of microalgae in aqueous suspension for the purpose of dewatering the algae is disclosed. The cells are ruptured prior to filtration. The aqueous suspension is then contacted with the deep bed filtration media and collected in the media. The algae may be recovered from the media by backwashing with the liquid selected from the group consisting of water, brine, and one or more organic solvents, including natural flavorants, synthetic flavorants, and edible oils.) 

386: (1800294835086314640) patent: WO2009032987A1 Title : ISOLATION OF PELLET-FORMING MICROORGANISMS) Abstract : The present disclosure provides technologies for identifying, characterizing and/or sorting pellet-forming microorganisms such as bacteria and/or fungi (e. g., yeast) in liquid culture, and particularly under fermentation conditions. In some embodiments, the pellet- forming microorganisms produce one or more commercial products. For example, in some embodiments the pellet-forming microorganisms produce one or more organic acids, carotenoid compounds, essential fatty acids, industrial enzymes, active pharmaceuticals, extracellular carbohydrates, and insecticidal compounds, etc. In many embodiments, the organisms are sorted while in their pellet form.) 

387: (1855148513078490155) patent: US5859700A Title : High resolution imaging microscope (HIRIM) and uses thereof) Abstract : The invention pertains to a high resolution imaging microscope, and more specifically, to a digital imaging spectrophotometer (DIS) configured to enable the direct determination of the ground state absorption spectra of microscopic samples from violet to near infrared. The instrument is capable of simultaneously recording hundreds of spectra, and can, using image processing techniques identify features (such as a single microbial cell) on a microscope slide or thin section. The invention additionally relates to the use of such an instrument.) 

388: (1874173227687026925) patent: EP2671596A1 Title : PROCESS FOR PRODUCING AQUEOUS SOLUTION CONTAINING FAT-SOLUBLE SUBSTANCE) Abstract : The purpose of the present invention is to provide a process for producing an aqueous solution containing a fat-soluble substance. A combination of a super dissolution aid, cyclodextrin and a fat-soluble substance or a combination of the super dis-solution aid and a cyclodextrin complex of the fat-soluble substance is used for dissolving the fat-soluble substance, whereby it becomes possible to provide an aqueous solution containing the fat-soluble substance at a high concentration and an aqueous solution having improved transdermal absorbability of the fat-soluble substance contained therein.) 

389: (9112229145059775931) patent: WO2014173759A1 Title : HYDROGEL-LINKED PRODRUGS RELEASING MODIFIED DRUGS) Abstract : The present invention relates to a process for the preparation of a hydrogel-linked prodrug releasing a tag moiety-bio logically active moiety conjugate, to a hydrogel-linked prodrug releasing a tag moiety-bio logically active moiety conjugate obtainable by such process, to pharmaceutical compositions comprising said prodrug and their use as a medicament.) 

390: (1209644888753855223) patent: US5201930A Title : Plant growth product) Abstract : A plant stimulant product prepared from seaweed, a method for preparation of said product, and methods of use of said product. The product contains oxygen derived from a peroxide and aloe and may also contain humic acid.) 

391: (7562224802453814542) patent: US20150290264A1 Title : SEAWEED EXTRACTS, UNSATURATED FATTY ACIDS, AND METHODS OF TREATMENT) Abstract : The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)-mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.) 

392: (7682138700390053953) patent: WO2015082688A1 Title : BIOMASS FORMULATION) Abstract : The present invention relates to a solid formulation comprising a carotenoid producing source bioorganism, which is storage stable, as well as the process of production of this formulation.) 

393: (2491681066441654528) patent: EP2465540B1 Title : DISINTEGRATING PARTICLE COMPOSITION AND ORALLY RAPIDLY DISINTEGRATING TABLET) Abstract : Disclosed is an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity. The orally rapidly disintegrating tablet, which has a good texture and taste, an appropriate hardness, and good disintegrating properties, can be produced by using a composition, which is prepared by dispersing, by spray-drying, an inorganic excipient and starch(es) in complex particles composed of mannitol and xylitol, in an orally rapidly disintegrating tablet.) 

394: (439629407991433778) patent: JP2010270021A Title : UCP GENE EXPRESSION-PROMOTING AGENT) Abstract : PROBLEM TO BE SOLVED: To provide a UCP gene expression-promoting agent containing a new ingredient as an active ingredient. ;SOLUTION: This UCP gene expression-promoting agent contains fucoxanthin as an active ingredient. The UCP gene expression-promoting agent may contain the extract of at least one selected from algae containing fucoxanthin as an active ingredient. ;COPYRIGHT: (C)2011,JPO&INPIT) 

395: (461288199452175995) patent: US20110052754A1 Title : SUBMARINE OR SUBMERSIBLE BOAT.) 

396: (3699897181785597954) patent: WO2012091812A1 Title : USE OF SACCHAROMYCES CEREVISIAE SUC2 GENE IN YARROWIA LIPOLYTICA FOR SUCROSE UTILIZATION) Abstract : Disclosed herein are transformed Yarrowia lipolytica comprising an exogenous polynucleotide encoding a polypeptide having sucrose invertase activity. Also disclosed are methods of using the transformed Y. lipolytica.) 

397: (3659193579479349168) patent: US20120149886A1 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present disclosure provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

398: (2421437302384950559) patent: US20080031906A1 Title : Cosmetic Composition and Method for Producing the Same) Abstract : An emulsion and dispersion system exhibiting excellent stability against heat and excellent stability over a long period time in interfaces between functional oily bases and water, or between functional granules as solid particles and water, etc., a cosmetic composition containing an emulsifying dispersant which is capable of performing emulsification and dispersion independently of required HLB values of the functional oily bases or the surface states of the functional granules, and a producing method of such a cosmetic composition. A cosmetic composition characterized in that an emulsifying dispersant including polysaccharides with particulate structure as a main component, and components to be emulsified are contained, and a producing method thereof. And a cosmetic composition characterized in that the emulsifying dispersant exists as a three-phase emulsifying dispersant which adheres to a periphery of the components to be emulsified like a layer to form an intermediate layer, and a producing method thereof.) 

399: (2456510779092753248) patent: US20040109920A1 Title : Coated carotenoid cyclodextrin complexes) Abstract : Coated cyclodextrin and carotenoid complexes are stable against oxidation and exhibit higher biouptake than oil-based, lipophile based, and micellular carotenoid compositions. The coating may be an oil, or a naturally occuring, optionally derivatized polymer or a pharmaceutically acceptable synthetic polymer.) 

400: (8990161125988914329) patent: US20150322412A1 Title : ACETYL TRANSFERASES AND THEIR USE FOR PRODUCING CAROTENOIDS) Abstract : The present invention relates to novel acetyl transferases, nucleic acid sequences coding therefore, expression constructs and vectors comprising these sequences, microorganisms transformed therewith and use thereof.) 

401: (8902206910935307071) patent: US20080274195A1 Title : Compositions and Methods for Making and Using Nanoemulsions) Abstract : The present invention discloses an improved nanoemulsion comprising a uniform and discrete range of very small particle nano-sized diameters. This uniformity results in improved bioavailability of incorporated compounds (i. e., pharmaceuticals or nutraceuticals) as reflected in various pharmacokinetic parameters including, but not limited to, decreased Tmax, increased Cmax, and increased AUC. The improved method of making these uniform nanoemulsions utilizes microfluidization which differs in both process and mechanics when compared to conventional milling and grinding techniques used to generate nanoparticulate compositions. Further, the improvement results, in part, from a novel step of mixing a substantially soluble compound into a heated dispersion medium. This is unlike current nanoparticulate composition methods that mix an insoluble compound with an unheated dispersion medium. Further, these nanoemulsions are observed to be bacterial-resistant and stable to extremes in both temperature and pH changes. Consequently, these nanoemulsions are expected to have a significantly prolonged shelf-life than currently available nanoemulsions.) 

402: (480444697559158694) patent: US20100269731A1 Title : ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL) Abstract : The present invention also relates to an anti-fouling composition comprising one or more aerogels. In one embodiment the aerogel encapsulate one or more bioactive agents. The one or more encapsulated bioactive agents can in one preferred embodiment be released from the aerogel over time. In one embodiment the encapsulated bioactive agents comprise one or more enzymes. In one preferred embodiment the anti-fouling composition comprising one or more aerogels is a coating composition.) 

403: (4481222389677523561) patent: US8697418B1 Title : Use of mixed species for rapid growth of aquatic biomass) Abstract : The present invention provides aquatic biomass having enhanced growth and methods for selecting and growing a mix of aquatic organisms to maximize production of such a biomass. In one aspect, for example, a method of enhancing aquatic biomass growth is provided. Such a method can include preselecting at least two organisms selected from the group consisting of an algae mixture, a cyanobacteria mixture, and a diatom mixture, combining the at least two organisms at a growth enhancing ratio in a growth environment, and growing the at least two organisms as an aquatic biomass under environmental conditions in the growth environment that further enhance biomass growth, wherein the aquatic biomass growth is synergistic.) 

404: (3727977296761668425) patent: WO2015021352A2 Title : METHYLOTROPHS FOR AQUACULTURE AND ANIMAL FEED) Abstract : Disclosed are methods of producing carotenoid compounds in a methylotrophic bacterial host cell. Such a host cell may be an unmodified Methylobacterium, spontaneous mutant, or transformed cell, any of which exhibit favorable properties, such as overproduction of carotenoid compounds, increased carbon flux, improved growth, or the production of additional nutrients, such as protein, vitamins, antioxidants, or fatty acids. Also disclosed are feed compositions for use in aquaculture, or as animal feed, or as human nutritional supplements containing processed or unprocessed biomass from such cells, as are methods of preparation of the feed compositions.) 

405: (7806703978930358721) patent: WO2009023803A2 Title : MODULATED RELEASE FORMULATION FOR THE DELIVERY OF ONE OR MORE MEDICAMENTS) Abstract : The present invention relates to modulated release formulations for the delivery of one or more medicaments. In particular, modulated release aerosol formulations are provided comprising: a) one or moe medicaments; b) one or more fluid carriers: and c) one or more binders. Wherein said binder forms a complex with a portion of said medicament such that the modulated release aerosol formulation contains both a portion of free medicament and a portion of complexed medicament.) 

406: (6129621971363410629) patent: US20160228391A1 Title : MATRIX AND LAYER COMPOSITIONS FOR PROTECTION OF BIOACTIVES) Abstract : The invention relates to matrix and layer compositions comprising a first polymer. The matrix and layer compositions are useful in the delivery of bioactives. In particular, the matrices and layers may have advantageous properties including mechanical properties and protection of bioactives and may also provide for pH-dependent release of a bioactive.) 

407: (377351478290113911) patent: US20160130542A1 Title : BIOREACTOR USING MACROALGAE) Abstract : The invention features a bioreactor for the growth of macroalgae and methods for using the bioreactor to maintain optimal nutrient levels for the organisms in an aquarium or aquaculture system. The devices and methods of the invention provide for the bioremediation of excess nutrients in order to maintain nutrient balance in an aquarium or aquaculture system that facilitates growth and/or health of one or more of the organisms that reside therein.) 

408: (4162257349456169127) patent: EP2465540A1 Title : DISINTEGRATING PARTICLE COMPOSITION AND ORALLY RAPIDLY DISINTEGRATING TABLET) Abstract : Disclosed is an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity. The orally rapidly disintegrating tablet, which has a good texture and taste, an appropriate hardness, and good disintegrating properties, can be produced by using a composition, which is prepared by dispersing, by spray-drying, an inorganic excipient and starch(es) in complex particles composed of mannitol and xylitol, in an orally rapidly disintegrating tablet.) 

409: (2229443184043465917) patent: US20040219629A1 Title : Increasing carotenoid production in bacteria via chromosomal integration) Abstract : The present invention relates to carotenoid overproducing bacteria The genes of the isoprenoid pathway in the bacterial hosts of the invention have been engineered such that certain genes are either up-regulated or down regulated resulting in the production of carotenoid compounds at a higher level than is found in the un-modified host. Genes that may be up-regulated include the dxs, idi, ispB, lytB and ygbBP genes. Additionally it has been found that a partial disruption of the yjeR gene has the effect of enhancing carotenoid production.) 

410: (2798413211018769274) patent: EP2515107A1 Title : METHOD FOR QUANTIFICATION OF CAROTENOID) Abstract : Provided is a method for quantitative analysis of carotenoids such as -cryptoxanthin contained in a sample such as citrus fruit or the like which enables simple and accurate quantitative analysis. An internal standard such as lycopene or retinal is used, whereby work is facilitated and an error of a measured value is reduced. Further, a dehydrating agent is added during saponification reaction in the preparation of a sample for analysis, whereby a deviation of a measured value can be reduced.) 

411: (1304011792829911810) patent: US8974839B2 Title : Dietary supplement system for multifunctional anti-aging management and method of use) Abstract : A dietary supplement system includes a dietary supplement composition for oral administration by an individual in the morning, the composition, including (a) a telomere maintenance complex including: Purslane extract (aerial parts); Turmeric rhizome extract (95% curcuminoids); Quercetin dehydrate, Cayenne pepper fruit; Vanadium (as vanadyl sulfate); Fenugreek seed; Astragalus root extract, Omega fatty acid complex including linoleic acid; alpha-linolenic acid; oleic acid borage seed oil gamma-linolenic acid), evening primrose oil fish body oil (eicosapentaenoic acid; docosahexaenoic acid); (b) a calorie restriction mimetics and gene expression complex including Trans-resveratrol (from Polygonum cuspidatum root extract); Pterostilbene Fisetin 50% (Buxus microphlla Sieb (stem and leaf; Alpha lipoic acid, Coenzyme Q-10, Betaine HCl, Sulfur (from methylsulfonylmethane); L-Carnitine tartrate; L-Carnitine HCl, and (c) a free radical scavenger complex, including Green tea leaf extract catechin and polyphenols); Anthocyanins (from bilberry fruit and grape skin extracts).) 

412: (1427740068505232670) patent: US7695932B2 Title : Gene targets for enhanced carotenoid production) Abstract : The present invention provides genetically manipulated cells and methods for utilizing same. Methods of enhanced carotenoid synthesis utilizing cells genetically disrupted for a yjiD, hnr or yjfP gene, or further disrupted for a gdhA, gpmB aceE, ppc, talB or fdhF gene, or any combination thereof, or cells inhibited for their expression, activity or function are disclosed. Methods of enhanced carotenoid synthesis utilizing cells genetically engineered to overexpress dxs, idi, yjiD, rpoS, torC, appY, ydgK, yeiA, yedR, tort, arcB, yggT, purDH, yfjN or a combination thereof, or further disrupted for the above-referenced genes are disclosed. Methods for identifying genes involved in optimized production of a carotenoid, and cells disrupted for, or inhibited for the expression, activity or function of genes thus identified are described.) 

413: (4975452406767315726) patent: US20070065901A1 Title : Process for chromosomal expression of foreign genes in the PAPS reductase (cysH) region of a methylotrophic microbial host cell) Abstract : Provided is a method for stably expressing an introduced gene or genes in a methylotrophic microorganism host wherein the gene(s) are integrated into the cysH region of the chromosome. This method provides stable, high-level expression of the integrated genes in which growth rate and/or viability of the host strain is not significantly affected and a selection marker is not required. The use of this method for expressing carotenoid biosynthetic genes and resulting production of carotenoids is also described.) 

414: (7942787333617600948) patent: US20120329978A1 Title : POLYMER DYE) Abstract : A polymer dye has repeating units of formula (I): Each of R1, R2, and R3 is independently a monocyclic carbocyclic group, a condensed polycyclic carbocyclic group, a monocyclic heterocyclic group, or a condensed polycyclic heterocyclic group. In any case, each of R1, R2, and R3 independently may have a substituent. R1 is a divalent group, and R2 and R3 are monovalent groups. D is an organic dye group and n is an integer of from 0 to 10. The polymer dye has a number-average molecular weight of from 500 to 500,000. The dye can be a component in a film. The dye can also be included in various industrial materials in automobiles; communication instruments, such as mobile phones, PDA, remote controllers, mobile information terminals, electronic dictionaries, and electronic organizers; home electric appliances; construction parts; and the like.) 

415: (2294511325861878601) patent: US20130156816A1 Title : METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE) Abstract : The invention features compositions, methods, and kits for the administration of an oxidatively transformed carotenoid, or a fractionated component thereof, for use in aquaculture.) 

416: (5731821427112251479) patent: US20070248668A1 Title : Pharmaceutical compositions and uses thereof) Abstract : The invention features pharmaceutical compositions including rifalazil, a surfactant, and a lipophilic antioxidant and methods of use thereof.) 

417: (2999364461112327637) patent: WO2014078459A1 Title : COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions comprise a combination of a PDE 5 inhibitor, such as sildenafil or icariin, and resveratrol, and a branched amino acid such as leucine, or its metabolite.) 

418: (4239024815223799205) patent: EP2731599A1 Title : COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS) 

419: (972248683219522983) patent: US20150315550A1 Title : CAROTENE HYDROXYLASES AND THEIR USE FOR PRODUCING CAROTENOIDS) Abstract : The present invention relates to novel hydroxylases, nucleic acid sequences coding therefore, expression constructs and vectors comprising these sequences, microorganisms transformed therewith, processes for the microbiological hydroxylation of isoprenoids, for example processes for converting beta-carotene into beta-cryptoxanthin and zeaxanthin, or canthaxanthin into astaxanthin.) 

420: (6808652574324531283) patent: US20140155961A1 Title : METHODS OF TREATING SKIN) Abstract : A topical composition comprising a lipoic acid, a carnitine, and a carnosine in a suitable vehicle for topical application and a method for treating skin is provided. The present compositions are useful in improving the appearance of aged skin characterized by wrinkles and loss of elasticity. Preferred components include R-lipoic acid or R-dihydrolipoic acid, acetyl-l-carnitine, and l-carnosine.) 

421: (1235510367038381919) patent: EP2919772A1 Title : COMPOSITIONS AND METHODS FOR INCREASING ENERGY METABOLISM) 

422: (3439510225268491894) patent: US20150284487A1 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention provides methods for surface-modifying a rubber vulcanizate or a thermoplastic elastomer, which can cost-effectively provide a variety of functions, such as sliding properties, according to the application. The present invention relates to a method for surface-modifying a rubber vulcanizate or a thermoplastic elastomer as a target for modification, the method including: step 1 of forming polymerization initiation points on a surface of the modification target; and step 2 of radically polymerizing a non-functional monomer, starting from the polymerization initiation points, to grow non-functional polymer chains, and then radically polymerizing a fluoropolyether segment-containing functional monomer to grow functional polymer chains.) 

423: (3883669538205945857) patent: EP2056835A2 Title : PHARMACEUTICAL COMPOSITIONS AND USES THEREOF) 

424: (7533781645190520417) patent: WO2014151326A1 Title : ENCLOSING MATERIALS IN NATURAL TRANSPORT SYSTEMS) Abstract : An edible composition, particularly an edible transport system, can be an edible substance and a cross-linked matrix encapsulating the edible substance, the cross-linked matrix comprising (1) at least one edible polymer and edible particles or (2) a plurality of edible polymers.) 

425: (6850469300344250837) patent: US8586107B2 Title : Schisandra sphenanthera fruit extract and cosmetic, dermatological, and nutraceutical compositions comprising same) Abstract : A cosmetic, dermatological or nutraceutical composition including a Schisandra sphenanthera fruit peptide and sugar extract, a crude oil, a refined oil, a refined oil concentrate, and/or the unsaponifiable fraction of the concentrate. A method for preparing a peptide and sugar extract, a refined oil, and/or a concentrate and an unsaponifiable fraction of oil of the Schisandra sphenanthera fruit.) 

426: (4403362999023414597) patent: US20160000117A1 Title : NATURAL AND SUSTAINABLE SEAWEED FORMULA THAT REPLACES SYNTHETIC ADDITIVES IN SWINE FEED) Abstract : A seaweed-based commercial swine feed additive which replaces the synthetic chemical additives that are currently used in swine feed is provided. Synthetic additives are replaced with a combination of seaweed species thereby providing a natural product that improves the nutritional value of the pork, and may replace the chemical use of antibiotics.) 

427: (1325723460685926284) patent: US20070118916A1 Title : Process for the production of fine chemicals) Abstract : The present invention relates to a process for the production of the fine chemical in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof, preferably in plastids. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use.) 

428: (3378979660764071030) patent: EP2644020A1 Title : LIGHT EMITTING DEVICE, LED LIGHT SOURCE FOR PLANT CULTIVATION, AND PLANT FACTORY) Abstract : A substrate-type LED light source (10) includes: at least one blue LED chip (2) which has an emission peak in a range from 400 nm to 480 nm so as to correspond to a blue light region absorption peak of chlorophyll; a red phosphor (7b) which emit, upon receiving excitation light from the at least one blue LED chip (2), light having a peak wavelength in a range from 620 nm to 700 nm so as to correspond to a red light region absorption peak of chlorophyll; and a resin layer (7) in which the red phosphor 7b is dispersed and which covers the at least one blue LED chip (2).) 

429: (7504393656088075518) patent: US5229118A Title : Feed and water additive and method of making same) Abstract : An animal feed and water additive prepared from seaweed and a method of preparing an additive for animal consumption containing seaweed. Seaweed is dried, ground to a powder, frozen and extracted at warm temperature. A solution of elements, and an oxygen-aloe solution are added to the extract. The extract may be given to animals with their drinking water and/or food.) 

430: (2603779348981596409) patent: US20050002879A1 Title : External skin compositions) Abstract : The external skin care composition of the present invention comprises N-acetylglucosamine and at least one member selected from the group consisting of retinoid and pro-vitamin A. The external skin care composition of the present invention has an effect of promoting the production of epidermal hyaluronic acid and can retain firmness and moisture of the skin.) 

431: (981490408493138615) patent: EP1733720A1 Title : COMPOSITION COMPRISING REDUCED-FORM COENZYME Q10 AND CAROTENOID COMPOUND) Abstract : A composition having an antioxidative activity, especially, having a sufficient activity for removing active oxygen and/or free radicals is provided. The composition includes both reduced coenzyme Q 10 and a carotenoid, and the activity for removing active oxygen and/or free radicals is synergistically enhanced. A method for removing active oxygen and/or free radicals by using the composition containing both reduced coenzyme Q 10 and a carotenoid is also provided.) 

432: (9131269902552624131) patent: US20090110674A1 Title : Health supplement) Abstract : A health supplement consisting of numerous ingredients from several general groups including: anti-aging, anti-oxidant, vitamins, minerals, and elemental substances including metals. The supplement is specifically formulated for maximizing synergistic interaction of the ingredients while eliminating harmful interaction among the ingredients. A holistic approach to health is followed with ingredients to aid all systems of the human body. By addressing all human body systems, the supplement acts as a precursor to anti-aging and, when body systems are detoxified and oxidation is controlled, the effect of aging may be reversed.) 

433: (3387265836273432981) patent: WO2016182929A1 Title : ALBUMIN-BASED NON-COVALENT COMPLEXES AND METHODS OF USE THEREOF) Abstract : A non-covalent complex of an albumin molecule and a hydrophobic ligand, compositions containing the same, and methods of use thereof are provided. The present complex may find use in delivering the hydrophobic ligand to microorganisms that have albumin-binding outer surfaces, such as a cell wall.) 

434: (183765551419478094) patent: EP2163252A1 Title : COMPOSITION CONTAINING LICORICE-DERIVED POLYPHENOL) Abstract : A composition containing a licorice polyphenol and other active ingredient (antioxidant ingredient, polyphenol other than licorice polyphenol or a component relating to lipid absorption or metabolism) is highly safe, can be produced easily, and can be utilized for foods and drinks such as health food, food with health claims (specified health food, food with nutrient function claims) and the like, pharmaceutical products, quasi-drugs, cosmetics and the like. In addition, since the composition has a body fat accumulation suppressing effect, a body fat decomposition promoting effect or energy production promoting effect, it is useful for the treatment of obesity, metabolic syndrome and the like.) 

435: (3193421654409955171) patent: WO2007117556A2 Title : PHARMACEUTICAL COMPOSITIONS AND USES THEREOF) Abstract : The invention features pharmaceutical compositions including rifalazil, a surfactant, and a lipophilic antioxidant and methods of use thereof.) 

436: (5444729509002596949) patent: WO2009063333A2 Title : COMPOSITIONS AND METHODS TO INCREASE BIOAVAILABILITY OF CAROTENOIDS) Abstract : The present invention relates to compositions and methods of use to increase the bioavailability of a carotenoid in a subject. The compositions include a carotenoid and either an anthocyanin or a compound having at least one -SH group or combinations of both an anthocyanin and a compound having at least one -SH group and mixtures thereof. The compositions provide that when the composition is administered, the resulting bioavailability of the carotenoid is increased relative to a carotenoid composition that is without either the anthocyanin, is without the compound having at least one -SH group or is without the combination of an anthocyanin/a compound having at least one -SH group and mixtures thereof.) 

437: (8634781167666189433) patent: EP1181375A2 Title : SULFOHYDROLASES, CORRESPONDING AMINO ACID AND NUCLEOTIDE SEQUENCES, SULFOHYDROLASE PREPARATIONS, PROCESSES, AND PRODUCTS THEREOF) 

438: (129388179130033415) patent: US20100239621A1 Title : GEL SHEET AND COSMETIC PREPARATION IN SHEET FORM USING THE SAME) Abstract : A gel sheet including a hydrogel, the hydrogel including at least 50 parts by mass of water-soluble divalent metal salt with respect to 100 parts by mass of anionic polymer compound is provided.) 

439: (1798181630292033867) patent: US9321872B2 Title : Surface modification method and surface-modified elastic body) Abstract : The present invention aims to provide a surface modification method for a rubber vulcanizate or a thermoplastic elastomer, which can impart various functions such as sliding properties and biocompatibility according to its use. The present invention relates to a surface modification method for modifying a rubber vulcanizate or a thermoplastic elastomer as an object to be modified, the method including: Step 1 of forming polymerization initiation points on a surface of the object to be modified; Step 2 of radical polymerizing monomers starting from the polymerization initiation points to grow polymer chains on the surface of the object to be modified; and Step 3 of functionalizing the polymer chains.) 

440: (6452188804387876527) patent: US20100210722A1 Title : COMPOSITION FOR PREVENTING OR TREATING LIPID METABOLIC DISORDERS COMPRISING FUCOXANTHIN OR MARINE PLANT EXTRACT CONTAINING SAME) Abstract : The present invention relates to a composition for the prevention or treatment lipid metabolic disorders comprising fucoxanthin or marine plant extract comtaining the same as an effective indredients. Fucoxanthin or a marine plant extract comprising the same is effective in reducing weight increase and reducing triglyceride and cholesterol level in liver tissue, or plasma through inhibiting the synthesis of fatty acid and promoting the oxidation of fatty acid. Therefore, the composition comprising fucoxanthin or a marine plant extract comprising the same as an effective ingredient may be effectively used for the prevention and treatment of lipid metabolic disorders.) 

441: (8490160026774653527) patent: US20110159152A1 Title : MICROCAPSULES, METHOD OF PRODUCING THE MICROCAPSULES AND FOOD AND DRINK CONTAINING THE MICROCAPSULES) Abstract : A method of producing microcapsules that comprises an emulsification step in which a fat-soluble substance and a sodium alginate aqueous solution are mixed to obtain an emulsified liquid in which there are dispersed emulsified particles composed of the fat-soluble substance and having a mean particle size of not greater than 800 nm, and a spraying step in which the emulsified liquid is sprayed into a calcium ion-containing solution to obtain microcapsules in which the emulsified particles are encapsulated.) 

442: (2712922509044511794) patent: US5776349A Title : Method for dewatering microalgae with a jameson cell) Abstract : Methods are disclosed for dewatering an aqueous suspension of microalgae, especially Dunaliella salina, with a Jameson cell. The algal cells are ruptured sufficiently to promote froth flotation of the cells from the suspension. The algal suspension is introduced into the top of the Jameson cell downcomer and passed through an orifice plate therein to generate a free liquid jet of the suspension. The jet is plunged downwardly through a gas and the gas is transported with the jet through a gas and liquid interface into the algal suspension. The momentum of the jet is dissipated, which disperses the gas into fine bubbles. The fine bubbles are intimately contacted with the aqueous suspension in cocurrent downward flow in a collection zone to absorb the algal bodies onto the surfaces of the bubbles. A froth of bubble and algal agglomerates is formed and collapsed to obtain a dewatered algal concentrate. The Jameson cell can be operated at sufficient inlet pressures so that the algal cells are ruptured by passing them through the orifice rather than in a separate step.) 

443: (4065710493077252237) patent: US20100152286A1 Title : Method for Producing Fucoxanthin) Abstract : The present invention provides a method for producing fucoxanthin extract, said method comprising: performing absorption of the fucoxanthin extract by using absorbent and then performing elution to remove heavy metals and arsenic salt contained in the fucoxanthin extract, wherein the absorbent is selected from a group having macroporous resin, polyamide, activated carbon, alumina and a combination thereof. The method for producing fucoxanthin extract according to the present invention, the content of heave metal in the fucoxanthin extract can be reduced, while the content of fucoxanthin in the fucoxanthin extract can increase. In addition, the present invention also provides a fucoxanthin extract obtained by the above method, as well as fucoxanthin products containing the fucoxanthin extract.) 

444: (5358342140942778319) patent: EP2552413A2 Title : NOVEL SUPPORT SYSTEM FOR THE TRANSPORT OF ACTIVE SUBSTANCES INTO THE SKIN) 

445: (2126391576313044373) patent: US9011832B2 Title : PROCESS FOR PRODUCING PIGMENTS.) 

446: (3966484649758559282) patent: US20050037995A1 Title : Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury) Abstract : A method of treating ischemic reperfusion injury in a subject. The method may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ester functionality.) 

447: (6096244783067615920) patent: US9427010B2 Title : Carotenoid-containing composition) Abstract : A carotenoid-containing composition, comprising: a carotenoid component comprising at least one crystalline carotenoid, at least 90% by mass of the crystalline carotenoid being non-crystalline; a (poly)glycerol fatty acid ester having from 1 to 6 glycerin units and from 1 to 6 fatty acid units and having at least one hydroxyl group from a glycerin unit; and at least one phenolic antioxidant selected from the group consisting of aromatic carboxylic acids, cinnamic acids, and ellagic acids.) 

448: (5053649575484510052) patent: EP1336602A1 Title : Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases) Abstract : New pharmaceutical compounds of general formula (I): F-(X)q where q is an integer from 1 to 5, preferably 1; -F is chosen among drugs described in the text, -X is chosen among 4 groups -M, -T, -V and -Y as described in the text. The compounds of general formula (I) are nitrate prodrugs which can release nitric oxide in vivo in a controlled and selective way and without hypotensive side effects and for this reason they are useful for the preparation of medicines for prevention and treatment of inflammatory, ischemic, degenerative and proliferative diseases of musculoskeletal, tegumental, respiratory, gastrointestinal, genito-urinary and central nervous systems.) 

449: (5819819674104769987) patent: US20050059635A1 Title : Carotenoid ester analogs or derivatives for controlling C-reactive protein levels) Abstract : A method of controlling (e. g., influencing or affecting) C-reactive protein levels in a subject may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ester functionality.) 

450: (7158891979917514104) patent: EP1384482A1 Title : EXTERNAL SKIN COMPOSITIONS) Abstract : The external skin care composition of the present invention comprises N-acetylglucosamine and at least one member selected from the group consisting of retinoid and pro-vitamin A. <??>The external skin care composition of the present invention has an effect of promoting the production of epidermal hyaluronic acid and can retain firmness and moisture of the skin.) 

451: (4506063819860874809) patent: US20160000701A1 Title : TOPICAL COMPOSITION COMPRISING TRANSFORMED BACTERIA EXPRESSING A COMPOUND OF INTEREST) Abstract : Compositions comprised of a population of transformed bacteria formulated for topical application to a subject are described. The population of transformed bacteria are created from a non-pathogenic bacteria and transformed to express a compound of interest for a therapeutic or a cosmetic purpose. In one embodiment, the composition is for protection of the skin from ultraviolet rays.) 

452: (3368758402522083247) patent: WO2014129974A1 Title : PROCESS FOR THE ISOLATION OF CAROTENOIDS) Abstract : Described herein is a material for reversibly binding to a carotenoid comprising a support coupled to silver ions in an amount to enable reversible binding with carotenoids, and wherein with the exception of silver ions, is substantially free of transition metals. Also described herein is a process for reversibly binding a carotenoid, the process comprising the steps of: providing a support coupled to silver ions in an amount to enable reversible binding with the carotenoid, wherein with the exception of silver, the support is substantially free of transition metals, contacting the support wth the carotenoid under binding conditions to bind it thereto and dissociating the carotenoidod from the support under dissociating conditions to release the carotenoid.) 

453: (1490410746427432516) patent: US20030185939A1 Title : Methods for processing crustacean material) Abstract : The inventor has found that enzymatic treatment of crustaceans with lipolytic enzymes promotes the extraction of coloured pigment. Accordingly, the invention relates to a method for recovering coloured pigment, e. g. astaxanthin, and/or chitin or chitosan and/or lysolecithins from crustaceans. Lipolytic enzyme(s) may e. g. be lipase or phospholipase. The lipolytic enzyme treated crustacean material may be subjected to additional process steps, including treatment with non-lipolytic enzymes such as e. g. protease. The process of the invention provides several suitable products and several uses of such products. Furthermore, the invention also relates to the cosmetic and consumable products (feed and food (including beverages) products and additives produced therefrom.) 

454: (3212137587195420085) patent: WO2013119955A1 Title : FUNCTIONALIZED POLYMER COMPOSITIONS) Abstract : Functionalized polymers include homopolymers and copolymers of 2-hydroxy-4-(methylthio)-butanoic acid (HMTBA) and uses in industrial applications and in agricultural applications. The homopolymers and copolymers may be, for example, used in polymer blends, used as nutritives and in feed compositions, and used in combination with a pharmaceutical or nutritive. The homopolymers and copolymers provided herein have advantageous physical properties which can, in some instances, provide a pH switch effect. The homopolymers and copolymers may be used in a variety of contexts including, in polymer blends, in animal feed, and in combination with a pharmaceutical agent.) 

455: (2040915675010355265) patent: US8110672B2 Title : Promoter engineering and genetic control) Abstract : The present invention relates to expression cassettes libraries of expression vectors comprising the same, wherein each vector comprises at least one gene of interest and a promoter operatively linked thereto wherein each promoter comprises a nucleic acid, whose sequence is randomly mutated with respect to that of another in the library and cells comprising the same. Methods utilizing either the libraries or cells of this invention, in optimizing gene expression, protein expression, or optimized gene or protein delivery are described.) 

456: (7240580222468819216) patent: US20130309218A1 Title : PROCESS FOR PRODUCING AQUEOUS SOLUTION CONTAINING FAT-SOLUBLE SUBSTANCE) Abstract : The purpose of the present invention is to provide a process for producing an aqueous solution containing a fat-soluble substance. A combination of a super dissolution aid, cyclodextrin and a fat-soluble substance or a combination of the super dissolution aid and a cyclodextrin complex of the fat-soluble substance is used for dissolving the fat-soluble substance, whereby it becomes possible to provide an aqueous solution containing the fat-soluble substance at a high concentration and an aqueous solution having improved transdermal absorbability of the fat-soluble substance contained therein.) 

457: (4184209905166690256) patent: EP2939657A1 Title : SKIN-EXTERIOR ANTI-AGEING COMPOSITION AND PRODUCTION METHOD THEREFOR) Abstract : The present invention has an object to provide an external dermal composition for anti-ageing, which prevents or improves apparent skin problems such as wrinkles, fine wrinkles, blemishes, and saggings caused by increasing age or ageing; and maintains or improves the barrier function and the hyaluronic acid production in the skin. The object is solved by providing an external dermal composition for anti-ageing, which contains an aqueous medium as a base material and one or more ingredients selected from L-ascorbic acid, derivatives thereof, and their salts as an effective ingredient(s).) 

458: (5767772111343670727) patent: WO2013137826A1 Title : GENERATION OF BROWN ADIPOSE TISSUE (BAT) FROM MESENCHYMAL CELLS) Abstract : Methods of generating functional human brown adipocytes, comprising exposing human stem cells, progenitor cells, or white adipocytes to culture with an differentiation cocktail that comprises one or more browning agents (e. g., one or more macromolecular crowders), and optionally one or more adipogenic agents, are described, as are populations of human brown adipocytes generated by the methods, and uses for the populations. Methods of generating functional human brown adipocytes in an individual, such as by administering a pharmaceutical composition comprising an differentiation cocktail, are also described.) 

459: (9137068460110504000) patent: US20110020519A1 Title : MAIN-ROD CONNECTION.) 

460: (3977163198090091660) patent: US20120165413A1 Title : DISINTEGRATING PARTICLE COMPOSITION AND ORALLY RAPIDLY DISINTEGRATING TABLET) Abstract : Disclosed is an orally rapidly disintegrating tablet which has a good texture and taste in the oral cavity, such a sufficient hardness as not giving any worry of being chipped or dusted during production or transportation and good disintegrating properties in the oral cavity. The orally rapidly disintegrating tablet, which has a good texture and taste, an appropriate hardness, and good disintegrating properties, can be produced by using a composition, which is prepared by dispersing, by spray-drying, an inorganic excipient and starch(es) in complex particles composed of mannitol and xylitol, in an orally rapidly disintegrating tablet.) 

461: (7085508723096098814) patent: WO2015137500A1 Title : ) Abstract : The purpose of the present invention is to provide an anti-obesity agent that actualizes an exceptional anti-obesity effect. This anti-obesity agent is characterized in containing astaxanthin and fucoxanthin as active ingredients. The mass ratio of the astaxanthin content and the fucoxanthin content is preferably 1:4-1:1. This anti-obesity agent is preferably applied in fields such as pharmaceuticals, health foods, foods for specified health uses, and the like.) 

462: (5209113242821088498) patent: US8709766B2 Title : USE OF ENDOGENOUS PROMOTERS IN GENETIC ENGINEERING OF NANNOCHLOROPSIS GADITANA) Abstract : The present disclosure is directed to novel polynucleotide sequences for use in Nannochloropsis gaditana. The novel polynucleotide sequences include control sequences and coding sequences. Also disclosed are novel gene expression constructs wherein N. gaditana promoters/control regions are operatively linked to N. gaditana or non-N. gaditana coding sequences. These novel polynucleotide sequences and expression constructs can be introduced into N. gaditana and can recombine into the N. gaditana genome. Expression from these polynucleotide sequences and expression constructs can enhance N. gaditana biomass and/or lipid biosynthesis. Also disclosed are methods for modifying N. gaditana, for example by stably transforming N. gaditana with nucleic acid sequences, growing the modified N. gaditana, and obtaining biomass and biofuels from the modified N. gaditana.) 

463: (7031745624419678727) patent: US20110244512A1 Title : PENTOSE PHOSPHATE PATHWAY UPREGULATION TO INCREASE PRODUCTION OF NON-NATIVE PRODUCTS OF INTEREST IN TRANSGENIC MICROORGANISMS) Abstract : Coordinately regulated over-expression of the genes encoding glucose 6-phosphate dehydrogenase [G6PDH] and 6-phospho-gluconolactonase [6PGL] in transgenic strains of the oleaginous yeast, Yarrowia lipolytica, comprising a functional polyunsaturated fatty acid [PUFA] biosynthetic pathway, resulted in increased production of PUFAs and increased total lipid content in the Yarrowia cells. This is achieved by increased cellular availability of the reduced form of nicotinamide adenine dinucleotide phosphate [NADPH], an important reducing equivalent for reductive biosynthetic reactions, within the transgenic microorganism.) 

464: (622188340973262925) patent: WO2002030412A1 Title : COMPOSITIONS CONTAINING TRYPTAMINES, CAROTENOIDS AND TOCOTRIENOLS HAVING SYNERGISTIC ANTIOXIDANT) Abstract : A novel formulation is provided that serves to synergistically inhibit the generation of free radicals and oxidative stress in warm blooded animals. The formulation comprises an effective amount of a first component of a tryptamine species or derivatives thereof, and, as a second component, at least one member selected from the group consisting of a carotenoid species, a tocotrienol species and derivatives thereof, and provides for synergistic anti-oxidant activity.) 

465: (626749446367747754) patent: US20150342914A1 Title : COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

466: (4607237339358416586) patent: US20070065903A1 Title : Process for chromosomal expression of foreign genes in the hsdM region of a methylotrophic microbial host cell) Abstract : Provided is a method for stably expressing an introduced gene or genes in a methylotrophic microorganism host wherein the gene(s) are integrated into the hsdM region of the chromosome. This method provides stable, high-level expression of the integrated genes in which growth rate of the host strain is not highly affected and a selection marker is not required. The use of this method for expressing carotenoid biosynthetic genes and resulting production of astaxanthin is also described.) 

467: (7131160962925724939) patent: US20130131183A1 Title : METHODS AND COMPOSITIONS FOR IMPROVING THE HEALTH OF ANIMALS) Abstract : The invention features compositions and methods for the administration of an oxidatively transformed carotenoid, or a fractionated component thereof, for improving the health of animals, such as increasing joint mobility, increasing activity, and improving coat quality.) 

468: (8058119106414606477) patent: WO2016012618A1 Title : IN VIVO PRODUCTION OF A RECOMBINANT CAROTENOID-PROTEIN COMPLEX) Abstract : The present invention relates to a method for producing a carotenoid-protein complex in vivo comprising the steps of transforming of prokaryote cell with genes involved in carotenoid synthesis and with a gene encoding an apo-carotenoprotein; culturing said porokaryote cells such as to induce sequential genes expression, isolating and purifying the carotenoid-protein complex.) 

469: (4914548929322749643) patent: US20040116514A1 Title : Compositions for preventing human cancer and method of preventing human cancer) Abstract : The composition of the present invention comprises vitamin E compounds in addition to carotenoid compounds. Carotenoid compounds and vitamin E compounds are preferably administered according to the method of the present invention such that the daily dosage of carotenoid compounds is 1-100 mg, and the daily dosage of vitamin E compounds is 10-200 mg. When capsules comprising 10 mg natural lycopene, 6 mg natural beta-carotene, 3 mg natural alpha-carotene, 1 mg other natural carotenoids, and alpha-tocopherol were administered to hepatic cirrhosis patients over a period of 5 years, the incidence rate of hepatic cancer after 5 years in the group who took the capsules was one-third that of the group who did not take the capsules. Significant cancer-preventive effects in humans are manifested for the first time in the composition of the present invention.) 

470: (2171724297559396099) patent: US20140037762A1 Title : ADIPONECTIN PRODUCTION PROMOTER, AND MEDICINAL COMPOSITION, FOOD, DRINK AND FEED CONTAINING ADIPONECTIN PRODUCTION PROMOTER) Abstract : Provided is an adiponectin production-promoting agent comprising Botanbouhu as an active component. Such an adiponectin production-promoting agent is able to be used for prevention or treatment of hypoadiponectinemia. Further provided are a pharmaceutical composition, food and drink, and feed comprising such an adiponectin production-promoting agent.) 

471: (3768623815950300218) patent: WO2009038030A1 Title : GEL SHEET AND SHEET-LIKE COSMETIC MATERIAL USING THE SAME) Abstract : The invention provides the gel sheet comprising a hydrogel which comprises an ether-based temperature-sensitive polymer, and at least one of collagen or decomposition products of collagen; and the sheet-like cosmetic material using the gel sheet described above.) 

472: (1570228214223473477) patent: WO2004087892A1 Title : GENE INVOLVED IN THE BIOSYNTHESIS OF CAROTENOID AND MARINE MICROORGANISM, PARACOCCUS HAEUNDAENSIS, PRODUCING THE CAROTENOID) Abstract : The present invention relates to a gene involved in the biosynthesis of carotenoid and a marine microorganism producing the carotenoid, more particularly to a gene represented by Seq ID. No. 5, 7, 9, 11, 13 and 15 which encoding the protein needed to biosynthesis of carotenoid and a marine microorganism, Paracoccus haeundaensis, producing the carotenoid. Since the gene and the microorganism can effectively be used for, the massive-production of carotenoid.) 

473: (6063961308207864979) patent: US20140255524A1 Title : ALPHA-GPC DIETARY SUPPLEMENTS FOR WEIGHT LOSS AND/OR INCREASING OR MAINTAINING LEAN BODY MASS) Abstract : Disclosed herein are methods for weight loss and/or maintaining weight and/or increasing and/or maintaining lean body mass using glycerylphosphorylcholine (alpha-GPC). Disclosed herein are formulations of glycerylphosphorylcholine (alpha-GPC) useful for weight loss, and/or maintaining weight and/or maintaining and/or increasing lean muscle mass.) 

474: (3471933073065843657) patent: US8367395B2 Title : PRODUCTION OF STEROLS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides methods for production of one or more sterol compounds. Further provided are methods and systems for producing engineered oleaginous yeast or fungi that are capable of production of one or more sterol compounds, and compositions which utilize the produced sterol compound(s).) 

475: (7753575698032351193) patent: US20040166199A1 Title : Increasing bioavailability of carotenoids) Abstract : A method of increasing a fraction of free carotenoids in a source of carotenoids in which at least some of the carotenoids are fatty acid esterified carotenoids is disclosed. The method is effected by contacting the source of carotenoids with an effective amount of an esterase under conditions effective in deesterifying the fatty acid esterified carotenoids, thereby increasing the fraction of free carotenoids in the source of carotenoids.) 

476: (8566856992423551018) patent: US6540654B2 Title : Carotenoid esters) Abstract : Monoesters, diesters and polyesters are provided wherein both the acid-derived moiety and the alcohol-derived moiety of the esters are carotenoid compounds. The synthetic ester linkage between two or more carotenoids provides new compounds in which the similar and complementary properties of the individual carotenoids are combined. The new all-carotenoid esters may be useful as antioxidants, therapeutic agents, pigmenting ingredients in poultry feed or as coloring agents for fats. The polyesters have the potential to act as molecular wires with unique electrical conductance characteristics. The all-carotenoid esters may be prepared from the esterification of at least one hydroxy carotenoid with at least one carboxylic carotenoid, or via the reaction of the acid chloride of a carboxylic carotenoid with a hydroxy carotenoid.; Preferred hydroxy carotenoids include lutein, zeaxanthin, cryptoxanthin, violaxanthin, carotene diol, hydroxy carotene, hydroxylycopene, alloxanthin and dehydrocryptoxanthin. Preferred carboxylic carotenoids include bixin, norbixin, beta-apo-8-carotenoic acid, crocetin, diapocarotenoic acid, carboxylcarotene and azafrin.) 

477: (3455520759841319508) patent: US20050059659A1 Title : Carotenoid analogs or derivatives for controlling C-reactive protein levels) Abstract : A method of controlling (e. g., influencing or affecting) C-reactive protein levels in a subject may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include an acyclic alkene including at least one substituent and/or a cyclic ring including at least one substituent. In some embodiments, a carotenoid analog or derivative may include at least one substituent.) 

478: (4640230468937298705) patent: US20130309338A1 Title : BIOLOGICALLY ACTIVE SUBSTANCE-CONTAINING WATER-SOLUBILIZING PREPARATION AND METHOD FOR PRODUCING THE SAME) Abstract : An object of the present invention is to provide a water-solubilizing preparation that is obtained by convenient steps without use of a special apparatus such as a high-pressure homogenizer, does not impair the original properties of a water-based material even after being added to the material, has high dispersibility and transparency and excellent heat resistance and acid resistance, and can maintain stability. The water-solubilizing preparation of the present invention is a biologically active substance-containing water-solubilizing preparation comprising 1 to 50% by weight of an oily ingredient (A) containing a biologically active substance and oil, 10 to 98% by weight of a polyglycerin fatty acid ester (B) having an HLB value of 12.5 or larger, and 1 to 40% by weight of a surfactant (C) having an HLB value of 7 to 11.8.) 

479: (3043033708141618143) patent: US9452143B2 Title : Matrix and layer compositions for protection of bioactives) Abstract : The invention relates to matrix and layer compositions comprising a first polymer. The matrix and layer compositions are useful in the delivery of bioactives. In particular, the matrices and layers may have advantageous properties including mechanical properties and protection of bioactives and may also provide for pH-dependent release of a bioactive.) 

480: (4155327398931137308) patent: US6000551A Title : Method for rupturing microalgae cells) Abstract : A method for rupturing microalgae in an aqueous suspension is disclosed. In one embodiment the aqueous suspension is passed through a constriction into a liquid phase at a pressure sufficient to rupture the cells by circulating the aqueous suspension through a constriction in a pump loop at a pressure and a percent recycle sufficient to rupture the cells. Cells of the alga Dunaliella salina can be ruptured by the method of the invention to promote froth flotation and mechanical filtration of the cells for recovery of mixed carotenoids.) 

481: (6837711423403685629) patent: WO2013136025A1 Title : PRODUCTION OF DOCOSAHEXAENOIC ACID AND/OR EICOSAPENTAENOIC ACID AND/OR CAROTENOIDS IN MIXOTROPHIC MODE USING NITZSCHIA) Abstract : The invention relates to new strains of microalgae belonging to the Nitzschia genus, allowing high-yield production of lipids, in particular of docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) and/or carotenoids, in particular fucoxanthin, in mixotrophic mode, and to a method for selecting and culturing such strains, using a variable and/or discontinuous light source, in particular a flashing light.) 

482: (7542389117088449344) patent: US20090181901A1 Title : COMPOSITIONS AND METHODS TO INCREASE BIOAVAILABILITY OF CAROTENOIDS) Abstract : The present invention relates to compositions and methods of use to increase the bioavailability of a carotenoid in a subject. The compositions include a carotenoid and either an anthocyanin or a compound having at least one -SH group or combinations of both an anthocyanin and a compound having at least one -SH group and mixtures thereof. The compositions provide that when the composition is administered, the resulting bioavailability of the carotenoid is increased relative to a carotenoid composition that is without either the anthocyanin, is without the compound having at least one -SH group or is without the combination of an anthocyanin/a compound having at least one -SH group and mixtures thereof.) 

483: (8612505865658074654) patent: US20130273123A1 Title : Colloidal Carrier System with Penetration Properties for Encapsulating Lipophilic Active Agents and Oils for Topical Use) Abstract : The invention relates to a colloidal carrier system in the form of a nanocapsule, comprising at least the following components: a liquid lipid core, a continuous shell surrounding the core, containing at least one membrane-forming, natural anionic emulsifier and at least one single-chain, natural non-ionic co-emulsifier selected from the group of diglyceryl-monooleates, diglyceryl-monolinoleates, polyglyceryl-monooleates, polyglyceryl-monolinoleates.) 

484: (5744262900074746212) patent: US20140370154A1 Title : EMULSION COMPOSITION, AND COMPOSITION CONTAINING SAME) Abstract : The present invention provides an emulsion composition that ensures excellent emulsion stability and excellent solubility in water, as well as excellent transparency and storage stability of a solution prepared by adding the emulsion composition to water. The present invention also provides an aqueous composition, in particular, a solution aqueous composition (aqueous liquid composition), preferably food or a beverage, containing the emulsion composition. The emulsion composition is an emulsion composition prepared by emulsifying an oil phase component and an aqueous phase component using gum ghatti, wherein the emulsion composition comprises gum ghatti in a proportion of more than 25 parts by weight based on 100 parts by weight, i. e., the total amount, of the oil phase component; and the gum ghatti has a viscosity of 50 to 3000 mPa. s, which is measured by preparing a 15 wt % aqueous solution of the gum ghatti and measuring its viscosity for 1 minute at 20 C. and 30 rpm using a Brookfield viscometer.) 

485: (1073166811819887571) patent: US20110274746A1 Title : Therapeutic Liposomes and Methods For Producing and Using the Same) Abstract : The present invention provides therapeutic liposomes and methods for producing and using the same. In particular, therapeutic liposomes of the invention comprise phospholipids comprising C16-C22 fatty acid ester moieties. In some embodiments, these therapeutic liposomes are used in assisting delivery of an active compound, e. g., a drug and/or a nutraceutical, to a subject. In some embodiments, compositions of the invention have synergistic therapeutic effect.) 

486: (1698888400085652174) patent: US20130102463A1 Title : Herbicidal Compositions) Abstract : The present invention relates to herbicidal compositions comprising as herbicide A at least one protoporphyrinogen-IX oxidase inhibitor (PPO inhibitor), and at least one light detoxifying compound B, compositions comprising them and their use as herbicides, i. e. for controlling harmful plants, and also a method for controlling unwanted vegetation which comprises allowing a herbicidal effective amount of said herbicidal composition to act on plants, their seed and/or their habitat.) 

487: (5261059932368764762) patent: US20030206972A1 Title : Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect) Abstract : A novel formulation is provided that serves to synergistically inhibit the generation of free radicals and oxidative stress in warm blooded animals. The formulation comprises an effective amount of a first component of a carotenoid species, and, as a second component, a tocotrienol species and derivatives thereof, and provides for synergistic anti-oxidant activity.) 

488: (7841275480094173799) patent: US20120214244A1 Title : METHOD FOR QUANTIFICATION OF CAROTENOID) Abstract : Provided is a method for quantitative analysis of carotenoids such as [beta]-cryptoxanthin contained in a sample such as citrus fruit or the like which enables simple and accurate quantitative analysis. An internal standard such as lycopene or retinal is used, whereby work is facilitated and an error of a measured value is reduced. Further, a dehydrating agent is added during saponification reaction in the preparation of a sample for analysis, whereby a deviation of a measured value can be reduced.) 

489: (4357610804835449802) patent: JP2000004848A Title : PRODUCTION OF DRIED KELP) Abstract : PROBLEM TO BE SOLVED: To provide a method for producing dried kelp, capable of removing a smell specific to raw kelp and capable of promoting the digestion and absorption of kelp and capable of utilizing even kelp which have not been used as waste kelp or low-grade one. SOLUTION: This method for producing dried kelp comprises the steps of (1) cutting raw kelp in lengths, followed by removing the salt from the cut kelp by washing it in water, or (1') removing the salt from raw kelp by washing it in water and then cutting the kelp in lengths; (2) boiling the cut kelp in water to green the brown pigment (fucoxanthin) rich in raw materials; and (3) hot-air drying the cut kelp after seasoning it.) 

490: (7045634706909671718) patent: WO2006102342A2 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

491: (8864243103088021829) patent: US9226911B2 Title : METHOD OF REDUCING WEIGHT USING COMPOSITION CONTAINING FUCOXANTHIN EXTRACT) Abstract : A method of reducing a weight of a subject includes administering to the subject in need thereof a composition comprised of fucoxanthin extract and at least one selected from the group consisting of tocotrienol, fucoidan and a combination thereof, wherein the subject is a mammal.) 

492: (1211104279615227042) patent: EP2078092A2 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) 

493: (3940682545620824009) patent: EP1572990A2 Title : INCREASING CAROTENOID PRODUCTION IN BACTERIA VIA CHROMOSOMAL INTEGRATION) 

494: (4198829766375604900) patent: US8445035B2 Title : DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF ARONIA AND METHOD OF USING SAME TO PROMOTE WEIGHT LOSS) Abstract : A dietary supplement composition comprising aronia extract containing at least 20% anthocyanins by dry weight. The aronia extract is derived from the aronia melanocarpa plant. The aronia extract comprises approximately 10%-30% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is provided in the composition. The dietary supplement composition is administered orally to promote weight loss.) 

495: (6317159777661166573) patent: WO2012125953A2 Title : LUMINESCENT DEVICES) Abstract : The methods, devices, and systems described herein describe a novel way to cause the emission of light from algae. By preparing algae and applying an appropriate electromagnetic wave or field to the prepared algae, the algae will then emit light. The prepared luminescent algae may also be incorporated into luminescent panels, which may then be integrated into a variety of applications. In some embodiments, these luminescent panels can be individually and remotely controlled, allowing for ease of use and installation. Furthermore, these luminescent panels also consume a relatively small amount of power compared to conventional light sources, creating a possibility to save significant amounts of energy and energy related costs.) 

496: (3802280505447515821) patent: EP1572990A4 Title : INCREASING CAROTENOID PRODUCTION IN BACTERIA VIA CHROMOSOMAL INTEGRATION) 

497: (2966124306582035538) patent: US20100221306A1 Title : ADHESIVE GEL SHEET FOR LIVING ORGANISMS AND SHEET FORM COSMETICS COMPRISING THE SAME) Abstract : To provide an adhesive gel sheet for living organisms which may allow efficient permeation of the skin by carotenoid, and also provide a sheet-form cosmetic using the same, It is provided an adhesive gel sheet for living organisms which includes a hydrogel having a carotenoid-containing O/W emulsion, gelatin or a derivative thereof and a hydrophilic polymer, and further comprises a polyvalent inorganic salt, wherein the content of the polyvalent inorganic salt is 0.1% or less by mass of the entire mass of the hydrogel. It is preferable that the hydrophilic polymer be a polysaccharide that forms a thermoreversible gel.) 

498: (9005644349610133053) patent: US9381223B2 Title : Methods for inhibiting advanced glycation end product production, inhibiting fibroblast apoptosis, and/or promoting human fibroblast-collagen grating formulation using cherry blossom and cherry leaf extract) Abstract : Disclosed is an AGE production inhibitor or the like, which effectively inhibits the production of an advanced glycation end product (AGE), while having improved biological safety. Specifically disclosed is an AGE production inhibitor or the like, which contains en extract of cherry tree (preferably blossoms or leaves thereof) and/or a processed product of the extract as an active substance. The AGE production inhibitor or the like contains, as an active substance, at least one compound that is selected from among 1-O-(E)-Caffeoyl--D-glucopyranoside, 1-O-(E)-Coumaroyl--D-glucopyranoside, 1-O-(E)-Cinnamoyl--D-glucopyranoside, Kaempferol 3-O--D-glucopyranoside, Quercetin 3-O--D-glucopyranoside, Kaempferol 3-O-(6-malony)--D-glucopyranoside, and Quercetin 3-O-(6-malony)--D-glucopyranoside.) 

499: (2708331781218095696) patent: EP2345409A1 Title : THERAPEUTIC AGENT FOR ADULT T-CELL LEUKEMIA) Abstract : An object is to provide a novel therapeutic drug for adult T-cell leukemia having an ATL cell specific antitumor effect. The therapeutic drug for adult T-cell leukemia according to the invention is characterized by containing a compound represented by the formula I or a prodrug thereof, wherein R 1 is H, OH, an alkoxy group, an acyl group, or a thioacyl group, R 2 is an acyl group, a thioacyl group, CONR 7 R 8 , or CSNR 7 R 8 (R 7 and R 8 being each independently H, an alkyl group containing 1 to 3 carbon atoms, or a phenyl group), or R 1 and R 2 together may form a ring, X 1 and X 2 may be the same or different and are each -CR 3 R 4 -SiR 3 R 4 - or oxygen, and R 3 and R 4 may be the same or different and are each an alkyl group containing 1 to 6 carbon atoms.) 

500: (4109016900834913708) patent: US7776915B2 Title : Topical formulations and methods of use) Abstract : A topical composition comprising a lipoic acid, a carnitine, and a carnosine in a suitable vehicle for topical application and a method for treating skin is provided. The present compositions are useful in improving the appearance of aged skin characterized by wrinkles and loss of elasticity. Preferred components include R-lipoic acid or R-dihydrolipoic acid, acetyl-1-carnitine, and 1-carnosine.) 

501: (2167988614008756921) patent: US8927285B2 Title : MICRO-ALGA BELONGING TO GENUS NAVICULA, PROCESS FOR PRODUCTION OF OIL BY CULTURE OF THE MICRO-ALGA, AND OIL COLLECTED FROM THE MICRO-ALGA) Abstract : Disclosed are: a microalga highly capable of producing aliphatic hydrocarbons of 16 to 26 carbon atoms; a process for producing oil, which comprises a step of culturing the microalga; oil collected from the microalga; a fuel produced from the microalga; and a method for fixing carbon dioxide, which comprises a step of culturing the microalga. Specifically disclosed is a microalga belonging to the genus Navicula, which is capable of producing aliphatic hydrocarbons of 16 to 26 carbon atoms. More specifically disclosed is a microalga, Navicula oiliticus strain JPCC DA0580 (FERM BP-11201).) 

502: (6087035610504958481) patent: EP2004801A2 Title : PRODUCTION OF QUINONE DERIVED COMPOUNDS IN OLEAGINOUS YEAST FUNGI) 

503: (5988604114845809245) patent: EP2226071A1 Title : COMPOSITION FOR ORAL ADMINISTRATION) Abstract : A composition which has high safety and is excellent in the effect of reducing body fat, such as visceral fat, subcutaneous fat and the like, and neutral fat, and a food, a pharmaceutical and a feed comprising the same, are provided. An oral administration composition having a body fat reducing action and/or a neutral fat reducing action, which is a composition comprising a carotenoid and a sphingolipid or a carotenoid and a flavonoid and/or a derivative thereof, preferably a composition comprising a cryptoxanthin and a sphingolipid or a cryptoxanthin and a flavonoid and/or a derivative thereof, wherein the cryptoxanthin and/or the sphingolipid and/or the flavonoid are derived from a citrus fruit and the citrus fruit is preferably Citrus unshiu .) 

504: (7876810652129017495) patent: WO2008075204A2 Title : LIPOIC ACID DERIVATIVES) Abstract : The invention describes alpha lipoic acid complexes, that can be oligomeric, polymeric, monomeric and mixtures thereof. The complexes can be salts, chelates, etc. of the oligomers, polymers, or monomeric alpha lipoic acid.) 

505: (8134391110288053546) patent: US20160192689A1 Title : ENCAPSULATED FUNCTIONAL FOOD COMPOSITIONS) Abstract : A functional food composition comprising an edible or potable substance, a cross-linked edible matrix encapsulating the edible or potable substance, a probiotic, and a prebiotic, with the proviso that the edible or potable substance and the matrix do not both contain the probiotic or both contain the prebiotic. The encapsulated composition provides certain advantages in its transport, handling and consumption. The edible membrane matrix can be constructed to include edible particles that impart advantages to the performance of the membrane matrix, provide functional nutrition, health and well-being benefits, therapeutic treatment to the consumer, and/or enhance consumer gustatory experience. In particular aspects, the functional food composition provides nutritive and health benefits for disease treatment and prevention, and health maintenance through the incorporation of certain biologically active compounds in the edible substance and/or as particles in the membrane matrix.) 

506: (4997059855552996854) patent: US20040175785A1 Title : Increasing bioavailability of carotenoids) Abstract : A method of increasing a fraction of free carotenoids in a source of carotenoids in which at least some of the carotenoids are fatty acid esterified carotenoids is disclosed. The method is effected by contacting the source of carotenoids with an effective amount of an esterase under conditions effective in deesterifying the fatty acid esterified carotenoids, thereby increasing the fraction of free carotenoids in the source of carotenoids.) 

507: (367918584099480120) patent: EP2348868A1 Title : NOVEL MITOCHONDRIAL UNCOUPLING METHODS AND COMPOSITIONS FOR ENHANCING ADIPOCYTE THERMOGENESIS) 

508: (2364710629529378301) patent: US20160000745A1 Title : METHODS AND COMPOSITIONS FOR TREATING OBESITY, PREVENTING WEIGHT GAIN, PROMOTING WEIGHT LOSS, PROMOTING SLIMMING, OR TREATING OR PREVENTING THE DEVELOPMENT OF DIABETES) Abstract : The present invention relates to compositions and kits including a chemical uncoupler, such as tyrphostin 9 or precursor or a salt thereof, and compositions including a chemical uncoupler, such as tyrphostin 9 in combination with one or more therapeutic agents, for example, L-carnitine, which are useful, for example, in treating obesity, preventing weight gain, promoting weight loss/slimming, and/or treating or preventing the development of diabetes.) 

509: (8701290204897333503) patent: US20040101942A1 Title : Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof) Abstract : A purified sulfohydrolase having a purity level based on total amount of protein of at least about 40 wt %. Isolated nucleic acid sequence and amino acid sequences. A process for purifying at least one sulfohydrolase, including subjecting an extract from seaweed to fractionation to obtain fractions; and subjecting at least one of the fractions to phenyl sepharose chromatography to obtain sepharose fractions containing at least one sulfohydrolase. An enzymatically modified compound which has been modified by an isolated sulfohydrolase having a purity level based on total amount of protein of at least about 40 wt %. A process of enzymatically modifying a sulfated compound, including combining at least one sulfohydrolase, having a purity level based on total amount of protein of at least about 40 wt %, with a sulfated compound form a reaction mixture; and incubating the reaction mixture to remove sulfate groups from the sulfated compound to form an enzymatically modified compound. A process of enzymatically modifying a sulfated compound, including incubating a first sulfohydrolase with a sulfated compound to remove sulfate groups from the sulfated compound to form an intermediate compound; and subsequently incubating the intermediate compound with a second sulfohydrolase to remove sulfate groups to form an enzymatically modified compound. A method for extracting one of nu- and mu-carrageenan from seaweed, including dispersing seaweed in a salt solution including K2CO3 to form a dispersion; filtering the dispersion to obtain a liquid; ultrafiltering the dispersion to remove salts; concentrating the liquid; adjusting the pH of the liquid to about 8 to 8.5; and precipitating one of nu- and mu-carrageenan from the liquid.) 

510: (6612067732693966108) patent: EP2745835B1 Title : Novel vesicle for topical application in pharmacy and cosmetics) Abstract : Aqueous composition comprises: vesicles formed from at least one amphiphilic, membrane-forming lipid of the group of esters or diacylglycerides polyacylglycerides with long-chain unsaturated fatty acids and at least one membrane-stabilizing long-chain unsaturated fatty acid monoester; an aqueous medium comprising both the vesicle and carrier vehicle of the same composition; at least one active substance which can be hydrophilic, amphiphilic or lipophilic.) 

511: (8349899332244715062) patent: US6579714B1 Title : Method of culturing algae capable of producing phototrophic pigments, highly unsaturated fatty acids, or polysaccharides at high concentration) Abstract : The present invention relates to a method for cultivation and manufacturing efficiently algae containing useful substances in cells thereof in a high concentration. According to conventional cultivation apparatus, shear stress applied to algae causes difficulty of high density cultivation; however, by cultivation of algae by using a convenient cultivation apparatus having a dome shape, conical shape, or cylindrical shape and made by a clear material, high density cultivation has been realized without shear stress. The present cultivation apparatus realizes more efficient cultivation in combined use with a separate gas discharging apparatus. In addition, the present invention can be applied to a wide variety of algal species having ability to produce highly unsaturated fatty acid, a photosynthetic pigment, or a polysaccharide.) 

512: (3119800130371576661) patent: EP2915838A1 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention provides methods for surface-modifying a rubber vulcanizate or a thermoplastic elastomer, which can cost-effectively provide a variety of functions, such as sliding properties, according to the application. The present invention relates to a method for surface-modifying a rubber vulcanizate or a thermoplastic elastomer as a target for modification, the method including: step 1 of forming polymerization initiation points on a surface of the modification target; and step 2 of radically polymerizing a non-functional monomer, starting from the polymerization initiation points, to grow non-functional polymer chains, and then radically polymerizing a fluoropolyether segment-containing functional monomer to grow functional polymer chains.) 

513: (8296926214205201020) patent: US8927043B2 Title : Stabilized formulations of fatty acids) Abstract : Disclosed herein are stabilized powder and aqueous formulations comprising a substantially water insoluble lipophilic bioactive compound and a micelle-forming surfactant. In one embodiment, the formulation further comprises a water soluble reducing agent, and/or a water insoluble reducing agent, and/or a metal chelator, and/or a metal bisulfite reducing agent, or combinations thereof, wherein the formulation remains substantially clear and stable when stored at or below room temperature for a period of at least 6 months or at least 12 months; and methods for preparing these formulations.) 

514: (883497256140109090) patent: WO2007094430A1 Title : CANCER INHIBITOR, CANCER INHIBITOR-CONTAINING PRODUCT AND PROCESS FOR PRODUCING CANCER INHIBITOR) Abstract : It is intended to provide a cancer inhibitor and a cancer inhibitor-containing product capable of enhancing the potency of cancer inhibitor containing fucoxanthin and providing an immediate effect, and a process for producing the cancer inhibitor. The cancer inhibitor is characterized by containing cis-fucoxanthin as an active ingredient. The cis-fucoxanthin can be added to foods, supplements, feeds for pets, sanitary products, cosmetics, or drugs. Further, the cis-fucoxanthin can be one obtained by combination of at least one member selected from the group consisting of one obtained by extraction from a natural product followed by purification, one obtained by organic synthesis and one obtained by synthesis with the use of a microorganism.) 

515: (4396833479944890014) patent: WO2013160340A1 Title : PRODRUGS OF HYDROXYL-COMPRISING DRUGS) Abstract : The present invention relates to a prodrug or a pharmaceutically acceptable salt thereof comprising a biologically active moiety-linker conjugate D-L, wherein D is a hydroxyl-comprising biologically active moiety; and L is a promoiety comprising a moiety L1 represented by formula (I) and wherein L1 is substituted with one to four groups L2-Z and optionally further substituted, provided that the hydrogen marked with the asterisk in formula (I) is not replaced by a substituent; wherein L2 is a single chemical bond or a spacer and Z is a carrier group. The invention also relates to pharmaceutical compositions comprising said prodrugs and their use as medicaments.) 

516: (6944991061318525751) patent: EP2226071B1 Title : COMPOSITION FOR ORAL ADMINISTRATION) Abstract : A composition which has high safety and is excellent in the effect of reducing body fat, such as visceral fat, subcutaneous fat and the like, and neutral fat, and a food, a pharmaceutical and a feed comprising the same, are provided. An oral administration composition having a body fat reducing action and/or a neutral fat reducing action, which is a composition comprising a carotenoid and a sphingolipid or a carotenoid and a flavonoid and/or a derivative thereof, preferably a composition comprising a cryptoxanthin and a sphingolipid or a cryptoxanthin and a flavonoid and/or a derivative thereof, wherein the cryptoxanthin and/or the sphingolipid and/or the flavonoid are derived from a citrus fruit and the citrus fruit is preferably Citrus unshiu .) 

517: (4940176462841209447) patent: US20080233209A1 Title : Composition and method of use for the treatment of metabolic syndrome and inflammation) Abstract : The present invention provides a method and composition for preventing, treating or managing Metabolic Syndrome. The composition contains brown marine vegetable extract containing an effective amount of fucoxanthin which is administered for preventing, treating or managing Metabolic Syndrome.) 

518: (4025355610445975761) patent: US20090324658A1 Title : Cosmetic and Method for Production Thereof) Abstract : A cosmetic exhibiting improved thermal stability and storage stability, which is prepared by using a three-phase emulsification-dispersing method in an aqueous phase. In the cosmetic containing an oily base material and/or a pigment as a component to be emulsification-dispersed, an emulsification-dispersing agent and water, the thermal stability and storage stability are improved, and the emulsification-dispersing agent composed of a polysaccharide having a particulate structure as a main component, and two or more kinds of components to be emulsification-dispersed are contained. The components to be emulsification-dispersed exhibit a dielectric constant ranging from 1 to 5 (F/m), and an inorganicity/organicity ratio ranging from 0 to 0.5.) 

519: (7466182579747630609) patent: EP2623335A2 Title : Surface modification method and surface-modified elastic body) Abstract : The present invention aims to provide a surface modification method for a rubber vulcanizate or a thermoplastic elastomer, which can impart various functions such as sliding properties and biocompatibility according to its use. The present invention relates to a surface modification method for modifying a rubber vulcanizate or a thermoplastic elastomer as an object to be modified, the method including: Step 1 of forming polymerization initiation points on a surface of the object to be modified; Step 2 of radical polymerizing monomers starting from the polymerization initiation points to grow polymer chains on the surface of the object to be modified; and Step 3 of functionalizing the polymer chains.) 

520: (7580265929878102531) patent: EP2745835A1 Title : Novel vesicle for topical application in pharmacy and cosmetics) Abstract : Aqueous composition comprises: vesicles formed from at least one amphiphilic, membrane-forming lipid of the group of esters or diacylglycerides polyacylglycerides with long-chain unsaturated fatty acids and at least one membrane-stabilizing long-chain unsaturated fatty acid monoester; an aqueous medium comprising both the vesicle and carrier vehicle of the same composition; at least one active substance which can be hydrophilic, amphiphilic or lipophilic.) 

521: (21385365452395000) patent: WO2013071029A1 Title : METHODS AND PRODUCTS FOR GENERATING OILS) Abstract : Compositions and methods for enhancing secretion of oils from oil producing cells are described herein. In particular, secretion of oils is enhanced by treating the cells with herbicides. The oils generated according to the invention may be useful, for example, in the production of biofuels.) 

522: (1743229918139853512) patent: EP2424512A1 Title : METHODS AND COMPOSITIONS FOR IMPROVING THE HEALTH OF ANIMALS) 

523: (9066580261755676728) patent: US20050065097A1 Title : Carotenoid ether analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury) Abstract : A method of treating ischemic reperfusion injury in a subject. The method may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ether functionality.) 

524: (2180941604007709290) patent: US9447068B2 Title : Functionalized polymer compositions) Abstract : The invention relates to functionalized polymers including homopolymers and copolymers and their uses in industrial applications and in agricultural applications. In particular, the homopolymers and copolymers may be, for example, used in polymer blends, used as nutritives and in feed compositions, and used in combination with a pharmaceutical or nutritive.) 

525: (5721404733676312864) patent: US20100273727A1 Title : ORAL ADMINISTRATION COMPOSITION) Abstract : A composition which has high safety and is excellent in the effect of reducing body fat, such as visceral fat, subcutaneous fat and the like, and neutral fat, and a food, a pharmaceutical and a feed comprising the same, are provided. An oral administration composition having a body fat reducing action and/or a neutral fat reducing action, which is a composition comprising a carotenoid and a sphingolipid or a carotenoid and a flavonoid and/or a derivative thereof, preferably a composition comprising a cryptoxanthin and a sphingolipid or a cryptoxanthin and a flavonoid and/or a derivative thereof, wherein the cryptoxanthin and/or the sphingolipid and/or the flavonoid are derived from a citrus fruit and the citrus fruit is preferably Citrus unshiu.) 

526: (2813262235340381793) patent: EP1932514A1 Title : PHARMACEUTICAL PREPARATION FOR EXTERNAL APPLICATION TO SKIN COMPRISING PHOSPHORYLATED SUGAR) Abstract : Provided is an external preparation for skin, comprising a phosphorylated saccharide. The phosphorylated saccharide may be an inorganic salt of a phosphorylated saccharide. The phosphorylated saccharide may be a calcium, magnesium, potassium, zinc, iron or sodium salt. Also provided is an external preparation for skin, comprising a phosphorylated saccharide and a second component, wherein the second component is selected from the group consisting of moisturizing agents, whitening components, ultraviolet absorbents, anti-inflammatory agents, cell-activating agents and antioxidants. The moisturizing agent may be ascorbic acid or an ascorbic acid derivative.) 

527: (7844628702607446134) patent: EP1660596A1 Title : MICROORGANISM COATING COMPONENTS, COATINGS, AND COATED SURFACES) 

528: (9208182079073211567) patent: US7098005B2 Title : Natural promoters for gene expression in C1 metabolizing bacteria) Abstract : Genes have been identified in the Methylomonas genome that are responsive to various metabolic and growth conditions. The identified responsiveness of these genes allows for the use of their promoters in regulated gene expression in C1 metabolizing bacteria. In particular, the hps promoter, which in its native state drives the expression of 3-hexulose-6-phosphate synthase (HPS), was found to be useful for directing expression of heterolgous coding regions (e. g., crtZ) in the obligate methanotroph Methylomonas sp. 16a.) 

529: (2555686017664929129) patent: US20040224383A1 Title : Genes encoding carotenoid compounds) Abstract : Genes have been isolated from Pectobacterium cypripedii encoding geranylgeranyl pyrophosphate (GGPP) synthase (CrtE), phytoene synthase (CrtB), phytoene desaturase (Crtl), lycopene cyclase (CrtY), beta-carotene hydroxylase (CrtZ), and zeaxanthin glucosyl transferase (CrtX) activity. The genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

530: (5386615601173137766) patent: EP2571991A1 Title : METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST) 

531: (693852196060638231) patent: US20130017283A1 Title : COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

532: (6917103620516786893) patent: WO2009135311A1 Title : ECHINODERM-DERIVED EXTRACTS, METHODS OF PREPARATION AND USES) Abstract : An Echinozoa tissue or organ extract comprising antioxidant compounds is disclosed. Also disclosed is a process for obtaining an Echinozoa tissue or organ extract, as well as an extract obtained by this process. Compositions comprising such an extract are also described. Uses of such extracts/compositions, as well as corresponding methods of treatment, for example as an antioxidant or to decrease or inhibit oxidative stress in a cell, tissue or subject are also described.) 

533: (213810710238917599) patent: US20080138851A1 Title : TROPHIC CONVERSION OF OBLIGATE PHOTOTROPHIC ALGAE THROUGH METABOLIC ENGINEERING) Abstract : Most microalgae are obligate photoautotrophs and their growth is strictly dependent on the generation of photosynthetically-derived energy. In this study it is shown that the microalga Phaeodaclylurn tricornutum can be engineered to import glucose and grow in the dark through the introduction of genes encoding glucose transporters. Both the human and Chlorella kessleri glucose transporters facilitated the uptake of glucose by P. tricornutum, allowing the cells to metabolize exogenous organic carbon and thrive, independent of light. This is the first successful trophic conversion of an obligate photoautotroph through metabolic engineering, and it demonstrates that methods of cell nourishment can be fundamentally altered with the introduction of a single gene.; Since strains transformed with the glucose transport genes are able to grow non-photosynthetically, they can be exploited for the analysis of photosynthetic processes through mutant generation and characterization. Finally, this work also represents critical progress toward large-scale commercial exploitation of obligate phototrophic algae through the use of microbial fermentation technology, eliminating significant limitations resulting from light-dependent growth.) 

534: (8095093927295598054) patent: US20120171719A1 Title : USE OF SACCHAROMYCES CEREVISIAE SUC2 GENE IN YARROWIA LIPOLYTICA FOR SUCROSE UTILIZATION) Abstract : Disclosed herein are transformed Yarrowia lipolytica comprising an exogenous polynucleotide encoding a polypeptide having sucrose invertase activity. Also disclosed are methods of using the transformed Y. lipolytica.) 

535: (8807815882698431183) patent: WO2014011857A1 Title : MATRIX AND LAYER COMPOSITIONS FOR PROTECTION OF BIOACTIVES) Abstract : The invention relates to matrix and layer compositions comprising a first polymer. The matrix and layer compositions are useful in the delivery of bioactives. In particular, the matrices and layers may have advantageous properties including mechanical properties and protection of bioactives and may also provide for pH-dependent release of a bioactive.) 

536: (1821574357913930591) patent: WO2004056975A2 Title : INCREASING CAROTENOID PRODUCTION IN BACTERIA VIA CHROMOSOMAL INTEGRATION) Abstract : The present invention relates to carotenoid overproducing bacteria. The genes of the isoprenoid pathway in the bacterial hosts of the invention have been engineered such that certain genes are either up-regulated or down regulated resulting in the production of carotenoid compounds at a higher level than is found in the un-modified host. Genes that may be up-regulated include the dxs, idi, ispB, lytB and ygbBP genes. Additionally it has been found that a partial disruption of the yjeR gene has the effect of enhancing carotenoid production.) 

537: (3741912590612547565) patent: US20130011455A1 Title : Novel Carrier System for the Transport of Active Substances into the Skin) Abstract : Vesicle, comprising at least the following components:-an aqueous core, which can comprise at least one cosmetic and/or at least one pharmaceutical active substance, and-a continuous membrane which surrounds the core and which is formed by at least one emulsifier, selected from the group of the food additives E 472 a to L and at least one membrane-stabilizing single-chain lipid and/or one or more lipophilic cosmetic and/or pharmaceutical active substances.) 

538: (4585958331411071618) patent: US20100197782A1 Title : THERAPEUTIC AGENT FOR VIRUS-ASSOCIATED MALIGNANCY) Abstract : A therapeutic agent comprising fucoxanthin or fucoxanthinol as an active component is disclosed. The therapeutic agent is effective and high clinical utility for medical treatment and prevention of virus-associated malignancy such as adult T-cell leukemia and Burkitt lymphoma.) 

539: (3969984622142116553) patent: WO2012103119A1 Title : COMPOSITIONS FOR ADMINISTERING RIFALAZIL AND OTHER ANTI-TUBERCULOSIS AGENTS IN UNIT DOSAGE FORM FOR ORAL ADMINISTRATION) Abstract : Pharmaceutical compositions including rifalazil, a surfactant, a lipophilic antioxidant, and one or more antibiotics selected from the group consisting of isoniazid, streptomycin, pyrazinamide, and ethambutol are provided in a single unit dosage form for oral administration. The compositions can be used to treat tuberculosis. By placing the multiple antibiotic agents in a single unit dosage form, patient compliance with otherwise complicated treatment regimens can be increased.) 

540: (379651691297353811) patent: EP1364943A1 Title : CYSTINE DERIVATIVES AND INHIBITORS FOR THE ACTIVATION OF INFLAMMATORY FACTORS) Abstract : A novel cystine derivative of a specific structure, such as N,N'-bis(2-hydroxybenzyl)-L-cystine (which may be in any form of free form, salt, solvate and the like) has been found to have an excellent action to suppress the activation of inflammatory factors. By using the derivative as an effective ingredient, an excellent agent for suppressing the activation of inflammatory factors can be provided. Additionally, the cystine derivative is preferably used for a method for suppressing the activation of inflammatory factors (in particular a method for preventing, ameliorating and/or therapeutically treating diseases (disorders), or skin injuries or disorders involved in the activation of inflammatory factors, a method for preventing, delaying, ameliorating and/or therapeutically treating skin change via aging or aesthetically unfavorable skin change as induced or promoted by inflammatory factors, and the like) and for pharmaceutical agents (pharmaceutical products; external skin application agents, eye drops, nutrition agents, transfusion and the like), cosmetics, foods or drinks and the like which are specific use applications to the agent for suppressing the activation of inflammatory factors. <??>The invention also provides the novel cystine derivative with the excellent action to suppress the activation of inflammatory factors, which can be used as the effective ingredient described above, and a method for producing the same, and additionally provides the method for suppressing the activation of inflammatory factors described above, a use of the cystine derivative (active ingredient) described above for the agent for suppressing the activation of inflammatory factors, and the like.) 

541: (2136881905475700611) patent: JP2008239609A Title : EXTERNAL PREPARATION FOR SKIN) Abstract : PROBLEM TO BE SOLVED: To provide an external preparation for skin stably formulated with carotenoids, such as astaxanthin. ;SOLUTION: The external preparation is formulated with carotenoids (A) and a platinum group metal colloid (B). One or more carotenoids selected from a group consisting of astaxanthin, lycopene, [beta]-carotene, zeaxanthin, lutein, canthaxanthin, cryptoxanthin, violaxanthin, capsanthin, fucoxanthin and derivatives thereof, are preferred as component (A). In particular, as the component (B), a platinum colloid is preferable. ;COPYRIGHT: (C)2009,JPO&INPIT) 

542: (2336066580232598971) patent: WO2012115954A2 Title : NUTRITIONAL COMPOSITION) Abstract : A nutritional composition containing a plant food and a mineral food, where the plant food includes at least one of aloe, green algae, red algae, brown algae, blue-green algae, kelp, kombu, hijiki, nori, arame, sea palm, bladderwrack, wakame, dulse, carrageenan, fungi, and bacteria. The mineral food includes at least one of shilajit, humic acid, fulvic acid, bentonite clay, charcoal, diatomaceous earth, dolomite, fossilized remains, rocks, gems, sodium chloride, sea salt, and derivatives or combinations thereof. In one embodiment of the composition, the plant food is a juice of aloe vera and the mineral food is fulvic acid.) 

543: (8817577135375726517) patent: US20050075316A1 Title : Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease) Abstract : A method for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals in a subject whereby a subject is administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The analog or derivative is administered such that the subject's risk of experiencing diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals may be thereby reduced. The analog or analog combination may be administered to a subject for the inhibition and/or amelioration of any disease that involves production of reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals.; In some embodiments, the invention may include a pharmaceutical composition including a carotenoid analog or derivative. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ester functionality. In some embodiments, a pharmaceutical composition may include a biologically inactive carrier. The pharmaceutical composition may be adapted to be administered to a human subject.) 

544: (6981930134638810407) patent: US20160263047A1 Title : Nanoparticle Compositions and Methods as Carriers of Nutraceutical Factors Across Cell Membranes and Biological Barriers) Abstract : Novel process and products thereby emplace nutraceutical factors within nanodelivery vehicles for various indications in mammals, including humans.) 

545: (3126970483128583141) patent: US20150367366A1 Title : AEROSOL DISPENSER WITH EDIBLE CARTRIDGE) Abstract : An aerosolizing delivery device can include a carriage configured to be detachably connected to a mouthpiece and to receive and support an aerosolizable powder-filled cartridges in a desired position relative to the mouthpiece. The carriage can include: a housing defining a reservoir and a carriage outlet, the carriage outlet configured to permit fluid communication between the reservoir and an exterior of the carriage. A surface of the housing can be configured to define a bypass port between the housing and a surface of the mouthpiece when the carriage is assembled with the mouthpiece to form the delivery device.) 

546: (5705988133232814656) patent: EP1328639A2 Title : CAROTENOID PRODUCTION BY RECOMBINANT, C1-METABOLIZING METHANOTROPHIC BACTERIA) 

547: (1508800733722188718) patent: US20130337116A1 Title : NUTRITIONAL COMPOSITION) Abstract : A nutritional composition containing a plant food and a mineral food, where the plant food includes at least one of aloe, green algae, red algae, brown algae, blue-green algae, kelp, kombu, hijiki, nori, arame, sea palm, bladderwrack, wakame, dulse, carrageenan, fungi, and bacteria. The mineral food includes at least one of shilajit, humic acid, fulvic acid, bentonite clay, charcoal, diatomaceous earth, dolomite, fossilized remains, rocks, gems, sodium chloride, sea salt, and derivatives or combinations thereof. In one embodiment of the composition, the plant food is a juice of aloe vera and the mineral food is fulvic acid.) 

548: (1389004076414428929) patent: EP1364943B1 Title : CYSTINE DERIVATIVES AND INHIBITORS FOR THE ACTIVATION OF INFLAMMATORY FACTORS) Abstract : A novel cystine derivative of a specific structure, such as N,N'-bis(2-hydroxybenzyl)-L-cystine (which may be in any form of free form, salt, solvate and the like) has been found to have an excellent action to suppress the activation of inflammatory factors. By using the derivative as an effective ingredient, an excellent agent for suppressing the activation of inflammatory factors can be provided. Additionally, the cystine derivative is preferably used for a method for suppressing the activation of inflammatory factors (in particular a method for preventing, ameliorating and/or therapeutically treating diseases (disorders), or skin injuries or disorders involved in the activation of inflammatory factors, a method for preventing, delaying, ameliorating and/or therapeutically treating skin change via aging or aesthetically unfavorable skin change as induced or promoted by inflammatory factors, and the like) and for pharmaceutical agents (pharmaceutical products; external skin application agents, eye drops, nutrition agents, transfusion and the like), cosmetics, foods or drinks and the like which are specific use applications to the agent for suppressing the activation of inflammatory factors. <??>The invention also provides the novel cystine derivative with the excellent action to suppress the activation of inflammatory factors, which can be used as the effective ingredient described above, and a method for producing the same, and additionally provides the method for suppressing the activation of inflammatory factors described above, a use of the cystine derivative (active ingredient) described above for the agent for suppressing the activation of inflammatory factors, and the like.) 

549: (7769972221111271933) patent: US9199952B2 Title : Method for producing composition containing fucoxanthin) Abstract : A method for producing a composition containing fucoxanthin includes a first step of adding a water-soluble solvent containing 0 to 80% by weight of water to seaweed to obtain a seaweed component extract, and then adding water and/or a water-soluble solvent to the seaweed component extract in such a manner that the concentration of the water-soluble solvent is 20 to 45% by weight and also adding a diluent thereto to obtain a diluent-containing extract, and a second step of stirring the diluent-containing extract, and then collecting a substance aggregating into the diluent-containing extract as a composition containing fucoxanthin by separation.) 

550: (8087008424373251641) patent: EP2692331A1 Title : CAROTENOID-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME) Abstract : Provided are a carotenoid-containing composition containing at least one carotenoid; at least one selected from the group consisting of ascorbic acid, derivatives thereof and salts of the acid and the derivatives; and an emulsifier, the at least one selected from the group consisting of ascorbic acid, derivatives thereof and salts of the acid and the derivatives being contained in an amount, in terms of a number of moles of ascorbic acid, in a range of from 30 times to 190 times a total number of moles of the at least one carotenoid, and the composition having a pH in the range of from 6.5 to 9.0; and a method for preparing the composition.) 

551: (5873853204174217522) patent: WO2016049236A1 Title : COMPOSITIONS, METHODS AND KITS FOR TREATMENT OF DIABETES AND/OR HYPERLIPIDEMIA) Abstract : Compositions, methods and kits for treatment of diabetes and/or hyperlipidemia are provided herein. Such compositions can contain synergizing amounts of leucine and/or one or more leucine metabolites in combination with nicotinic acid, nicotinamide riboside and/or nicotinic acid metabolites, and with at least one or more anti-diabetic agents. Such compositions can contain sub-therapeutic amounts of nicotinic acid, nicotinamide riboside and/or nicotinic acid metabolites, and/or sub-therapeutic amounts of one or more anti-diabetic agents that can achieve the same therapeutic efficacy as therapeutic amounts of said compositions in diabetes and/or hyperlipidemia medicaments. The composition can also reduce the side effects associated with treatment using anti-diabetic agents and/or nicotinic acid.) 

552: (883431352093215911) patent: US8278358B2 Title : LIPOIC ACID DERIVATIVES) Abstract : The invention describes alpha lipoic acid complexes, that can be oligomeric, polymeric, monomeric and mixtures thereof. The complexes can be salts, chelates, etc. of the oligomers, polymers, or monomeric alpha lipoic acid.) 

553: (2672569296028789983) patent: WO2015057751A1 Title : NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF NUTRACEUTICAL FACTORS ACROSS CELL MEMBRANES AND BIOLOGICAL BARRIERS) Abstract : Novel process and products thereby emplace nutraceutical factors within nanodelivery vehicles for various indications in mammals, including humans.) 

554: (1607803711007473739) patent: US20160296581A1 Title : EXTRACTS OF ROSEMARY OR HEMEROCALLIS FULVA AND METHODS OF USING SAME TO PROMOTE CIRCADIAN RHYTHM) Abstract : Provided are process of regulating expression of one or more genes or proteins involved in circadian rhythm. A subject such as a cell is administered or contacted to an extract of rosemary, an extract of hemerocallis fulva, or combinations thereof, optionally provided as a component of a dietary supplement. The presence of one or more active agents in the extracts administered at a targeted administration time alters the expression of one or more genes or proteins involved in circadian rhythm, illustratively CLOCK, BMAL1, FBXL3, FBXL21, or SIRT1.) 

555: (2211586550275903750) patent: US20100305341A1 Title : PRODUCTION OF STEROLS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides methods for production of one or more sterol compounds. Further provided are methods and systems for producing engineered oleaginous yeast or fungi that are capable of production of one or more sterol compounds, and compositions which utilize the produced sterol compound(s).) 

556: (5725656530460046755) patent: US8158683B2 Title : DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF ARONIA AND METHODS OF USING SAME TO PROMOTE WEIGHT LOSS) Abstract : A dietary supplement composition comprising aronia extract containing at least 20% anthocyanins by dry weight. The aronia extract is derived from the aronia melanocarpa plant. The aronia extract comprises approximately 10%-30% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is provided in the composition. The dietary supplement composition is administered orally to promote weight loss.) 

557: (7887313173520791283) patent: EP1377547B1 Title : NOVEL CAROTENOID ESTERS) 

558: (3798527264286170883) patent: US20110123680A1 Title : MICROCAPSULE, PROCESS FOR PRODUCTION THEREOF, AND FOOD OR BEVERAGE CONTAINING MICROCAPSULE) Abstract : The method of producing microcapsules 100 comprises a primary dispersion step in which a water-soluble substance and a fat-soluble substance are mixed to obtain a primary dispersion liquid having primary dispersion particles 10 composed of the water-soluble substance dispersed in the fat-soluble substance, a secondary dispersion step in which the primary dispersion liquid and a sodium alginate aqueous solution are mixed to obtain a secondary dispersion liquid having secondary dispersion particles 20 composed of the primary dispersion liquid dispersed in the sodium alginate aqueous solution, and a spraying step in which the secondary dispersion liquid is sprayed for contact with a calcium ion-containing solution 9 to form a calcium alginate gel 30 and to obtain microcapsules 100 having the secondary dispersion particles 20 dispersed in the calcium alginate gel 30.) 

559: (5994514168954579291) patent: US8454970B2 Title : COMPOSITIONS CONTAINING FUCOXANTHIN EXTRACT) Abstract : A composition comprises extract of fucoxanthin, wherein said composition further comprises tocotrienols and/or fucoidan. Said composition can be used to treat obesity. Said composition shows outstanding effect of weight loss. There is outstanding synergy effect among those constituents of the composition.) 

560: (1890080378279660409) patent: US20100272763A1 Title : SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING THE SAME) Abstract : A skin external preparation includes an oil-in-water emulsion composition. The emulsion composition contains first oil droplet particles having a minimum particle diameter of 200 nm or more and second oil droplet particles having an average particle diameter of 70 nm or less. The first oil droplet particles contain a first functional oil component, and the second oil droplet particles contain a second functional oil component. A method of producing the skin external preparation includes mixing a first emulsion containing the first oil droplet particles having a minimum particle diameter of 200 nm or more and a second emulsion containing the second oil droplet particles having an average particle diameter of 70 nm or less) 

561: (360261604981076659) patent: EP3034612A1 Title : Chitin and chitosan producing methods) Abstract : The invention relates to the field of polymer production, in particular to the production of chitin and chitosan from microalgae belonging to the phylum Haptophyta to the phylum Chlorophyta, or to the phylum Heterokontophyta, particularly from microalgae of the genus Isochrysis, Chlorella, Bracteacoccus, Chlorococcum, Scenedesmus, Dunaliella, Haematococcus, Thalassiosira and Nannochloropsis, as well as to microalgal extracts thereof and their uses.) 

562: (5396137488421556819) patent: EP3030648A2 Title : METHYLOTROPHS FOR AQUACULTURE AND ANIMAL FEED) 

563: (2369788352346024071) patent: JP2009191008A Title : METHOD FOR EXTRACTING FUNCTIONAL COMPONENT DERIVED FROM BROWN ALGAE) Abstract : PROBLEM TO BE SOLVED: To provide a method for extracting functional components derived from brown algae, which solves problems in a conventional method for extracting functional components derived from brown algae and efficiently extracts functional components derived from brown algae being useful components contained in brown algae, further in a greatly shortened time. ;SOLUTION: The method for extracting functional components derived from brown algae includes extracting brown algae with a supercritical fluid. Preferably the functional components derived from brown algae are fucoxanthin and fucosterol. ;COPYRIGHT: (C)2009,JPO&INPIT) 

564: (7191275769469368191) patent: EP2812313A1 Title : FUNCTIONALIZED POLYMER COMPOSITIONS) 

565: (7441130017198025172) patent: EP2767274A1 Title : CAROTENOID-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME) Abstract : A carotenoid-containing composition including: a carotenoid component containing a crystalline carotenoid that is in an amorphous state; a (poly)glycerol fatty acid ester that contains from one to six glycerol units and from one to six fatty acid units and has at least one hydroxyl group resulting from a glycerol unit; a fatty acid ester component which is at least one selected from the group consisting of triesters of glycerol and fatty acids, and esters of alcohols having one hydroxyl group and fatty acids, contains no hydroxyl group in a molecule, and has from 10 to 60 carbon atoms in total; and an antioxidant.) 

566: (3338872243402173120) patent: US8008061B2 Title : TROPHIC CONVERSION OF OBLIGATE PHOTOTROPHIC ALGAE THROUGH METABOLIC ENGINEERING) Abstract : Most microalgae are obligate photoautotrophs and their growth is strictly dependent on the generation of photosynthetically-derived energy. In this study it is shown that the microalga Phaeodaclylurn tricornutum can be engineered to import glucose and grow in the dark through the introduction of genes encoding glucose transporters. Both the human and Chlorella kessleri glucose transporters facilitated the uptake of glucose by P. tricornutum, allowing the cells to metabolize exogenous organic carbon and thrive, independent of light. This is the first successful trophic conversion of an obligate photoautotroph through metabolic engineering, and it demonstrates that methods of cell nourishment can be fundamentally altered with the introduction of a single gene.; Since strains transformed with the glucose transport genes are able to grow non-photosynthetically, they can be exploited for the analysis of photosynthetic processes through mutant generation and characterization. Finally, this work also represents critical progress toward large-scale commercial exploitation of obligate phototrophic algae through the use of microbial fermentation technology, eliminating significant limitations resulting from light-dependent growth.) 

567: (5205641718351953788) patent: EP1553101B1 Title : N-ACETYLGLUCOSAMINE DERIVATIVES AND USE THEREOF) Abstract : The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: <CHEM> wherein R<1> is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R<2>, R<3>, and R<4> are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be alpha or beta ; provided that R<1>, R<2>, R<3>, and R<4> must not be all hydrogen atoms. <??>It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.) 

568: (1631978973073022872) patent: US20140039052A1 Title : Labeling machine) 

569: (6242985470803389584) patent: EP2752436B1 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention aims to provide a method for surface-modifying a rubber vulcanizate or a thermoplastic elastomer, which is capable of cost-effectively imparting a variety of functions, such as sliding properties and biocompatibility, according to the applications. The present invention relates to a surface modification method for surface-modifying an object of a rubber vulcanizate or a thermoplastic elastomer, the method including: step 1 of forming polymerization initiation points A on a surface of the object; step 2 of radically polymerizing a non-functional monomer, starting from the polymerization initiation points A, to grow non-functional polymer chains; step 3 of forming polymerization initiation points B on the surface of the object where the non-functional polymer chains are formed; and step 4 of radically polymerizing a functional monomer, starting from the polymerization initiation points B, to grow functional polymer chains.) 

570: (1503411449573029610) patent: US20150327446A1 Title : LED LIGHT SOURCE FOR PLANT CULTIVATION) Abstract : A plant cultivation LED light source (1A) of the present invention includes: a substrate (2A); at least one blue LED chip (11), provided on the substrate (2A), for emitting blue light; a red phosphor mixed resin (12) which is provided so as to cover the blue LED chip (11) and contains red phosphors (12a) being dispersed or settled down therein, each of the red phosphors (12a) emitting red light in response to excitation light emitted from the blue LED chip (11); and a silicone resin (13) which is transparent and is provided so as to cover the red phosphor mixed resin (12).) 

571: (2091866324244553105) patent: WO2006077433A1 Title : SUNSCREEN COMPOSITIONS COMPRISING CAROTENOIDS) Abstract : The invention concerns methods of treating or preventing the effects of irradiation in a human or non-human animal using carotenoid compounds, preferably diadinoxanthin, diatoxanthin and/or fucoxanthin as well as photoprotective compositions and their use to prepare photoprotective or photoprotected products.) 

572: (4662456524596795593) patent: US20130309719A1 Title : HETEROTROPHIC MICROBIAL PRODUCTION OF XANTHOPHYLL PIGMENTS) Abstract : The invention relates to a microbial biomass wherein the biomass comprises at least one xanthophyll selected from any one or more of fucoxanthin, diatoxanthin and diadinoxanthin. The invention further relates to a process for producing such a microbial biomass. Further the invention relates to compositions comprising at least one xanthophyll selected from any one or more of fucoxanthin, diatoxanthin and diadinoxanthin and processes for producing such compositions.) 

573: (2681392693085392499) patent: WO2015136123A1 Title : EXTRACT FROM MICROALGAE COMPRISING FUCOXANTHIN, FUCOXANTHINOL AND FATTY ACIDS, PROCESS FOR ITS PRODUCTION AND APPLICATIONS THEREOF) Abstract : The invention relates to an algal extract comprising fucoxanthin, fucoxanthinol and fatty acids, its production process, and the use thereof in cosmetic, cosmeceutical, food, nutraceutical, or pharmaceutical applications.) 

574: (5090527891411962590) patent: US20110274716A1 Title : COMPOSITIONS CONTAINING FUCOXANTHIN EXTRACT) Abstract : A composition comprises extract of fucoxanthin, wherein said composition further comprises tocotrienols and/or fucoidan. Said composition can be used to treat obesity. Said composition shows outstanding effect of weight loss. There is outstanding synergy effect among those constituents of the composition.) 

575: (7186761431334516872) patent: US20140356420A1 Title : MICRO-PARTICLE COMPRISING A PROTEIN EXTRACT FROM SWEET POTATO FOR EXTENDING SATIETY AND CONTROLLING BLOOD GLUCOSE AND LIPID LEVELS) Abstract : The present invention relates to a micro-particle for extending satiety and controlling blood glucose and lipid levels, comprising a core having the protein extract from sweet potato, an active ingredient layer coated on the core, and a protection layer coated over the active ingredient layer as an external layer, wherein the protein extract from sweet potato contains trypsin inhibitor and glycoprotein. The micro-particle comprising a protein extract from sweet potato can effectively extend satiety, control blood glucose and lipid levels and increase metabolism effectively.) 

576: (3942736934652824109) patent: EP2918278A1 Title : Algal extracts comprising fucoxanthin and fucoxanthinol) Abstract : The invention relates to an algal extract comprising fucoxanthin and fucoxanthinol, its production process, and the use thereof in cosmetic, cosmeceutical, food, nutraceutical, or pharmaceutical applications.) 

577: (5909110497930344583) patent: US20060188955A1 Title : Gene targets for enhanced carotenoid production) Abstract : The present invention provides genetically manipulated cells and methods for utilizing same. Methods of enhanced carotenoid synthesis utilizing cells genetically disrupted for a yjiD, hnr or yjfP gene, or further disrupted for a gdhA, gpmB aceE, ppc, talB or fdhF gene, or any combination thereof, or cells inhibited for their expression, activity or function are disclosed. Methods of enhanced carotenoid synthesis utilizing cells genetically engineered to overexpress dxs, idi, yjiD, rpoS, torC, appY, ydgK, yeiA, yedR, tort, arcB, yggT, purDH, yfjN or a combination thereof, or further disrupted for the above-referenced genes are disclosed. Methods for identifying genes involved in optimized production of a carotenoid, and cells disrupted for, or inhibited for the expression, activity or function of genes thus identified are described.) 

578: (844679457430363843) patent: WO2009048249A2 Title : COMPOSITION FOR PREVENTING OR TREATING LIPID METABOLIC DISORDERS COMPRISING FUCOXANTHIN OR MARINE PLANT EXTRACT CONTAINING SAME) Abstract : The present invention relates to a composition for the prevention or treatment lipid metabolic disorders comprising fucoxanthin or marine plant extract comtaining the same as an effective indredients. Fucoxanthin or a marine plant extract comprising the same is effective in reducing weight increase and reducing triglyceride and cholesterol level in liver tissue, or plasma through inhibiting the synthesis of fatty acid and promoting the oxidation of fatty acid. Therefore, the composition comprising fucoxanthin or a marine plant extract comprising the same as an effective ingredient may be effectively used for the prevention and treatment of lipid metabolic disorders.) 

579: (2261883515938162283) patent: EP1409454A4 Title : INCREASING BIOAVAILABILITY OF CAROTENOIDS) 

580: (8270503709426591803) patent: WO2009048249A3 Title : COMPOSITION FOR PREVENTING OR TREATING LIPID METABOLIC DISORDERS COMPRISING FUCOXANTHIN OR MARINE PLANT EXTRACT CONTAINING SAME) Abstract : The present invention relates to a composition for the prevention or treatment lipid metabolic disorders comprising fucoxanthin or marine plant extract comtaining the same as an effective indredients. Fucoxanthin or a marine plant extract comprising the same is effective in reducing weight increase and reducing triglyceride and cholesterol level in liver tissue, or plasma through inhibiting the synthesis of fatty acid and promoting the oxidation of fatty acid. Therefore, the composition comprising fucoxanthin or a marine plant extract comprising the same as an effective ingredient may be effectively used for the prevention and treatment of lipid metabolic disorders.) 

581: (5370624321622401708) patent: US7317008B2 Title : Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury) Abstract : A method of treating ischemic reperfusion injury in a subject. The method may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ester functionality.) 

582: (9009471485552809845) patent: US20100255458A1 Title : BIOREACTOR) Abstract : The invention provides devices and methods for the growth of photoautotrophic organisms. The devices and methods address issues related to the design of bioreactors, selection of a photoautotrophic organism, growth of the photoautotrophic organisms, extraction of biomass products, and/or use of the biomass products as a renewable energy source.) 

583: (7948245394050883709) patent: EP1409454A2 Title : INCREASING BIOAVAILABILITY OF CAROTENOIDS) 

584: (185683490730795263) patent: US20050009788A1 Title : Carotenoid ester analogs or derivatives for controlling connexin 43 expression) Abstract : A method of controlling (e. g., influencing or affecting) connexin 43 expression in a subject may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. In some embodiments, controlling connexin 43 expression in a subject may effectively treat cardiac arrhythmia and/or cancerous and pre-cancerous cells in a subject. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ester functionality.) 

585: (7750736460908602518) patent: US20080025929A1 Title : Topical Formulations for the Treatment of Skin Conditions) Abstract : The invention features compositions for topical administration of an oxidatively transformed carotenoid or 2-methyl-6-oxo-2,4-heptadienal and methods of treating skin conditions therewith.) 

586: (4294731158799669) patent: WO2011152689A3 Title : METHOD FOR PURIFYING FUCOXANTHIN DERIVED FROM SEAWEED) Abstract : The present invention relates to a method for providing more stabilized fucoxanthin by using vitamin C, which is a water-soluble antioxidizing agent, in the step of extracting fucoxanthin from brown alga. According to the present invention, fucoxanthin is more stabilized, and thus the problem of the deterioration of yield with time is improved.) 

587: (3906852760700334744) patent: JP2014198706A Title : ) Abstract : PROBLEM TO BE SOLVED: To provide a cosmetic preparation which develops color better when it is used to a cholesteric liquid crystal cosmetic preparation, having high efficacy. SOLUTION: Carotenoid and cholesteric liquid crystal are contained in a cosmetic preparation. For carotenoid, one or more selected from [alpha]-, [beta]-, [gamma]-, [delta]-carotene, vitamin A, lutein, zeaxanthin, cryptoxanthin, physalien, bixin, norbixin, crocetin, lycopene, capsanthin, astaxanthin, capsorubin, violaxanthin, torularhodin, canthaxanthin, myxoxanthin, and fucoxanthin, or an extract derived from animals and plants comprising them are selected. Furthermore, ceramides, an oil soluble vitamin, and an oil soluble anti-inflammatory agent are combined.) 

588: (1857035073295551337) patent: WO2011152689A9 Title : METHOD FOR PURIFYING FUCOXANTHIN DERIVED FROM SEAWEED) Abstract : The present invention relates to a method for providing more stabilized fucoxanthin by using vitamin C, which is a water-soluble antioxidizing agent, in the step of extracting fucoxanthin from brown alga. According to the present invention, fucoxanthin is more stabilized, and thus the problem of the deterioration of yield with time is improved.) 

589: (4966109014945241524) patent: EP2658610B1 Title : COLLOIDAL CARRIER SYSTEM WITH PENETRATION PROPERTIES FOR ENCAPSULATING LIPOPHILIC ACTIVE AGENTS AND OILS FOR TOPICAL USE) 

590: (6711728285278816712) patent: US8741337B2 Title : Encapsulation of oxidatively unstable compounds) Abstract : An encapsulated material containing an oxidation-sensitive core is covered by at least a dried phospholipid layer, and contains at least one phytosterol in the core, the phospholipid layer or in a further layer or layers. By using microencapsulation, oxidatively unstable materials may be provided with a synthetic protective barrier and rendered less susceptible to oxidative degradation.) 

591: (2575211233078228487) patent: US20120052137A1 Title : LOG-CUTTING MACHINE.) 

592: (2140970606506707886) patent: EP2174658A1 Title : Compositions comprising nebivolol) Abstract : Described is the use of a safe and therapeutically effective amount of a combination of: (i) nebivolol or a pharmaceutically acceptable salt thereof; (ii) at least one hydralazine compound or a pharmaceutically acceptable salt thereof; and (iii) at least one of isosorbide dinitrate and/or isosorbide mononitrate; in the preparation if a medicament for improving NO release in a black patient, which results in reducing mortality associated with cardiovascular disease and improving exercise tolerance or the quality of life.) 

593: (5199367020245032982) patent: EP2902102A1 Title : CAROTENOID-CONTAINING OIL-IN-WATER EMULSION COMPOSITION) Abstract : A carotenoid-containing oil-in-water emulsion composition, which includes a carotenoid; a higher fatty acid having a total carbon number of 12 or more in an amount of from 0.001 times to 2 times the amount of the carotenoid by mass ratio; and a surfactant other than the higher fatty acid having a total carbon number of 12 or more, wherein an average particle diameter of the emulsion particles is 120 nm or less.) 

594: (2636765499298970671) patent: WO2015073628A1 Title : TREATMENT OR PROPHYLAXIS OF CIRCADIAN PROTEIN RELATED CONDITIONS) Abstract : Provided are compositions and processes of treating or preventing one or more conditions related to a protein involved in circadian rhythm. A composition includes an extract of rosemary, an extract of hemerocallis fulva, active portion or component thereof, or combinations thereof, optionally provided as a component of a dietary supplement. The presence of one or more active ingredients in the extracts optionally administered at a targeted administration time alters the expression of one or more genes or proteins involved in circadian rhythm, illustratively CLOCK, BMAL1, FBXL3, FBXL21, or SIRT1.) 

595: (7804830900031994666) patent: EP1884238B1 Title : Fucoxanthinol as anti-obesity agent) Abstract : [Problem] Fucoxanthin extracted from wakame seaweed (Undaria pinnatifida) is effective as an anti-obesity active agent. However, fucoxanthin is contained in mature (adult) brown algae in a small amount, and accordingly, it takes a long time and high cost to obtain fcoxanthin in an amount sufficient for practical use. Further, an anti-obesity active agent showing a stronger effect has been desired. It is, therefore, an object of the present invention to specify a carotenoid exhibiting anti-obesity activity stronger than that of fucoxanthin and to provide an anti-obesity active agent and an anti-obesity method which use the caritenoid. [Means to Solve the Problem] Intensive and extensive studies have been made as to what carotenoid has an anti-obesity activity stronger than that of fucoxanthin and what material should be used in order to economically obtain such a carotenoid. As a result, the answer has been found that the carotenoid is fucoxanthinol. "Sea squirt (ascidian)" is a generic name of marine animals which belong to class Ascidiacea, subphylum Urochordata (Tunicata), phylum Chordata and which live nationwide. As described above, sea squirt (ascidian) is abundantly found as resources. In the present invention, fucoxanthinol is extracted particularly from internal organs and hard skins of sea squirt (ascidian), and it has been revealed that fucoxanthinol exhibits strong anti-obesity activity.) 

596: (5961130910255179853) patent: EP2453762A1 Title : NATURAL AND SUSTAINABLE SEAWEED FORMULA THAT REPLACES SYNTHETIC ADDITIVES IN FISH FEED) 

597: (4648385281803738130) patent: US20150164782A1 Title : TOPICAL COMPOSITION FOR TREATMENTOF SKIN, HAIR, AND/OR NAILS AND METHOD OF USING THE SAME) Abstract : A topical composition includes an amount of a concentrate derived from Ecklonia marima (sea kelp) effective for treating the skin, hair and/or nails and a dermatologically acceptable carrier.) 

598: (5785029064051824451) patent: US20040268439A1 Title : Genes encoding carotenoid compounds) Abstract : Genes have been isolated from strain DC260, a member of the Enterobacteriaceae family, encoding geranylgeranyl pyrophosphate (GGPP) synthetase (CrtE), phytoene synthase (CrtB), phytoene desaturase (CrtI), lycopene cyclase (CrtY), beta-carotene hydroxylase (CrtZ), and zeaxanthin glucosyl transferase (CrtX) activity. The genes and their products are useful for the conversion of farnesyl pyrophosphate to carotenoids. Vectors containing those DNA segments, host cells containing the vectors and methods for producing those enzymes by recombinant DNA technology in transformed host organisms are disclosed.) 

599: (7626048502934825111) patent: WO2006034570A1 Title : COMPOSITIONS AND METHODS FOR PROMOTING WEIGHT GAIN AND FEED CONVERSION) Abstract : The invention features compositions for administration of an oxidatively transformed carotenoid or a component thereof and methods of promoting weight gain and feed conversion efficiency therewith.) 

600: (1636145376034314307) patent: JPH05331010A Title : ANTIFOULING AGENT FOR UNDERWATER NOXIOUS ATTACHING ORGANISM) Abstract : PURPOSE:To obtain an antifouling agent for underwater noxious attaching organisms, comprising any of peridinin, fucoxanthin and mytiloxanthin, having high safety and excellent antifouling effects as an active ingredient and capable of inhibiting only the attaching function without killing the attaching organisms. CONSTITUTION:The antifouling agent for underwater noxious attaching organisms comprises peridinin of formula I, fucoxanthin of formula II or mytiloxanthin of formula III as an active ingredient. The active ingredient of this antifouling agent is a compound, derived from natural products, having high biodegradability, high safety for the human body, the environment and even fishes and shellfishes and action on prevention of only the attaching function without killing attaching organisms and excellent in repellent effects on the underwater noxious attaching organisms. This antifouling agent is a new use of compounds of formula I to III known as an anticancer agent, etc.) 

601: (4334654085590432503) patent: US8663690B2 Title : Method for Nanoencapsulation) Abstract : Methods of nanoencapsulation are described herein. Embodiments of the method utilize the coacervation of a cationic polyelectrolyte with an anionic polyelectrolyte to form a novel capsular matrix. In particular, the novel methods may be used to encapsulate a suspension of a hydrophobic material such as a carotenoid. The disclosed methods do not require lengthy pH adjustments nor do they require the use of any toxic crosslinking agents. In one embodiment, a method of encapsulation comprises dispersing a hydrophobic compound in an organic solvent to form a solution. The method also comprises admixing an anionic polyelectrolyte and a cationic polyelectrolyte with the suspension to form a mixture. In addition, the method comprises quiescently cooling the mixture so as to cause self-crosslinking of a capsular matrix encapsulating the hydrophobic particles.) 

602: (3241080531802111607) patent: EP2658610A2 Title : COLLOIDAL CARRIER SYSTEM WITH PENETRATION PROPERTIES FOR ENCAPSULATING LIPOPHILIC ACTIVE AGENTS AND OILS FOR TOPICAL USE) 

603: (1447078449828066918) patent: WO2009089117A1 Title : ENCAPSULATION OF OXIDATIVELY UNSTABLE COMPOUNDS) Abstract : An encapsulated material containing an oxidation-sensitive core is covered by at least a dried phospholipid layer, and contains at least one phytosterol in the core, the phospholipid layer or in a further layer or layers. By using microencapsulation, oxidatively unstable materials may be provided with a synthetic protective barrier and rendered less susceptible to oxidative degradation.) 

604: (8486596951061803500) patent: EP1632556A1 Title : NOVEL METHOD OF DEODORIZATION FOR FAT ODOR AND COMPSOITION OBTAINED BY THE SAME) Abstract : The present invention provides a novel deodorizing composition and a novel deodorizing method. A composition is provided in which oily odors have been deodorized by containing a xanthophyll or other carotenoid in an oil such as a highly unsaturated fatty acid or compound containing a highly unsaturated fatty acid as a constituent fatty acid, and a deodorizing method, for oily odors, comprising containing a carotenoid in an oil is provided.) 

605: (5742240773296067129) patent: JPH07224278A Title : ANTIOXIDANT COMPRISING FUCOXANTHIN AND METHOD OF OXIDATION PREVENTION) Abstract : PURPOSE:To provide an antioxidant which has satisfactory oxidation-resistant ability, is highly safe, and can be easily produced, and to provide the title method. CONSTITUTION:This antioxidant comprises fucoxanthin extracted from alga, e. g. diatom, which is represented by the formula. Fucoxanthin is effective in preventing the oxidation of, e. g. an unsaturated fatty acid, and is a highly safe natural substance. It is contained in alga in large quantities and can be easily extracted. It is suited for use in a food, a cosmetic, and a medicine.) 

606: (6074756295618413082) patent: US20160310460A1 Title : ITCH SUPPRESSION BY FUCOXANTHIN) Abstract : The present invention provides a method of suppressing mast cell differentiation and/or itch in the skin of a subject, comprising topically administering to the skin in need thereof an effective amount of fucoxanthin or a derivative thereof.) 

607: (7686373638229140384) patent: EP2459220A1 Title : BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS) 

608: (1018466414312033028) patent: US5951875A Title : Adsorptive bubble separation methods and systems for dewatering suspensions of microalgae and extracting components therefrom) Abstract : A process and system are disclosed for recovering mixed carotenoids from the alga Dunaliella salina. The harvested cells are ruptured, typically by circulating the algal suspension at high pressure through a pump loop. The cells can then be dewatered by absorptive bubble separation techniques, including a froth floatation circuit that has a roughing zone and a concentrating zone. If further concentration is desired, the algal concentrate can be mechanically filtered in a cross flow microfiltration unit in the absence of flocculating agents with substantially no loss of carotenoids in the permeate. Various methods for extracting mixed carotenoids and other components from the algae are disclosed, including dense gas extraction, and extractions with natural and synthetic flavorants, and edible oils.) 

609: (3500331647393085070) patent: EP1884238A4 Title : Fucoxanthinol as anti-obesity agent) Abstract : [Problem] Fucoxanthin extracted from wakame seaweed (Undaria pinnatifida) is effective as an anti-obesity active agent. However, fucoxanthin is contained in mature (adult) brown algae in a small amount, and accordingly, it takes a long time and high cost to obtain fcoxanthin in an amount sufficient for practical use. Further, an anti-obesity active agent showing a stronger effect has been desired. It is, therefore, an object of the present invention to specify a carotenoid exhibiting anti-obesity activity stronger than that of fucoxanthin and to provide an anti-obesity active agent and an anti-obesity method which use the caritenoid. [Means to Solve the Problem] Intensive and extensive studies have been made as to what carotenoid has an anti-obesity activity stronger than that of fucoxanthin and what material should be used in order to economically obtain such a carotenoid. As a result, the answer has been found that the carotenoid is fucoxanthinol. "Sea squirt (ascidian)" is a generic name of marine animals which belong to class Ascidiacea, subphylum Urochordata (Tunicata), phylum Chordata and which live nationwide. As described above, sea squirt (ascidian) is abundantly found as resources. In the present invention, fucoxanthinol is extracted particularly from internal organs and hard skins of sea squirt (ascidian), and it has been revealed that fucoxanthinol exhibits strong anti-obesity activity.) 

610: (7354016337398919196) patent: US20110275592A1 Title : EMULSION COMPOSITION AND FOOD AND COSMETIC PRODUCTS CONTAINING THE EMULSION COMPOSITION) Abstract : The invention provides an emulsion composition obtained by mixing an oil phase containing a carotenoid having a melting point of 100 C. or more as detected when it is contained in an oil; and an aqueous phase containing a polyglycerol fatty acid ester and a nonionic emulsifier different from the polyglycerol fatty acid ester, wherein a weight ratio (A)/(B) of an amount (A) of the polyglycerol fatty acid ester to an amount (B) of the nonionic emulsifier different from the polyglycerol fatty acid ester is in the range of 2.5 to 10, and a particle diameter of dispersed particles that contain the carotenoid is 200 nm or less.) 

611: (8074514166386523732) patent: EP1553101A1 Title : N-ACETYLGLUCOSAMINE DERIVATIVES AND USE THEREOF) Abstract : The present invention relates to An N-acetylglucosamine derivative represented by the following formula (1), and a hyaluronic acid production promoting agent containing the same and a skin external preparation containing the same: <CHEM> wherein R<1> is a hydrogen atom or an alkyl group having 2 to 18 carbon atoms; R<2>, R<3>, and R<4> are hydrogen atoms or acyl groups having 2 to 18 carbon atoms and may be all the same or different from others; the steric structure at position 1 may be alpha or beta ; provided that R<1>, R<2>, R<3>, and R<4> must not be all hydrogen atoms. <??>It is intended to provide an easily available hyaluronic acid production promoting agent and a skin external preparation whereby the production of hyaluronic acid can be promoted in the skin and thus the skin can be maintained in a vital and moist state so that it is expected that the human skin can be prevented from age.) 

612: (5816802099528366565) patent: EP1884238A1 Title : Fucoxanthinol as anti-obesity agent) Abstract : [Problem] Fucoxanthin extracted from wakame seaweed (Undaria pinnatifida) is effective as an anti-obesity active agent. However, fucoxanthin is contained in mature (adult) brown algae in a small amount, and accordingly, it takes a long time and high cost to obtain fcoxanthin in an amount sufficient for practical use. Further, an anti-obesity active agent showing a stronger effect has been desired. It is, therefore, an object of the present invention to specify a carotenoid exhibiting anti-obesity activity stronger than that of fucoxanthin and to provide an anti-obesity active agent and an anti-obesity method which use the caritenoid. [Means to Solve the Problem] Intensive and extensive studies have been made as to what carotenoid has an anti-obesity activity stronger than that of fucoxanthin and what material should be used in order to economically obtain such a carotenoid. As a result, the answer has been found that the carotenoid is fucoxanthinol. "Sea squirt (ascidian)" is a generic name of marine animals which belong to class Ascidiacea, subphylum Urochordata (Tunicata), phylum Chordata and which live nationwide. As described above, sea squirt (ascidian) is abundantly found as resources. In the present invention, fucoxanthinol is extracted particularly from internal organs and hard skins of sea squirt (ascidian), and it has been revealed that fucoxanthinol exhibits strong anti-obesity activity.) 

613: (8955491634849074481) patent: EP2752436A1 Title : SURFACE MODIFICATION METHOD AND SURFACE-MODIFIED ELASTIC BODY) Abstract : The present invention aims to provide a method for surface-modifying a rubber vulcanizate or a thermoplastic elastomer, which is capable of cost-effectively imparting a variety of functions, such as sliding properties and biocompatibility, according to the applications. The present invention relates to a surface modification method for surface-modifying an object of a rubber vulcanizate or a thermoplastic elastomer, the method including: step 1 of forming polymerization initiation points A on a surface of the object; step 2 of radically polymerizing a non-functional monomer, starting from the polymerization initiation points A, to grow non-functional polymer chains; step 3 of forming polymerization initiation points B on the surface of the object where the non-functional polymer chains are formed; and step 4 of radically polymerizing a functional monomer, starting from the polymerization initiation points B, to grow functional polymer chains.) 

614: (5355827036239609544) patent: JP2008001623A Title : VASCULARIZATION INHIBITOR) Abstract : PROBLEM TO BE SOLVED: To provide a safe and excellent vascularization inhibitor. ;SOLUTION: The vascularization inhibitor and the medicinal composition contain fucoxanthin and/or fucoxanthinol. The cosmetic composition contains the fucoxanthinol. ;COPYRIGHT: (C)2008,JPO&INPIT) 

615: (198413743516852020) patent: US20130052719A1 Title : PHOTOBIOREACTOR FOR MASS CULTURE OF MICROALGAE, AND METHOD FOR CULTURING MICROALGAE BY USING SAME) Abstract : The present invention relates to a photobioreactor for mass culture of microalgae. The present invention provides a photobioreactor for mass culture of microalgae, comprising: a culture container comprising external walls which comprise an optical filter zone capable of selective penetration or blocking of a part of wavelength or region from sunlight and/or a heat conversion zone for selectively absorbing a part of wavelength or region from sunlight to convert the same into heat, and a reaction chamber which is three-dimensionally formed so as to accommodate microalgae and is an inner space restricted by the external walls; and a coupling means for connecting a floating means which is connected to the culture container or the culture container to the bottom of the water or a structure on the water, thereby locating the culture container near the surface of the water for the exposure of the culture container to sunlight.) 

616: (8887451137387432017) patent: US20140315279A1 Title : PRODUCTION OF QUINONE DERIVED COMPOUNDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express quinone derived compounds.) 

617: (3051737386358343279) patent: US20100303913A1 Title : Method for Nanoencapsulation) Abstract : Methods of nanoencapsulation are described herein. Embodiments of the method utilize the coacervation of a cationic polyelectrolyte with an anionic polyelectrolyte to form a novel capsular matrix. In particular, the novel methods may be used to encapsulate a suspension of a hydrophobic material such as a carotenoid. The disclosed methods do not require lengthy pH adjustments nor do they require the use of any toxic crosslinking agents. In one embodiment, a method of encapsulation comprises dispersing a hydrophobic compound in an organic solvent to form a solution. The method also comprises admixing an anionic polyelectrolyte and a cationic polyelectrolyte with the suspension to form a mixture. In addition, the method comprises quiescently cooling the mixture so as to cause self-crosslinking of a capsular matrix encapsulating the hydrophobic particles.) 

618: (5798552882291260497) patent: EP3028691A1 patent: EP3028691 patent: CN105431132 patent: JP6016728B patent: WO2015015947 patent: JP2015030705 Title : CERAMIDE DISPERSION COMPOSITION) Abstract : A ceramide dispersion composition having a pH of equal to or less than 6.5, including a natural ceramide, a polyol, a first surfactant which is a nonionic surfactant, and a second surfactant which is at least one kind of surfactant selected from the group consisting of a cationic surfactant and an amphoteric surfactant excluding phospholipids.) 

619: (1135261110651963476) patent: US20060216251A1 Title : Topical formulations and methods of use) Abstract : A topical composition comprising a lipoic acid, a carnitine, and a carnosine in a suitable vehicle for topical application and a method for treating skin is provided. The present compositions are useful in improving the appearance of aged skin characterized by wrinkles and loss of elasticity. Preferred components include R-lipoic acid or R-dihydrolipoic acid, acetyl-1-carnitine, and 1-carnosine.) 

620: (6581860667287989371) patent: US20050090469A1 Title : Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease) Abstract : A method of treating liver disease in a subject may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include a cyclic ring including at least one substituent. In some embodiments, a cyclic ring of a carotenoid analog or derivative may include at least one substituent. The substituent may be coupled to the cyclic ring with an ester functionality.) 

621: (8396288759341131229) patent: WO2011047530A1 Title : CAROTENOID DERIVATIVES, PREPARATION METHOD AND USE THEREOF) Abstract : Compounds having the structure of general formula I or pharmaceutically acceptable salts thereof which are derivatives of fucoxanthin and fucoxanthol are disclosed. A preparation method of the compound and its use in weight reducing are also disclosed.) 

622: (322947182555515755) patent: US20130137138A1 Title : METHOD OF PRODUCING ISOPRENOID COMPOUNDS IN YEAST) Abstract : Yeast strains capable of increased prenyl phosphate production are provided, enabling increased terpenoid molecule production. Heterologous yeast strains with high prenyl phosphate availability are prepared using one or both of two different strategies for increasing the availability of prenyl phosphates for terpenoid production. First, by co-expressing multiple mevalonate pathway gene analogs, a novel heterologous combination of genes results, some of which increases the inherent availability of prenyl phosphates in yeast. Second, by expressing the non-endogenous enzyme ATP citrate lysase (ACL), a buildup of high cytosolic concentration of acetyl-CoA is produced in the cytosol of S. cerevisiae.) 

623: (8983188665249822505) patent: US20080187526A1 Title : Micronutrient formulations for hearing health) Abstract : A hearing health micronutrient formulation is provided and the formulation comprises dietary antioxidants and endogenous antioxidants, and the dietary antioxidants are selected from a group consisting essentially of Vitamin A (Palmitate), Vitamin E, Vitamin C (Calcium Ascorbate), Vitamin D3 (Cholecalciferol), B Vitamins, Biotin, Pantothenic Acid (as D-Calcium Pantothenate), Calcium Citrate, Magnesium Citrate, Zinc Glycinate, Selenium (Seleno-L-Methionine), Chromium (as Chromium Picolinate), Mixed Carotenoids and mixtures thereof, and the endogenous antioxidants are selected from a group consisting essentially of N-Acetyl Cysteine (NAC), Coenzyme Q10, R-alpha Lipoic Acid, L-Carnitine and mixtures thereof,) 

624: (2582324544788455322) patent: US20120141387A1 Title : COMPOSITION INCLUDING AN UNSAPONIFIABLE FRACTION) Abstract : The present invention relates to a composition, notably cosmetic, nutraceutical, dermatological, pharmaceutical or dietary, including at least one unsaponif iable extract, a drug including one such composition, the use of one such composition, a treatment method consisting in administering one such composition and a method comprising the administration of one such composition.) 

625: (9011344855488781810) patent: WO2011047530A8 Title : CAROTENOID DERIVATIVES, PREPARATION METHOD AND USE THEREOF) Abstract : Compounds having the structure of general formula I or pharmaceutically acceptable salts thereof which are derivatives of fucoxanthin and fucoxanthol are disclosed. A preparation method of the compound and its use in weight reducing are also disclosed.) 

626: (6915876629685727663) patent: US20110293525A1 Title : TUMOR STEM CELLS) Abstract : Tumor stem cells can be obtained by culturing a tumor cell population, and exposing the cultured tumor cell population to free radicals. In certain embodiments, the free radical agent can be a nitric oxide (NO) donor. In one embodiment, the free radical agent can be Diethylenetriamine NONOate (DETA NONOate) or agents that constitutively increase cellular nitric oxide, such as phosphodiesterase inhibitors or L-arginine, or agents that increase NO synthase in the population. The methods can further include inducing stem cells present in the population to expand and/or inducing dedifferentiation of tumor cells into tumor stem cells. Additionally, the present invention provides methods of selecting stem cells from a tumor cell population. Another aspect provides methods of screening for anti-tumor stem cell teherapeutic compounds by providing high nitric oxide (HNO) tumor cells, exposing the HNO cells to at least one compound, assessing one or more indicators of HNO cell health and determining toxicity of the compound to HNO tumor cells.) 

627: (4800738389685205813) patent: US20120128800A1 Title : DIETARY SUPPLEMENTS CONTAINING EXTRACTS OF ARONIA AND METHOD OF USING SAME TO PROMOTE WEIGHT LOSS) Abstract : A dietary supplement composition comprising aronia extract containing at least 20% anthocyanins by dry weight. The aronia extract is derived from the aronia melanocarpa plant. The aronia extract comprises approximately 10%-30% of the dry weight of the composition. A vitamin, weight loss agent, or antioxidant is provided in the composition. The dietary supplement composition is administered orally to promote weight loss.) 

628: (4208671194890246035) patent: US20160068615A1 Title : Device for controlling and adjusting the current passing through an arc fed with alternating current) 

629: (3909118473063970330) patent: WO2002013835A1 Title : COMPOSITION EXHIBITING SYNERGISTIC ANTIOXIDANT ACTIVITY) Abstract : A novel formulation is provided that serves to synergistically inhibit the generation of free radicals and oxidative stress in animals. The formulation comprises as a first component a carotenoid species, and, as a second component, at least one member selected from the group consisting of lipoic acid, dihydrolipoic acid (DHLA), a stilbene species, ergothioneine, a flavone species, a triterpene species, ascorbic acid and derivatives thereof. The figure illustrates relative antioxidant activity of garlic alone and the combination of garlic and algal meal in a weight ration of 24:1.) 

630: (7594584074995071345) patent: US8617886B2 Title : Compositions and methods for modulating metabolic pathways) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

631: (8040029383686957585) patent: WO2016166755A1 patent: WO2016166755 Title : COMPOSITIONS COMPRISING CAROTENOIDS AND USE THEREOF) Abstract : Microalgae extract and microalgae dried biomass compositions comprising carotenoids including but not limited to fucoxanthin and fatty acids, are provided.) 

632: (2467658369417398522) patent: US8765198B2 Title : Anti-stretch mark active agent, and compositions containing same) Abstract : The invention relates to a method for the cosmetic prevention and/or treatment of stretch marks on the skin, characterised in that the method comprises administering a composition containing arabinogalactan as an active principle to a person that may develop or has stretch marks. Said cosmetic composition can be administered in a topical or oral manner.) 

633: (603040052209560888) patent: US20160206588A1 Title : STABILIZED FORMULATIONS OF FATTY ACIDS) Abstract : Disclosed herein are stabilized powder and aqueous formulations comprising a substantially water insoluble lipophilic bioactive compound and a micelle-forming surfactant. In one embodiment, the formulation further comprises a water soluble reducing agent, and/or a water insoluble reducing agent, and/or a metal chelator, and/or a metal bisulfite reducing agent, or combinations thereof, wherein the formulation remains substantially clear and stable when stored at or below room temperature for a period of at least 6 months or at least 12 months; and methods for preparing these formulations.) 

634: (5295840854155083466) patent: US20160256511A1 Title : COMPOSITIONS AND METHODS FOR THE TREATMENT OR PROPHYLAXIS OF CIRCADIAN PROTEIN RELATED CONDITIONS) Abstract : Provided are compositions and processes of treating or preventing one or more conditions related to a protein involved in circadian rhythm. A composition includes an extract of rosemary, an extract of hemerocallis fulva, active portion or component thereof, or combinations thereof, optionally provided as a component of a dietary supplement. The presence of one or more active ingredients in the extracts optionally administered at a targeted administration time alters the expression of one or more genes or proteins involved in circadian rhythm, illustratively CLOCK, BMAL1, FBXL3, FBXL21, or SIRT1.) 

635: (3564150623063485575) patent: US6620604B1 Title : Sulfohydrolases, corresponding amino acid and nucleotide sequences, sulfohydrolase preparations, processes, and products thereof) Abstract : A purified sulfohydrolase having a purity level based on total amount of protein of at least about 40 wt %. Isolated nucleic acid sequence and amino acid sequences. A process for purifying at least one sulfohydrolase, including subjecting an extract from seaweed to fractionation to obtain fractions; and subjecting at least one of the fractions to phenyl sepharose chromatography to obtain sepharose fractions containing at least one sulfohydrolase. An enzymatically modified compound which has been modified by an isolated sulfohydrolase having a purity level based on total amount of protein of at least about 40 wt %. A process of enzymatically modifying a sulfated compound, including combining at least one sulfohydrolase, having a purity level based on total amount of protein of at least about 40 wt %, with a sulfated compound form a reaction mixture; and incubating the reaction mixture to remove sulfate groups from the sulfated compound to form an enzymatically modified compound. A process of enzymatically modifying a sulfated compound, including incubating a first sulfohydrolase with a sulfated compound to remove sulfate groups from the sulfated compound to form an intermediate compound; and subsequently incubating the intermediate compound with a second sulfohydrolase to remove sulfate groups to form an enzymatically modified compound. A method for extracting one of nu- and mu-carrageenan from seaweed, including dispersing seaweed in a salt solution including K2CO3 to form a dispersion; filtering the dispersion to obtain a liquid; ultrafiltering the dispersion to remove salts; concentrating the liquid; adjusting the pH of the liquid to about 8 to 8.5; and precipitating one of nu- and mu-carrageenan from the liquid.) 

636: (7485191750174254150) patent: EP1428884A1 Title : Sulfohydrolase I from Chondrus crispus seaweed, and uses thereof) Abstract : The present invention relates to an isolated sulfohydrolase from Chondrus crispus seaweed, comprising an amino acid sequence of SEQ ID NO:22, and uses thereof for enzymatically modifying sulfated compounds.) 

637: (1586258445139909674) patent: WO2009126890A2 Title : PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present disclosure provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.) 

638: (1014631890311388156) patent: US20150111263A1 Title : METHODS AND PRODUCTS FOR GENERATING OILS) Abstract : Compositions and methods for enhancing secretion of oils from oil producing cells are described herein. In particular, secretion of oils is enhanced by treating the cells with herbicides. The oils generated according to the invention may be useful, for example, in the production of biofuels.) 

639: (4701733624537679097) patent: EP2997955A1 patent: EP2997955 patent: JP5981032B patent: CN105188645 patent: KR20150139963 patent: WO2014185315 patent: JPWO2014185315 Title : OIL-IN-WATER COSMETIC) Abstract : An oil-in-water cosmetic including surface-treated powder including at least one oxide selected from a group consisting of titanium oxide and zinc oxide and having 4-tert-butyl-4-methoxy benzoyl methane on a surface, at least one carotenoid, and at least one copolymer including acryloyldimethyl taurate as a copolymerization component.) 

640: (2455257577505096984) patent: WO2015180993A1 patent: WO2015180993 patent: DE102014210308 Title : YEAST STRAIN FOR PRODUCING CAROTENOIDS) Abstract : The invention concerns a yeast strain of the Saccharomyces genus with an established carotenoid biosynthesis pathway, characterised in that it can overexpress a PDR1 gene or PDR1 homologue.) 

641: (6447577425142974184) patent: WO2016073843A2 Title : ENHANCED EXPRESSION OF MTOR AND INHIBITED EXPRESSION OF MYOSTATIN IN SKELETAL MUSCLE CELLS) 

642: (790606769239813192) patent: US7252942B2 Title : Parallel chromosomal stacking of traits in bacteria) Abstract : The invention describes a method for the stacking of traits in a recombination proficient host using a phage transduction system. The method makes use of a nucleic acid integration cassette that has homology to a specific site on a host chromosome for the insertion of genetic elements and the stacking of traits. Repetition of the method results in the stacking of traits on a single genetic element.) 

643: (7598448596408855428) patent: WO2010022364A1 Title : WATER SOLUBLE DRUGS AND SUPPLEMENTS) Abstract : A method of forming water soluble microparticles is disclosed that includes the steps of providing a water insoluble food supplement, mixing the food supplement in a water miscible polar solvent, heating the mixture to increase the solubility and dissolve the food supplement into the solvent to form a saturated solution, and streaming the solution into water to form a solvent-water mix such that microparticles of the food supplement are produced.) 

644: (4560756764536699467) patent: US20160145668A1 patent: JP2016523554 patent: WO2015004403 patent: FR3008422 patent: US2016145668 patent: EP3019593 Title : UNCOUPLED CELL CULTURE METHOD) Abstract : Disclosed is a method for producing biomass by culturing cells in mixotrophic conditions, in particular in the presence of discontinuous and/or variable lighting conditions, and/or in heterotrophic conditions, making it possible to obtain an increase in both the cellular concentration and the production of molecules of interest.) 

645: (422276973774835100) patent: WO2008130372A2 Title : PRODUCTION OF STEROLS IN OLEAGINOUS YEAST AND FUNGI) Abstract : The present invention provides methods for production of one or more sterol compounds. Further provided are methods and systems for producing engineered oleaginous yeast or fungi that are capable of production of one or more sterol compounds, and compositions which utilize the produced sterol compound(s).) 

646: (3799182201823548728) patent: WO2011103464A1 Title : METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE) Abstract : The invention features compositions, methods, and kits for the administration of an oxidatively transformed carotenoid, or a fractionated component thereof, for use in aquaculture.) 

647: (5738030934895210201) patent: US20140170700A1 Title : Method For Producing Carotenoids Each Having 50 Carbon Atoms) Abstract : The present invention provides a method of producing a carotenoid having 50 carbon atoms which comprises culturing, in a medium, a cell transformed with a mutant phytoene desaturase gene and obtaining the carotenoid having 50 carbon atoms from the culture. The mutant phytoene desaturase gene has an introduced mutation to encode a mutant phytoene desaturase having an enhanced activity to desaturate a carotenoid backbone compound of 50 carbon atoms.) 

648: (1522742005960162744) patent: US20160302452A1 Title : NUTRITIONAL COMPOSITION) Abstract : A nutritional composition containing a plant food and a mineral food, where the plant food includes at least one of aloe, green algae, red algae, brown algae, blue-green algae, kelp, kombu, hijiki, nori, arame, sea palm, bladderwrack, wakame, dulse, carrageenan, fungi, and bacteria. The mineral food includes at least one of shilajit, humic acid, fulvic acid, bentonite clay, charcoal, diatomaceous earth, dolomite, fossilized remains, rocks, gems, sodium chloride, sea salt, and derivatives or combinations thereof. In one embodiment of the composition, the plant food is a juice of aloe vera and the mineral food is fulvic acid.) 

649: (7413776545084219328) patent: US20130172426A1 Title : FAT-REDUCING AGENT) Abstract : A fat-reducing agent includes a carotenoid-containing composition as an active ingredient, the carotenoid-containing composition including: a carotenoid component including at least one crystalline carotenoid, wherein at least 90% by mass of the crystalline carotenoid is in the non-crystalline state; and a (poly)glycerin fatty acid ester containing from 1 to 6 glycerin units and from 1 to 6 fatty acid units, and having at least one hydroxyl group in the glycerin units.) 

650: (8542893475471291379) patent: US20080287393A1 Title : External Skin Composition) Abstract : The external skin care composition of the present invention comprises N-acetylglucosamine and at least one member selected from the group consisting of retinoid and pro-vitamin A. The external skin care composition of the present invention has an effect of promoting the production of epidermal hyaluronic acid and can retain firmness and moisture of the skin.) 

651: (9014347578151202324) patent: EP2536293A1 Title : METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE) 

652: (5538281375738221363) patent: US20150342854A1 Title : EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME) Abstract : The present invention has an object to provide an external dermal composition for anti-ageing, which prevents or improves apparent skin problems such as wrinkles, fine wrinkles, blemishes, and saggings caused by increasing age or ageing; and maintains or improves the barrier function and the hyaluronic acid production in the skin. The object is solved by providing an external dermal composition for anti-ageing, which contains an aqueous medium as a base material and one or more ingredients selected from L-ascorbic acid, derivatives thereof, and their salts as an effective ingredient(s).) 

653: (6605652876457110261) patent: WO2016007841A1 Title : EX VIVO BROWNING OF ADIPOSE TISSUE THERAPY FOR REVERSAL OF OBESITY AND TYPE II DIABETES) Abstract : Provided are methods, apparatus, pharmaceutical compositions, and kits for treatment of a metabolic condition, including obesity and type 2 diabetes, by administration to a subject of a therapeutically effective amount of a cell or tissue preparation such as brown adipose microtissues or brown adipose tissue directly converted from white adipose tissue. Modified approaches to creating brown adipose tissue involve differentiation of explanted white adipose tissue and direct browning of white adipose tissue in a bioreactor rather than isolation and expansion of adipose stems cells or endothelial cells and formation and differentiation of 3D cell aggregates.) 

654: (2325093995308527173) patent: WO2011073205A1 Title : COMBINATION OF CAROTENOIDS AND EPI-LUTEIN) Abstract : The invention describes the preparation and use of carotenoid and epi-lutein compositions to treat various ocular diseases.) 

655: (3097432209003184697) patent: WO2006092449A2 Title : PROCESS FOR THE PRODUCTION OF FINE CHEMICALS) Abstract : The present invention relates to a process for the production of the fine chemical in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof, preferably in plastids. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use.) 

656: (3013939310634835188) patent: US20040209365A1 Title : Parallel chromosomal stacking of traits in bacteria) Abstract : The invention describes a method for the stacking of traits in a recombination proficient host using a phage transduction system. The method makes use of a nucleic acid integration cassette that has homology to a specific site on a host chromosome for the insertion of genetic elements and the stacking of traits. Repetition of the method results in the stacking of traits on a single genetic element.) 

657: (8430658333005700131) patent: US9211238B2 Title : Carrier system for the transport of active substances into the skin) Abstract : Vesicle, comprising at least the following components: -an aqueous core, which can comprise at least one cosmetic and/or at least one pharmaceutical active substance, and -a continuous membrane which surrounds the core and which is formed by at least one emulsifier, selected from the group of the food additives E 472 a to f, and at least one membrane-stabilizing single-chain lipid and/or one or more lipophilic cosmetic and/or pharmaceutical active substances.) 

658: (2304183002329702762) patent: US20150133712A1 Title : PROCESS FOR THE ISOLATION OF CAROTENOIDS) Abstract : Described herein is a material for reversibly binding to a carotenoid comprising a support coupled to silver ions in an amount to enable reversible binding with carotenoids, and wherein with the exception of silver ions, is substantially free of transition metals. Also described herein is a process for reversibly binding a carotenoid, the process comprising the steps of: providing a support coupled to silver ions in an amount to enable reversible binding with the carotenoid, wherein with the exception of silver, the support is substantially free of transition metals, contacting the support with the carotenoid under binding conditions to bind it thereto and dissociating the carotenoidod from the support under dissociating conditions to release the carotenoid.) 

659: (1067509530555466198) patent: US7838552B2 Title : Compositions comprising nebivolol) Abstract : Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention features a pharmaceutical composition comprising nebivolol and at least one other active agent, wherein the at least one other active agent is a cardiovascular agent.) 

660: (1495711863465285272) patent: WO2010048114A1 Title : NOVEL MITOCHONDRIAL UNCOUPLING METHODS AND COMPOSITIONS FOR ENHANCING ADIPOCYTE THERMOGENESIS) Abstract : Disclosed are methods, compounds, and compositions comprising botanically based drugs, medical foods, and dietary supplements for the prevention and treatment of metabolic disorders, in particular obesity, weight gain, insulin resistance syndromes, diabetes, fasting hyperlipidemia and osteoarthritis. More specifically, the invention relates to pharmaceutical therapeutic methods and compositions utilizing phytochemicals, natural plant extracts and combinations to modify adipocyte physiology to enhance thermogenesis and modify cytokine secretion.) 

661: (4989726727305940828) patent: EP2194140A2 Title : Process for the production of fine chemicals) Abstract : The present invention relates to a process for the production of the fine chemical in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof, preferably in plastids. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use.) 

662: (8908508091752590054) patent: US8412469B1 Title : Environmental monitoring of microbe metabolic transformation) Abstract : Mobile system and method for monitoring environmental parameters involved in growth or metabolic transformation of algae in a liquid. Each of one or more mobile apparati, suspended or partly or wholly submerged in the liquid, includes at least first and second environmental sensors that sense and transmit distinct first and second environmental, growth or transformation parameter values, such as liquid temperature, temperature of gas adjacent to and above the exposed surface, liquid pH, liquid salinity, liquid turbidity, O2 dissolved in the liquid, CO2 contained in the liquid, oxidization and reduction potential of the liquid, nutrient concentrations in the liquid, nitrate concentration in the liquid, ammonium concentration in the liquid, bicarbonate concentration in the liquid, phosphate concentration in the liquid, light intensity at the liquid surface, electrical conductivity of the liquid, and a parameter [alpha](alga) associated with growth stage of the alga, using PAM fluorometry or other suitable parameter measurements.) 

663: (8117156910734741290) patent: US20070015237A1 Title : Production of carotenoids in oleaginous yeast and fungi) Abstract : The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids) 

664: (4805939432316816169) patent: EP2882494A1 Title : TOPICAL COMPOSITION COMPRISING TRANSFORMED BACTERIA EXPRESSING A COMPOUND OF INTEREST) 

665: (2657760993575128701) patent: US20130337068A1 Title : CAROTENOID PARTICLES AND USES THEREOF) Abstract : This invention relates to the incorporation of bioactive cargo molecules into particles with carotenoids, such as lycopene. The incorporation of a cargo molecule into a carotenoid particle may for example increase the bioavailability of the cargo molecule in the bloodstream compared to other delivery systems. Carotenoid particles as described herein may be useful in the formulation of therapeutic and nutritional compounds for oral administration to individuals.) 

666: (6147235479711178941) patent: US20060036088A1 Title : Natural promoters for gene expression in C1 metabolizing bacteria) Abstract : Genes have been identified in the Methylomonas genome that are responsive to various metabolic and growth conditions. The identified responsiveness of these genes allows for the use of their promoters in regulated gene expression in C1 metabolizing bacteria. In particular, the hps promoter, which in its native state drives the expression of 3-hexulose-6-phosphate synthase (HPS), was found to be useful for directing expression of heterolgous coding regions (e. g., crtZ) in the obligate methanotroph Methylomonas sp. 16a.) 

667: (3004588929170741806) patent: US20050143475A1 Title : Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury) Abstract : A method of treating ischemic reperfusion injury in a subject. The method may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include an acyclic alkene including at least one substituent and/or a cyclic ring including at least one substituent. In some embodiments, a carotenoid analog or derivative may include at least one substituent.) 

668: (3389899939942257676) patent: WO2006002630A1 Title : SELF-POLISHING ANTI-FOULING COATING COMPOSITIONS COMPRISING AN ENZYME) Abstract : The present invention relates to self-polishing, anti-fouling coating compositions comprising an enzyme, methods for producing such coating compositions and uses thereof. The coating composition can comprise e. g. a pigment in which case the coating composition can be used as a painting composition. In a first aspect, the invention relates to a self-polishing anti-fouling coating composition comprising a first enzyme having anti-fouling activity, and at least one hydrolysable polymer composition capable of being non-enzymatically hydrolysed in an aqueous environment. In a further aspect there is provided a self-polishing anti-fouling coating composition comprising a first enzyme having anti-fouling activity, a second enzyme having polymer-hydrolysing activity, and at least one hydrolysable polymer composition capable of being hydrolysed by said second enzyme. In the latter case, the first enzyme does preferably not contribute to the self-polishing effect. The second enzyme typically does not have a direct anti-fouling species.) 

669: (4580246625646225421) patent: WO2012155202A1 Title : DETECTION OF SAXITOXIN-PRODUCING DINOFLAGELLATES) Abstract : The current disclosure generally relates to the field of saxitoxins and the identification of microorganisms capable of producing them. In particular, the saxitoxin A (sxtA) gene comprising catalytic domain sequences saxitoxin A1 (sxtA1) and saxitoxin A4 (sxtA4) is identified in a number of dinoflagellate species. The disclosure relates to methods of detection of saxitoxin-producing dinoflagellates by amplification and detection of the sxtA gene (in particular by PCR) and kits and primers for use in the method are also disclosed. Saxitoxin-producing dinoflagellate genera detected by the method include Alexandrium, Pyrodinium or Gymnodinium.) 

670: (6656939027031142598) patent: WO2014112573A1 patent: WO2014112573 patent: JPWO2014112573 patent: CN104936588 Title : FUCOXANTHIN-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME) Abstract : A fucoxanthin-containing composition containing: (A) fucoxanthin; (B) one or more emulsifiers selected from the group consisting of a glycerin fatty-acid ester, a polyglycerin fatty-acid ester, a sucrose fatty-acid ester, and lecithin; and (C) one or more excipients selected from the group consisting of cyclodextrin and a gum. A method for producing a fucoxanthin-containing composition, having: a step for mixing (A) fucoxanthin, (B) one or more emulsifiers selected from the group consisting of a glycerin fatty-acid ester, a polyglycerin fatty-acid ester, a sucrose fatty-acid ester, and lecithin, and (C) one or more excipients selected from the group consisting of cyclodextrin and a gum; and a step for drying the obtained composition.) 

671: (9035038407821990317) patent: WO2013133903A1 patent: WO2013133903 Title : PARTICLES FOR AEROSOLIZING APPARATUS) Abstract : Formulations and particle size descriptions are provided for an ingestible powder for use in an aerosolizing delivery apparatus. Particle formulations are designed to be aerosolized for delivery to a user's mouth. Formulations are can be designed for good delivery and payload performance, flavoring, comfort and sensory experience to a recipient. Formulations are provided for energy supplements, pharmaceutical compounds, over-the-counter pharmaceutical compounds, sleep-aid compounds, weight-loss compounds, and oral health compounds.) 

672: (4863485091003721566) patent: WO2005079143A2 Title : TOPICAL FORMULATIONS FOR THE TREATMENT OF SKIN CONDITIONS) Abstract : The invention features compositions for topical administration of an oxidatively transformed carotenoid or 2-methyl-6-oxo-2,4-heptadienal and methods of treating skin conditions therewith.) 

673: (8119803961012363037) patent: US20080153148A1 Title : Increasing bioavailability of carotenoids) Abstract : A method of increasing a fraction of free carotenoids in a source of carotenoids in which at least some of the carotenoids are fatty acid esterified carotenoids is disclosed. The method is effected by contacting the source of carotenoids with an effective amount of an esterase under conditions effective in deesterifying the fatty acid esterified carotenoids, thereby increasing the fraction of free carotenoids in the source of carotenoids.) 

674: (8821192127678724012) patent: JP2009108022A patent: JP2009108022 Title : THERAPEUTIC AGENT) Abstract : PROBLEM TO BE SOLVED: To provide a therapeutic agent containing fucoxanthin and/or fucoxanthinol as active ingredients, while the fucoxanthin is known to have functions such as a diabetes-improving action, a neovascularization-inhibiting action, and a DHA synthesis-promoting action, and further effectively has especially remarkable effects for various other diseases. ;SOLUTION: A hyperuricemia-preventing or improving agent, an anti-osteoporosis agent, an antidepressant-antistress agent, an adiponectin production-promoting agent, a hypocholesterolemic agent, a hypotensive agent, or an antiallergic agent contains the fucoxanthin and/or the fucoxanthinol as active ingredients. ;COPYRIGHT: (C)2009,JPO&INPIT) 

675: (6788351013053178118) patent: WO2007049786A1 Title : FAT-SOLUBLE OIL COMPRISING FUCOXANTHIN, PROCESS FOR PRODUCTION OF THE OIL, AND PROCESS FOR PRODUCTION OF FUCOXANTHIN) Abstract : [PROBLEMS] To provide a fat-soluble oil comprising fucoxanthin which is extracted with a high yield in an economically advantageous manner, a process for production of the oil, and a process for production of fucoxanthin. [MEANS FOR SOLVING PROBLEMS] A fat-soluble oil almost certainly comprising fucoxanthin can be extracted from a brown alga by performing a first step wherein the brown alga is heat-treated and a second step wherein a fat-soluble oil is extracted from the brown alga heat-treated in the first step with an organic solvent. Fucoxanthin can be purified from a fat-soluble oil readily by developing the fat-soluble oil by silica gel column chromatography, wherein the fat-soluble oil is produced from the heat-treated brown alga and has chlorophyll partially decomposed by immersing the brown alga in hot water.) 

676: (4380527021711192985) patent: EP2676670A1 Title : ADIPONECTIN PRODUCTION PROMOTER, AND MEDICINAL COMPOSITION, FOOD, DRINK AND FEED CONTAINING ADIPONECTIN PRODUCTION PROMOTER) Abstract : Provided is an adiponectin production-promoting agent comprising Botanbouhu as an active component. Such an adiponectin production-promoting agent is able to be used for prevention or treatment of hypoadiponectinemia. Further provided are a pharmaceutical composition, food and drink, and feed comprising such an adiponectin production-promoting agent.) 

677: (2607636588659189743) patent: US20050147579A1 Title : Antifouling composition comprising an enzyme in the absence of its substrate) Abstract : The present invention in one aspect relates to a coating composition comprising at least one enzyme capable of acting on a compound, wherein said action results in the formation of an antifouling species comprising an antifouling activity, and wherein said compound does not form part of said coating composition. The coating composition preferably comprises at least one oxidase capable of acting on a compound, such as a substrate for said oxidase, wherein said action results in the formation of an antifouling species including an antimicrobial species comprising an antimicrobial activity. More preferred, the oxidase comprises an activity which results in the formation of a peroxide. The oxidase can be present in said coating composition in combination with one or more additional enzymes including, but not limited to, an esterase, including a lipase, an amidase, including a protease, and a polysaccharide degrading enzyme, wherein said one or more additional enzyme(s), alone or in any combination, can be included in the presence or absence of one or more substrates for one or more of said enzymes.) 

678: (6413854271011967408) patent: US7628984B2 Title : Micronutrient formulations for pulmonary and heart health) Abstract : A heart and pulmonry health micronutrient formulation is provided and the formulation comprises dietary antioxidants and endogenous antioxidants, and the formulation comprising dietary micronutrients and endogenous antioxidants, the dietary antioxidants are selected from a group consisting essentially of Vitamin A (Palmitate), Vitamin E, Vitamin C, Vitamin D3 (Cholecalciferol), B Vitamins, Biotin, Pantothenic Acid (as D-Calcium Pantothenate), Calcium Citrate, Magnesium Citrate, Zinc Glycinate, Selenium (Seleno-L-Methionine), Chromium (as Chromium Picolinate), Mixed Carotenoids and mixtures thereof, and the endogenous antioxidants are selected from a group consisting essentially of N-Acetyl Cysteine (NAC), Coenzyme Q10, R-alpha Lipoic Acid, Omega-3 fatty Acid, and L-Carnitine and mixtures thereof.) 

679: (3301789157067292842) patent: US20130189722A1 Title : ISOLATION OF PELLET-FORMING MICROORGANISMS) Abstract : The present disclosure provides technologies for identifying, characterizing and/or sorting pellet-forming microorganisms such as bacteria and/or fungi (e. g., yeast) in liquid culture, and particularly under fermentation conditions. In some embodiments, the pellet-forming microorganisms produce one or more commercial products. For example, in some embodiments the pellet-forming microorganisms produce one or more organic acids, carotenoid compounds, essential fatty acids, industrial enzymes, active pharmaceuticals, extracellular carbohydrates, and insecticidal compounds, etc. In many embodiments, the organisms are sorted while in their pellet form.) 

680: (8788114677539407922) patent: EP2982364A1 Title : OIL-IN-WATER EMULSION COMPOSITION) Abstract : Provided is an oil-in-water emulsion composition containing an oil phase, which contains oil having an I/O value of equal to or less than 0.15 and an oil-soluble antioxidant, and a water phase which contains a water-soluble antioxidant, in which the average particle size of emulsion particles is equal to or less than 120 nm.) 

681: (1365951251245460680) patent: EP3046555A1 Title : COMPOSITIONS CAPABLE OF ENHANCING THERMOGENESIS AND USES THEREOF) 

682: (979643448747681929) patent: WO2016055196A1 patent: WO2016055196 Title : LONG-CHAINED MONO AND DI-ESTERS OF 2,5-DI(HYDROXYMETHYL)TETRAHYDROFURAN, USE AND PRODUCTION THEREOF) Abstract : The invention relates to a mono-and diester of 2,5-di(hydroxymethyl)-tetrahydrofuran, to methods for the production thereof by esterification in the presence of tertiary amines or in the presence of enzymatic esterfication catalysts and to the use of said mono-and diester as surface-active compounds, rheology modifiers and emollients. The invention also relates to cosmetic and pharmaceutical agents such as washing, cleaning and dishwashing agents which contain said mono-and diester of 2,5-di(hydroxymethyl)tetrahydrofuran.) 

683: (2246710665457266857) patent: US9453232B2 Title : Topical composition comprising transformed bacteria expressing a compound of interest) Abstract : Compositions comprised of a population of transformed bacteria formulated for topical application to a subject are described. The population of transformed bacteria are created from a non-pathogenic bacteria and transformed to express a compound of interest for a therapeutic or a cosmetic purpose. In one embodiment, the composition is for protection of the skin from ultraviolet rays.) 

684: (8321182172092273575) patent: WO2013052433A2 Title : METHODS AND COMPOSITIONS FOR REDUCING FOOD INTAKE AND BODY WEIGHT GAIN IN ANIMALS) Abstract : Methods and compositions for reducing food intake and body weight gain and particularly to the use of carotenoids and unsaturated fatty acids (UFA) for reducing food intake and body weight gain in animals. The methods comprise administering in conjunction to the animal one or more carotenoids and one or more UFA in an amount effective for reducing food intake and body weight gain in the animal.) 

685: (7291585084009142525) patent: EP2812372A1 Title : HETEROATOM CONTAINING CYCLIC DIMERS) 

686: (325135051448530056) patent: WO2011006261A1 Title : NATURAL AND SUSTAINABLE SEAWEED FORMULA THAT REPLACES SYNTHETIC ADDITIVES IN FISH FEED) Abstract : A seaweed-based commercial salmon feed additive which replaces the synthetic chemical additives that are currently used in salmon fish feed is provided. Synthetic additives are replaced with a combination of seaweed species thereby providing a natural product that improves the nutritional value of the farmed fish, qualifies the fish for marketing as organic, reduces the environmental impact of fish farming practices and may replace the chemical use of lice treatment.) 

687: (5647059736134510867) patent: US20070298483A1 Title : Method to increase carotenoid production in a microbial host cell by down-regulating glycogen synthase) Abstract : A method to increase carotenoid production in carotenogenic microbial host cells is provided by down-regulating or disrupting glycogen synthesis. Disruption of glycogen synthase activity in a carotenogenic microbial host cell significantly increased carotenoid production. Carotenogenic microorganisms are also provided that have been optimized for the production of carotenoid compounds through the down-regulation and/or disruption of glycogen synthase activity.) 

688: (1886470663021437506) patent: WO2007112587A1 Title : CAROTENOID-CONTAINING DIETARY SUPPLEMENT) Abstract : The invention features compositions for administration of an oxidatively transformed carotenoid, fractionated oxidatively transformed carotenoid and components of oxidatively transformed carotenoid. The compositions are useful for supplementing the diet of an animal.) 

689: (1143185547076877705) patent: WO2012040938A1 Title : USE OF FUCOXANTHIN IN THE PREPARATION OF PRODUCT HAVING NEUROPROTECTIVE EFFECT ASSOCIATED WITH NEURODEGENERATIVE DISORDER AND IMPROVING MEMORY) Abstract : Use of fucoxanthin in the preparation of a product having neuroprotective effect associated with neurodegenerative disorder and improving memory is disclosed in the present invention. A product having neuroprotective effect associated with neurodegenerative disorder is also disclosed in the present invention. Fucoxanthin can inhibit oxidative stress of cells and has the effect of preventing or treating Alzheimer's disease and improving memory.) 

690: (5016566052897776462) patent: US20160051604A1 patent: US1651604 Title : Tank-head construction) 

691: (5370752484642239490) patent: WO2012155094A1 patent: WO2012155094 patent: AU2012253281 patent: CA2839264 Title : FORMULATIONS OF PHOSPHOLIPID COMPRISING OMEGA FATTY ACIDS) Abstract : Disclosed herein are stabilized powder and aqueous formulations comprising a phospholipid comprising omega fatty acid and a micelle-forming surfactant. In one embodiment, the formulation further comprises a water soluble reducing agent, and/or a metal chelator, and/or a metal bisulfite reducing agent, or combinations thereof, wherein the formulation remains substantially clear and stable when stored at or below room temperature for a period of at least 6 months or at least 12 months; and methods for preparing these formulations.) 

692: (5128147779589430998) patent: EP2573188A2 Title : Process for the production of fine chemicals) Abstract : The present invention relates to a process for the production of hexadecenoic acid, 2-hydroxy-tetracosenoic acid or lignoceric acid or citrulline, isoleucine or leucine in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof, preferably in plastids. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use.) 

693: (8409823323783181938) patent: US20160113915A1 Title : COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

694: (7111047662727956552) patent: US20150216779A1 Title : COMPOSITIONS FOR TARGETED ANTI-AGING THERAPY) Abstract : This invention relates to compositions for delaying aging. The compositions comprise branched-chain amino acids and whey protein, and combinations thereof, containing the same, such as L-leucine, L-isoleucine, L-valine, lactoferrin, and -lactoglobulin. The compositions are heat stable when dissolved in water at near neutral pH. The compositions are palatable and suitable for delivering orally administrable anti-aging agents such as -3 fatty acids, coenzyme Q10, xanthophylls, L-arginine, and L-glutathione.) 

695: (7686457113856302148) patent: WO2011116738A2 Title : NOVEL SUPPORT SYSTEM FOR THE TRANSPORT OF ACTIVE SUBSTANCES INTO THE SKIN) Abstract : Vesicle, comprising at least the following components: - an aqueous core, which can comprise at least one cosmetic and/or at least one pharmaceutical active substance, and - a continuous membrane which surrounds the core and which is formed by at least one emulsifier, selected from the group of the food additives E 472 a to f, and at least one membrane-stabilizing single-chain lipid and/or one or more lipophilic cosmetic and/or pharmaceutical active substances.) 

696: (7759270563661186489) patent: EP3027058A1 Title : ENCAPSULATED FUNCTIONAL FOOD COMPOSITIONS) 

697: (4588772034227658771) patent: US20150157577A1 Title : MATRIX AND LAYER COMPOSITIONS FOR PROTECTION OF BIOACTIVES) Abstract : The invention relates to matrix and layer compositions comprising a first polymer. The matrix and layer compositions are useful in the delivery of bioactives. In particular, the matrices and layers may have advantageous properties including mechanical properties and protection of bioactives and may also provide for pH-dependent release of a bioactive.) 

698: (8306736564009891276) patent: US9149056B2 Title : Compositions and Methods Relating to Carotenoids) Abstract : A pet food composition having at least two carotenoids. The carotenoids can include a keto-carotenoid and at least one non-keto-carotenoid. The keto-carotenoid can include astaxanthin. The keto-carotenoid can include astaxanthin ester. The non-keto-carotenoid can include beta-carotene and/or lutein.) 

699: (309636942690911200) patent: US7232666B2 Title : Optimized bacterial host strains of Methylomonas sp. 16a) Abstract : Methanotrophic bacterial strains are provided that have been optimized for the production of carotenoid compounds through the down-regulation of one or more of the crtN1, ald, crtN2 and crtN3 genes of the carotenoid biosynthetic pathway. The resulting strains lack pigmented C30 carotenoid compounds, and show an increase in the production of C40 carotenoids. The use of the optimized host strains for the production of the C40 carotenoids canthaxanthin and astaxanthin is also described.) 

700: (3987680978417879496) patent: US20160287528A1 Title : METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE) Abstract : The invention features compositions, methods, and kits for the administration of an oxidatively transformed carotenoid, or a fractionated component thereof, for use in aquaculture.) 

701: (937396427349307486) patent: WO2014144765A1 Title : SEAWEED EXTRACTS, UNSATURATED ALDEHYDES, AND METHODS OF TREATMENT) Abstract : The instant invention relates to seaweed extract compositions, processes for isolation, isolated active agents, and methods of treating disease, disorders and conditions in a subject, including, reactive oxygen species (ROS)- mediated diseases and diseases mediated through the activation of the Nrf2-ARE (antioxidant response element) pathway, including proliferative diseases and disorders, Alzheimer's disease, stroke, and certain diseases and disorders of aging and associated with aging and exposure, by use of the extracts, compounds, and compositions thereof.) 

702: (8719670502173101461) patent: US20090004304A1 Title : COMPOSITION COMPRISING BIOACTIVE SUBSTANCE) Abstract : The present invention provides a powder superior in water-dispersibility/solubility, workability and tabletability, which contains an oil component containing a bioactive substance, a water-soluble polymer, a saccharide other than polysaccharides and a surfactant, at a particular ratio. The powder can be utilized for food, food with nutrient function claims, food for specified health uses, nutritional supplement, nutritional product, animal drug, drinks, feed, pharmaceutical product, quasi-drug, cosmetic and the like.) 

703: (7687607216835690609) patent: US20080254188A1 Title : FORMULATIONS OF LIPOPHILIC BIOACTIVE MOLECULES) Abstract : This invention provides aqueous and non-aqueous clear formulations including at least one lipophilic bioactive molecules and an amphiphilic solubilizing agent. Exemplary aqueous formulations include a water-soluble reducing agent, which diminishes or prevents chemical degradation of the lipophilic bioactive molecule. The invention also provides methods of using the formulations of the invention. For example, the invention provides beverages including the formulations of the invention. The invention further provides methods of making the formulations and beverages.) 

704: (8543622855144385211) patent: US20120315345A1 Title : FUNCTIONAL FOOD AND PHARMACEUTICAL COMPOSITIONS FOR ANTI-OBESITY COMPRISING CAPSANTHIN AND FATTY-ACYL ESTER OF CAPSANTHIN HAVING ANTI-ADIPOGENIC ACTIVITY) Abstract : One or more embodiments of the present invention describe a novel use of capsanthin and/or fatty-acyl ester of capsanthin to inhibit both the differentiation of pre-adipocytes to adipocytes and the accumulation of fat in the adipocytes. One or more embodiments of the present invention are based on findings that capsanthin contained in some natural products such as red pepper, paprika, bell pepper, etc. have anti-adipogenic activity by inhibiting both the differentiation of pre-adipocyte into adipocyte and the accumulation of fat in adipocytes, Therefore, this findings provide a functional food and a pharmaceutical composition wherein capsanthins and the extract of any natural products containing the same components are included in the functional food and the pharmaceutical composition, to offer obesity prevention and/or treatment effects.) 

705: (2161915426818540776) patent: US20160022556A1 Title : 1,5-ANHYDRO-D-GLUCITOL-CONTAINING COLLAGEN PRODUCTION ACCELERATOR) Abstract : A collagen production promoter in cells, containing at least one member selected from the group consisting of 1,5-anhydro-D-glucitol and derivatives thereof; and a composition containing the collagen production promoter. Since the collagen production promoter containing 1,5-AG or derivatives thereof of the present invention is suitably used as cosmetics, medicinal formulations, foods, and the like, for promoting collagen production in cells, for example, preventing and/or improving wrinkles of skin.) 

706: (1741398527580688067) patent: US20080274068A1 Title : External Preparation for Skin Containing a Phosphorlated Saccharide) Abstract : Provided is an external preparation for skin, comprising a phosphorylated saccharide. The phosphorylated saccharide may be an inorganic salt of a phosphorylated saccharide. The phosphorylated saccharide may be a calcium, magnesium, potassium, zinc, iron or sodium salt. Also provided is an external preparation for skin, comprising a phosphorylated saccharide and a second component, wherein the second component is selected from the group consisting of moisturizing agents, whitening components, ultraviolet absorbents, anti-inflammatory agents, cell-activating agents and antioxidants. The moisturizing agent may be ascorbic acid or an ascorbic acid derivative.) 

707: (337106638215800877) patent: US8017162B2 Title : PROCESS OF TREATING ALKALINE STORAGE BATTERIES.) 

708: (1200929778046654475) patent: WO2013012760A1 Title : COMPOSITIONS AND METHODS FOR MODULATING METABOLIC PATHWAYS) Abstract : Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt 1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.) 

709: (2062803113903898793) patent: WO1997046622A1 Title : USE OF NATURAL COLORANTS OR SYNTHETIC COLORANTS IDENTICAL TO NATURAL ONES FOR THE TEMPORARY MARKING OR COLOURING OF MATERIALS) Abstract : The use of natural colorants or synthetic colorants identical to natural ones selected from the group chlorophyll, flavonoids, retinoids, betalains, carotinides or plant extracts containing these colorants, their natural or synthetic derivatives or mixtures of the colorants, plant extracts containing them or their natural or synthetic derivatives, for the temporary marking or colouring of solid or liquid materials except for foodstuffs.) 

710: (8861678666863881656) patent: US7892580B2 Title : PROCESS FOR PRODUCING A STABLE CONCENTRATED DIETARY SUPPLEMENT AND SUPPLEMENT PRODUCED THEREBY) Abstract : A process for producing a stable concentrated dietary supplement containing fucoxanthin as the main active component. The method entails grinding crude freeze-dried flakes of wakame seaweed (Undaria pinnatifida) with desirable characteristics into a powder, extracting the active fucoxanthin from the powder with use of an aliphatic or aromatic organic solvent, then filtering and distilling the extract to form a thick syrupy fucoxanthin-containing mass having a solids content of from about 10-99% by wt.; The mass is then purified by dissolving it in an organic non-polar solvent having a Polarity Index of <6, wherein the resultant solution is filtered to remove any solid material therefrom and the remaining liquid is then concentrated to a dried mass by removing substantially all of the solvent, which mass is thereafter ground and sifted to obtain a plurality of particles measuring approximately 60-100 mesh in size. The particles contain at least about 10% by weight of fucoxanthin. The particles by themselves, or in admixture with other components well known in the relevant art, thus comprise a supplement which may be constituted in a form selected from, for example, tablets, capsules, powders and granules.) 

711: (7289961207469853095) patent: EP2829263A1 Title : OIL-IN-WATER EMULSION COMPOSITION) Abstract : An oil-in-water emulsion composition, including dispersed particles containing from 0.05% by mass to 2.5% by mass of lycopene; and at least one kind of compound selected from the group consisting of phenoxyethanol, an aliphatic diol compound having a carbon chain length of from 3 to 10 carbon atoms, an ether compound of glycerin and aliphatic alcohol, and a carbamic acid ester compound.) 

712: (8302924013315137814) patent: EP2574337A1 Title : CAROTENOID-CONTAINING COMPOSITION AND PRODUCTION METHOD THEREFOR) Abstract : A method of producing a carotenoid-containing composition including: obtaining a carotenoid-containing oil phase composition by heating an oil phase component mixed liquid containing a carotenoid component containing at least one crystalline carotenoid, and a (poly)glyceryl fatty acid ester having form 1 to 6 of a glycerin unit and from 1 to 6 of a fatty acid unit and in which the glycerin unit has at least one hydroxyl group, at a temperature of a melting point of the carotenoid component or higher; and obtaining an oil-in-water emulsified composition by emulsifying under pressure the carotenoid-containing oil phase composition with an aqueous-phase composition comprising an emulsifying agent.) 

713: (3300103687597136006) patent: US20160185899A1 Title : FUNCTIONALIZED POLYMER COMPOSITIONS) Abstract : The invention relates to functionalized polymers including homopolymers and copolymers and their uses in industrial applications and in agricultural applications. In particular, the homopolymers and copolymers may be, for example, used in polymer blends, used as nutritives and in feed compositions, and used in combination with a pharmaceutical or nutritive.) 

714: (6159507477767728120) patent: US20130162999A1 Title : Classification Using Multivariate Optical Computing) Abstract : Methods for in situ detection and classification of analyte within a fluid sample are provided. In one embodiment, the method can include: (a) continuously flowing the fluid sample through a multivariate optical computing device, wherein the multivariate optical computing device illuminates an area of the fluid sample as it flows through the multivariate optical computing device to elicit a continuous series of spectral responses; (b) continuously measuring the series of multivariate spectral responses as the fluid sample flows through the multivariate optical computing device; (c) detecting an analyte (e. g., phytoplankton) in the sample based on an multivariate spectral response of the plurality of spectral responses; and (d) classifying the analyte based on the multivariate spectral response generated by the analyte.) 

715: (5463417054538308208) patent: US20040175407A1 Title : Microorganism coating components, coatings, and coated surfaces) Abstract : Disclosed herein are novel paints and coatings comprising a cell-based particulate material. Specifically disclosed herein is cell-based particulate material prepared from microorganisms for use as a coating component. Also disclosed herein are methods of preparing a coating that comprises a cell-based particulate material.) 

716: (6762255248694224605) patent: US20040077068A1 Title : Carotenoid production from a single carbon substrate) Abstract : A method for the production of carotenoid compounds is disclosed. The method relies on the use of microorganisms which metabolize single carbon substrates for the production of carotenoid compounds in high yields.) 

717: (3551153733526630109) patent: US20150250203A1 Title : ENCLOSING MATERIALS IN NATURAL TRANSPORT SYSTEMS) Abstract : An edible composition, particularly an edible transport system, comprising an edible substance and a cross-linked matrix encapsulating the edible substance, the cross-linked matrix comprising (1) at least one edible polymer and edible particles or (2) a plurality of edible polymers.) 

718: (5647938671956996316) patent: WO2009062518A1 Title : ANTI-FOULING COMPOSITION COMPRISING AN AEROGEL) Abstract : The present invention also relates to an anti-fouling composition comprising one or more aerogels. In one embodiment the aerogel encapsulate one or more bioactive agents. The one or more encapsulated bioactive agents can in one preferred embodiment be released from the aerogel over time. In one embodiment the encapsulated bioactive agents comprises one or more enzymes. In one preferred embodiment the anti-fouling composition comprising one or more aerogels is a coating composition.) 

719: (3124698409813699893) patent: WO2002030419A1 Title : COMPOSITIONS CONTAINING CAROTENOIDS AND TOCOTRIENOLS AND HAVING SYNERGISTIC ANTIOXIDANT EFFECT) Abstract : A novel formulation is provided that serves to synergistically inhibit the generation of free radicals and oxidative stress in warm blooded animals. The formulation comprises an effective amount of a first component of a carotenoid species, and, as a second component, a tocotrienol species and derivatives thereof, and provides for synergistic anti-oxidant activity.) 

720: (3383337993767311705) patent: JP2007314451A Title : ANTIDIABETIC) Abstract : PROBLEM TO BE SOLVED: To provide an antidiabetic functioning to inhibit the formation of a conjugate of a retinol binding protein and transthyretin by binding a substance with larger side chain than retinol to the retinol binding protein for easily secreting the retinol binding protein from the kidney and lower the blood retinol binding protein in an insulin-nondependent diabetic to its normal levels. ;SOLUTION: The antidiabetic comprises a carotenoid fraction derived from brown algae and inhibiting the formation of a conjugate of a retinol binding protein and transthyretin. The carotenoid fraction consists preferably of fucoxanthin and/or an analog thereof. The brown algae as raw material to be used include naturally occurring or cultivated Nemacystus decipiens such as especially Cladoshiphonokamuranus Tokida, Cladoshiphonnovae-caledoniae Kylin or Cladoshiphoncaledoniae Kylin. ;COPYRIGHT: (C)2008,JPO&INPIT) 

721: (3323002394610363639) patent: US20080089851A1 Title : Brown Algae Cell Lyophilisate, Method For The Obtention Thereof) Abstract : This invention is related to a freeze-dried product of cells of brown algae, the process for obtaining thereof, a cosmetic composition containing thereof, a food complement containing thereof, and the use thereof.) 

722: (6514232886818878209) patent: US8902423B2 Title : Classification Using Multivariate Optical Computing) Abstract : Methods for in situ detection and classification of analyte within a fluid sample are provided. In one embodiment, the method can include: (a) continuously flowing the fluid sample through a multivariate optical computing device, wherein the multivariate optical computing device illuminates an area of the fluid sample as it flows through the multivariate optical computing device to elicit a continuous series of spectral responses; (b) continuously measuring the series of multivariate spectral responses as the fluid sample flows through the multivariate optical computing device; (c) detecting an analyte (e. g., phytoplankton) in the sample based on an multivariate spectral response of the plurality of spectral responses; and (d) classifying the analyte based on the multivariate spectral response generated by the analyte.) 

723: (3843226262173255146) patent: US4539230A Title : Method for preventing deposition of polymer scale and a coating agent therefor) Abstract : The invention provides a method for preventing deposition of polymer scale on the reactor walls in the polymerization of an ethylenically unsaturated monomer, in particular, by emulsion polymerization. The method comprises coating the reactor walls with a coating composition containing, as the essential components, (A) an organic compound having at least 5 conjugated pi bonds in a molecule, (B) a chelating agent and (C) a metal compound capable of producing metal ions having a coordination number of at least 2 which presumably forms a metallic chelate compound with the chelating agent contributing to the formation of a strongly adsorbed layer on the reactor walls. The coating composition may be further admixed with a silicic acid compound such as a colloidal silica.) 

724: (6023095086731815152) patent: US20160030455A1 Title : Circuit closer for hold-up alarms) 

725: (8443544540008192185) patent: US20130196937A1 Title : AGE PRODUCTION INHIBITOR) Abstract : Disclosed is an AGE production inhibitor or the like, which effectively inhibits the production of an advanced glycation end product (AGE), while having improved biological safety. Specifically disclosed is an AGE production inhibitor or the like, which contains en extract of cherry tree (preferably blossoms or leaves thereof) and/or a processed product of the extract as an active substance. The AGE production inhibitor or the like contains, as an active substance, at least one compound that is selected from among 1-O-(E)-Caffeoyl-beta-D-glucopyranoside, 1-O-(E)-Coumaroyl-beta-D-glucopyranoside, 1-O-(E)-Cinnamoyl-beta-D-glucopyranoside, Kaempferol 3-O-beta-D-glucopyranoside, Quercetin 3-O-beta-D-glucopyranoside, Kaempferol 3-O-(6''-malony)-beta-D-glucopyranoside, and Quercetin 3-O-(6''-malony)-beta-D-glucopyranoside.) 

726: (5657824276813446800) patent: EP2728012A1 Title : METHOD FOR PRODUCING CAROTENOID COMPOSITION) Abstract : The present invention provides an efficient method for industrially producing a naturally-derived carotenoid composition with a large amount of a carotenoid such as astaxanthin from a culture of a yeast of the genus Xanthophyllomyces without requiring any special extraction equipment and any complicated refinement process and without any need for organic solvents harmful to humans. Provided is a method for producing a carotenoid composition, including the steps of washing a carotenoid-containing yeast of the genus Xanthophyllomyces with an organic solvent (A) at 30C or lower, and extracting a carotenoid from the washed yeast with an organic solvent (B) at 10C to 70C.) 

727: (3054710490412968003) patent: US20110111038A1 Title : PROCESS FOR PRODUCING A STABLE CONCENTRATED DIETARY SUPPLEMENT AND SUPPLEMENT PRODUCED THEREBY) Abstract : A stable concentrated dietary supplement containing fucoxanthin as the main active component. The dietary supplement is made by a process including grinding crude freeze-dried flakes of wakame seaweed (Undaria pinnatifida) with desirable characteristics into a powder, extracting the active fucoxanthin from the powder with use of an aliphatic or aromatic organic solvent, then filtering and distilling the extract to form a thick syrupy fucoxanthin-containing mass having a solids content of from about 10-99% by wt.; The mass is then purified by dissolving it in an organic non-polar solvent having a Polarity Index of <6, wherein the resultant solution is filtered to remove any solid material therefrom and the remaining liquid is then concentrated to a dried mass by removing substantially all of the solvent, which mass is thereafter ground and sifted to obtain a plurality of particles measuring approximately 60-100 mesh in size. The supplement contains at least about 10% by weight of fucoxanthin, less than about 1 ppm iodine and less than about 1 ppm arsenic, and the fucoxanthin contained in the supplement remains substantially stable for at least about 2 years. The particles by themselves, or in admixture with other components well known in the relevant art, comprise a supplement that may be constituted in a form selected from, for example, tablets, capsules, powders and granules.) 
